
<html lang="en"     class="pb-page"  data-request-id="e847a5c3-34d8-4be2-b0fc-dc9dfe7ad274"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2021.64.issue-10;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.0c02062;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Novel Mixed NOP/Opioid Receptor Peptide Agonists" /></meta><meta name="dc.Creator" content="Salvatore  Pacifico" /></meta><meta name="dc.Creator" content="Valentina  Albanese" /></meta><meta name="dc.Creator" content="Davide  Illuminati" /></meta><meta name="dc.Creator" content="Erika  Marzola" /></meta><meta name="dc.Creator" content="Martina  Fabbri" /></meta><meta name="dc.Creator" content="Federica  Ferrari" /></meta><meta name="dc.Creator" content="Victor A.D.  Holanda" /></meta><meta name="dc.Creator" content="Chiara  Sturaro" /></meta><meta name="dc.Creator" content="Davide  Malfacini" /></meta><meta name="dc.Creator" content="Chiara  Ruzza" /></meta><meta name="dc.Creator" content="Claudio  Trapella" /></meta><meta name="dc.Creator" content="Delia  Preti" /></meta><meta name="dc.Creator" content="Ettore  Lo Cascio" /></meta><meta name="dc.Creator" content="Alessandro  Arcovito" /></meta><meta name="dc.Creator" content="Stefano  Della Longa" /></meta><meta name="dc.Creator" content="Martina  Marangoni" /></meta><meta name="dc.Creator" content="Davide  Fattori" /></meta><meta name="dc.Creator" content="Romina  Nassini" /></meta><meta name="dc.Creator" content="Girolamo  Calò" /></meta><meta name="dc.Creator" content="Remo  Guerrini" /></meta><meta name="dc.Description" content="The nociceptin/orphanin FQ (N/OFQ)/N/OFQ receptor (NOP) system controls different biological functions including pain and cough reflex. Mixed NOP/opioid receptor agonists elicit similar effects to ..." /></meta><meta name="Description" content="The nociceptin/orphanin FQ (N/OFQ)/N/OFQ receptor (NOP) system controls different biological functions including pain and cough reflex. Mixed NOP/opioid receptor agonists elicit similar effects to ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 17, 2021" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c02062" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2021 The Authors. Published by American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c02062" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c02062" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c02062" /></link>
        
    
    

<title>Novel Mixed NOP/Opioid Receptor Peptide Agonists | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c02062" /></meta><meta property="og:title" content="Novel Mixed NOP/Opioid Receptor Peptide Agonists" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c02062/20210520/images/large/jm0c02062_0007.jpeg" /></meta><meta property="og:description" content="The nociceptin/orphanin FQ (N/OFQ)/N/OFQ receptor (NOP) system controls different biological functions including pain and cough reflex. Mixed NOP/opioid receptor agonists elicit similar effects to strong opioids but with reduced side effects. In this work, 31 peptides with the general sequence [Tyr/Dmt1,Xaa5]N/OFQ(1-13)-NH2 were synthesized and pharmacologically characterized for their action at human recombinant NOP/opioid receptors. The best results in terms of NOP versus mu opioid receptor potency were obtained by substituting both Tyr1 and Thr5 at the N-terminal portion of N/OFQ(1-13)-NH2 with the noncanonical amino acid Dmt. [Dmt1,5]N/OFQ(1-13)-NH2 has been identified as the most potent dual NOP/mu receptor peptide agonist so far described. Experimental data have been complemented by in silico studies to shed light on the molecular mechanisms by which the peptide binds the active form of the mu receptor. Finally, the compound exerted antitussive effects in an in vivo model of cough." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c02062"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c02062">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c02062&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c02062&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c02062&amp;href=/doi/10.1021/acs.jmedchem.0c02062" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 10</span><span class="cit-fg-pageRange">, 6656-6669</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/10" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c02001" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c02067" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Novel Mixed NOP/Opioid Receptor Peptide Agonists</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Salvatore Pacifico</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Salvatore Pacifico</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Via Luigi Borsari 46, Ferrara 44121, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Salvatore++Pacifico">Salvatore Pacifico</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-3377-5107" title="Orcid link">https://orcid.org/0000-0002-3377-5107</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Valentina Albanese</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Valentina Albanese</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Via Luigi Borsari 46, Ferrara 44121, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Valentina++Albanese">Valentina Albanese</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Davide Illuminati</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Davide Illuminati</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Via Luigi Borsari 46, Ferrara 44121, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Davide++Illuminati">Davide Illuminati</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Erika Marzola</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Erika Marzola</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Via Luigi Borsari 46, Ferrara 44121, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Erika++Marzola">Erika Marzola</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Martina Fabbri</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Martina Fabbri</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Via Luigi Borsari 46, Ferrara 44121, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Martina++Fabbri">Martina Fabbri</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Federica Ferrari</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Federica Ferrari</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Neuroscience and Rehabilitation, Section of Pharmacology, University of Ferrara, Via Fossato di Mortara 17/19, Ferrara 44121, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Federica++Ferrari">Federica Ferrari</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Victor A.D. Holanda</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Victor A.D. Holanda</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Neuroscience and Rehabilitation, Section of Pharmacology, University of Ferrara, Via Fossato di Mortara 17/19, Ferrara 44121, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Victor+A.D.++Holanda">Victor A.D. Holanda</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Chiara Sturaro</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Chiara Sturaro</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Neuroscience and Rehabilitation, Section of Pharmacology, University of Ferrara, Via Fossato di Mortara 17/19, Ferrara 44121, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Chiara++Sturaro">Chiara Sturaro</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Davide Malfacini</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Davide Malfacini</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Largo Meneghetti 2, Padova 35131, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Davide++Malfacini">Davide Malfacini</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Chiara Ruzza</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Chiara Ruzza</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Neuroscience and Rehabilitation, Section of Pharmacology, University of Ferrara, Via Fossato di Mortara 17/19, Ferrara 44121, Italy</div><div class="loa-info-affiliations-info">Technopole of Ferrara, LTTA Laboratory for Advanced Therapies, via Fossato di Mortara 70, Ferrara 44121, Italy</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#5f3c37363e2d3e712d2a25253e1f2a3136393a71362b"><span class="__cf_email__" data-cfemail="c9aaa1a0a8bba8e7bbbcb3b3a889bca7a0aface7a0bd">[email protected]</span></a>. Phone: +39-0532-455220.</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Chiara++Ruzza">Chiara Ruzza</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Claudio Trapella</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Claudio Trapella</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Via Luigi Borsari 46, Ferrara 44121, Italy</div><div class="loa-info-affiliations-info">Technopole of Ferrara, LTTA Laboratory for Advanced Therapies, via Fossato di Mortara 70, Ferrara 44121, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Claudio++Trapella">Claudio Trapella</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Delia Preti</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Delia Preti</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Via Luigi Borsari 46, Ferrara 44121, Italy</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#dfbbbab3b6bef1afadbaabb69faab1b6b9baf1b6ab"><span class="__cf_email__" data-cfemail="9ffbfaf3f6feb1efedfaebf6dfeaf1f6f9fab1f6eb">[email protected]</span></a>. Phone: +39-0532-455501.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Delia++Preti">Delia Preti</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-1075-3781" title="Orcid link">https://orcid.org/0000-0002-1075-3781</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ettore Lo Cascio</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ettore Lo Cascio</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dipartimento di Scienze Biotecnologiche di Base, Cliniche Intensivologiche e Perioperatorie, Università Cattolica del Sacro Cuore, Largo F. Vito 1, Roma 00168, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ettore++Lo+Cascio">Ettore Lo Cascio</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Alessandro Arcovito</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alessandro Arcovito</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Dipartimento di Scienze Biotecnologiche di Base, Cliniche Intensivologiche e Perioperatorie, Università Cattolica del Sacro Cuore, Largo F. Vito 1, Roma 00168, Italy</div><div class="loa-info-affiliations-info">Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo F. Vito 1, Roma 00168, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alessandro++Arcovito">Alessandro Arcovito</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Stefano Della Longa</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stefano Della Longa</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Life, Health and Environmental Sciences, University of L’Aquila, Pza S. Tommasi 1, L’Aquila 67100, Italy</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#bbc8cfdedddad5d495dfded7d7dad7d4d5dcdafbced5d2cddaca95d2cf"><span class="__cf_email__" data-cfemail="6112150407000f0e4f05040d0d000d0e0f060021140f081700104f0815">[email protected]</span></a>. Phone: +39-0862-433568.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stefano++Della+Longa">Stefano Della Longa</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-8157-9530" title="Orcid link">https://orcid.org/0000-0002-8157-9530</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Martina Marangoni</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Martina Marangoni</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Viale Pieraccini, 6, Florence 50139, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Martina++Marangoni">Martina Marangoni</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Davide Fattori</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Davide Fattori</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Viale Pieraccini, 6, Florence 50139, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Davide++Fattori">Davide Fattori</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Romina Nassini</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Romina Nassini</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Viale Pieraccini, 6, Florence 50139, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Romina++Nassini">Romina Nassini</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Girolamo Calò</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Girolamo Calò</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Largo Meneghetti 2, Padova 35131, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Girolamo++Cal%C3%B2">Girolamo Calò</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Remo Guerrini</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Remo Guerrini</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Via Luigi Borsari 46, Ferrara 44121, Italy</div><div class="loa-info-affiliations-info">Technopole of Ferrara, LTTA Laboratory for Advanced Therapies, via Fossato di Mortara 70, Ferrara 44121, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Remo++Guerrini">Remo Guerrini</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c02062&amp;href=/doi/10.1021%2Facs.jmedchem.0c02062" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 10</span><span class="cit-pageRange">, 6656–6669</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 17, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>27 November 2020</li><li><span class="item_label"><b>Published</b> online</span>17 May 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 May 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c02062" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02062</a></div><div class="article_header-article-copyright"><strong>Copyright © 2021 The Authors. Published by American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="https://acsopenscience.org/open-access/licensing-options/"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a><span class="article_header-cc-by"><a href="https://creativecommons.org/licenses/by/4.0/"><img src="/pb-assets/images/licensesLogos/OA_Icons_cc-1612971093887.svg" alt="CC: Creative Commons" /></img><span><strong>CC: </strong>Creative Commons</span></a><a href="https://creativecommons.org/licenses/by/4.0/"><img src="/pb-assets/images/licensesLogos/OA_Icons_by-1612971093257.svg" alt="BY: Credit must be given to the creator" /></img><span><strong>BY: </strong>Credit must be given to the creator</span></a></span></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c02062"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1222</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val">-</div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c02062" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Novel Mixed NOP/Opioid Receptor Peptide Agonists&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Salvatore&quot;,&quot;last_name&quot;:&quot;Pacifico&quot;},{&quot;first_name&quot;:&quot;Valentina&quot;,&quot;last_name&quot;:&quot;Albanese&quot;},{&quot;first_name&quot;:&quot;Davide&quot;,&quot;last_name&quot;:&quot;Illuminati&quot;},{&quot;first_name&quot;:&quot;Erika&quot;,&quot;last_name&quot;:&quot;Marzola&quot;},{&quot;first_name&quot;:&quot;Martina&quot;,&quot;last_name&quot;:&quot;Fabbri&quot;},{&quot;first_name&quot;:&quot;Federica&quot;,&quot;last_name&quot;:&quot;Ferrari&quot;},{&quot;first_name&quot;:&quot;Victor&quot;,&quot;last_name&quot;:&quot;A.D. Holanda&quot;},{&quot;first_name&quot;:&quot;Chiara&quot;,&quot;last_name&quot;:&quot;Sturaro&quot;},{&quot;first_name&quot;:&quot;Davide&quot;,&quot;last_name&quot;:&quot;Malfacini&quot;},{&quot;first_name&quot;:&quot;Chiara&quot;,&quot;last_name&quot;:&quot;Ruzza&quot;},{&quot;first_name&quot;:&quot;Claudio&quot;,&quot;last_name&quot;:&quot;Trapella&quot;},{&quot;first_name&quot;:&quot;Delia&quot;,&quot;last_name&quot;:&quot;Preti&quot;},{&quot;first_name&quot;:&quot;Ettore&quot;,&quot;last_name&quot;:&quot;Lo Cascio&quot;},{&quot;first_name&quot;:&quot;Alessandro&quot;,&quot;last_name&quot;:&quot;Arcovito&quot;},{&quot;first_name&quot;:&quot;Stefano&quot;,&quot;last_name&quot;:&quot;Della Longa&quot;},{&quot;first_name&quot;:&quot;Martina&quot;,&quot;last_name&quot;:&quot;Marangoni&quot;},{&quot;first_name&quot;:&quot;Davide&quot;,&quot;last_name&quot;:&quot;Fattori&quot;},{&quot;first_name&quot;:&quot;Romina&quot;,&quot;last_name&quot;:&quot;Nassini&quot;},{&quot;first_name&quot;:&quot;Girolamo&quot;,&quot;last_name&quot;:&quot;Calò&quot;},{&quot;first_name&quot;:&quot;Remo&quot;,&quot;last_name&quot;:&quot;Guerrini&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;17&quot;,&quot;issue&quot;:&quot;10&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;6656-6669&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c02062&quot;},&quot;abstract&quot;:&quot;The nociceptin/orphanin FQ (N/OFQ)/N/OFQ receptor (NOP) system controls different biological functions including pain and cough reflex. Mixed NOP/opioid receptor agonists elicit similar effects to strong opioids but with reduced side effects. In this work, 31 peptides with the general sequence [Tyr/Dmt1,Xaa5]N/OFQ(1-13)-NH2 were synthesized and pharmacologically characterized for their action at human recombinant NOP/opioid receptors. The best results in terms of NOP versus mu opioid receptor potency were obtained by substituting both Tyr1 and Thr5 at the N-terminal portion of N/OFQ(1-13)-NH2 with the noncanonical amino acid Dmt. [Dmt1,5]N/OFQ(1-13)-NH2 has been identified as the most potent dual NOP/mu receptor peptide agonist so far described. Experimental data have been complemented by in silico studies to shed light on the molecular mechanisms by which the peptide binds the active form of the mu receptor. Finally, the compound exerted antitussive effects in an in vivo model of cough.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c02062&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c02062" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c02062&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c02062" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c02062&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c02062" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c02062&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c02062&amp;href=/doi/10.1021/acs.jmedchem.0c02062" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c02062" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c02062" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c02062%26sid%3Dliteratum%253Aachs%26pmid%3D33998786%26genre%3Darticle%26aulast%3DPacifico%26date%3D2021%26atitle%3DNovel%2BMixed%2BNOP%252FOpioid%2BReceptor%2BPeptide%2BAgonists%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D10%26spage%3D6656%26epage%3D6669%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (4)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=290831" title="Monomers">Monomers</a>,</li><li><a href="/action/doSearch?ConceptID=292529" title="Aromatic compounds">Aromatic compounds</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/10" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/jmcmar.2021.64.issue-10/20210527/jmcmar.2021.64.issue-10.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c02062/20210520/images/medium/jm0c02062_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c02062/20210520/images/large/jm0c02062_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02062&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The nociceptin/orphanin FQ (N/OFQ)/N/OFQ receptor (NOP) system controls different biological functions including pain and cough reflex. Mixed NOP/opioid receptor agonists elicit similar effects to strong opioids but with reduced side effects. In this work, 31 peptides with the general sequence [Tyr/Dmt<sup>1</sup>,Xaa<sup>5</sup>]N/OFQ(1-13)-NH<sub>2</sub> were synthesized and pharmacologically characterized for their action at human recombinant NOP/opioid receptors. The best results in terms of NOP versus mu opioid receptor potency were obtained by substituting both Tyr<sup>1</sup> and Thr<sup>5</sup> at the N-terminal portion of N/OFQ(1-13)-NH<sub>2</sub> with the noncanonical amino acid Dmt. [Dmt<sup>1,5</sup>]N/OFQ(1-13)-NH<sub>2</sub> has been identified as the most potent dual NOP/mu receptor peptide agonist so far described. Experimental data have been complemented by <i>in silico</i> studies to shed light on the molecular mechanisms by which the peptide binds the active form of the mu receptor. Finally, the compound exerted antitussive effects in an <i>in vivo</i> model of cough.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06663" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06663" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Nociceptin/orphanin FQ (N/OFQ; FGGFTGARKSARKLANQ) is the endogenous ligand of the N/OFQ peptide (NOP) receptor.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> N/OFQ and the NOP receptor display high structural homology with peptides and receptors of the opioid family but distinct pharmacology.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The N/OFQ-NOP receptor system controls several biological functions at both central and peripheral levels including pain transmission, mood and anxiety, food intake, learning and memory, locomotion, cough and micturition reflexes, cardiovascular homeostasis, intestinal motility, and immune responses.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a></div><div class="NLM_p">The effects of N/OFQ and selective NOP agonists in analgesiometric assays are complex depending on the dose, administration route, type of pain, and animal species.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5,6)</a> On the contrary, strong and consistent experimental evidence suggests that the simultaneous activation of NOP and opioid receptors elicits synergistic analgesic effects.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6,7)</a> On these bases, mixed NOP/opioid receptor agonists (cebranopadol,<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8,9)</a> AT-121,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> BU10038,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> and BPR1M97<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a>) have been developed and investigated for their antinociceptive properties. It was consistently demonstrated that these drugs elicit similar analgesic effects to strong opioids but with substantially reduced side effects including respiratory depression, tolerance, and abuse liability (see the recent review by Kiguchi <i>et al.</i><a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a>).</div><div class="NLM_p">Other ligands targeting multiple opioid receptors have been studied.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> For example, dual-acting mu agonist/delta antagonist peptidomimetics demonstrated to produce antinociception <i>in vivo</i> with reduced tolerance liability compared with morphine.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15,16)</a> Moreover, mixed kappa agonist/mu partial agonist ligands have been investigated as potential treatment agents for cocaine and other psychostimulant abuses.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Finally, mixed kappa agonist/delta antagonist ligands have been developed as tools for the characterization of delta and kappa-opioid receptor phenotypes.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><div class="NLM_p">With the aim of generating a peptide acting as a nonselective NOP/opioid agonist, we investigated different approaches. On one hand, the peptide [Dmt<sup>1</sup>]N/OFQ(1-13)-NH<sub>2</sub> has been identified as a nonselective agonist for NOP and opioid receptors<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> and its tetrabranched derivative, generated using the peptide welding technology (PWT),<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> was demonstrated to produce a robust analgesic effect after spinal administration in nonhuman primates. However, this action was sensitive to NOP but not opioid receptor antagonists.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> On the other hand, N/OFQ and dermorphin-related peptides were linked together to generate the hetero-tetrabranched derivative H-PWT1-N/OFQ-[Dmt<sup>1</sup>]dermorphin<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> or the dimeric compound DeNo.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Despite its promising <i>in vitro</i> pharmacological profile as a mixed NOP/opioid agonist, DeNo was not effective as a spinal analgesic.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> In the present study, we further investigate the possibility of generating a mixed NOP/opioid agonist based on the following evidence: (i) mixed NOP/kappa ligands can be obtained combining the C-terminal sequence of N/OFQ with the N-terminal of dynorphin A, where amino acids in positions 5 and 6 were particularly important for receptor selectivity;<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> (ii) Thr<sup>5</sup> in N/OFQ(1-13)-NH<sub>2</sub> can be replaced with several different residues without loss of peptide efficacy and potency at the NOP receptor;<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> (iii) the substitution of Phe<sup>1</sup> in N/OFQ with Tyr<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> and particularly with Dmt<a onclick="showRef(event, 'ref19 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref19 ref27 ref28">(19,27,28)</a> increases affinity/potency at classical opioid receptors. Thus, in the present study, 31 peptide derivatives with the general sequence [Tyr/Dmt<sup>1</sup>,Xaa<sup>5</sup>]N/OFQ(1-13)-NH<sub>2</sub> were generated and tested for their action at NOP and opioid receptors (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c02062/20210520/images/medium/jm0c02062_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c02062/20210520/images/large/jm0c02062_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. SAR investigation leading to a series of [Tyr/Dmt<sup>1</sup>,Xaa<sup>5</sup>]N/OFQ(1-13)-NH<sub>2</sub> peptide derivatives as possible mixed NOP/opioid receptor ligands.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c02062/20210520/images/large/jm0c02062_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02062&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Experimental data have been complemented by an <i>in silico</i> study of the binding of [Dmt<sup>1,5</sup>]N/OFQ(1-9)-NH<sub>2</sub> to the mu receptor. This non-natural peptide has been compared with the agonist peptide DAMGO ([<span class="smallcaps smallerCapital">D</span>-Ala<sup>2</sup>, <i>N</i>-MePhe<sup>4</sup>, Gly-ol]-enkephalin) and the N-terminal fragment of N/OFQ (N/OFQ(1-9)-NH<sub>2</sub>). The starting point of the computational study was the structure of the activated mu receptor in complex with the agonist peptide DAMGO that has been previously reported by X-ray diffraction and cryo-electron microscopy.<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29,30)</a> The last structure of the complex DAMGO-mu receptor was used as a model, allowing the setup of the two unknown complexes with the selected peptides by molecular docking. Specifically, docking of a flexible ligand to multiple receptor conformations as already applied to the study of NOP agonists and antagonists<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31,32)</a> was carried out to provide the best binding pose of the two peptides [Dmt<sup>1,5</sup>]N/OFQ(1-9)-NH<sub>2</sub> and N/OFQ(1-9)-NH<sub>2</sub>. This docking procedure was further challenged by long-lasting molecular dynamics (MD) simulations and compared with an MD simulation of the DAMGO-mu receptor-G<sub>i</sub> protein complex to identify the key interactions necessary for a successful nonselective NOP/opioid agonist. Finally, considering that NOP receptor agonists have demonstrated antitussive effects <i>in vivo</i><a onclick="showRef(event, 'ref33 ref34 ref35 ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref33 ref34 ref35 ref36 ref37">(33−37)</a> and that opioids are effective drugs currently in use to treat cough,<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> the most potent mixed NOP/opioid agonist has been evaluated <i>in vivo</i> for its antitussive effects in guinea pigs.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15832" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15832" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div class="NLM_p">The peptide derivatives reported in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>–<named-content content-type="anchor" rid="tbl2" type="simple"></named-content><named-content content-type="anchor" rid="tbl3" type="simple"></named-content><a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> were prepared through automated Fmoc/<i>t</i>Bu-based solid-phase peptide synthesis (SPPS) on a Rink amide MBHA resin. Commercially available protected amino acids were employed as synthetic precursors of the target peptides except for Fmoc-2′,6′-dimethyl-tyrosine (Fmoc-Dmt-OH) that was instead synthesized in analogy to an approach previously published by Wang <i>et al.</i><a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> (Scheme S1 of the <a href="/doi/suppl/10.1021/acs.jmedchem.0c02062/suppl_file/jm0c02062_si_001.pdf" class="ext-link">Supporting Informatio</a>n). Specifically, H-Tyr-OH was first esterified to H-Tyr-OMe under standard conditions, and then, the phenolic hydroxyl was protected with a <i>tert</i>-butyldimethylsilyl ether moiety before the following coupling with picolinic acid. The latter function worked as a directing group for the subsequent Pd(OAc)<sub>2</sub>-catalyzed C–H alkylation with CH<sub>3</sub>I and K<sub>2</sub>CO<sub>3</sub> allowing the simultaneous and regioselective introduction of two methyl groups at the ortho-positions of the aromatic ring. Then, full deprotection under strongly acidic conditions, followed by treatment with Fmoc-Cl, led to the desired 2′,6′-dimethyl tyrosine scaffold (detailed procedures and analytical characterizations of Fmoc-Dmt-OH and its precursors have been reported in the <a href="/doi/suppl/10.1021/acs.jmedchem.0c02062/suppl_file/jm0c02062_si_001.pdf" class="ext-link">Supporting Information</a>). The structures of other nonproteinogenic amino acids employed in this work have been depicted in <a href="/doi/suppl/10.1021/acs.jmedchem.0c02062/suppl_file/jm0c02062_si_001.pdf" class="ext-link">Table S1</a>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Effects of Standard Agonists and a First Series of [Tyr<sup>1</sup>,Xaa<sup>5</sup>]N/OFQ(1-13)-NH<sub>2</sub> Derivatives at NOP and mu Opioid Receptors in Calcium Mobilization Studies</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">NOP</th><th class="rowsep1 colsep0" colspan="2" align="center">mu</th><th class="rowsep1 colsep0" align="center">NOP/mu</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">pEC<sub>50</sub> (CL<sub>95%</sub>)</th><th class="colsep0 rowsep0" align="center"><i>E</i><sub>max</sub> ± S.E.M.</th><th class="colsep0 rowsep0" align="center">pEC<sub>50</sub> (CL<sub>95%</sub>)</th><th class="colsep0 rowsep0" align="center"><i>E</i><sub>max</sub> ± S.E.M</th><th class="colsep0 rowsep0" align="center">CR</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">N/OFQ(1-13)NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">9.29 (9.12–9.46)</td><td class="colsep0 rowsep0" align="left">368 ± 11</td><td class="colsep0 rowsep0" colspan="2" align="left">inactive</td><td class="colsep0 rowsep0" align="left"><0.001</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">dermorphin</td><td class="colsep0 rowsep0" colspan="2" align="left">inactive</td><td class="colsep0 rowsep0" align="left">7.71 (7.35–8.07)</td><td class="colsep0 rowsep0" align="left">380 ± 15</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">[Tyr<sup>1</sup>]N/OFQ(1-13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">9.23 (9.07–9.39)</td><td class="colsep0 rowsep0" align="left">380 ± 11</td><td class="colsep0 rowsep0" colspan="2" align="left">crc incomplete; 10 μM: 197 ± 69</td><td class="colsep0 rowsep0" align="left">0.001</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">[Tyr<sup>1</sup>,Asn<sup>5</sup>]N/OFQ(1-13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">8.70 (8.26–9.11)</td><td class="colsep0 rowsep0" align="left">327 ± 15</td><td class="colsep0 rowsep0" colspan="2" align="left">crc incomplete; 10 μM: 209 ± 29</td><td class="colsep0 rowsep0" align="left">0.002</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">[Tyr<sup>1</sup>,Val<sup>5</sup>]N/OFQ(1-13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">8.70 (8.53–8.87)</td><td class="colsep0 rowsep0" align="left">334 ± 19</td><td class="colsep0 rowsep0" colspan="2" align="left">crc incomplete; 10 μM: 254 ± 19</td><td class="colsep0 rowsep0" align="left">0.002</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">[Tyr<sup>1</sup>,Lys(Ac)<sup>5</sup>]N/OFQ(1-13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">8.55 (7.88–9.22)</td><td class="colsep0 rowsep0" align="left">370 ± 16</td><td class="colsep0 rowsep0" colspan="2" align="left">crc incomplete; 10 μM: 161 ± 31</td><td class="colsep0 rowsep0" align="left">0.003</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">[Tyr<sup>1</sup>,Abu<sup>5</sup>]N/OFQ(1-13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">8.15 (7.61–8.69)</td><td class="colsep0 rowsep0" align="left">366 ± 20</td><td class="colsep0 rowsep0" colspan="2" align="left">crc incomplete; 10 μM: 213 ± 37</td><td class="colsep0 rowsep0" align="left">0.007</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">[Tyr<sup>1</sup>,Lys<sup>5</sup>]N/OFQ(1-13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">7.26 (6.74–7.78)</td><td class="colsep0 rowsep0" align="left">366 ± 6</td><td class="colsep0 rowsep0" colspan="2" align="left">crc incomplete; 10 μM: 113 ± 35</td><td class="colsep0 rowsep0" align="left">0.05</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">[Tyr<sup>1</sup>,Dap<sup>5</sup>]N/OFQ(1-13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">7.20 (6.95–7.45)</td><td class="colsep0 rowsep0" align="left">367 ± 9</td><td class="colsep0 rowsep0" colspan="2" align="left">crc incomplete; 10 μM: 144 ± 44</td><td class="colsep0 rowsep0" align="left">0.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">[Tyr<sup>1</sup>,Dab<sup>5</sup>]N/OFQ(1-13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">6.43 (6.28–6.58)</td><td class="colsep0 rowsep0" align="left">340 ± 22</td><td class="colsep0 rowsep0" colspan="2" align="left">crc incomplete; 10 μM: 41 ± 4</td><td class="colsep0 rowsep0" align="left">0.37</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">[Tyr<sup>1</sup>,Leu<sup>5</sup>]N/OFQ(1-13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">8.03 (7.46–8.60)</td><td class="colsep0 rowsep0" align="left">339 ± 24</td><td class="colsep0 rowsep0" align="left">6.08 (5.95–6.21)</td><td class="colsep0 rowsep0" align="left">339 ± 25</td><td class="colsep0 rowsep0" align="left">0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">[Tyr<sup>1</sup>,Nle<sup>5</sup>]N/OFQ(1-13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">8.77 (8.45–9.09)</td><td class="colsep0 rowsep0" align="left">375 ± 9</td><td class="colsep0 rowsep0" align="left">6.74 (6.15–7.33)</td><td class="colsep0 rowsep0" align="left">323 ± 4</td><td class="colsep0 rowsep0" align="left">0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">[Tyr<sup>1</sup>,Nva<sup>5</sup>]N/OFQ(1-13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">8.43 (7.55–9.31)</td><td class="colsep0 rowsep0" align="left">358 ± 14</td><td class="colsep0 rowsep0" align="left">6.25 (5.59–6.91)</td><td class="colsep0 rowsep0" align="left">313 ± 19</td><td class="colsep0 rowsep0" align="left">0.007</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">[Tyr<sup>1,5</sup>]N/OFQ(1-13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">7.07 (6.68–7.46)</td><td class="colsep0 rowsep0" align="left">332 ± 19</td><td class="colsep0 rowsep0" align="left">6.76 (6.34–7.18)</td><td class="colsep0 rowsep0" align="left">357 ± 21</td><td class="colsep0 rowsep0" align="left">0.49</td></tr></tbody></table></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Effects of Standard Agonists and [Tyr<sup>1</sup>,Xaa<sup>5</sup>]N/OFQ(1-13)-NH<sub>2</sub> Derivatives with Different Aromatic Residues as Xaa<sup>5</sup> at NOP and mu Opioid Receptors in Calcium Mobilization Studies</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">NOP</th><th class="rowsep1 colsep0" colspan="2" align="center">mu</th><th class="rowsep1 colsep0" align="center">NOP/mu</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">pEC<sub>50</sub> (CL<sub>95%</sub>)</th><th class="colsep0 rowsep0" align="center"><i>E</i><sub>max</sub> ± S.E.M.</th><th class="colsep0 rowsep0" align="center">pEC<sub>50</sub> (CL<sub>95%</sub>)</th><th class="colsep0 rowsep0" align="center"><i>E</i><sub>max</sub> ± S.E.M.</th><th class="colsep0 rowsep0" align="center">CR</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">N/OFQ(1-13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">9.40 (9.19–9.61)</td><td class="colsep0 rowsep0" align="left">288 ± 15</td><td class="colsep0 rowsep0" colspan="2" align="left">inactive</td><td class="colsep0 rowsep0" align="left"><0.001</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">dermorphin</td><td class="colsep0 rowsep0" colspan="2" align="left">inactive</td><td class="colsep0 rowsep0" align="left">7.83 (7.56–8.11)</td><td class="colsep0 rowsep0" align="left">306 ± 23</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">[Tyr<sup>1</sup>]N/OFQ(1-13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">9.13 (8.83–9.43)</td><td class="colsep0 rowsep0" align="left">266 ± 14</td><td class="colsep0 rowsep0" colspan="2" align="left">crc incomplete; 10 μM: 217 ± 29</td><td class="colsep0 rowsep0" align="left">0.001</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">[Tyr<sup>1</sup>,Phe<sup>5</sup>]N/OFQ(1-13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">7.72 (7.56–7.87)</td><td class="colsep0 rowsep0" align="left">242 ± 11</td><td class="colsep0 rowsep0" align="left">6.41 (5.85–6.97)</td><td class="colsep0 rowsep0" align="left">315 ± 32</td><td class="colsep0 rowsep0" align="left">0.05</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">[Tyr<sup>1</sup>,His<sup>5</sup>]N/OFQ(1-13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">7.39 (7.16–7.62)</td><td class="colsep0 rowsep0" align="left">249 ± 23</td><td class="colsep0 rowsep0" colspan="2" align="left">crc incomplete; 10 μM: 230 ± 37</td><td class="colsep0 rowsep0" align="left">0.05</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">[Tyr<sup>1</sup>,Trp<sup>5</sup>]N/OFQ(1-13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">7.27 (7.19–7.35)</td><td class="colsep0 rowsep0" align="left">288 ± 28</td><td class="colsep0 rowsep0" colspan="2" align="left">crc incomplete; 10 μM: 193 ± 31</td><td class="colsep0 rowsep0" align="left">0.07</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">[Tyr<sup>1</sup>,hPhe<sup>5</sup>]N/OFQ(1-13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">8.70 (8.24–9.16)</td><td class="colsep0 rowsep0" align="left">301 ± 26</td><td class="colsep0 rowsep0" colspan="2" align="left">crc incomplete; 10 μM: 228 ± 29</td><td class="colsep0 rowsep0" align="left">0.003</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">[Tyr<sup>1</sup>,Phg<sup>5</sup>]N/OFQ(1-13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">7.57 (7.12–8.02)</td><td class="colsep0 rowsep0" align="left">293 ± 31</td><td class="colsep0 rowsep0" align="left">6.81 (6.33–7.29)</td><td class="colsep0 rowsep0" align="left">287 ± 48</td><td class="colsep0 rowsep0" align="left">0.17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">[Tyr<sup>1</sup>,p(OCH<sub>3</sub>)Phe<sup>5</sup>]N/OFQ(1-13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">7.88 (7.81–7.95)</td><td class="colsep0 rowsep0" align="left">246 ± 18</td><td class="colsep0 rowsep0" colspan="2" align="left">crc incomplete; 10 μM: 221 ± 49</td><td class="colsep0 rowsep0" align="left">0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">[Tyr<sup>1</sup>,(pF)Phe<sup>5</sup>]N/OFQ(1-13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">7.31 (6.81–7.81)</td><td class="colsep0 rowsep0" align="left">311 ± 22</td><td class="colsep0 rowsep0" colspan="2" align="left">crc incomplete; 10 μM: 256 ± 55</td><td class="colsep0 rowsep0" align="left">0.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">[Tyr<sup>1</sup>,(pNO<sub>2</sub>)Phe<sup>5</sup>]N/OFQ(1-13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">7.31 (6.90–7.72)</td><td class="colsep0 rowsep0" align="left">305 ± 22</td><td class="colsep0 rowsep0" colspan="2" align="left">crc incomplete; 10 μM: 192 ± 64</td><td class="colsep0 rowsep0" align="left">0.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">[Tyr<sup>1</sup>,Dip<sup>5</sup>]N/OFQ(1-13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">6.61 (6.13–7.09)</td><td class="colsep0 rowsep0" align="left">240 ± 26</td><td class="colsep0 rowsep0" align="left">6.78 (6.28–7.27)</td><td class="colsep0 rowsep0" align="left">331 ± 32</td><td class="colsep0 rowsep0" align="left">1.48</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">[Tyr<sup>1</sup>,Bip<sup>5</sup>]N/OFQ(1-13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">6.93 (6.63–7.22)</td><td class="colsep0 rowsep0" align="left">272 ± 29</td><td class="colsep0 rowsep0" colspan="2" align="left">crc incomplete; 10 μM: 151 ± 66</td><td class="colsep0 rowsep0" align="left">0.15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">[Tyr<sup>1</sup>,1Nal<sup>5</sup>]N/OFQ(1-13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">7.17 (6.82–7.52)</td><td class="colsep0 rowsep0" align="left">245 ± 16</td><td class="colsep0 rowsep0" align="left">6.08 (5.67–6.49)</td><td class="colsep0 rowsep0" align="left">319 ± 31</td><td class="colsep0 rowsep0" align="left">0.08</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">[Tyr<sup>1</sup>,2Nal<sup>5</sup>]N/OFQ(1-13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">6.82 (6.60–7.04)</td><td class="colsep0 rowsep0" align="left">266 ± 15</td><td class="colsep0 rowsep0" colspan="2" align="left">crc incomplete; 10 μM: 244 ± 10</td><td class="colsep0 rowsep0" align="left">0.19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">[Tyr<sup>1</sup>,(pNH<sub>2</sub>)Phe<sup>5</sup>]N/OFQ(1-13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">7.52 (7.11–7.93)</td><td class="colsep0 rowsep0" align="left">274 ± 15</td><td class="colsep0 rowsep0" align="left">6.43 (5.80–7.05)</td><td class="colsep0 rowsep0" align="left">329 ± 37</td><td class="colsep0 rowsep0" align="left">0.08</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">[Tyr<sup>1</sup>,Dmt<sup>5</sup>]N/OFQ(1-13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">7.75 (7.22–8.27)</td><td class="colsep0 rowsep0" align="left">251 ± 22</td><td class="colsep0 rowsep0" align="left">6.71 (6.36–7.07)</td><td class="colsep0 rowsep0" align="left">301 ± 35</td><td class="colsep0 rowsep0" align="left">0.09</td></tr></tbody></table></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Effects of Standard Agonists and [Dmt<sup>1</sup>,Xaa<sup>5</sup>]N/OFQ(1-13)-NH<sub>2</sub> Derivatives at NOP and mu Opioid Receptors in Calcium Mobilization Studies</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">NOP</th><th class="rowsep1 colsep0" colspan="2" align="center">mu</th><th class="rowsep1 colsep0" align="center">NOP/mu</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">pEC<sub>50</sub> (CL<sub>95%</sub>)</th><th class="colsep0 rowsep0" align="center"><i>E</i><sub>max</sub> ± S.E.M.</th><th class="colsep0 rowsep0" align="center">pEC<sub>50</sub> (CL<sub>95%</sub>)</th><th class="colsep0 rowsep0" align="center" char="±"><i>E</i><sub>max</sub> ± S.E.M.</th><th class="colsep0 rowsep0" align="center">CR</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">N/OFQ(1-13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">9.59 (9.30–9.88)</td><td class="colsep0 rowsep0" align="left">289 ± 34</td><td class="colsep0 rowsep0" colspan="2" align="left">inactive</td><td class="colsep0 rowsep0" align="left"><0.001</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">dermorphin</td><td class="colsep0 rowsep0" colspan="2" align="left">inactive</td><td class="colsep0 rowsep0" align="left">8.15 (7.97–8.33)</td><td class="colsep0 rowsep0" align="char" char="±">359 ± 18</td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">[Tyr<sup>1</sup>]N/OFQ(1-13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">9.15 (8.48–9.82)</td><td class="colsep0 rowsep0" align="left">236 ± 13</td><td class="colsep0 rowsep0" align="left">5.80 (5.22–6.38)</td><td class="colsep0 rowsep0" align="char" char="±">251 ± 34</td><td class="colsep0 rowsep0" align="left"><0.001</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">[Dmt<sup>1</sup>]N/OFQ(1-13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">8.57 (8.26–8.87)</td><td class="colsep0 rowsep0" align="left">294 ± 22</td><td class="colsep0 rowsep0" align="left">7.37 (7.12–7.51)</td><td class="colsep0 rowsep0" align="char" char="±">311 ± 20</td><td class="colsep0 rowsep0" align="left">0.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">[Dmt<sup>1</sup>,Tyr<sup>5</sup>]N/OFQ(1-13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">6.91 (6.81–7.01)</td><td class="colsep0 rowsep0" align="left">304 ± 21</td><td class="colsep0 rowsep0" align="left">7.81 (7.47–8.15)</td><td class="colsep0 rowsep0" align="char" char="±">410 ± 25</td><td class="colsep0 rowsep0" align="left">7.94</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">[Dmt<sup>1</sup>,Phe<sup>5</sup>]N/OFQ(1-13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">7.25 (6.69–7.81)</td><td class="colsep0 rowsep0" align="left">277 ± 28</td><td class="colsep0 rowsep0" align="left">8.19 (7.71–8.66)</td><td class="colsep0 rowsep0" align="char" char="±">335 ± 22</td><td class="colsep0 rowsep0" align="left">8.71</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">[Dmt<sup>1</sup>,Phg<sup>5</sup>]N/OFQ(1-13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">6.95 (6.78–7.12)</td><td class="colsep0 rowsep0" align="left">282 ± 12</td><td class="colsep0 rowsep0" align="left">8.54 (8.13–8.96)</td><td class="colsep0 rowsep0" align="char" char="±">339 ± 28</td><td class="colsep0 rowsep0" align="left">39</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">[Dmt<sup>1</sup>,1Nal<sup>5</sup>]N/OFQ(1-13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">7.22 (6.91–7.54)</td><td class="colsep0 rowsep0" align="left">286 ± 19</td><td class="colsep0 rowsep0" align="left">7.80 (7.51–8.09)</td><td class="colsep0 rowsep0" align="char" char="±">349 ± 20</td><td class="colsep0 rowsep0" align="left">3.80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">[Dmt<sup>1</sup>,(pNH<sub>2</sub>)Phe<sup>5</sup>]N/OFQ(1-13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">7.58 (7.37–7.79)</td><td class="colsep0 rowsep0" align="left">258 ± 20</td><td class="colsep0 rowsep0" align="left">7.82 (7.35–8.29)</td><td class="colsep0 rowsep0" align="char" char="±">358 ± 15</td><td class="colsep0 rowsep0" align="left">1.73</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">[Dmt<sup>1,5</sup>]N/OFQ(1-13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">8.39 (8.05–8.72)</td><td class="colsep0 rowsep0" align="left">270 ± 25</td><td class="colsep0 rowsep0" align="left">8.08 (7.74–8.42)</td><td class="colsep0 rowsep0" align="char" char="±">354 ± 16</td><td class="colsep0 rowsep0" align="left">0.49</td></tr></tbody></table></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Effects of Standard Agonists and [Dmt<sup>1,5</sup>]N/OFQ(1-13)-NH<sub>2</sub> at NOP and mu Opioid Receptors in DMR Studies</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">NOP</th><th class="rowsep1 colsep0" colspan="2" align="center">mu</th><th class="rowsep1 colsep0" align="center">mu/NOP</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">pEC<sub>50</sub> (CL<sub>95%</sub>)</th><th class="colsep0 rowsep0" align="center"><i>E</i><sub>max</sub> ± S.E.M.</th><th class="colsep0 rowsep0" align="center">pEC<sub>50</sub> (CL<sub>95%</sub>)</th><th class="colsep0 rowsep0" align="center" char="±"><i>E</i><sub>max</sub> ± S.E.M.</th><th class="colsep0 rowsep0" align="center">CR</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">N/OFQ</td><td class="colsep0 rowsep0" align="left">9.37 (8.96–9.79)</td><td class="colsep0 rowsep0" align="left">209 ± 14</td><td class="colsep0 rowsep0" colspan="2" align="left">inactive</td><td class="colsep0 rowsep0" align="left"><0.001</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">dermorphin</td><td class="colsep0 rowsep0" colspan="2" align="left">inactive</td><td class="colsep0 rowsep0" align="left">8.92 (8.74–9.10)</td><td class="colsep0 rowsep0" align="char" char="±">151 ± 16</td><td class="colsep0 rowsep0" align="left">>500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">[Dmt<sup>1,5</sup>]N/OFQ(1-13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">7.71 (6.65–8.76)</td><td class="colsep0 rowsep0" align="left">223 ± 11</td><td class="colsep0 rowsep0" align="left">8.64 (8.28–9.01)</td><td class="colsep0 rowsep0" align="char" char="±">202 ± 20</td><td class="colsep0 rowsep0" align="left">8.51</td></tr></tbody></table></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> <i>In Vitro</i> Structure–Activity Relationship</h3><div class="NLM_p">N/OFQ(1-13)-NH<sub>2</sub> stimulated calcium mobilization with high potency and maximal effects in cells coexpressing NOP receptors and chimeric G proteins, while being inactive in cells expressing the mu opioid receptor. On the contrary, dermorphin stimulated calcium mobilization with high potency and maximal effects in mu expressing cells, while it was inactive in NOP cells (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). The substitution of Phe<sup>1</sup> with Tyr as in [Tyr<sup>1</sup>]N/OFQ(1-13)-NH<sub>2</sub> did not affect NOP potency while promoting a minor increase in mu potency. Thr<sup>5</sup> in [Tyr<sup>1</sup>]N/OFQ(1-13)-NH<sub>2</sub> was replaced with a series of both proteinogenic and nonproteinogenic amino acids with different polar/nonpolar, aliphatic/aromatic, linear/branched side chains with the aim to explore the effect of several structural parameters on the biological activity. The substitution of Thr<sup>5</sup> with Asn, Val, Lys(Ac) caused a slight (<10-fold) reduction in NOP potency and no modification of mu potency. The same substitution with Abu, Lys, Dap, and Dab induced a larger loss (>10-fold) of NOP potency. The introduction in position 5 of Leu, Nle, and Nva promoted a moderate decrease in NOP potency associated with a significant increase in mu potency. A similar increase in mu potency was achieved with [Tyr<sup>1,5</sup> ]N/OFQ(1-13)-NH<sub>2</sub>, which however displayed a larger decrease in NOP potency; thus, the NOP/mu concentration ratio for this peptide was near 1 (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). None of the amino acid substitutions evaluated in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> modified ligand efficacy at both NOP and mu receptors. Based on these results, aromatic residues were selected for further modifications of position 5 of [Tyr<sup>1</sup>]N/OFQ(1-13)-NH<sub>2</sub>.</div><div class="NLM_p">As shown in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, 14 compounds with an aromatic residue substituting Thr<sup>5</sup> in [Tyr<sup>1</sup>]N/OFQ(1-13)-NH<sub>2</sub> were assayed in NOP and mu receptor expressing cells. The different amino acids did not modify ligand efficacy but produced different effects on NOP and mu potency. In particular, the NOP potency of these derivatives was in the range of 8.70–6.61, while the mu potency of these compounds was <6 with the exceptions of peptides substituted with Phe, Phg, 1Nal, (pNH<sub>2</sub>)Phe, and Dmt (range 6.08–6.81). Then, for further investigation, we selected those sequences showing pEC<sub>50</sub> values >7 for the NOP receptor and >6 for the mu receptor associated with an NOP/mu concentration ratio >0.05. These criteria were matched by [Tyr<sup>1</sup>]N/OFQ(1-13)-NH<sub>2</sub> derivatives substituted in position 5 with Tyr, Phe, Phg, 1Nal, (pNH<sub>2</sub>)Phe, and Dmt.</div><div class="NLM_p">The third series of peptides was generated by substituting Tyr<sup>1</sup> with Dmt that is known to increase opioid receptor potency.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> In fact, as shown in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, [Dmt<sup>1</sup>]N/OFQ(1-13)-NH<sub>2</sub> displayed a moderate (10-fold) decrease in NOP potency compared to [Tyr<sup>1</sup>]N/OFQ(1-13)-NH<sub>2</sub> associated to a more pronounced increase (approx. 40-fold) in mu potency. The substitution of Thr<sup>5</sup> of [Dmt<sup>1</sup>]N/OFQ(1-13)-NH<sub>2</sub> with the above-mentioned amino acids generated results similar to those obtained with [Tyr<sup>1</sup>]N/OFQ(1-13)-NH<sub>2</sub>, that is, a slight to moderate decrease in NOP potency associated to a large increase in mu potency. The most exciting result has been obtained with [Dmt<sup>1,5</sup>]N/OFQ(1-13)-NH<sub>2</sub> that displayed similar and high potency at both NOP and mu receptors.</div><div class="NLM_p">[Dmt<sup>1,5</sup>]N/OFQ(1-13)-NH<sub>2</sub> was further evaluated in dynamic mass redistribution (DMR) experiments performed on CHO cells expressing the human NOP and mu receptors. As summarized in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>, N/OFQ elicited a concentration-dependent positive DMR signal in cells expressing the NOP receptor being inactive in mu expressing cells. Opposite results were obtained with dermorphin that behaves as a mu-selective agonist. [Dmt<sup>1,5</sup>].N/OFQ(1-13)-NH<sub>2</sub> elicited a robust DMR response in both cell lines with similar maximal effects to standard agonists. [Dmt<sup>1,5</sup>].N/OFQ(1-13)-NH<sub>2</sub> displayed nanomolar potency at both NOP and the mu receptor with a mu/NOP potency ratio of 8.51 (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>).</div><div class="NLM_p">Finally, the agonist properties of [Dmt<sup>1,5</sup>]N/OFQ(1-13)-NH<sub>2</sub> were evaluated at delta and kappa opioid receptors in calcium mobilization experiments. As shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, [Dmt<sup>1,5</sup>]N/OFQ(1-13)-NH<sub>2</sub> displayed low potency and efficacy at the delta receptor. On the contrary, the peptide showed at the kappa opioid receptor high potency (pEC<sub>50</sub> = 8.49) similar to that displayed at NOP (pEC<sub>50</sub> = 8.39) and mu (pEC<sub>50</sub> = 8.08) receptors. Thus, [Dmt<sup>1,5</sup>]N/OFQ(1-13)-NH<sub>2</sub> should be classified as a mixed NOP/mu/kappa full agonist.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c02062/20210520/images/medium/jm0c02062_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c02062/20210520/images/large/jm0c02062_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Effects of [Dmt<sup>1,5</sup>]N/OFQ(1-13)-NH<sub>2</sub> at NOP and classical opioid receptors in calcium mobilization studies.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c02062/20210520/images/large/jm0c02062_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02062&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Molecular Dynamics</h3><div class="NLM_p">As explained in the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>, MD simulations have been performed setting up nine-residue long peptides (i.e., [Phe/Dmt<sup>1</sup>,Thr/Dmt<sup>5</sup>]N/OFQ(1-9)-NH<sub>2</sub>) due to the fact that longer peptides lack reliable starting conformations by molecular docking. Moreover, in the following, we will focus on the first five residues of the peptides, those entering the mu opioid receptor orthosteric site, as residues 6–9 represent the more flexible part of the peptides along the MD simulation. The results obtained for [Dmt<sup>1,5</sup>]N/OFQ(1-9)-NH<sub>2</sub> were compared with those obtained by similar simulations performed on the mu agonist peptide DAMGO and also on N/OFQ(1-9)-NH<sub>2</sub> as a sort of negative control since this peptide lacks mu receptor affinity.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div><div class="NLM_p">In <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A, the 3D conformation obtained after docking and MD for [Dmt<sup>1,5</sup>]N/OFQ(1-9)-NH<sub>2</sub> (colored purple) is superimposed to the known one reported for DAMGO (colored yellow, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DDF">6DDF</a>).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Subsequent panels (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B–E) show the main interactions relating to each of the three aromatic residues, that is, Dmt<sup>1</sup>, Phe<sup>4</sup>, and Dmt<sup>5</sup>. Furthermore, a general comparison between the results of MD simulations performed on DAMGO (blue), [Dmt<sup>1,5</sup>]N/OFQ(1-9)-NH<sub>2</sub> (green), and N/OFQ(1-9)-NH<sub>2</sub> (red) is shown in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>. In this figure, patterns of the main receptor-peptide interactions provided are displayed and superimposed, that is, hydrophobic and polar average number of contacts (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A,B), percentage of formation of hydrogen bonds, and average “strength” of π–π stacking and π–cation interaction (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>C–E, respectively). Accordingly, the representative conformation of [Dmt<sup>1,5</sup>]N/OFQ(1-9)-NH<sub>2</sub> in the orthosteric site largely overlaps with that of DAMGO (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A). The N-terminus of Dmt<sup>1</sup> forms salt bridge/hydrogen bond contacts with D<sup>147</sup> (a residue conserved all along the opioid family) similar to both DAMGO and the morphinan agonist BU72 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5C1M">5C1M</a>).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> MD simulations show that this important interaction is strongly stabilized by the presence of another conserved residue, Q<sup>124</sup> (TM2), whose nitrogen and oxygen side-chain atoms reinforce the hydrogen bond network by contacts with both the carboxyl oxygen of D<sup>147</sup> and the N-terminus of Dmt<sup>1</sup>. Moreover, water bridges fill the small remaining volume between the D<sup>147</sup> and Q<sup>124</sup> side chains and the backbone donor/acceptors of Dmt<sup>1</sup>, Gly<sup>3</sup>, and Gly<sup>2</sup>, with the latter being in direct H-bond with W<sup>318</sup> of TM7.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c02062/20210520/images/medium/jm0c02062_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c02062/20210520/images/large/jm0c02062_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Orthosteric site of [Dmt<sup>1,5</sup>]N/OFQ(1-9)-NH<sub>2</sub> (colored purple) in the active mu receptor, according to “<i>in silico</i>” docking and MD (starting receptor structure from PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DDF">6DDF</a>). Only the first five residues are shown. The reported DAMGO conformation (the same PDB code) is superimposed (yellow). (B) Hydrophobic contacts between Dmt<sup>1</sup>, Phe<sup>4</sup>, and Dmt<sup>5</sup> with their neighboring residues. (C–E) Interaction histograms of residues Dmt<sup>1</sup>, Phe<sup>4</sup>, and Dmt<sup>5</sup>, respectively, including hydrophobic, polar, H-bonds, water bridges of first and second order, salt bridges, and π–cation and π–π stacking as derived from long-lasting MD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c02062/20210520/images/large/jm0c02062_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02062&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c02062/20210520/images/medium/jm0c02062_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c02062/20210520/images/large/jm0c02062_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Maps of hydrophobic (A), polar (B), H-bond (C), π–π stacking (D), and π–cation (E) interactions between the mu receptor and the studied ligands along MD trajectories. Only residues 1–5 are considered for [Dmt<sup>1,5</sup>]N/OFQ(1-9)-NH<sub>2</sub> and N/OFQ(1-9)-NH<sub>2</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c02062/20210520/images/large/jm0c02062_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02062&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Dmt<sup>1</sup> is also in direct hydrophobic contact with TM6 residues (W<sup>293</sup>, H<sup>297</sup>, and especially I<sup>296</sup>, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B,C). Along the MD trajectories, its aromatic head moves alternating first- and second-order water bridges with H<sup>297</sup> of TM6 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C). Partial π–π stacking between the Dmt<sup>1</sup> and H297 rings is also observed during the simulations. Hydrophobic, π-stacking, and water bridge contacts between Dmt<sup>1</sup> and Y<sup>148</sup> (TM3), H<sup>297</sup> and W<sup>293</sup> (TM6) frequently occur (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C). The latter residue, in the so-called receptor polar cavity, is thought to be very important for the activation mechanism in many class A GPCRs, and these interactions, although not fully stable, could contribute to stabilize the receptor active state.</div><div class="NLM_p">The formation of alternating second-order water bridges (along 78% of the trajectory) shows that the N-terminus of Dmt<sup>1</sup>, together with D<sup>147</sup>, is also in contact with N<sup>150</sup> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C), an important conserved residue that in the reported high-resolution structure of the inactive delta receptor<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> is shown to connect the orthosteric site to the sodium pocket in the central part of the receptor.</div><div class="NLM_p">While Dmt<sup>1</sup> interacts with both TM3 (more than 40 contacts with residues Y<sup>148</sup> and M<sup>151</sup>) and TM6 (about 80 contacts with residues W<sup>293</sup>, I<sup>296</sup>, and H<sup>297</sup>), Phe<sup>4</sup> is immersed in the same hydrophobic pocket as the phenyl group of DAMGO between TM2 (residues F<sup>123</sup> and Q<sup>124</sup>) and TM3 (residues V<sup>143</sup> and I<sup>144</sup>) (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B,D), still participating with its amidic nitrogen and water bridges to the main hydrogen bond network linking the peptide to D<sup>147</sup> and Q<sup>124</sup> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>D).</div><div class="NLM_p">The Dmt<sup>5</sup> peptide residue mainly interacts with residues not conserved within the opiate family, that is, E<sup>229</sup> and K<sup>233</sup> of TM5, V<sup>300</sup>, and K<sup>303</sup> of TM6, and W<sup>318</sup> of TM7. Movements of this ring allow an alternation of nonpolar interactions with the aliphatic chains of K<sup>303</sup> (TM6) and K<sup>233</sup> (TM5) (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B) and of possible π–cation interactions with the positively charged amine of both the same K residues (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>E). Similarly, the amidic oxygens of Gly<sup>3</sup>, Dmt<sup>5</sup>, and Gly<sup>6</sup> alternate in H-bond or water bridge contacts with R<sup>211</sup> (ECL2) and E<sup>229</sup> (TM5) on two opposite sides of the receptor.</div><div class="NLM_p">Details on the MD simulations of DAMGO and [Dmt<sup>1,5</sup>]N/OFQ(1-9)-NH<sub>2</sub> in complex with the mu receptor are given in <a href="/doi/suppl/10.1021/acs.jmedchem.0c02062/suppl_file/jm0c02062_si_001.pdf" class="ext-link">Figures S1 and S2</a>, reporting the root-mean-square deviation (RMSD) analyses and clustering outcomes for each of the investigated peptides. Moreover, the RMSD analysis (<a href="/doi/suppl/10.1021/acs.jmedchem.0c02062/suppl_file/jm0c02062_si_001.pdf" class="ext-link">Figure S3</a>) and the representative conformation of residues 1–5 of N/OFQ(1-9)-NH<sub>2</sub> (purple) are shown, compared to DAMGO (yellow). MD shows that the interactions of N/OFQ(1-9)-NH<sub>2</sub> with TM6 are strongly diminished; in addition to the absence of polar contacts and the water density between residues 1–5 of the peptide and TM6, there are only about 20 nonpolar contacts (between Phe<sup>1</sup> and W<sup>293</sup> and between Phe<sup>1</sup> and F<sup>236</sup>), while both polar and nonpolar interactions with TM3 increase.</div><div class="NLM_p last">In <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>, the maps of hydrophobic, polar, hydrogen bond, π–π stacking, and π–cation interactions for the peptides under study are superimposed for an overall immediate comparison. The hydrophobic and polar interaction maps are widely superimposable on all peptides (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A,B), attesting the similarity of their conformation inside the orthosteric site, with an increase of nonpolar contacts between [Dmt<sup>1,5</sup>]N/OFQ(1-9)-NH<sub>2</sub> and TM6 (I<sup>296</sup>, V<sup>300</sup>, and K<sup>303</sup>) essentially due to the aromatic ring of Dmt<sup>5</sup>. The N-terminus of all three peptides forms hydrogen bonds with D<sup>147</sup> and Q<sup>124</sup> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>C). More interestingly, according to our simulation, the H-bond contact reported in the crystal structure between the amidic oxygen of Gly<sup>3</sup> of DAMGO and the indole nitrogen of W<sup>318</sup> is not fully stable; in the same time, the phenolic head of Tyr<sup>1</sup> tends to extend toward the so-called “polar cavity” between Y<sup>326</sup> and W<sup>293</sup> in the intracellular side (<a href="/doi/suppl/10.1021/acs.jmedchem.0c02062/suppl_file/jm0c02062_si_001.pdf" class="ext-link">Figure S1C</a>), with the possibility to form π-stacking with W<sup>293</sup> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>D) and a H-bond besides a π–cation contact between its N-terminus and the phenol group of Y<sup>326</sup>. On the other hand, the H-bond between Gly<sup>2</sup> of [Dmt<sup>1,5</sup>]N/OFQ(1-9)-NH<sub>2</sub> and W<sup>318</sup> remains quite stable, as reinforced by partial π-stacking between W<sup>318</sup> and Dmt<sup>5</sup> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>E and <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>D), while the Dmt<sup>1</sup> phenolic head, sterically hindered by the two methyl groups, does not extend toward the polar cavity. Concerning N/OFQ (1-9)-NH<sub>2</sub>, Phe<sup>1</sup> has negligible hydrogen and water bond contacts with the inner side of the receptor, and the contacts between Phe<sup>4</sup>, Thr<sup>5</sup> of the peptide and T<sup>218</sup>, L<sup>219</sup> of extracellular loop 2 (ECL2) are stronger (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>C). The N-terminus of the three peptides can form π–cation interactions with the aromatic ring of Y<sup>326</sup>, while as mentioned above, π–cation contributions due to interactions of K<sup>233</sup> and K<sup>303</sup> are exclusive of [Dmt<sup>1,5</sup>]N/OFQ(1-9)-NH<sub>2</sub> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>E).</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> <i>In Vivo</i> Experiments: [Dmt<sup>1,5</sup>]N/OFQ(1-13)-NH<sub>2</sub> Effect on Citric Acid-Induced Cough in the Conscious Guinea Pig</h3><div class="NLM_p">To test the antitussive effect of [Dmt<sup>1,5</sup>]N/OFQ(1-13)-NH<sub>2</sub>, we used a model of cough induced by citric acid in guinea pigs. Data showed that the coadministration of [Dmt<sup>1,5</sup>]N/OFQ(1-13)-NH<sub>2</sub> with citric acid did not affect the tussive response (coughs/15 min: vehicle = 17.83 ± 3.95 vs [Dmt<sup>1,5</sup>]N/OFQ(1-13)-NH<sub>2</sub> 17.67 ± 1.73). However, the nebulization with [Dmt<sup>1,5</sup>]N/OFQ(1-13)-NH<sub>2</sub> before (30 min) the challenge with the tussive agent significantly reduced the cough number induced by citric acid (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>).</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c02062/20210520/images/medium/jm0c02062_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c02062/20210520/images/large/jm0c02062_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of [Dmt<sup>1,5</sup>]N/OFQ(1-13)-NH<sub>2</sub> on citric acid-induced cough in conscious guinea pigs. Schematic representation of the experimental procedure for the cough measurement in conscious guinea pigs and pooled data of cough number after [Dmt<sup>1,5</sup>]N/OFQ(1-13)-NH<sub>2</sub> (1 mM) or vehicle (0.9% NaCl) nebulization, 30 min before the nebulization of the tussive agent, citric acid (0.4 M). Values are the mean ± SEM of the numbers of coughs/15 min, with data points overlaid (<i>n</i> = 6 guinea pigs for each condition). *<i>p</i> < 0.05 vs vehicle, Student’s <i>t</i>-test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c02062/20210520/images/large/jm0c02062_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02062&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42205" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42205" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">This structure activity investigation was aimed at the identification of novel peptides acting as mixed NOP/mu receptor agonists. To this aim, we substituted Phe<sup>1</sup> of N/OFQ(1-13)-NH<sub>2</sub> with amino acids containing a phenol moiety and Thr<sup>5</sup> with several proteinogenic and nonproteinogenic residues. Novel peptides were investigated in calcium mobilization experiments performed in cells expressing the human recombinant receptors and chimeric G proteins. The structure activity investigation led to the identification of the potent mixed agonist [Dmt<sup>1,5</sup>]N/OFQ(1-13)-NH<sub>2</sub> whose NOP and mu agonist properties were confirmed in DMR studies. Moreover, [Dmt<sup>1,5</sup>]N/OFQ(1-13)-NH<sub>2</sub> was also able to potently stimulate kappa but not delta opioid receptors. The capability of this peptide to bind the mu receptor has been also investigated in MD studies that suggested a similar active conformation for [Dmt<sup>1,5</sup>]N/OFQ(1-13)-NH<sub>2</sub> and DAMGO and crucial interactions with D<sup>147</sup> and H<sup>297</sup>. Moreover, the binding of [Dmt<sup>1,5</sup>]N/OFQ(1-13)-NH<sub>2</sub> is reinforced by additional polar interactions of Dmt<sup>5</sup> with K<sup>223</sup> and K<sup>303</sup>. Finally, [Dmt<sup>1,5</sup>]N/OFQ(1-13)-NH<sub>2</sub> elicited a robust antitussive action <i>in vivo</i> in a model of cough induced by nebulization of citric acid in conscious guinea pigs.</div><div class="NLM_p">Previous studies demonstrated that the substitution of Phe<sup>1</sup> in N/OFQ with Tyr reduces NOP selectivity over opioid receptors<a onclick="showRef(event, 'ref26 ref42'); return false;" href="javascript:void(0);" class="ref ref26 ref42">(26,42)</a> and that Thr<sup>5</sup> of N/OFQ(1-13)-NH<sub>2</sub> can be substituted with different amino acids with no changes in peptide efficacy and relatively little modifications of potency.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Thus, we selected a series of amino acids to substitute Thr<sup>5</sup> in [Tyr<sup>1</sup>]N/OFQ(1-13)-NH<sub>2</sub> in order to increase the mu receptor activity of the peptide derivatives. The results obtained with [Tyr<sup>1</sup>]N/OFQ(1-13)-NH<sub>2</sub> derivatives were similar to those previously obtained with N/OFQ(1-13)-NH<sub>2</sub> derivatives in terms of NOP receptor activity. As far as the mu receptor is concerned, an increase in potency has been obtained with Leu, Nle, Nva, and Tyr. These results are not unexpected since Leu in position 5 is found in naturally occurring opioid ligands (Leu-enkephalin and dynorphin) and Nle (and possibly Nva) may mimic methionine, which is also present in position 5 of other endogenous opioid peptides (Met-enkephalin, beta-endorphin). In addition, the same can be said for Tyr<sup>5</sup>, which is found in amphibian opioid peptides such as the mu-selective agonist dermorphin. Moreover, previous studies demonstrated that position 5 of enkephalin can be replaced with aromatic residues<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> or non-natural aliphatic residues<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> with no major changes of bioactivity. Interestingly, [Tyr<sup>1,5</sup>]N/OFQ(1-13)-NH<sub>2</sub> displayed very similar potency at NOP and the mu opioid receptor; thus, with the aim to identify potent mixed NOP/mu agonists, further studies were performed substituting position 5 with aromatic amino acids.</div><div class="NLM_p">Despite the investigation of 14 chemically different aromatic residues, no clear structure activity information was obtained. In fact, with the exception of hPhe<sup>5</sup>, little changes in NOP potency were measured and the same can be said for mu receptor activity. Thus, for further studies, we selected compounds matching the following criteria: pEC<sub>50</sub> > 7 for the NOP receptor and >6 for the mu receptor, with NOP/mu ratio > 0.05. This let us to select Tyr, Phe, Phg, 1Nal, (pNH<sub>2</sub>)Phe, and Dmt to be substituted in position 5 of [Dmt<sup>1</sup>]N/OFQ(1-13)-NH<sub>2</sub>.</div><div class="NLM_p">The opioid receptor binding enhancing properties of Dmt in position 1<sup>19, 27, 28</sup> were confirmed by the present results. In fact, compared to [Tyr<sup>1</sup>]N/OFQ(1-13)-NH<sub>2</sub>, [Dmt<sup>1</sup>]N/OFQ(1-13)-NH<sub>2</sub> displayed approximately 3-fold reduced potency at NOP associated with almost 100-fold increased potency at the mu receptor. The same pattern of effects, that is, no change or modest reduction of NOP potency associated with a large increase in mu potency was obtained with [Dmt<sup>1</sup>]N/OFQ(1-13)-NH<sub>2</sub> derivatives substituted in position 5 with Tyr, Phe, Phg, 1Nal, and (pNH<sub>2</sub>)Phe. [Dmt<sup>1,5</sup>]N/OFQ(1-13)-NH<sub>2</sub> is however the exception to this rule; in fact, this peptide displayed, compared to [Tyr<sup>1</sup>,Dmt<sup>5</sup>]N/OFQ(1-13)-NH<sub>2</sub>, increased potency at both NOP and mu receptors. This led to an NOP/mu ratio of potency of [Dmt<sup>1,5</sup>]N/OFQ(1-13)-NH<sub>2</sub> near 1. Interestingly, a very similar NOP/mu ratio was displayed by [Tyr<sup>1,5</sup>]N/OFQ(1-13)-NH<sub>2</sub>, which was however approximately 30-fold less potent at both receptors.</div><div class="NLM_p">The calcium mobilization assay used in the present study has been previously set up<a onclick="showRef(event, 'ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref45 ref46">(45,46)</a> in our laboratories and then validated by investigating a large number of NOP and opioid receptor ligands.<a onclick="showRef(event, 'ref19 ref23 ref47'); return false;" href="javascript:void(0);" class="ref ref19 ref23 ref47">(19,23,47)</a> However, this assay is based on the aberrant signaling generated by the expression of chimeric G proteins; therefore, we reassessed the pharmacological effects of [Dmt<sup>1,5</sup>]N/OFQ(1-13)-NH<sub>2</sub> with the DMR assay. This test measures the physiological G<sub>i</sub>-dependent signaling of NOP and opioid receptors as demonstrated by its sensitivity to pertussis toxin treatment.<a onclick="showRef(event, 'ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref48 ref49">(48,49)</a> DMR studies confirmed the mixed mu/NOP full agonist properties of [Dmt<sup>1,5</sup>]N/OFQ(1-13)-NH<sub>2</sub>.</div><div class="NLM_p">Finally, the effects of [Dmt<sup>1,5</sup>]N/OFQ(1-13)-NH<sub>2</sub> at kappa and delta opioid receptors were investigated. At delta receptors, [Dmt<sup>1,5</sup>]N/OFQ(1-13)-NH<sub>2</sub> displayed low potency and efficacy, while it behaved as a potent full agonist at the kappa receptor. Of note, the kappa potency of [Dmt<sup>1,5</sup>]N/OFQ(1-13)-NH<sub>2</sub> was similar to that shown at NOP and mu receptors. These results were not unexpected. In fact, binding experiments performed in guinea-pig brain membranes demonstrated the following rank order of affinity for [Tyr<sup>1</sup>]N/OFQ(1-13)-NH<sub>2</sub>: NOP > mu = kappa > delta.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Moreover, similar results have been previously obtained in functional studies performed with human recombinant receptors with [Dmt<sup>1</sup>]N/OFQ(1-13)-NH<sub>2</sub> that displayed the following rank order of potency: NOP = mu > kappa > delta.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Collectively, these findings indicate that modifications of position 1 of N/OFQ such as Tyr and Dmt are sufficient for increasing mu and kappa but not delta receptor binding. Most probably, this is due to the fact that the C-terminal portion of N/OFQ is enriched in positively charged residues that may favor mu and kappa interactions but are detrimental for delta receptor binding.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></div><div class="NLM_p">To get insights into the mechanisms by which [Dmt<sup>1,5</sup>]N/OFQ(1-13)-NH<sub>2</sub> binds the mu receptor, MD studies were performed using the recently solved DAMGO-mu receptor-G<sub>i</sub> complex.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The results obtained with [Dmt<sup>1,5</sup>]N/OFQ(1-9)-NH<sub>2</sub> were compared with those of DAMGO and N/OFQ(1-9)-NH<sub>2</sub> used as the positive and negative control, respectively. These studies show that beyond the pivotal and expected interaction between the [Dmt<sup>1,5</sup>]N/OFQ(1-9)-NH<sub>2</sub> N-terminus and D<sup>147</sup>, the phenol oxygen of Dmt<sup>1</sup> can make first- or second-order water bridges with H<sup>297</sup> (Gln in NOP) of TM6 of the mu receptor. This is in good agreement with the observation of a water bridge between the agonist BU72 and H<sup>297</sup> in the active mu receptor and other small molecules or peptide mimetic agonists of kappa and delta receptors<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> and can account for the reduction of NOP selectivity and the increase of mu potency as simply induced by the presence of the phenol groups of Tyr<sup>1</sup> or Dmt<sup>1</sup> in N/OFQ instead of the phenyl group of Phe<sup>1</sup>. Partial π–π stacking between Dmt<sup>1</sup> (or Tyr<sup>1</sup>) and H297 could further contribute to peptide stabilization in the orthosteric site, thus enhancing these effects. Analogous contacts have been reported for cocrystallized mu<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> and delta<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> but not NOP<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> antagonists. Importantly, Phe<sup>1</sup> of the N/OFQ sequence cannot form water bridges with H<sup>297</sup>, and this is most probably the reason for the lack of mu affinity of the peptide.</div><div class="NLM_p">Interestingly, as stated above, Dmt<sup>5</sup> mainly interacts with residues that differ within the opiate family, that is, E<sup>229</sup> (G in NOP, D in kappa and delta) and K<sup>233</sup> (A in NOP) of TM5, V<sup>300</sup> (I in kappa), and K<sup>303</sup> (W, E, and Q in delta, kappa, and NOP receptor, respectively) of TM6, and W<sup>318</sup> (L in NOP) of TM7. While the carbonyl oxygen of Dmt<sup>5</sup> is in water bridge contact with E<sup>229</sup>, its aromatic bulky head is stacked between the aliphatic chains of K<sup>303</sup> and K<sup>233</sup>, making possible π–cation interactions with the positively charged amine of both lysines (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B,E). In the reported crystal structure of mu-DAMGO<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DDF">6DDF</a>), the K<sup>303</sup> positive charge is found at a 3.3 Å distance of the carbonyl oxygen of N(Me)-Phe of DAMGO, compatible with a weak H-bond, whereas K<sup>233</sup> does not appear to contribute to the stabilization of the mu active state induced by both DAMGO and BU72;<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> the K<sup>233</sup> amine group is found covalently linked to the antagonist β-funaltrexamine in the crystal structure of the inactive mu receptor.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> As K<sup>303</sup> and K<sup>233</sup> are present in the mu but not the NOP receptor, the above-mentioned interactions between Dmt<sup>5</sup> and the two lysine residues could contribute to explain the mu-selective increase of affinity of [Dmt<sup>1,5</sup>]N/OFQ(1-13)-NH<sub>2</sub> compared to [Dmt<sup>1</sup>]N/OFQ(1-13)-NH<sub>2</sub>, thus making [Dmt<sup>1,5</sup>]N/OFQ(1-13)-NH<sub>2</sub> a mixed mu/NOP agonist. Last, as observed along the MD runs, the indole nitrogen of W<sup>318</sup> in TM7 does not interact with N/OFQ but can form H-bond contact with Gly<sup>2</sup> of [Dmt<sup>1,5</sup>]N/OFQ(1-9)-NH<sub>2</sub> as well as with DAMGO (49 and 63% of the trajectory, respectively). Thus, beyond differences in steric hindrance of Tyr<sup>1</sup> and Dmt<sup>1</sup> that may generically contribute to a larger hydrophobic core for the last one, the entity of the interaction between W<sup>318</sup> and Gly<sup>2</sup> could also contribute to explain the enhanced potency of [Dmt<sup>1,5</sup>] N/OFQ(1-13)-NH<sub>2</sub>. Data obtained from this molecular modeling investigation are in agreement with those reported by recent studies performed on a series of cyclic opioid peptides.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a></div><div class="NLM_p last">The role of the N/OFQ-NOP receptor system has been widely reported in several biological functions at the central and peripheral levels, including the cough reflex.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Previous studies showed that NOP receptor agonists given centrally or peripherally suppress capsaicin and acid inhalation-induced cough in guinea pigs.<a onclick="showRef(event, 'ref33 ref34 ref35 ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref33 ref34 ref35 ref36 ref37">(33−37)</a> Moreover, opioid drugs are widely used as antitussive agents,<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> and inhalation of encephalin was shown to be effective in reducing cough reflex <i>in vivo</i>.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> The novel mixed NOP/opioid agonist [Dmt<sup>1,5</sup>]N/OFQ(1-13)-NH<sub>2</sub> showed an inhibitory activity against citric acid-induced cough in guinea pigs, thus demonstrating the <i>in vivo</i> activity of the compound. However, further studies are needed to investigate the receptor mechanism involved in the antitussive action of the molecule.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88311" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88311" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In this study, starting from the NOP-selective sequence of N/OFQ(1-13)-NH<sub>2</sub>, we developed a structure activity investigation focused on positions 1 and 5. Regarding position 1, a phenol moiety is required to increase mu receptor binding, and regarding position 5, aromatic residues generated the best results in terms of similar potency at NOP and mu receptors. This study led to the identification of [Dmt<sup>1,5</sup>]N/OFQ(1-13)-NH<sub>2</sub> as the most potent mixed peptide agonist for NOP and mu receptors so far described in the literature. MD studies shed light on the molecular mechanisms adopted by this peptide to bind the active form of the mu receptor: some features of the mode of binding of [Dmt<sup>1,5</sup>]N/OFQ(1-9)-NH<sub>2</sub> are superimposable to those of DAMGO, that is, the ionic bond with D<sup>147</sup> of TM3 and the H-bond network with H<sup>297</sup> of TM6, while others are peculiar of [Dmt<sup>1,5</sup>]N/OFQ(1-9)-NH<sub>2</sub>, that is, polar interactions of Dmt<sup>5</sup> with K<sup>223</sup> and K<sup>303</sup> of TM5 and TM6, respectively.</div><div class="NLM_p last">[Dmt<sup>1,5</sup>]N/OFQ(1-13)-NH<sub>2</sub> is a novel mixed agonist for NOP and mu receptors that exerted antitussive effects in an <i>in vivo</i> model of cough. The compound will be evaluated in future studies for its antinociceptive properties. In fact, mixed NOP/mu agonists of both peptide and nonpeptide structures have been consistently demonstrated in preclinical studies to promote antinociceptive effects similar to those of morphine being however better tolerated particularly in terms of respiratory depression, tolerance, and abuse liability.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Importantly, phase II and III clinical studies performed with the mixed NOP/mu agonist cebranopadol have confirmed this favorable profile in pain patients.<a onclick="showRef(event, 'ref9 ref56'); return false;" href="javascript:void(0);" class="ref ref9 ref56">(9,56)</a> Nowadays, the availability of safer analgesic drugs is particularly needed for facing the opioid epidemic that leads to a progressive increase of fatal overdoses over the past 2 decades.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86400" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86400" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Chemistry</h3><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> Materials and Methods</h4><div class="NLM_p last">All solvents and reagents were purchased from Sigma-Aldrich and Fisher Scientific. Enantiopure Fmoc-protected amino acids and the resins for SPPS were purchased from AAPPTec. Peptides were synthesized using a standard Fmoc/<i>t</i>-butyl strategy<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> with a Syro XP multiple peptide synthesizer (MultiSynTech GmbH, Witten Germany) on a Rink amide MBHA resin (4-(2′,4′-dimethoxyphenyl-Fmoc-aminomethyl)-phenoxyacetamido-norleucyl-MBHA resin; loading 0.55 mmol/g). Fmoc-amino acids were used with a 4-fold excess on a 0.11 mM scale of the resin and coupled to the growing peptide chain using <i>N</i>,<i>N</i>′-diisopropylcarbodiimide and 1-hydroxybenzotriazole (DIC/HOBt, 4-fold excess) for 1 h at room temperature. Each Fmoc removal step was performed using 40% piperidine in <i>N</i>,<i>N</i>-dimethylformamide, and all the subsequent couplings were repeated until the desired peptide-bound resin was completed. The cleavage cocktail to obtain the peptides from the resin consisted of 95% trifluoroacetic acid, 2.5% water, and 2.5% triethylsilane, and cleavages were conducted for 3 h at room temperature. After filtration of the resin, diethyl ether was added to the filtrate to promote precipitation of the peptide products that were finally isolated by centrifugation. Reverse-phase purification of crude peptides was carried out on a Waters Prep 600 high-performance liquid chromatography (HPLC) system with a Jupiter column C18 (250 × 30 mm, 300 Å, 15 μm spherical particle size) using a gradient, programmed time by time, of acetonitrile/water [with 0.1% trifluoroacetic acid (TFA)] at a flow rate of 20 mL/min. Nonpeptide derivatives were purified through flash column chromatography using a Biotage System Isolera One. Analytical HPLC was performed with a Beckman 116 liquid chromatograph furnished of a UV detector. The purity of peptides in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> was assessed with a Symmetry C18 column (4.6 × 75 mm, 3.5 μm particle size, SYSTEM GOLD) at a flow rate of 0.5 mL/min using a linear gradient from 100% of A (water + 0.1% TFA) to 100% of B (acetonitrile + 0.1% TFA) over a period of 25 min. The purity of peptides in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Tables <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> was assessed with an Agilent Zorbax C18 column (4.6 × 150 mm, 3.5 μm particle size, KARAT32) at a flow rate of 0.7 mL/min using a linear gradient from 100% of A (water + 0.1% TFA) to 100% of B (acetonitrile + 0.1% TFA) over a period of 25 min. All final compounds were monitored at 220 nm showing ≥95% purity, and their molecular weights were confirmed using an ESI Micromass ZQ, Waters (HPLC chromatograms and ESI mass spectra of the final peptide derivatives have been reported in the <a href="/doi/suppl/10.1021/acs.jmedchem.0c02062/suppl_file/jm0c02062_si_001.pdf" class="ext-link">Supporting Information</a>). <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded for nonpeptide derivatives on a Varian 400 MHz instrument, and all experiments were performed in deuterated DMSO using its residual shifts as reference (s: singolet, d: doublet, dd: double doublet, t: triplet, m: multiplet).</div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> <i>In Vitro</i> Pharmacological Studies</h3><div id="sec5_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> Drugs and Reagents</h4><div class="NLM_p last">[<span class="smallcaps smallerCapital">D</span>-Pen<sup>2</sup>,D-Pen<sup>5</sup>]enkephalin (DPDPE) and naltrexone were purchased from Tocris Bioscience (Bristol, UK). Concentrated solutions (1 mM) were made in bidistilled water and kept at −20 °C until use. The medium and reagents for cell culture were from Euroclone (Milan, Italy). Fluo-4 AM and pluronic acid were from Invitrogen/ThermoFisher Scientific (Waltham, USA). <i>N</i>-(2-Hydroxyethyl)piperazine-<i>N</i>′-ethanesulfonic acid (HEPES), probenecid, brilliant black, and bovine serum albumin (BSA) fraction V were from Sigma-Aldrich (St. Louis, USA).</div></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> Calcium Mobilization Assay</h4><div class="NLM_p last">CHO cells stably coexpressing the human NOP or kappa or the mu receptor and the C-terminally modified G<sub>αqi5</sub> and CHO cells coexpressing the delta receptor and the G<sub>αqG66Di5</sub> protein were generated and cultured as described previously.<a onclick="showRef(event, 'ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref45 ref46">(45,46)</a> Cells were maintained in Dulbecco’s modified Eagle’s medium/nutrient mixture F-12 (DEMEM/F-12) supplemented with 10% FBS, 100 U/mL penicillin and 100 μg/mL streptomycin, 100 μg/mL hygromicin B, and 200 μg/mL G418 and cultured at 37 °C in 5% CO<sub>2</sub> humidified air. Cells were seeded at a density of 50,000 cells/well into 96-well black, clear-bottom plates. The following day, the cells were incubated with Hanks’ balanced salt solution (HBSS) supplemented with 2.5 mM probenecid, 3 μM of the calcium-sensitive fluorescent dye Fluo-4 AM, and 0.01% pluronic acid for 30 min at 37 °C. After that time, the loading solution was aspirated and 100 μL/well of HBSS supplemented with 20 mM HEPES, 2.5 mM probenecid, and 500 μM brilliant black was added. Serial dilutions were carried out in HBSS/HEPES (20 mM) buffer (containing 0.02% BSA fraction V). After placing both plates (cell culture and master plate) into the fluorometric imaging plate reader FlexStation II (Molecular Devices, Sunnyvale, CA), fluorescence changes were measured. On-line additions were carried out in a volume of 50 μL/well. To facilitate drug diffusion into the wells, the present studies were performed at 37 °C. Maximum change in fluorescence, expressed as percent over the baseline fluorescence, was used to determine agonist response.</div></div><div id="sec5_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> DMR Assay</h4><div class="NLM_p last">CHO cells stably expressing the human NOP and mu receptors were kindly provided by D.G. Lambert (University of Leicester, UK). Cells were cultured in DMEM/F-12 medium supplemented with 10% FBS, 100 U/mL penicillin, 100 μg/mL streptomycin, and 2 mmol/L <span class="smallcaps smallerCapital">l</span>-glutamine. The medium was supplemented with 400 μg/mL G418 to maintain expression. Cells were cultured at 37 °C in 5% CO<sub>2</sub> humidified air. For DMR measurements, the label-free EnSight Multimode Plate Reader (Perkin Elmer, MA, US) was used. Cells were seeded 15,000 cells/well in a volume of 30 μL onto fibronectin-coated 384-well DMR microplates and cultured for 20 h to obtain confluent monolayers. Cells were starved in the assay buffer (HBSS with 20 mM HEPES, 0.01% BSA fraction V) for 90 min before the test. Serial dilutions were made in the assay buffer. After reading the baseline, compounds were added in a volume of 10 μL; then, DMR changes were recorded for 60 min. Responses were described as picometer (pm) shifts over time (sec) following subtraction of values from vehicle-treated wells. Maximum picometer (pm) modification (peak) was used to generate concentration response curves. All the experiments were carried out at 37 °C.</div></div><div id="sec5_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> Data Analysis and Terminology</h4><div class="NLM_p">The pharmacological terminology adopted in this paper is consistent with IUPHAR recommendations.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> All data are expressed as the mean ± standard error of the mean (SEM) of at least three experiments performed in duplicate. For potency values, 95% confidence limits (CL<sub>95%</sub>) were indicated. Agonist potencies are given as pEC<sub>50</sub>, that is, the negative logarithm to base 10 of the molar concentration of an agonist that produces 50% of the maximal effect of that agonist. Concentration-response curves to agonists were fitted to the classical four-parameter logistic nonlinear regression model:</div><div class="NLM_p last">Effect = Baseline + (<i>E</i><sub>max</sub> – Baseline)/(1 + 10<sup>(LogEC<sub>50</sub> – Log[compound]) × Hillslope</sup>). Curve fitting was performed using PRISM 6.0 (GraphPad Software Inc., San Diego).</div></div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Molecular Dynamics</h3><div class="NLM_p">The setup of an <i>in silico</i> model of the non-natural peptides [Dmt<sup>1,5</sup>] N/OFQ(1-9)-NH<sub>2</sub> and N/OFQ(1-9)-NH<sub>2</sub> in complex with the human mu receptor has been described in the <a href="/doi/suppl/10.1021/acs.jmedchem.0c02062/suppl_file/jm0c02062_si_001.pdf" class="ext-link">Supporting Information</a>. Classical MD simulations of these two receptor-peptide complexes were performed and compared with an MD simulation of the experimental system DAMGO-mu receptor-G<sub>i</sub> protein complex as derived by the PDB file 6DDF.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The GROMACS 2018.3 package<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> was used under the AMBER parm99sb force field<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> at the full atomistic level using a TIP3P water solvent and an explicit pre-equilibrated phospholipid bilayer of 128 POPC (1-palmitoyl-2-oleoyl-<i>sn</i>-glycero-3-phosphocholine) molecules obtained by the Prof. Tieleman website (<a href="http://moose.bio.ucalgary.ca" class="extLink">http://moose.bio.ucalgary.ca</a>). All the MD sessions were performed in a water–membrane system prepared as previously described.<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31,32)</a> The receptor-peptide-membrane systems were solvated in a triclinic water box (having basis vector lengths of 7, 7.4, and 9.3 nm) under periodic boundary conditions for a total number of about 45,000 atoms (6400 solvent molecules). The total charge of the system was neutralized by randomly substituting water molecules with Na<sup>+</sup> ions and Cl<sup>–</sup> ions to obtain neutrality with a 0.15M salt concentration. Following a steepest descent minimization algorithm, the system was equilibrated under canonical ensemble (<i>NVT</i>) conditions for 300 ps using a V-rescale, modified Berendsen thermostat with position restrains for both the receptor-peptide complex and the lipids and thereafter in a isothermal–isobaric ensemble (<i>NPT</i>) for 500 ps, applying position restraints to the heavy atoms of the protein-peptide complex, and using a Nose–Hoover thermostat and a Parrinello-Rahman barostat at 1 atm with a relaxation time of 2.0 ps. The MD simulation of the mu receptor-DAMGO-G<sub>i</sub> protein was carried out on the whole ternary complex without positional restraints. On the other hand, in order to reduce the computational time, in the two mu receptor-peptide complexes, the G<sub>i</sub> protein was not included in the system, but all residues within 5 Å of the G<sub>i</sub> protein interface were restrained to the initial structure of the activated receptor using 5.0 kcal mol<sup>–1</sup> Å<sup>–2</sup> harmonic restraints applied to non-hydrogen atoms. Using such restraints ensures that the receptor maintains an active conformation throughout the simulation. MD runs were performed under <i>NPT</i> conditions at 300 K with a T-coupling constant of 1 ps. van der Waals interactions were modeled using a 6–12 Lennard-Jones potential with a 1.2 nm cutoff. Long-range electrostatic interactions were calculated, with a cutoff for the real space term of 1.2 nm. All covalent bonds were constrained using the LINCS algorithm. The time step employed was 2 fs, and the coordinates were saved every 5 ps for analysis.</div><div class="NLM_p">The MD analysis of the DAMGO-mu receptor-G<sub>i</sub> protein complex (<a href="/doi/suppl/10.1021/acs.jmedchem.0c02062/suppl_file/jm0c02062_si_001.pdf" class="ext-link">Figure S1</a>) shows an overall stability of the starting configuration (corresponding to the crystal structure) with some motion of the phenolic head toward the intracellular side of the receptor, still conserving the water bridge contact with H<sup>297</sup>. A non-negligible rearrangement is observed (<a href="/doi/suppl/10.1021/acs.jmedchem.0c02062/suppl_file/jm0c02062_si_001.pdf" class="ext-link">Figures S2 and S3</a>) along the MD sessions, starting from the docked conformations of [Dmt<sup>1,5</sup>]N/OFQ(1-9)-NH<sub>2</sub> and N/OFQ(1-9)-NH<sub>2</sub>, probably due to the limitations of the docking procedures applied to molecules with a large number of torsions, and confirms the importance of performing long-lasting MD sessions. Analysis of MD trajectories was performed using state-of-the-art computational tools, as described in the <a href="/doi/suppl/10.1021/acs.jmedchem.0c02062/suppl_file/jm0c02062_si_001.pdf" class="ext-link">Supporting Information</a>.</div><div id="sec5_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> Artwork</h4><div class="NLM_p last">3D images of peptide-receptor structures were obtained by the Chimera software.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a></div></div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> <i>In Vivo</i> Pharmacological Studies</h3><div id="sec5_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> Animals</h4><div class="NLM_p last">Guinea pigs (Dunkin Hartley, male, 400–450 g, Charles River, Milan, Italy) were used. The group size of <i>n</i> = 6 animals was determined by sample size estimation using G*Power (v3.1)<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> to detect the size effect in a post-hoc test with type 1 and 2 error rates of 5 and 20%, respectively. Allocation concealment to the vehicle(s) or treatment group was performed using a randomization procedure (<a href="http://www.randomizer.org/" class="extLink">http://www.randomizer.org/</a>). The assessors were blinded to the identity (allocation to the treatment group) of the animals. Guinea pigs were housed in a temperature- and humidity-controlled vivarium (12 h dark/light cycle, free access to food and water) for at least 1 week before the start of the experiments. Cough experiments were done in a quiet, temperature-controlled (20–22 °C) room between 9 am and 5 pm and were performed by an operator blinded to the treatment. All experiments were carried out according to the European Union (EU) guidelines for animal care procedures and the Italian legislation (DLgs 26/2014) application of the EU Directive 2010/63/EU. All animal studies were approved by the Animal Ethics Committee of the University of Florence and the Italian Ministry of Health (permit #450/2019-PR) and followed the animal research reporting <i>in vivo</i> experiment (ARRIVE) guidelines.</div></div><div id="sec5_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> Measurement of Cough in Conscious Guinea Pigs</h4><div class="NLM_p">Cough experiments were performed using a whole-body plethysmography system (Buxco, Wilmington, NC, USA, upgraded version 2018).<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> The apparatus consists of four plethysmographs (four transparent Perspex chambers) ventilated with a constant airflow and each provided by a nebulizing head (Aerogen) and adjustable bias flow rates for acclimation and nebulization. The particle size presents an aerodynamic mass median diameter of 6 μm, and the output of the nebulizing heads can be set in the range between 0 and 0.4 mL per minute. The number of elicited coughs was automatically counted using the instrument. The nebulization rate used in the following experiments was 0.15 mL/min, and the air flows were 1750 mL/min during the acclimation phase and 800 mL/min during nebulization. These rates were previously found in our lab to elicit a significant number of cough events in the citric acid-induced cough model.</div><div class="NLM_p">On the day of experiments, guinea pigs were individually placed into the chambers and let to acclimate for 10 min. To test the antitussive effect of [Dmt<sup>1,5</sup>]N/OFQ(1-13)-NH<sub>2</sub>, two different protocols were used. Protocol 1: after acclimation, a mixture of [Dmt<sup>1,5</sup>]N/OFQ(1-13)-NH<sub>2</sub> (1 mM) or its vehicle (0.9% NaCl) and the tussive agent, citric acid (0.4 M), was nebulized for 10 min. During the 10 min of nebulization and for 5 min immediately post challenge (recovery period), the number of elicited coughs was automatically recorded using the BUXCO system. Protocol 2: after acclimation, [Dmt<sup>1,5</sup>]N/OFQ(1-13)-NH<sub>2</sub> (1 mM) or its vehicle (0.9% NaCl) was nebulized for 10 min. After 20 min of recovery, the tussive agent, citric acid (0.4 M), was delivered by aerosol via a nebulizer for 10 min. During the 10 min of the citric acid challenge and 5 min immediately post challenge (recovery period), the number of elicited coughs was automatically recorded using the BUXCO system.</div><div class="NLM_p last">For the <i>in vivo</i> experiment, the statistical significance of differences between groups was assessed using Student’s <i>t</i>-test.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27"><a href="/doi/suppl/10.1021/acs.jmedchem.0c02062" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51104" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51104" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c02062?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c02062</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Synthesis of Fmoc-2′,6′-dimethyltyrosine; synthetic procedures for the preparation of Fmoc-2′,6′-dimethyltyrosine; structures of nonproteinogenic amino acids; HPLC chromatograms and ESI mass spectra of the final peptide derivatives; model setup of non-natural peptides for MD; model setup of the mu receptor; model setup of the peptide-mu receptor complexes; and analysis of MD trajectories (<a href="/doi/suppl/10.1021/acs.jmedchem.0c02062/suppl_file/jm0c02062_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.0c02062/suppl_file/jm0c02062_si_002.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Model coordinates: representative structure of the [Dmt<sup>1,5</sup>]N/OFQ(1-9)-NH<sub>2</sub>-mu receptor complex (<a href="/doi/suppl/10.1021/acs.jmedchem.0c02062/suppl_file/jm0c02062_si_003.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Model coordinates: representative structure of the N/OFQ(1-9)NH<sub>2</sub>-mu receptor complex (<a href="/doi/suppl/10.1021/acs.jmedchem.0c02062/suppl_file/jm0c02062_si_004.pdb" class="ext-link">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c02062/suppl_file/jm0c02062_si_001.pdf">jm0c02062_si_001.pdf (3.63 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c02062/suppl_file/jm0c02062_si_002.csv">jm0c02062_si_002.csv (10.33 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c02062/suppl_file/jm0c02062_si_003.pdb">jm0c02062_si_003.pdb (187.16 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c02062/suppl_file/jm0c02062_si_004.pdb">jm0c02062_si_004.pdb (201.74 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c02062" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48503" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48503" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chiara Ruzza</span> - <span class="hlFld-Affiliation affiliation">Department
of Neuroscience and Rehabilitation, Section of Pharmacology, University of Ferrara, Via Fossato di Mortara 17/19, Ferrara 44121, Italy</span>; 
    <span class="hlFld-Affiliation affiliation">Technopole
of Ferrara, LTTA Laboratory for Advanced Therapies, via Fossato di Mortara 70, Ferrara 44121, Italy</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#c3a0abaaa2b1a2edb1b6b9b9a283b6adaaa5a6edaab7"><span class="__cf_email__" data-cfemail="a0c3c8c9c1d2c18ed2d5dadac1e0d5cec9c6c58ec9d4">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Delia Preti</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Via Luigi Borsari 46, Ferrara 44121, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-1075-3781" title="Orcid link">https://orcid.org/0000-0002-1075-3781</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#7c181910151d520c0e1908153c0912151a19521508"><span class="__cf_email__" data-cfemail="acc8c9c0c5cd82dcdec9d8c5ecd9c2c5cac982c5d8">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefano Della Longa</span> - <span class="hlFld-Affiliation affiliation">Department
of Life, Health and Environmental Sciences, University of L’Aquila, Pza S. Tommasi 1, L’Aquila 67100, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-8157-9530" title="Orcid link">https://orcid.org/0000-0002-8157-9530</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#4536312023242b2a6b2120292924292a2b222405302b2c3324346b2c31"><span class="__cf_email__" data-cfemail="1063647576717e7f3e74757c7c717c7f7e777150657e796671613e7964">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Salvatore Pacifico</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Via Luigi Borsari 46, Ferrara 44121, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-3377-5107" title="Orcid link">https://orcid.org/0000-0002-3377-5107</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Valentina Albanese</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Via Luigi Borsari 46, Ferrara 44121, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Davide Illuminati</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Via Luigi Borsari 46, Ferrara 44121, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Erika Marzola</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Via Luigi Borsari 46, Ferrara 44121, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martina Fabbri</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Via Luigi Borsari 46, Ferrara 44121, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Federica Ferrari</span> - <span class="hlFld-Affiliation affiliation">Department
of Neuroscience and Rehabilitation, Section of Pharmacology, University of Ferrara, Via Fossato di Mortara 17/19, Ferrara 44121, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Victor A.D. Holanda</span> - <span class="hlFld-Affiliation affiliation">Department
of Neuroscience and Rehabilitation, Section of Pharmacology, University of Ferrara, Via Fossato di Mortara 17/19, Ferrara 44121, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chiara Sturaro</span> - <span class="hlFld-Affiliation affiliation">Department
of Neuroscience and Rehabilitation, Section of Pharmacology, University of Ferrara, Via Fossato di Mortara 17/19, Ferrara 44121, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Davide Malfacini</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical and Pharmacological Sciences, University of Padova, Largo Meneghetti 2, Padova 35131, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Claudio Trapella</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Via Luigi Borsari 46, Ferrara 44121, Italy</span>; 
    <span class="hlFld-Affiliation affiliation">Technopole
of Ferrara, LTTA Laboratory for Advanced Therapies, via Fossato di Mortara 70, Ferrara 44121, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ettore Lo Cascio</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Scienze Biotecnologiche di Base, Cliniche Intensivologiche e Perioperatorie, Università Cattolica del Sacro Cuore, Largo F. Vito 1, Roma 00168, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alessandro Arcovito</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Scienze Biotecnologiche di Base, Cliniche Intensivologiche e Perioperatorie, Università Cattolica del Sacro Cuore, Largo F. Vito 1, Roma 00168, Italy</span>; 
    <span class="hlFld-Affiliation affiliation">Fondazione
Policlinico Universitario A. Gemelli IRCCS, Largo F. Vito 1, Roma 00168, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martina Marangoni</span> - <span class="hlFld-Affiliation affiliation">Department
of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Viale Pieraccini, 6, Florence 50139, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Davide Fattori</span> - <span class="hlFld-Affiliation affiliation">Department
of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Viale Pieraccini, 6, Florence 50139, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Romina Nassini</span> - <span class="hlFld-Affiliation affiliation">Department
of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Viale Pieraccini, 6, Florence 50139, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Girolamo Calò</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical and Pharmacological Sciences, University of Padova, Largo Meneghetti 2, Padova 35131, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Remo Guerrini</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Via Luigi Borsari 46, Ferrara 44121, Italy</span>; 
    <span class="hlFld-Affiliation affiliation">Technopole
of Ferrara, LTTA Laboratory for Advanced Therapies, via Fossato di Mortara 70, Ferrara 44121, Italy</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): S.P., V.A., D.I., C.T., E.M., C.R., D.P., G.C., and R.G. are inventors of the patent application (102020000025972) focused on NOP/mu mixed agonists. G.C. and R.G. are founders of the University of Ferrara spin off company UFPeptides s.r.l., the assignee of such patent application. C.R. is CEO of UFPeptides s.r.l.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i28">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12317" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12317" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">FAR (Fondo di Ateneo per la Ricerca Scientifica) grants from the University of Ferrara support D.P., C.R., G.C., and R.G. C.R. is supported by an FIR (Fondo per l’Incentivazione alla Ricerca) grant from the University of Ferrara. S.P., F.F., D.P., G.C., and R.G. are supported by the grant PRIN 2015 (Prot. 2015WX8Y5B_002) from the Italian Ministry of Research and Education.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">CHO cells</td><td class="NLM_def"><p class="first last">chinese hamster ovary cells</p></td></tr><tr><td class="NLM_term">CL<sub>95%</sub></td><td class="NLM_def"><p class="first last">95% confidence limits</p></td></tr><tr><td class="NLM_term">CR</td><td class="NLM_def"><p class="first last">concentration ratio</p></td></tr><tr><td class="NLM_term">crc</td><td class="NLM_def"><p class="first last">concentration–response curve</p></td></tr><tr><td class="NLM_term">DAMGO</td><td class="NLM_def"><p class="first last">[<span class="smallcaps smallerCapital">D</span>-Ala<sup>2</sup>, <i>N</i>-MePhe<sup>4</sup>, Gly-ol]-enkephalin</p></td></tr><tr><td class="NLM_term">DIC</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>′-diisopropylcarbodiimide</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DMEM/F-12</td><td class="NLM_def"><p class="first last">Dulbecco’s modified Eagle’s medium/nutrient mixture F-12</p></td></tr><tr><td class="NLM_term">DMR</td><td class="NLM_def"><p class="first last">dynamic mass redistribution</p></td></tr><tr><td class="NLM_term">DPDPE</td><td class="NLM_def"><p class="first last">[<span class="smallcaps smallerCapital">D</span>-Pen<sup>2</sup>,D-Pen<sup>5</sup>]enkephalin</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">FBS</td><td class="NLM_def"><p class="first last">fetal bovine serum</p></td></tr><tr><td class="NLM_term">FmocCl</td><td class="NLM_def"><p class="first last">Fmoc chloride</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last">hexafluorophosphate azabenzotriazole tetramethyl uronium</p></td></tr><tr><td class="NLM_term">HBSS</td><td class="NLM_def"><p class="first last">Hanks’ balanced salt solution</p></td></tr><tr><td class="NLM_term">LINCS</td><td class="NLM_def"><p class="first last">LINear Constraint Solver</p></td></tr><tr><td class="NLM_term">MBHA resin</td><td class="NLM_def"><p class="first last">4-methylbenzhydrylamine resin</p></td></tr><tr><td class="NLM_term">N/OFQ</td><td class="NLM_def"><p class="first last">nociceptin/orphanin FQ</p></td></tr><tr><td class="NLM_term"><i>NPT</i></td><td class="NLM_def"><p class="first last">isothermal–isobaric ensemble</p></td></tr><tr><td class="NLM_term"><i>NVT</i></td><td class="NLM_def"><p class="first last">canonical ensemble conditions</p></td></tr><tr><td class="NLM_term">PWT</td><td class="NLM_def"><p class="first last">peptide welding technology</p></td></tr><tr><td class="NLM_term">SEM</td><td class="NLM_def"><p class="first last">standard error of the mean</p></td></tr><tr><td class="NLM_term">SPPS</td><td class="NLM_def"><p class="first last">solid-phase peptide synthesis</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i30">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56730" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56730" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 64 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meunier, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollereau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toll, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suaudeau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moisand, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvinerie, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butour, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillemot, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrara, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monsarrat, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazarguil, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vassart, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmentier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costentin, J.</span></span> <span> </span><span class="NLM_article-title">Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>377</i></span>,  <span class="NLM_fpage">532</span>– <span class="NLM_lpage">535</span>, <span class="refDoi"> DOI: 10.1038/377532a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1038%2F377532a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=7566152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADyaK2MXoslWltr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=377&publication_year=1995&pages=532-535&author=J.-C.+Meunierauthor=C.+Mollereauauthor=L.+Tollauthor=C.+Suaudeauauthor=C.+Moisandauthor=P.+Alvinerieauthor=J.+L.+Butourauthor=J.+C.+Guillemotauthor=P.+Ferraraauthor=B.+Monsarratauthor=H.+Mazarguilauthor=G.+Vassartauthor=M.+Parmentierauthor=J.+Costentin&title=Isolation+and+structure+of+the+endogenous+agonist+of+opioid+receptor-like+ORL1+receptor&doi=10.1038%2F377532a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor</span></div><div class="casAuthors">Meunier, Jean-Claude; Mollereau, Catherine; Toll, Lawrence; Suaudeau, Charles; Moisand, Christiane; Alvinerie, Paul; Butour, Jean-Luc; Guillemot, Jean-Claude; Ferrara, Pascual; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">377</span>
        (<span class="NLM_cas:issue">6549</span>),
    <span class="NLM_cas:pages">532-5</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">The ORL1 receptor, an orphan receptor whose human and murine complementary DNAs have recently been characterized, structurally resembles opioid receptors and is neg. coupled with adenylate cyclase.  ORL1 transcripts are particularly abundant in the central nervous system.  Here the authors report the isolation, on the basis of its ability to inhibit the cyclase in a stable recombinant CHO(ORL1+) cell line, of a neuropeptide that resembles dynorphin A and whose amino acid sequences is Phe-Gly-Gly-Phe-Thr-Gly-Ala-Arg-Lys-Ser-Ala-Arg-Lys-Leu-Ala-Asn-Gln.  A rat-brain cDNA encodes the peptide flanked by Lys-Arg proteolytic cleavage motifs.  The synthetic heptadecapeptide potently inhibits adenylate cyclase in CHO(ORL1+) cells in culture and induces hyperalgesia when administered intracerebroventricularly to mice.  Taken together, these data indicate that the newly discovered heptadecapeptide is an endogenous agonist of the ORL1 receptor and that it may be endowed with pro-nociceptive properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-Ma-3fqZODbVg90H21EOLACvtfcHk0lh1ZftQnaQDtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXoslWltr4%253D&md5=664f5b56671b66e3c7caee4d2acc4a5b</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2F377532a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F377532a0%26sid%3Dliteratum%253Aachs%26aulast%3DMeunier%26aufirst%3DJ.-C.%26aulast%3DMollereau%26aufirst%3DC.%26aulast%3DToll%26aufirst%3DL.%26aulast%3DSuaudeau%26aufirst%3DC.%26aulast%3DMoisand%26aufirst%3DC.%26aulast%3DAlvinerie%26aufirst%3DP.%26aulast%3DButour%26aufirst%3DJ.%2BL.%26aulast%3DGuillemot%26aufirst%3DJ.%2BC.%26aulast%3DFerrara%26aufirst%3DP.%26aulast%3DMonsarrat%26aufirst%3DB.%26aulast%3DMazarguil%26aufirst%3DH.%26aulast%3DVassart%26aufirst%3DG.%26aulast%3DParmentier%26aufirst%3DM.%26aulast%3DCostentin%26aufirst%3DJ.%26atitle%3DIsolation%2520and%2520structure%2520of%2520the%2520endogenous%2520agonist%2520of%2520opioid%2520receptor-like%2520ORL1%2520receptor%26jtitle%3DNature%26date%3D1995%26volume%3D377%26spage%3D532%26epage%3D535%26doi%3D10.1038%2F377532a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reinscheid, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nothacker, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ardati, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henningsen, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunzow, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grandy, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monsma, F. J.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Civelli, O.</span></span> <span> </span><span class="NLM_article-title">Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>270</i></span>,  <span class="NLM_fpage">792</span>– <span class="NLM_lpage">794</span>, <span class="refDoi"> DOI: 10.1126/science.270.5237.792</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1126%2Fscience.270.5237.792" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=7481766" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADyaK2MXptV2isr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1995&pages=792-794&author=R.+K.+Reinscheidauthor=H.+P.+Nothackerauthor=A.+Boursonauthor=A.+Ardatiauthor=R.+A.+Henningsenauthor=J.+R.+Bunzowauthor=D.+K.+Grandyauthor=H.+Langenauthor=F.+J.+Monsmaauthor=O.+Civelli&title=Orphanin+FQ%3A+a+neuropeptide+that+activates+an+opioidlike+G+protein-coupled+receptor&doi=10.1126%2Fscience.270.5237.792"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor</span></div><div class="casAuthors">Reinscheid, Rainer K.; Nothacker, Hans-Peter; Bourson, Anne; Ardati, Ali; Henningsen, Robert A.; Bunzow, James R.; Grady, David K.; Langen, Hanno; Monsma, Frederick J., Jr.; Civelli, Olivier</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">270</span>
        (<span class="NLM_cas:issue">5237</span>),
    <span class="NLM_cas:pages">792-4</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A heptadecapeptide was identified and purified from porcine brain tissue as a ligand for an orphan heterotrimeric GTP-binding protein (G protein)- coupled receptor (LC132) that is similar in sequence to opioid receptors.  This peptide, orphanin FQ, has a primary structure reminiscent of that of opioid peptides.  Nanomolar concns. of orphanin FQ inhibited forskolin-stimulated adenylyl cyclase activity in cells transfected with LC132.  This inhibitory activity was not affected by the addn. of opioid ligands, nor did the peptide activate opioid receptors.  Orphanin FQ bound to its receptor in a saturable manner and with high affinity.  When injected intracerebroventricularly into mice, orphanin FQ caused a decrease in locomotor activity but did not induce analgesia in the hot-plate test.  However, the peptide produced hyperalgesia in the tail-flick assay.  Thus, orphanin FQ may act as a transmitter in the brain by modulating nociceptive and locomotor behavior.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpERb2sP0w_6bVg90H21EOLACvtfcHk0liHvRzH0czPlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXptV2isr4%253D&md5=64b046d1497af57d0841c0de710dcad5</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1126%2Fscience.270.5237.792&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.270.5237.792%26sid%3Dliteratum%253Aachs%26aulast%3DReinscheid%26aufirst%3DR.%2BK.%26aulast%3DNothacker%26aufirst%3DH.%2BP.%26aulast%3DBourson%26aufirst%3DA.%26aulast%3DArdati%26aufirst%3DA.%26aulast%3DHenningsen%26aufirst%3DR.%2BA.%26aulast%3DBunzow%26aufirst%3DJ.%2BR.%26aulast%3DGrandy%26aufirst%3DD.%2BK.%26aulast%3DLangen%26aufirst%3DH.%26aulast%3DMonsma%26aufirst%3DF.%2BJ.%26aulast%3DCivelli%26aufirst%3DO.%26atitle%3DOrphanin%2520FQ%253A%2520a%2520neuropeptide%2520that%2520activates%2520an%2520opioidlike%2520G%2520protein-coupled%2520receptor%26jtitle%3DScience%26date%3D1995%26volume%3D270%26spage%3D792%26epage%3D794%26doi%3D10.1126%2Fscience.270.5237.792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Toll, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruchas, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calò, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaveri, N. T.</span></span> <span> </span><span class="NLM_article-title">Nociceptin/Orphanin FQ receptor structure, signaling, ligands, functions, and interactions with opioid systems</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">419</span>– <span class="NLM_lpage">457</span>, <span class="refDoi"> DOI: 10.1124/pr.114.009209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1124%2Fpr.114.009209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=26956246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A280%3ADC%252BC28josFaltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2016&pages=419-457&author=L.+Tollauthor=M.+R.+Bruchasauthor=G.+Cal%C3%B2author=B.+M.+Coxauthor=N.+T.+Zaveri&title=Nociceptin%2FOrphanin+FQ+receptor+structure%2C+signaling%2C+ligands%2C+functions%2C+and+interactions+with+opioid+systems&doi=10.1124%2Fpr.114.009209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems</span></div><div class="casAuthors">Toll Lawrence; Bruchas Michael R; Calo' Girolamo; Cox Brian M; Zaveri Nurulain T</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">419-57</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The NOP receptor (nociceptin/orphanin FQ opioid peptide receptor) is the most recently discovered member of the opioid receptor family and, together with its endogenous ligand, N/OFQ, make up the fourth members of the opioid receptor and opioid peptide family.  Because of its more recent discovery, an understanding of the cellular and behavioral actions induced by NOP receptor activation are less well developed than for the other members of the opioid receptor family.  All of these factors are important because NOP receptor activation has a clear modulatory role on mu opioid receptor-mediated actions and thereby affects opioid analgesia, tolerance development, and reward.  In addition to opioid modulatory actions, NOP receptor activation has important effects on motor function and other physiologic processes.  This review discusses how NOP pharmacology intersects, contrasts, and interacts with the mu opioid receptor in terms of tertiary structure and mechanism of receptor activation; location of receptors in the central nervous system; mechanisms of desensitization and downregulation; cellular actions; intracellular signal transduction pathways; and behavioral actions with respect to analgesia, tolerance, dependence, and reward.  This is followed by a discussion of the agonists and antagonists that have most contributed to our current knowledge.  Because NOP receptors are highly expressed in brain and spinal cord and NOP receptor activation sometimes synergizes with mu receptor-mediated actions and sometimes opposes them, an understanding of NOP receptor pharmacology in the context of these interactions with the opioid receptors will be crucial to the development of novel therapeutics that engage the NOP receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT4KujB2a63gCEJCPKhJPuqfW6udTcc2eYMuoJBRbg2Abntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28josFaltw%253D%253D&md5=2a2c601fcd493fa3f67b0adee9259e02</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1124%2Fpr.114.009209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.114.009209%26sid%3Dliteratum%253Aachs%26aulast%3DToll%26aufirst%3DL.%26aulast%3DBruchas%26aufirst%3DM.%2BR.%26aulast%3DCal%25C3%25B2%26aufirst%3DG.%26aulast%3DCox%26aufirst%3DB.%2BM.%26aulast%3DZaveri%26aufirst%3DN.%2BT.%26atitle%3DNociceptin%252FOrphanin%2520FQ%2520receptor%2520structure%252C%2520signaling%252C%2520ligands%252C%2520functions%252C%2520and%2520interactions%2520with%2520opioid%2520systems%26jtitle%3DPharmacol.%2520Rev.%26date%3D2016%26volume%3D68%26spage%3D419%26epage%3D457%26doi%3D10.1124%2Fpr.114.009209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, D. G.</span></span> <span> </span><span class="NLM_article-title">The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">694</span>– <span class="NLM_lpage">710</span>, <span class="refDoi"> DOI: 10.1038/nrd2572</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1038%2Fnrd2572" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=18670432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptFOqsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=694-710&author=D.+G.+Lambert&title=The+nociceptin%2Forphanin+FQ+receptor%3A+a+target+with+broad+therapeutic+potential&doi=10.1038%2Fnrd2572"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential</span></div><div class="casAuthors">Lambert, David G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">694-710</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  In this Review, Lambert describes the physiol. and potential clin. applications of nociceptin/orphanin FQ and its receptor.  This peptide-receptor system has been implicated in a wide range of biol. functions such as pain, drug abuse, cardiovascular control and immunity.  Identification of the enigmatic nociceptin/orphanin FQ peptide (N/OFQ) in 1995 represented the first successful use of reverse pharmacol. and led to deorphanization of the N/OFQ receptor (NOP).  Subsequently, the N/OFQ-NOP system has been implicated in a wide range of biol. functions, including pain, drug abuse, cardiovascular control and immunity.  Although this could be considered a hurdle for the development of pharmaceuticals selective for a specific disease indication, NOP represents a viable drug target.  This article describes potential clin. indications and highlights the current status of the very limited no. of clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuID92HZwUB7Vg90H21EOLACvtfcHk0liHvRzH0czPlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptFOqsL0%253D&md5=46c1952ed4a0ac1aa7779276bda5bba6</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrd2572&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2572%26sid%3Dliteratum%253Aachs%26aulast%3DLambert%26aufirst%3DD.%2BG.%26atitle%3DThe%2520nociceptin%252Forphanin%2520FQ%2520receptor%253A%2520a%2520target%2520with%2520broad%2520therapeutic%2520potential%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2008%26volume%3D7%26spage%3D694%26epage%3D710%26doi%3D10.1038%2Fnrd2572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schröder, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, T.</span></span> <span> </span><span class="NLM_article-title">Functional plasticity of the N/OFQ-NOP receptor system determines analgesic properties of NOP receptor agonists</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>171</i></span>,  <span class="NLM_fpage">3777</span>– <span class="NLM_lpage">3800</span>, <span class="refDoi"> DOI: 10.1111/bph.12744</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1111%2Fbph.12744" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=24762001" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A280%3ADC%252BC2cnmsVensg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2014&pages=3777-3800&author=W.+Schr%C3%B6derauthor=D.+G.+Lambertauthor=M.+C.+Koauthor=T.+Koch&title=Functional+plasticity+of+the+N%2FOFQ-NOP+receptor+system+determines+analgesic+properties+of+NOP+receptor+agonists&doi=10.1111%2Fbph.12744"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Functional plasticity of the N/OFQ-NOP receptor system determines analgesic properties of NOP receptor agonists</span></div><div class="casAuthors">Schroder W; Lambert D G; Ko M C; Koch T</div><div class="citationInfo"><span class="NLM_cas:title">British journal of pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3777-800</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Despite high sequence similarity between NOP (nociceptin/orphanin FQ opioid peptide) and opioid receptors, marked differences in endogenous ligand selectivity, signal transduction, phosphorylation, desensitization, internalization and trafficking have been identified; underscoring the evolutionary difference between NOP and opioid receptors.  Activation of NOP receptors affects nociceptive transmission in a site-specific manner, with antinociceptive effects prevailing after peripheral and spinal activation, and pronociceptive effects after supraspinal activation in rodents.  The net effect of systemically administered NOP receptor agonists on nociception is proposed to depend on the relative contribution of peripheral, spinal and supraspinal activation, and this may depend on experimental conditions.  Functional expression and regulation of NOP receptors at peripheral and central sites of the nociceptive pathway exhibits a high degree of plasticity under conditions of neuropathic and inflammatory pain.  In rodents, systemically administered NOP receptor agonists exerted antihypersensitive effects in models of neuropathic and inflammatory pain.  However, they were largely ineffective in acute pain while concomitantly evoking severe motor side effects.  In contrast, systemic administration of NOP receptor agonists to non-human primates (NHPs) exerted potent and efficacious antinociception in the absence of motor and sedative side effects.  The reason for this species difference with respect to antinociceptive efficacy and tolerability is not clear.  Moreover, co-activation of NOP and μ-opioid peptide (MOP) receptors synergistically produced antinociception in NHPs.  Hence, both selective NOP receptor as well as NOP/MOP receptor agonists may hold potential for clinical use as analgesics effective in conditions of acute and chronic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRKk8UmQyPtHQ8IxFYvehhofW6udTcc2eYMuoJBRbg2Abntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cnmsVensg%253D%253D&md5=04241ff79c2ff0853c7a4513961d0648</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1111%2Fbph.12744&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12744%26sid%3Dliteratum%253Aachs%26aulast%3DSchr%25C3%25B6der%26aufirst%3DW.%26aulast%3DLambert%26aufirst%3DD.%2BG.%26aulast%3DKo%26aufirst%3DM.%2BC.%26aulast%3DKoch%26aufirst%3DT.%26atitle%3DFunctional%2520plasticity%2520of%2520the%2520N%252FOFQ-NOP%2520receptor%2520system%2520determines%2520analgesic%2520properties%2520of%2520NOP%2520receptor%2520agonists%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2014%26volume%3D171%26spage%3D3777%26epage%3D3800%26doi%3D10.1111%2Fbph.12744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Toll, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozawa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cippitelli, A.</span></span> <span> </span><span class="NLM_article-title">NOP-related mechanisms in pain and analgesia</span>. <i>Handb. Exp. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>254</i></span>,  <span class="NLM_fpage">165</span>– <span class="NLM_lpage">186</span>, <span class="refDoi"> DOI: 10.1007/164_2019_214</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1007%2F164_2019_214" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=31119465" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmtlGlurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=254&publication_year=2019&pages=165-186&author=L.+Tollauthor=A.+Ozawaauthor=A.+Cippitelli&title=NOP-related+mechanisms+in+pain+and+analgesia&doi=10.1007%2F164_2019_214"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">NOP-Related Mechanisms in Pain and Analgesia</span></div><div class="casAuthors">Toll, Lawrence; Ozawa, Akihiko; Cippitelli, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">254</span>
        (<span class="NLM_cas:issue">Nociceptin/Orphanin FQ Peptide Receptor</span>),
    <span class="NLM_cas:pages">165-186</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">1865-0325</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  Since the discovery of the NOP receptor and N/OFQ as the endogenous ligand, evidence has appeared demonstrating the involvement of this receptor system in pain.  However, as data accumulated, it became clear that not only the potency but the activity per se was different when N/OFQ or small mol. NOP agonists were administered in the brain vs. the spinal cord and it also depended upon the pain assay used.  When administered systemically, NOP receptor agonists are generally ineffective in attenuating heat pain but are antinociceptive in an acute inflammatory pain model.  Most antagonists administered systemically have no antinociceptive activity of their own, even though selective peptide NOP antagonists have potent antinociceptive activity when administered i.c.v.  Chronic pain models provide different results as well, as small mol. NOP receptor agonists have potent anti-allodynic and anti-hyperalgesic activity after systemic administration.  A considerable no. of electrophysiol. and anatomical expts., in particular with NOP-eGFP mice, have been conducted in an attempt to explain the complicated profile resulting from NOP receptor modulation, to examine receptor plasticity, and to elucidate mechanisms by which selective NOP agonists, bifunctional NOP/mu agonists, or NOP receptor antagonists modulate acute and chronic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgJGQSmP8Q77Vg90H21EOLACvtfcHk0lgNXo5EHfdEyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmtlGlurk%253D&md5=c018e446413a389756f637094ab3f086</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1007%2F164_2019_214&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F164_2019_214%26sid%3Dliteratum%253Aachs%26aulast%3DToll%26aufirst%3DL.%26aulast%3DOzawa%26aufirst%3DA.%26aulast%3DCippitelli%26aufirst%3DA.%26atitle%3DNOP-related%2520mechanisms%2520in%2520pain%2520and%2520analgesia%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2019%26volume%3D254%26spage%3D165%26epage%3D186%26doi%3D10.1007%2F164_2019_214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kiguchi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, M. C.</span></span> <span> </span><span class="NLM_article-title">Effects of NOP-related ligands in nonhuman primates</span>. <i>Handb. Exp. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>254</i></span>,  <span class="NLM_fpage">323</span>– <span class="NLM_lpage">343</span>, <span class="refDoi"> DOI: 10.1007/164_2019_211</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1007%2F164_2019_211" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=30879202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmtlGlurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=254&publication_year=2019&pages=323-343&author=N.+Kiguchiauthor=M.+C.+Ko&title=Effects+of+NOP-related+ligands+in+nonhuman+primates&doi=10.1007%2F164_2019_211"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of NOP-Related Ligands in Nonhuman Primates</span></div><div class="casAuthors">Kiguchi, Norikazu; Ko, Mei-Chuan</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">254</span>
        (<span class="NLM_cas:issue">Nociceptin/Orphanin FQ Peptide Receptor</span>),
    <span class="NLM_cas:pages">323-343</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">1865-0325</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">The nociceptin/orphanin FQ peptide (NOP) receptor-related ligands have been demonstrated in preclin. studies for several therapeutic applications.  This article highlights (1) how nonhuman primates (NHP) were used to facilitate the development and application of positron emission tomog. tracers in humans; (2) effects of an endogenous NOP ligand, nociceptin/orphanin FQ, and its interaction with mu opioid peptide (MOP) receptor agonists; and (3) promising functional profiles of NOP-related agonists in NHP as analgesics and treatment for substance use disorders.  NHP models offer the most phylogenetically appropriate evaluation of opioid and non-opioid receptor functions and drug effects.  Based on preclin. and clin. data of ligands with mixed NOP/MOP receptor agonist activity, several factors including their intrinsic efficacies for activating NOP vs. MOP receptors and different study endpoints in NHP could contribute to different pharmacol. profiles.  Ample evidence from NHP studies indicates that bifunctional NOP/MOP receptor agonists have opened an exciting avenue for developing safe, effective medications with fewer side effects for treating pain and drug addiction.  In particular, bifunctional NOP/MOP partial agonists hold a great potential as (1) effective spinal analgesics without itch side effects; (2) safe, nonaddictive analgesics without opioid side effects such as respiratory depression; and (3) effective medications for substance use disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxfWAnvaq1t7Vg90H21EOLACvtfcHk0lgNXo5EHfdEyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmtlGlurg%253D&md5=5e66fee75b464850aec7f44f4abae0ca</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1007%2F164_2019_211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F164_2019_211%26sid%3Dliteratum%253Aachs%26aulast%3DKiguchi%26aufirst%3DN.%26aulast%3DKo%26aufirst%3DM.%2BC.%26atitle%3DEffects%2520of%2520NOP-related%2520ligands%2520in%2520nonhuman%2520primates%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2019%26volume%3D254%26spage%3D323%26epage%3D343%26doi%3D10.1007%2F164_2019_211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Linz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christoph, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tzschentke, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiene, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gautrois, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schröder, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kögel, B. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beier, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Englberger, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schunk, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Vry, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahnel, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frosch, S.</span></span> <span> </span><span class="NLM_article-title">Cebranopadol: a novel potent analgesic nociceptin/orphanin FQ peptide and opioid receptor agonist</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>349</i></span>,  <span class="NLM_fpage">535</span>– <span class="NLM_lpage">548</span>, <span class="refDoi"> DOI: 10.1124/jpet.114.213694</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1124%2Fjpet.114.213694" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=24713140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVGltbrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=349&publication_year=2014&pages=535-548&author=K.+Linzauthor=T.+Christophauthor=T.+M.+Tzschentkeauthor=T.+Kochauthor=K.+Schieneauthor=M.+Gautroisauthor=W.+Schr%C3%B6derauthor=B.+Y.+K%C3%B6gelauthor=H.+Beierauthor=W.+Englbergerauthor=S.+Schunkauthor=J.+De+Vryauthor=U.+Jahnelauthor=S.+Frosch&title=Cebranopadol%3A+a+novel+potent+analgesic+nociceptin%2Forphanin+FQ+peptide+and+opioid+receptor+agonist&doi=10.1124%2Fjpet.114.213694"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Cebranopadol: a novel potent analgesic nociceptin/orphanin FQ peptide and opioid receptor agonist</span></div><div class="casAuthors">Linz, Klaus; Christoph, Thomas; Tzschentke, Thomas M.; Koch, Thomas; Schiene, Klaus; Gautrois, Michael; Schroeder, Wolfgang; Koegel, Babette Y.; Beier, Horst; Englberger, Werner; Schunk, Stefan; De Vry, Jean; Jahnel, Ulrich; Frosch, Stefanie</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">349</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">535-548, 14 pp.</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Cebranopadol (trans-6'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro[cyclohexane-1,1'(3'H)-pyrano[3,4-b]indol]-4-amine) is a novel analgesic nociceptin/orphanin FQ peptide (NOP) and opioid receptor agonist [Ki (nM)/EC50 (nM)/relative efficacy (%): human NOP receptor 0.9/13.0/89; human mu-opioid peptide (MOP) receptor 0.7/1.2/104; human kappa-opioid peptide receptor 2.6/17/67; human delta-opioid peptide receptor 18/110/105].  Cebranopadol exhibits highly potent and efficacious antinociceptive and antihypersensitive effects in several rat models of acute and chronic pain (tail-flick, rheumatoid arthritis, bone cancer, spinal nerve ligation, diabetic neuropathy) with ED50 values of 0.5-5.6 μg/kg after i.v. and 25.1 μg/kg after oral administration.  In comparison with selective MOP receptor agonists, cebranopadol was more potent in models of chronic neuropathic than acute nociceptive pain.  Cebranopadol's duration of action is long (up to 7 h after i.v. 12 μg/kg; >9 h after oral 55 μg/kg in the rat tail-flick test).  The antihypersensitive activity of cebranopadol in the spinal nerve ligation model was partially reversed by pretreatment with the selective NOP receptor antagonist J-1133'7[1-[(3R,4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one] or the opioid receptor antagonist naloxone, indicating that both NOP and opioid receptor agonism are involved in this activity.  Development of analgesic tolerance in the chronic constriction injury model was clearly delayed compared with that from an equianalgesic dose of morphine (complete tolerance on day 26 vs. day 11, resp.).  Unlike morphine, cebranopadol did not disrupt motor coordination and respiration at doses within and exceeding the analgesic dose range.  Cebranopadol, by its combination of agonism at NOP and opioid receptors, affords highly potent and efficacious analgesia in various pain models with a favorable side effect profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvDj3QJY4fYrVg90H21EOLACvtfcHk0lgNXo5EHfdEyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVGltbrE&md5=c3fcc301bf4dde5706565d9187578df4</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1124%2Fjpet.114.213694&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.114.213694%26sid%3Dliteratum%253Aachs%26aulast%3DLinz%26aufirst%3DK.%26aulast%3DChristoph%26aufirst%3DT.%26aulast%3DTzschentke%26aufirst%3DT.%2BM.%26aulast%3DKoch%26aufirst%3DT.%26aulast%3DSchiene%26aufirst%3DK.%26aulast%3DGautrois%26aufirst%3DM.%26aulast%3DSchr%25C3%25B6der%26aufirst%3DW.%26aulast%3DK%25C3%25B6gel%26aufirst%3DB.%2BY.%26aulast%3DBeier%26aufirst%3DH.%26aulast%3DEnglberger%26aufirst%3DW.%26aulast%3DSchunk%26aufirst%3DS.%26aulast%3DDe%2BVry%26aufirst%3DJ.%26aulast%3DJahnel%26aufirst%3DU.%26aulast%3DFrosch%26aufirst%3DS.%26atitle%3DCebranopadol%253A%2520a%2520novel%2520potent%2520analgesic%2520nociceptin%252Forphanin%2520FQ%2520peptide%2520and%2520opioid%2520receptor%2520agonist%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2014%26volume%3D349%26spage%3D535%26epage%3D548%26doi%3D10.1124%2Fjpet.114.213694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Calò, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, D. G.</span></span> <span> </span><span class="NLM_article-title">Nociceptin/orphanin FQ receptor ligands and translational challenges: focus on cebranopadol as an innovative analgesic</span>. <i>Br. J. Anaesth.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>121</i></span>,  <span class="NLM_fpage">1105</span>– <span class="NLM_lpage">1114</span>, <span class="refDoi"> DOI: 10.1016/j.bja.2018.06.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1016%2Fj.bja.2018.06.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=30336855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC1MXkvVGjtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2018&pages=1105-1114&author=G.+Cal%C3%B2author=D.+G.+Lambert&title=Nociceptin%2Forphanin+FQ+receptor+ligands+and+translational+challenges%3A+focus+on+cebranopadol+as+an+innovative+analgesic&doi=10.1016%2Fj.bja.2018.06.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Nociceptin/orphanin FQ receptor ligands and translational challenges: focus on cebranopadol as an innovative analgesic</span></div><div class="casAuthors">Calo, G.; Lambert, D. G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Anaesthesia</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1105-1114</span>CODEN:
                <span class="NLM_cas:coden">BJANAD</span>;
        ISSN:<span class="NLM_cas:issn">1471-6771</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Opioids are characterised as classical (mu, delta, and kappa) along with the non-classical nociceptin/orphanin FQ (N/OFQ) receptor or NOP.  Targeting NOP has therapeutic indications in control of the cardiovascular and respiratory systems and micturition, and a profile as an antidepressant.  For all of these indications, there are translational human data.  Opioids such as morphine and fentanyl (activating the mu receptor) are the mainstay of pain treatment in the perioperative period, despite a challenging side-effect profile.  Opioids in general have poor efficacy in neuropathic pain.  Moreover, longer term use is assocd. with tolerance.  There is good evidence interactions between opioid receptors, and receptor co-activation can reduce side-effects without compromising analgesia; this is particularly true for mu and NOP co-activation.  Recent pharmaceutical development has produced a mixed opioid/NOP agonist, cebranopadol.  This new chem. entity is effective in animal models of nociceptive and neuropathic pain with greater efficacy in the latter.  In animal models, there is little evidence for respiratory depression, and tolerance (compared with morphine) only develops after long treatment periods.  There is now early phase clin. development in diabetic neuropathy, cancer pain, and low back pain where cebranopadol displays significant efficacy.  In 1996, N/OFQ was formally identified with an innovative analgesic profile.  Approx. 20 yr later, cebranopadol as a clin. ligand is advancing through the human trials process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYrn8LanDB8bVg90H21EOLACvtfcHk0lgU-b28aI0zQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXkvVGjtg%253D%253D&md5=bcc4df676d94a0250830edd3ea13c74e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.bja.2018.06.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bja.2018.06.024%26sid%3Dliteratum%253Aachs%26aulast%3DCal%25C3%25B2%26aufirst%3DG.%26aulast%3DLambert%26aufirst%3DD.%2BG.%26atitle%3DNociceptin%252Forphanin%2520FQ%2520receptor%2520ligands%2520and%2520translational%2520challenges%253A%2520focus%2520on%2520cebranopadol%2520as%2520an%2520innovative%2520analgesic%26jtitle%3DBr.%2520J.%2520Anaesth.%26date%3D2018%26volume%3D121%26spage%3D1105%26epage%3D1114%26doi%3D10.1016%2Fj.bja.2018.06.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ding, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiguchi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasuda, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daga, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polgar, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czoty, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kishioka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaveri, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, M.-C.</span></span> <span> </span><span class="NLM_article-title">A bifunctional nociceptin and mu opioid receptor agonist is analgesic without opioid side effects in nonhuman primates</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>, <span class="NLM_elocation-id">eaar3483</span> <span class="refDoi"> DOI: 10.1126/scitranslmed.aar3483</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1126%2Fscitranslmed.aar3483" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=30158150" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&author=H.+Dingauthor=N.+Kiguchiauthor=D.+Yasudaauthor=P.+R.+Dagaauthor=W.+E.+Polgarauthor=J.+J.+Luauthor=P.+W.+Czotyauthor=S.+Kishiokaauthor=N.+T.+Zaveriauthor=M.-C.+Ko&title=A+bifunctional+nociceptin+and+mu+opioid+receptor+agonist+is+analgesic+without+opioid+side+effects+in+nonhuman+primates&doi=10.1126%2Fscitranslmed.aar3483"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aar3483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aar3483%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DH.%26aulast%3DKiguchi%26aufirst%3DN.%26aulast%3DYasuda%26aufirst%3DD.%26aulast%3DDaga%26aufirst%3DP.%2BR.%26aulast%3DPolgar%26aufirst%3DW.%2BE.%26aulast%3DLu%26aufirst%3DJ.%2BJ.%26aulast%3DCzoty%26aufirst%3DP.%2BW.%26aulast%3DKishioka%26aufirst%3DS.%26aulast%3DZaveri%26aufirst%3DN.%2BT.%26aulast%3DKo%26aufirst%3DM.-C.%26atitle%3DA%2520bifunctional%2520nociceptin%2520and%2520mu%2520opioid%2520receptor%2520agonist%2520is%2520analgesic%2520without%2520opioid%2520side%2520effects%2520in%2520nonhuman%2520primates%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2018%26volume%3D10%26doi%3D10.1126%2Fscitranslmed.aar3483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kiguchi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cami-Kobeci, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sukhtankar, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czoty, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeLoid, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, F.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toll, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Husbands, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, M.-C.</span></span> <span> </span><span class="NLM_article-title">BU10038 as a safe opioid analgesic with fewer side-effects after systemic and intrathecal administration in primates</span>. <i>Br. J. Anaesth.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">e146</span>– <span class="NLM_lpage">e156</span>, <span class="refDoi"> DOI: 10.1016/j.bja.2018.10.065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1016%2Fj.bja.2018.10.065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=30916003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC1MXktFOrtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2019&pages=e146-e156&author=N.+Kiguchiauthor=H.+Dingauthor=G.+Cami-Kobeciauthor=D.+D.+Sukhtankarauthor=P.+W.+Czotyauthor=H.+B.+DeLoidauthor=F.-C.+Hsuauthor=L.+Tollauthor=S.+M.+Husbandsauthor=M.-C.+Ko&title=BU10038+as+a+safe+opioid+analgesic+with+fewer+side-effects+after+systemic+and+intrathecal+administration+in+primates&doi=10.1016%2Fj.bja.2018.10.065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">BU10038 as a safe opioid analgesic with fewer side-effects after systemic and intrathecal administration in primates</span></div><div class="casAuthors">Kiguchi, Norikazu; Ding, Huiping; Cami-Kobeci, Gerta; Sukhtankar, Devki D.; Czoty, Paul W.; DeLoid, Heather B.; Hsu, Fang-Chi; Toll, Lawrence; Husbands, Stephen M.; Ko, Mei-Chuan</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Anaesthesia</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e146-e156</span>CODEN:
                <span class="NLM_cas:coden">BJANAD</span>;
        ISSN:<span class="NLM_cas:issn">1471-6771</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The marked increase in mis-use of prescription opioids has greatly affected our society.  One potential soln. is to develop improved analgesics which have agonist action at both mu opioid peptide (MOP) and nociceptin/orphanin FQ peptide (NOP) receptors.  BU10038 is a recently identified bifunctional MOP/NOP partial agonist.  The aim of this study was to det. the functional profile of systemic or spinal delivery of BU10038 in primates after acute and chronic administration.  A series of behavioral and physiol. assays have been established specifically to reflect the therapeutic (analgesia) and side-effects (abuse potential, respiratory depression, itch, phys. dependence, and tolerance) of opioid analgesics in rhesus monkeys.  After systemic administration, BU10038 (0.001-0.01 mg kg-1) dose-dependently produced long-lasting antinociceptive and antihypersensitive effects.  Unlike the MOP agonist oxycodone, BU10038 lacked reinforcing effects (i.e. little or no abuse liability), and BU10038 did not compromise the physiol. functions of primates including respiration, cardiovascular activities, and body temp. at antinociceptive doses and a 10-30-fold higher dose (0.01-0.1 mg kg-1).  After intrathecal administration, BU10038 (3 μg) exerted morphine-comparable antinociception and antihypersensitivity without itch scratching responses.  Unlike morphine, BU10038 did not cause the development of phys. dependence and tolerance after repeated and chronic administration.  These in vivo findings demonstrate the translational potential of bifunctional MOP/NOP receptor agonists such as BU10038 as a safe, non-addictive analgesic with fewer side-effects in primates.  This study strongly supports that bifunctional MOP/NOP agonists may provide improved analgesics and an alternative soln. for the ongoing prescription opioid crisis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlVLOISUSOFbVg90H21EOLACvtfcHk0lgU-b28aI0zQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXktFOrtr8%253D&md5=77bae3bd7f251e8a5db31de871acca02</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.bja.2018.10.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bja.2018.10.065%26sid%3Dliteratum%253Aachs%26aulast%3DKiguchi%26aufirst%3DN.%26aulast%3DDing%26aufirst%3DH.%26aulast%3DCami-Kobeci%26aufirst%3DG.%26aulast%3DSukhtankar%26aufirst%3DD.%2BD.%26aulast%3DCzoty%26aufirst%3DP.%2BW.%26aulast%3DDeLoid%26aufirst%3DH.%2BB.%26aulast%3DHsu%26aufirst%3DF.-C.%26aulast%3DToll%26aufirst%3DL.%26aulast%3DHusbands%26aufirst%3DS.%2BM.%26aulast%3DKo%26aufirst%3DM.-C.%26atitle%3DBU10038%2520as%2520a%2520safe%2520opioid%2520analgesic%2520with%2520fewer%2520side-effects%2520after%2520systemic%2520and%2520intrathecal%2520administration%2520in%2520primates%26jtitle%3DBr.%2520J.%2520Anaesth.%26date%3D2019%26volume%3D122%26spage%3De146%26epage%3De156%26doi%3D10.1016%2Fj.bja.2018.10.065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chao, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ou, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuang, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsu-An Hsu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loh, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shih, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueng, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, S. H.</span></span> <span> </span><span class="NLM_article-title">BPR1M97, a dual mu opioid receptor/nociceptin-orphanin FQ peptide receptor agonist, produces potent antinociceptive effects with safer properties than morphine</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>166</i></span>,  <span class="NLM_fpage">107678</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2019.107678</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1016%2Fj.neuropharm.2019.107678" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=31278929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtl2gtrfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2020&pages=107678&author=P.+K.+Chaoauthor=H.+F.+Changauthor=W.+T.+Changauthor=T.+K.+Yehauthor=L.+C.+Ouauthor=J.+Y.+Chuangauthor=J.+Tsu-An+Hsuauthor=P.+L.+Taoauthor=H.+H.+Lohauthor=C.+Shihauthor=S.+H.+Uengauthor=S.+H.+Yeh&title=BPR1M97%2C+a+dual+mu+opioid+receptor%2Fnociceptin-orphanin+FQ+peptide+receptor+agonist%2C+produces+potent+antinociceptive+effects+with+safer+properties+than+morphine&doi=10.1016%2Fj.neuropharm.2019.107678"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">BPR1M97, a dual mu opioid receptor/nociceptin-orphanin FQ peptide receptor agonist, produces potent antinociceptive effects with safer properties than morphine</span></div><div class="casAuthors">Chao, Po-Kuan; Chang, Hsiao-Fu; Chang, Wan-Ting; Yeh, Teng-Kuang; Ou, Li-Chin; Chuang, Jian-Ying; Tsu-An Hsu, John; Tao, Pao-Luh; Loh, Horace H.; Shih, Chuan; Ueng, Shau-Hua; Yeh, Shiu-Hwa</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">107678</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">There is unmet need to design an analgesic with fewer side effects for severe pain management.  Although traditional opioids are the most effective painkillers, they are accompanied by severe adverse responses, such as respiratory depression, constipation symptoms, tolerance, withdrawal, and addiction.  We indicated BPR1M97 as a dual mu opioid receptor (MOP)/nociceptin-orphanin FQ peptide (NOP) receptor full agonist and investigated the pharmacol. of BPR1M97 in multiple animal models.  In vitro studies on BPR1M97 were assessed using cyclic-adenosine monophosphate prodn., β-arrestin, internalization, and membrane potential assays.  In vivo studies were characterized using the tail-flick, tail-clip, lung functional, heart functional, acetone drop, von Frey hair, charcoal meal, glass bead, locomotor activity, conditioned place preference (CPP) and naloxone pptn. tests.  BPR1M97 elicited full agonist properties for all cell-based assays tested in MOP-expressing cells.  However, it acted as a G protein-biased agonist for NOP.  BPR1M97 initiated faster antinociceptive effects at 10 min after s.c. injection and elicited better analgesia in cancer-induced pain than morphine.  Unlike morphine, BPR1M97 caused less respiratory, cardiovascular, and gastrointestinal dysfunction.  In addn., BPR1M97 decreased global activity and induced less withdrawal jumping pptd. by naloxone.  Thus, BPR1M97 could serve as a novel small mol. dual receptor agonist for antinociception with fewer side effects than morphine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcOK2jCjR8ubVg90H21EOLACvtfcHk0lgU-b28aI0zQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtl2gtrfN&md5=a2d5202400186003f9c81f4e4f22303b</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2019.107678&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2019.107678%26sid%3Dliteratum%253Aachs%26aulast%3DChao%26aufirst%3DP.%2BK.%26aulast%3DChang%26aufirst%3DH.%2BF.%26aulast%3DChang%26aufirst%3DW.%2BT.%26aulast%3DYeh%26aufirst%3DT.%2BK.%26aulast%3DOu%26aufirst%3DL.%2BC.%26aulast%3DChuang%26aufirst%3DJ.%2BY.%26aulast%3DTsu-An%2BHsu%26aufirst%3DJ.%26aulast%3DTao%26aufirst%3DP.%2BL.%26aulast%3DLoh%26aufirst%3DH.%2BH.%26aulast%3DShih%26aufirst%3DC.%26aulast%3DUeng%26aufirst%3DS.%2BH.%26aulast%3DYeh%26aufirst%3DS.%2BH.%26atitle%3DBPR1M97%252C%2520a%2520dual%2520mu%2520opioid%2520receptor%252Fnociceptin-orphanin%2520FQ%2520peptide%2520receptor%2520agonist%252C%2520produces%2520potent%2520antinociceptive%2520effects%2520with%2520safer%2520properties%2520than%2520morphine%26jtitle%3DNeuropharmacology%26date%3D2020%26volume%3D166%26spage%3D107678%26doi%3D10.1016%2Fj.neuropharm.2019.107678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kiguchi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, M.-C.</span></span> <span> </span><span class="NLM_article-title">Therapeutic potentials of NOP and MOP receptor coactivation for the treatment of pain and opioid abuse</span>. <i>J. Neurosci. Res.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="refDoi"> DOI: 10.1002/jnr.24624</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1002%2Fjnr.24624" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=32255240" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=N.+Kiguchiauthor=H.+Dingauthor=M.-C.+Ko&title=Therapeutic+potentials+of+NOP+and+MOP+receptor+coactivation+for+the+treatment+of+pain+and+opioid+abuse&doi=10.1002%2Fjnr.24624"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1002%2Fjnr.24624&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjnr.24624%26sid%3Dliteratum%253Aachs%26aulast%3DKiguchi%26aufirst%3DN.%26aulast%3DDing%26aufirst%3DH.%26aulast%3DKo%26aufirst%3DM.-C.%26atitle%3DTherapeutic%2520potentials%2520of%2520NOP%2520and%2520MOP%2520receptor%2520coactivation%2520for%2520the%2520treatment%2520of%2520pain%2520and%2520opioid%2520abuse%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2020%26doi%3D10.1002%2Fjnr.24624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Azzam, A. A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, D. G.</span></span> <span> </span><span class="NLM_article-title">Hot topics in opioid pharmacology: mixed and biased opioids</span>. <i>Br. J. Anaesth.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">e136</span>– <span class="NLM_lpage">e145</span>, <span class="refDoi"> DOI: 10.1016/j.bja.2019.03.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1016%2Fj.bja.2019.03.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=31010646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnvV2mtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2019&pages=e136-e145&author=A.+A.+H.+Azzamauthor=J.+McDonaldauthor=D.+G.+Lambert&title=Hot+topics+in+opioid+pharmacology%3A+mixed+and+biased+opioids&doi=10.1016%2Fj.bja.2019.03.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Hot topics in opioid pharmacology: mixed and biased opioids</span></div><div class="casAuthors">Azzam, Ammar A. H.; McDonald, John; Lambert, David G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Anaesthesia</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e136-e145</span>CODEN:
                <span class="NLM_cas:coden">BJANAD</span>;
        ISSN:<span class="NLM_cas:issn">1471-6771</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Analgesic design and evaluation have been driven by the desire to create high-affinity high-selectivity mu (μ)-opioid peptide (MOP) receptor agonists.  Such ligands are the mainstay of current clin. practice, and include morphine and fentanyl.  Advances in this sphere have come from designing pharmacokinetic advantage, as in rapid metab. for remifentanil.  These produce analgesia, but also the adverse-effect profile that currently defines this drug class: ventilatory depression, tolerance, and abuse liability.  The MOP receptor is part of a family, and there are significant functional interactions between other members of the family (delta [δ]-opioid peptide [DOP], kappa [κ]-opioid peptide [KOP], and nociceptin/orphanin FQ receptor [NOP]).  Exptl., MOP agonism and DOP antagonism produce anti-nociception (animals) with no tolerance, and low doses of MOP and NOP ligands synergise to antinociceptive advantage.  In this latter context, the lack of effect of NOP agonists on ventilation is an addnl. advantage.  Recent development has been to move towards low-selectivity multifunctional 'mixed ligands', such as cebranopadol, or ligand mixts., such as Targinact.  Moreover, the observation that β-arrestin coupling underlies the side-effect profile for MOP ligands (from knockout animal studies) led to the discovery of biased (to G-protein and away from β-arrestin intracellular signalling) MOP ligands, such as oliceridine.  There is sufficient excitement in the opioid field to suggest that opioid analgesics without significant side-effects may be on the horizon, and the 'opioid Holy Grail' might be in reach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_ORCa8YK6UbVg90H21EOLACvtfcHk0lgdoBwHzXi1CA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnvV2mtbs%253D&md5=915276eb393731de0a519ee5fcab14e6</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.bja.2019.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bja.2019.03.006%26sid%3Dliteratum%253Aachs%26aulast%3DAzzam%26aufirst%3DA.%2BA.%2BH.%26aulast%3DMcDonald%26aufirst%3DJ.%26aulast%3DLambert%26aufirst%3DD.%2BG.%26atitle%3DHot%2520topics%2520in%2520opioid%2520pharmacology%253A%2520mixed%2520and%2520biased%2520opioids%26jtitle%3DBr.%2520J.%2520Anaesth.%26date%3D2019%26volume%3D122%26spage%3De136%26epage%3De145%26doi%3D10.1016%2Fj.bja.2019.03.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anand, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kochan, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nastase, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montgomery, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griggs, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynor, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosberg, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jutkiewicz, E. M.</span></span> <span> </span><span class="NLM_article-title">In vivo effects of μ-opioid receptor agonist/δ-opioid receptor antagonist peptidomimetics following acute and repeated administration</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>175</i></span>,  <span class="NLM_fpage">2013</span>– <span class="NLM_lpage">2027</span>, <span class="refDoi"> DOI: 10.1111/bph.14148</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1111%2Fbph.14148" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=29352503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC1cXot1Cru70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=2018&pages=2013-2027&author=J.+P.+Anandauthor=K.+E.+Kochanauthor=A.+F.+Nastaseauthor=D.+Montgomeryauthor=N.+W.+Griggsauthor=J.+R.+Traynorauthor=H.+I.+Mosbergauthor=E.+M.+Jutkiewicz&title=In+vivo+effects+of+%CE%BC-opioid+receptor+agonist%2F%CE%B4-opioid+receptor+antagonist+peptidomimetics+following+acute+and+repeated+administration&doi=10.1111%2Fbph.14148"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo effects of μ-opioid receptor agonist/δ-opioid receptor antagonist peptidomimetics following acute and repeated administration</span></div><div class="casAuthors">Anand, Jessica P.; Kochan, Kelsey E.; Nastase, Anthony F.; Montgomery, Deanna; Griggs, Nicholas W.; Traynor, John R.; Mosberg, Henry I.; Jutkiewicz, Emily M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">175</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2013-2027</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Agonists at μ-opioid receptors (μ-receptors) are used for pain management but produce adverse effects including tolerance, dependence and euphoria.  The co-administration of a μ-receptor agonist with a δ-opioid receptor (δ-receptor) antagonist has been shown to produce antinociception with reduced development of some side effects.  We characterized the effects of three μ-receptor agonist/δ-receptor antagonist peptidomimetics in vivo after acute and repeated administration to det. if this profile provides a viable alternative to traditional opioid analgesics.  Three μ-receptor agonist / δ-receptor antagonist peptidomimetics, AAH8, AMB46 and AMB47, and morphine were evaluated for the development of tolerance and dependence after 5 days of twice daily treatment with escalating doses of drug (10-50 mg·kg-1).  Antinociceptive effects were measured in the warm water tail withdrawal assay before and after repeated drug treatment.  Phys. dependence was evaluated by naltrexone-pptd. withdrawal jumping.  The rewarding effects of AAH8 were evaluated using a conditioned place preference (CPP) assay with twice daily conditioning sessions performed for 5 days.  Morphine, AAH8, AMB47 and AMB46 all demonstrated acute antinociceptive effects, but repeated administration only produced tolerance in animals treated with morphine and AMB46.  Injection of naltrexone pptd. fewer jumps in mice treated repeatedly with AAH8 as compared with morphine, AMB47 or AMB46.  Conditioning with morphine, but not AAH8, produced significant CPP.  AAH8 may be a better alternative than traditional opioid analgesics, producing antinociception with less development of tolerance and dependence and may be less rewarding than morphine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruammciHxwYLVg90H21EOLACvtfcHk0lgdoBwHzXi1CA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXot1Cru70%253D&md5=6ad59ce996adbd8e4e76019e851e1ce5</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1111%2Fbph.14148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.14148%26sid%3Dliteratum%253Aachs%26aulast%3DAnand%26aufirst%3DJ.%2BP.%26aulast%3DKochan%26aufirst%3DK.%2BE.%26aulast%3DNastase%26aufirst%3DA.%2BF.%26aulast%3DMontgomery%26aufirst%3DD.%26aulast%3DGriggs%26aufirst%3DN.%2BW.%26aulast%3DTraynor%26aufirst%3DJ.%2BR.%26aulast%3DMosberg%26aufirst%3DH.%2BI.%26aulast%3DJutkiewicz%26aufirst%3DE.%2BM.%26atitle%3DIn%2520vivo%2520effects%2520of%2520%25CE%25BC-opioid%2520receptor%2520agonist%252F%25CE%25B4-opioid%2520receptor%2520antagonist%2520peptidomimetics%2520following%2520acute%2520and%2520repeated%2520administration%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2018%26volume%3D175%26spage%3D2013%26epage%3D2027%26doi%3D10.1111%2Fbph.14148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aceto, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Negus, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banks, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akgun, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Portoghese, P. S.</span></span> <span> </span><span class="NLM_article-title">MDAN-21: a bivalent opioid ligand containing mu-agonist and delta-antagonist pharmacophores and its effects in rhesus monkeys</span>. <i>Int. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>2012</i></span>,  <span class="NLM_fpage">327257</span>, <span class="refDoi"> DOI: 10.1155/2012/327257</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1155%2F2012%2F327257" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=25954526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A280%3ADC%252BC2MfitV2jtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2012&publication_year=2012&pages=327257&author=M.+D.+Acetoauthor=L.+S.+Harrisauthor=S.+S.+Negusauthor=M.+L.+Banksauthor=L.+D.+Hughesauthor=E.+Akgunauthor=P.+S.+Portoghese&title=MDAN-21%3A+a+bivalent+opioid+ligand+containing+mu-agonist+and+delta-antagonist+pharmacophores+and+its+effects+in+rhesus+monkeys&doi=10.1155%2F2012%2F327257"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">MDAN-21: A Bivalent Opioid Ligand Containing mu-Agonist and Delta-Antagonist Pharmacophores and Its Effects in Rhesus Monkeys</span></div><div class="casAuthors">Aceto Mario D; Harris Louis S; Negus S Stevens; Banks Matthew L; Hughes Larry D; Akgun Eyup; Portoghese Philip S</div><div class="citationInfo"><span class="NLM_cas:title">International journal of medicinal chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2012</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">327257</span>
        ISSN:<span class="NLM_cas:issn">2090-2069</span>.
    </div><div class="casAbstract">MDAN-21, 7'-{2-[(7-{2-[({(5α, 6α)-4,5-Epoxy-3,14-dihydroxy-17-methylmorphin-6-yl}-aminocarbonyl)metoxy]-acetylamino}-heptylaminocarbonyl)-methoxy]-acetylamino}-naltrindole, a bivalent opioid ligand containing a mu-opioid receptor agonist (derived from oxymorphone) linked to the delta-opioid receptor antagonist (related to naltrindole) by a spacer of 21 atoms, was reported to have potent analgesic properties in mice.  Tolerance, physical dependence, and conditioned place preference were not evident in that species.  The finding that bivalent ligands in this series, with spacers 19 atoms or greater, were devoid of tolerance and dependence led to the proposal that MDAN-21 targets heteromeric mu-delta-opioid receptors.  The present study focused on its effects in nonhuman primates (Macaca mulatta), a species with a physiology and behavioral repertoire not unlike humans.  With regard to opioids, this species usually better predicts clinical outcomes.  MDAN-21 substituted for morphine in morphine-dependent monkeys in the remarkably low dose range 0.006-0.032 mg/kg, subcutaneously.  Although MDAN-21 failed to produce reliable thermal analgesia in the dose range 0.0032-0.032 mg/kg, intramuscularly, it was active in the same dose range and by the same route of administration, in the capsaicin-induced thermal allodynia assay.  The results suggest that MDAN-21 may be useful in the treatment of opioid dependence and allodynia.  The data provide additional evidence that opioid withdrawal is associated with sensitized pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTOLp2jGEspD8K3uFsUIZtkfW6udTcc2eYeUzi6Uk0ri7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MfitV2jtQ%253D%253D&md5=4ef855db6741aff9565944d70738e520</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1155%2F2012%2F327257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2012%252F327257%26sid%3Dliteratum%253Aachs%26aulast%3DAceto%26aufirst%3DM.%2BD.%26aulast%3DHarris%26aufirst%3DL.%2BS.%26aulast%3DNegus%26aufirst%3DS.%2BS.%26aulast%3DBanks%26aufirst%3DM.%2BL.%26aulast%3DHughes%26aufirst%3DL.%2BD.%26aulast%3DAkgun%26aufirst%3DE.%26aulast%3DPortoghese%26aufirst%3DP.%2BS.%26atitle%3DMDAN-21%253A%2520a%2520bivalent%2520opioid%2520ligand%2520containing%2520mu-agonist%2520and%2520delta-antagonist%2520pharmacophores%2520and%2520its%2520effects%2520in%2520rhesus%2520monkeys%26jtitle%3DInt.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D2012%26spage%3D327257%26doi%3D10.1155%2F2012%2F327257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Greedy, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradbury, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grivas, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cami-Kobeci, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Archambeau, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosse, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aceto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynor, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Husbands, S. M.</span></span> <span> </span><span class="NLM_article-title">Orvinols with mixed kappa/mu opioid receptor agonist activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3207</span>– <span class="NLM_lpage">3216</span>, <span class="refDoi"> DOI: 10.1021/jm301543e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301543e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtVWrtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3207-3216&author=B.+M.+Greedyauthor=F.+Bradburyauthor=M.+P.+Thomasauthor=K.+Grivasauthor=G.+Cami-Kobeciauthor=A.+Archambeauauthor=K.+Bosseauthor=M.+J.+Clarkauthor=M.+Acetoauthor=J.+W.+Lewisauthor=J.+R.+Traynorauthor=S.+M.+Husbands&title=Orvinols+with+mixed+kappa%2Fmu+opioid+receptor+agonist+activity&doi=10.1021%2Fjm301543e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Orvinols with Mixed Kappa/Mu Opioid Receptor Agonist Activity</span></div><div class="casAuthors">Greedy, Benjamin M.; Bradbury, Faye; Thomas, Mark P.; Grivas, Konstantinos; Cami-Kobeci, Gerta; Archambeau, Ashley; Bosse, Kelly; Clark, Mary J.; Aceto, Mario; Lewis, John W.; Traynor, John R.; Husbands, Stephen M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3207-3216</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Dual-acting kappa opioid receptor (KOR) agonist and mu opioid receptor (MOR) partial agonist ligands have been put forward as potential treatment agents for cocaine and other psychostimulant abuse.  Members of the orvinol series of ligands are known for their high binding affinity to both KOR and MOR, but efficacy at the individual receptors has not been thoroughly evaluated.  In this study, it is shown that a predictive model for efficacy at KOR can be derived, with efficacy being controlled by the length of the group attached to C20 and by the introduction of branching into the side chain.  In vivo evaluation of two ligands with the desired in vitro profile confirms both display KOR, and to a lesser extent MOR, activity in an analgesic assay suggesting that, in this series, in vitro measures of efficacy using the [35S]GTPγS assay are predictive of the in vivo profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJpdjCZTQt5bVg90H21EOLACvtfcHk0lgPIHv7ZMI7mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtVWrtbo%253D&md5=d692909a8c772cfa79f3c9697a9c64d1</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm301543e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301543e%26sid%3Dliteratum%253Aachs%26aulast%3DGreedy%26aufirst%3DB.%2BM.%26aulast%3DBradbury%26aufirst%3DF.%26aulast%3DThomas%26aufirst%3DM.%2BP.%26aulast%3DGrivas%26aufirst%3DK.%26aulast%3DCami-Kobeci%26aufirst%3DG.%26aulast%3DArchambeau%26aufirst%3DA.%26aulast%3DBosse%26aufirst%3DK.%26aulast%3DClark%26aufirst%3DM.%2BJ.%26aulast%3DAceto%26aufirst%3DM.%26aulast%3DLewis%26aufirst%3DJ.%2BW.%26aulast%3DTraynor%26aufirst%3DJ.%2BR.%26aulast%3DHusbands%26aufirst%3DS.%2BM.%26atitle%3DOrvinols%2520with%2520mixed%2520kappa%252Fmu%2520opioid%2520receptor%2520agonist%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3207%26epage%3D3216%26doi%3D10.1021%2Fjm301543e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulkarni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhushan, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Portoghese, P. S.</span></span> <span> </span><span class="NLM_article-title">A bivalent ligand (KDAN-18) containing δ-antagonist and κ-agonist pharmacophores bridges δ2 and κ1 opioid receptor phenotypes†</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">1713</span>– <span class="NLM_lpage">1716</span>, <span class="refDoi"> DOI: 10.1021/jm034234f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm034234f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnsleis7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1713-1716&author=D.+J.+Danielsauthor=A.+Kulkarniauthor=Z.+Xieauthor=R.+G.+Bhushanauthor=P.+S.+Portoghese&title=A+bivalent+ligand+%28KDAN-18%29+containing+%CE%B4-antagonist+and+%CE%BA-agonist+pharmacophores+bridges+%CE%B42+and+%CE%BA1+opioid+receptor+phenotypes%E2%80%A0&doi=10.1021%2Fjm034234f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">A Bivalent Ligand (KDAN-18) Containing δ-Antagonist and κ-Agonist Pharmacophores Bridges δ2 and κ1 Opioid Receptor Phenotypes</span></div><div class="casAuthors">Daniels, David J.; Kulkarni, Amol; Xie, Zhihua; Bhushan, Rashmi G.; Portoghese, Philip S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1713-1716</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To characterize δ- and κ-opioid receptor phenotypes, bivalent ligands (KDAN series) contg. δ-antagonist (naltrindole) and κ1-agonist (ICI-199,441) pharmacophores were synthesized and evaluated by the intrathecal route using the mouse tail-flick assay and binding studies.  The data have suggested that KDAN-18 (2) bridges phenotypic δ2- and κ1-receptors.  A conceptual model is presented to explain the organizational differences between the opioid receptors that give rise to the phenotypes (δ1, δ2, κ1, κ2).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJUuIBhG8Hu7Vg90H21EOLACvtfcHk0lgPIHv7ZMI7mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnsleis7c%253D&md5=c183f9b2bd1d7a13161d2e3b5b236611</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm034234f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm034234f%26sid%3Dliteratum%253Aachs%26aulast%3DDaniels%26aufirst%3DD.%2BJ.%26aulast%3DKulkarni%26aufirst%3DA.%26aulast%3DXie%26aufirst%3DZ.%26aulast%3DBhushan%26aufirst%3DR.%2BG.%26aulast%3DPortoghese%26aufirst%3DP.%2BS.%26atitle%3DA%2520bivalent%2520ligand%2520%2528KDAN-18%2529%2520containing%2520%25CE%25B4-antagonist%2520and%2520%25CE%25BA-agonist%2520pharmacophores%2520bridges%2520%25CE%25B42%2520and%2520%25CE%25BA1%2520opioid%2520receptor%2520phenotypes%25E2%2580%25A0%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1713%26epage%3D1716%26doi%3D10.1021%2Fjm034234f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Molinari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camarda, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzola, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvadori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzola, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molinari, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calò, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span> <span> </span><span class="NLM_article-title">[Dmt<sup>1</sup>]N/OFQ(1-13)-NH<sub>2</sub>: a potent nociceptin/orphanin FQ and opioid receptor universal agonist</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>168</i></span>,  <span class="NLM_fpage">151</span>– <span class="NLM_lpage">162</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.2012.02115.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1111%2Fj.1476-5381.2012.02115.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=22827708" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC3sXitFOktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2013&pages=151-162&author=S.+Molinariauthor=V.+Camardaauthor=A.+Rizziauthor=G.+Marzolaauthor=S.+Salvadoriauthor=E.+Marzolaauthor=P.+Molinariauthor=J.+McDonaldauthor=M.+Koauthor=D.+Lambertauthor=G.+Cal%C3%B2author=R.+Guerrini&title=%5BDmt1%5DN%2FOFQ%281-13%29-NH2%3A+a+potent+nociceptin%2Forphanin+FQ+and+opioid+receptor+universal+agonist&doi=10.1111%2Fj.1476-5381.2012.02115.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">[Dmt1]N/OFQ(1-13)-NH2: a potent nociceptin/orphanin FQ and opioid receptor universal agonist</span></div><div class="casAuthors">Molinari, S.; Camarda, V.; Rizzi, A.; Marzola, G.; Salvadori, S.; Marzola, E.; Molinari, P.; McDonald, J.; Ko, M. C.; Lambert, D. G.; Calo, G.; Guerrini, R.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">168</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">151-162</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose Intrathecally (i.t.) administered nociceptin/orphanin FQ (N/OFQ) evokes antinociceptive effects in rodents.  Recent studies in monkeys demonstrated that i.t. co-application of N/OFQ and morphine elicits synergistic antinociceptive actions suggesting mixed N/OFQ peptide (NOP) and μ opioid receptor agonists as innovative spinal analgesics.  Thus, novel N/OFQ related peptides were synthesized in order to identify and pharmacol. characterize a mixed NOP/ μ opioid receptor agonist.  Exptl. Approach The following in vitro assays were used: calcium mobilization in cells expressing the human NOP or classical opioid receptors and chimeric G proteins, receptor and [35S]-GTPγS binding, [35S]-GTPγS binding in rat spinal cord membranes, guinea pig ileum bioassay.  In vivo expts. were performed in monkeys using the tail withdrawal assay.  Key Results From calcium mobilization studies [Dmt1]N/OFQ(1-13)-NH2 was selected as the most potent and least selective compd.  The mixed NOP/opioid full agonist activity and high affinity of [Dmt1]N/OFQ(1-13)-NH2 was confirmed at human recombinant receptors in receptor binding, calcium mobilization and/or [35S]-GTPγS binding studies, at rat spinal cord receptors in [35S]-GTPγS binding expts., and at guinea pig receptors inhibiting neurogenic contractions in the ileum.  In vivo in the tail withdrawal assay in monkeys i.t. [Dmt1]N/OFQ(1-13)-NH2 was able to elicit robust and long-lasting antinociceptive effects.  Conclusions and Implications Collectively, these results demonstrate that [Dmt1]N/OFQ(1-13)-NH2 behaves as NOP/opioid receptor universal agonist and substantiate the suggestion that such mixed ligands are worthy of development as innovative spinal analgesics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqe2WHGVR0p2rVg90H21EOLACvtfcHk0lgPIHv7ZMI7mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXitFOktg%253D%253D&md5=aa3e4fc89f2daf2c8a12a5bc95289118</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2012.02115.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2012.02115.x%26sid%3Dliteratum%253Aachs%26aulast%3DMolinari%26aufirst%3DS.%26aulast%3DCamarda%26aufirst%3DV.%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DMarzola%26aufirst%3DG.%26aulast%3DSalvadori%26aufirst%3DS.%26aulast%3DMarzola%26aufirst%3DE.%26aulast%3DMolinari%26aufirst%3DP.%26aulast%3DMcDonald%26aufirst%3DJ.%26aulast%3DKo%26aufirst%3DM.%26aulast%3DLambert%26aufirst%3DD.%26aulast%3DCal%25C3%25B2%26aufirst%3DG.%26aulast%3DGuerrini%26aufirst%3DR.%26atitle%3D%255BDmt1%255DN%252FOFQ%25281-13%2529-NH2%253A%2520a%2520potent%2520nociceptin%252Forphanin%2520FQ%2520and%2520opioid%2520receptor%2520universal%2520agonist%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D168%26spage%3D151%26epage%3D162%26doi%3D10.1111%2Fj.1476-5381.2012.02115.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzola, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapella, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelà, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molinari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerlesi, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malfacini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvadori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calò, G.</span></span> <span> </span><span class="NLM_article-title">A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">3703</span>– <span class="NLM_lpage">3712</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2014.05.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1016%2Fj.bmc.2014.05.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=24878361" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC2cXosl2isr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=3703-3712&author=R.+Guerriniauthor=E.+Marzolaauthor=C.+Trapellaauthor=M.+Pel%C3%A0author=S.+Molinariauthor=M.+C.+Cerlesiauthor=D.+Malfaciniauthor=A.+Rizziauthor=S.+Salvadoriauthor=G.+Cal%C3%B2&title=A+novel+and+facile+synthesis+of+tetra+branched+derivatives+of+nociceptin%2Forphanin+FQ&doi=10.1016%2Fj.bmc.2014.05.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ</span></div><div class="casAuthors">Guerrini, Remo; Marzola, Erika; Trapella, Claudio; Pela', Michela; Molinari, Stefano; Cerlesi, Maria Camilla; Malfacini, Davide; Rizzi, Anna; Salvadori, Severo; Calo', Girolamo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3703-3712</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Branched peptides have been found to be useful in several research fields however their synthesis and purifn. is complicated.  Here we present a novel and facile synthesis of tetra branched derivs. of nociceptin/orphanin FQ (N/OFQ).  Three N/OFQ tetra branched derivs. were prepd. using novel cores (PWT1, PWT2 and PWT3) contg. a maleimido moiety. [Cys18]N/OFQ-NH2 was linked to the cores via thiol-Michael reaction characterized by high yield and purity of the desired final product.  In the elec. stimulated mouse Vas deferens PWT-N/OFQ derivs. mimicked the inhibitory action of the natural sequence showing similar maximal effects and 3 fold higher potencies.  The NOP selective antagonist SB-612111 antagonized the effects of N/OFQ and PWT derivs. with similar pKB values (8.02-8.48).  In vivo after supraspinal administration PWT2-N/OFQ stimulated food intake in mice mimicking the action of N/OFQ.  Compared to the natural peptide PWT2-N/OFQ was 40 fold more potent and elicited larger effects.  These findings suggest that the PWT chem. strategy can be successfully applied to biol. active peptides to generate, with unprecedented high purity and yield, tetra branched derivs. displaying an in vitro pharmacol. profile similar to that of the natural sequence assocd., in vivo, to increased potency and effectiveness.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9fI1tT-vvlrVg90H21EOLACvtfcHk0ligNnbu-5fyJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXosl2isr4%253D&md5=8c08302a2080aaa8754cf5bda60e7d4c</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.05.005%26sid%3Dliteratum%253Aachs%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DMarzola%26aufirst%3DE.%26aulast%3DTrapella%26aufirst%3DC.%26aulast%3DPel%25C3%25A0%26aufirst%3DM.%26aulast%3DMolinari%26aufirst%3DS.%26aulast%3DCerlesi%26aufirst%3DM.%2BC.%26aulast%3DMalfacini%26aufirst%3DD.%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DSalvadori%26aufirst%3DS.%26aulast%3DCal%25C3%25B2%26aufirst%3DG.%26atitle%3DA%2520novel%2520and%2520facile%2520synthesis%2520of%2520tetra%2520branched%2520derivatives%2520of%2520nociceptin%252Forphanin%2520FQ%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D3703%26epage%3D3712%26doi%3D10.1016%2Fj.bmc.2014.05.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cerlesi, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bird, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiguchi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malfacini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruzza, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calò, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span> <span> </span><span class="NLM_article-title">Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt<sup>1</sup>]N/OFQ(1-13)</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>794</i></span>,  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">126</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2016.11.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1016%2Fj.ejphar.2016.11.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=27871910" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFGgtLfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=794&publication_year=2017&pages=115-126&author=M.+C.+Cerlesiauthor=H.+Dingauthor=M.+F.+Birdauthor=N.+Kiguchiauthor=F.+Ferrariauthor=D.+Malfaciniauthor=A.+Rizziauthor=C.+Ruzzaauthor=D.+G.+Lambertauthor=M.+C.+Koauthor=G.+Cal%C3%B2author=R.+Guerrini&title=Pharmacological+studies+on+the+NOP+and+opioid+receptor+agonist+PWT2-%5BDmt1%5DN%2FOFQ%281-13%29&doi=10.1016%2Fj.ejphar.2016.11.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt1]N/OFQ(1-13)</span></div><div class="casAuthors">Cerlesi, Maria Camilla; Ding, Huiping; Bird, Mark F.; Kiguchi, Norikazu; Ferrari, Federica; Malfacini, Davide; Rizzi, Anna; Ruzza, Chiara; Lambert, David G.; Ko, Mei-Chuan; Calo, Girolamo; Guerrini, Remo</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">794</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">115-126</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">An innovative chem. strategy named peptide welding technol. (PWT) has been developed for the facile synthesis of tetrabranched peptides. [Dmt1]N/OFQ(1-13)-NH2 acts as a universal agonist for nociceptin/orphanin FQ (N/OFQ) and classical opioid receptors.  The present study investigated the pharmacol. profile of the PWT deriv. of [Dmt1]N/OFQ(1-13)NH2 (PWT2-[Dmt1]) in several assays in vitro and in vivo after spinal administration in monkeys subjected to the tail withdrawal assay.  PWT2-[Dmt1] mimicked the effects of [Dmt1]N/OFQ(1-13)-NH2 displaying full agonist activity, similar affinity/potency and selectivity at human recombinant N/OFQ (NOP) and opioid receptors in receptor binding, stimulation of [35S]GTPγS binding, calcium mobilization in cells expressing chimeric G proteins, and BRET studies for measuring receptor/G-protein and receptor/β-arrestin 2 interaction.  In vivo in monkeys PWT2-[Dmt1] elicited dose-dependent and robust antinociceptive effects being more potent and longer lasting than [Dmt1]N/OFQ(1-13)-NH2.  The analgesic action of PWT2-[Dmt1] was sensitive to the NOP receptor antagonist J-113397, but not naltrexone.  Thus, the present study demonstrated that the tetrabranched deriv. of [Dmt1]N/OFQ(1-13)-NH2 obtained with the PWT technol. maintains the in vitro pharmacol. profile of the parent peptide but displays higher potency and longer lasting action in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaU2tLfW3W0LVg90H21EOLACvtfcHk0ligNnbu-5fyJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFGgtLfI&md5=972be07440d904aa7463e15506271d23</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2016.11.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2016.11.026%26sid%3Dliteratum%253Aachs%26aulast%3DCerlesi%26aufirst%3DM.%2BC.%26aulast%3DDing%26aufirst%3DH.%26aulast%3DBird%26aufirst%3DM.%2BF.%26aulast%3DKiguchi%26aufirst%3DN.%26aulast%3DFerrari%26aufirst%3DF.%26aulast%3DMalfacini%26aufirst%3DD.%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DRuzza%26aufirst%3DC.%26aulast%3DLambert%26aufirst%3DD.%2BG.%26aulast%3DKo%26aufirst%3DM.%2BC.%26aulast%3DCal%25C3%25B2%26aufirst%3DG.%26aulast%3DGuerrini%26aufirst%3DR.%26atitle%3DPharmacological%2520studies%2520on%2520the%2520NOP%2520and%2520opioid%2520receptor%2520agonist%2520PWT2-%255BDmt1%255DN%252FOFQ%25281-13%2529%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2017%26volume%3D794%26spage%3D115%26epage%3D126%26doi%3D10.1016%2Fj.ejphar.2016.11.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pacifico, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albanese, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Illuminati, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fantinati, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzola, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neto, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturaro, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruzza, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calò̀, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span> <span> </span><span class="NLM_article-title">Tetrabranched hetero-conjugated peptides as bifunctional agonists of the NOP and mu opioid receptors</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">2444</span>– <span class="NLM_lpage">2451</span>, <span class="refDoi"> DOI: 10.1021/acs.bioconjchem.9b00519</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.bioconjchem.9b00519" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhs1KksL3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2019&pages=2444-2451&author=S.+Pacificoauthor=V.+Albaneseauthor=D.+Illuminatiauthor=A.+Fantinatiauthor=E.+Marzolaauthor=F.+Ferrariauthor=J.+A.+Netoauthor=C.+Sturaroauthor=C.+Ruzzaauthor=G.+Cal%C3%B2%CC%80author=D.+Pretiauthor=R.+Guerrini&title=Tetrabranched+hetero-conjugated+peptides+as+bifunctional+agonists+of+the+NOP+and+mu+opioid+receptors&doi=10.1021%2Facs.bioconjchem.9b00519"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Tetrabranched Hetero-Conjugated Peptides as Bifunctional Agonists of the NOP and Mu Opioid Receptors</span></div><div class="casAuthors">Pacifico, Salvatore; Albanese, Valentina; Illuminati, Davide; Fantinati, Anna; Marzola, Erika; Ferrari, Federica; Neto, Joaquim Azevedo; Sturaro, Chiara; Ruzza, Chiara; Calo, Girolamo; Preti, Delia; Guerrini, Remo</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2444-2451</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The general aim of the work was the validation of a new synthetic methodol. designed for obtaining bifunctional heterotetrabranched peptide ligands.  Applying an easily accessible synthetic route, we provided a small series of heteromultimeric peptide conjugates targeting the nociceptin/orphanin FQ (N/OFQ) peptide receptors (NOP) and mu opioid receptors.  Among these, H-PWT1-N/OFQ-[Dmt1]dermorphin demonstrated a similar and high agonist potency at the NOP and mu receptors.  The achieved results confirmed the robustness of the approach that is extremely versatile and virtually applicable to different peptide sequences whose pharmacol. activity can be combined for generating dual acting multimeric compds.  These innovative pharmacol. tools will be extremely helpful for investigating the consequences of the simultaneous activation and/or blockage of different peptidergic receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom00_e11aupbVg90H21EOLACvtfcHk0ligNnbu-5fyJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhs1KksL3K&md5=643c7bb57212e5eed8193d852eb444fd</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Facs.bioconjchem.9b00519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.bioconjchem.9b00519%26sid%3Dliteratum%253Aachs%26aulast%3DPacifico%26aufirst%3DS.%26aulast%3DAlbanese%26aufirst%3DV.%26aulast%3DIlluminati%26aufirst%3DD.%26aulast%3DFantinati%26aufirst%3DA.%26aulast%3DMarzola%26aufirst%3DE.%26aulast%3DFerrari%26aufirst%3DF.%26aulast%3DNeto%26aufirst%3DJ.%2BA.%26aulast%3DSturaro%26aufirst%3DC.%26aulast%3DRuzza%26aufirst%3DC.%26aulast%3DCal%25C3%25B2%25CC%2580%26aufirst%3DG.%26aulast%3DPreti%26aufirst%3DD.%26aulast%3DGuerrini%26aufirst%3DR.%26atitle%3DTetrabranched%2520hetero-conjugated%2520peptides%2520as%2520bifunctional%2520agonists%2520of%2520the%2520NOP%2520and%2520mu%2520opioid%2520receptors%26jtitle%3DBioconjugate%2520Chem.%26date%3D2019%26volume%3D30%26spage%3D2444%26epage%3D2451%26doi%3D10.1021%2Facs.bioconjchem.9b00519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bird, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerlesi, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malfacini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vezzi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molinari, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Micheli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mannelli, L. D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghelardini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calò, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, D. G.</span></span> <span> </span><span class="NLM_article-title">Characterisation of the novel mixed mu-NOP peptide ligand dermorphin-N/OFQ (DeNo)</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>, <span class="NLM_elocation-id">e0156897</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0156897</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1371%2Fjournal.pone.0156897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=27272042" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslCqu7nI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&author=M.+F.+Birdauthor=M.+C.+Cerlesiauthor=M.+Brownauthor=D.+Malfaciniauthor=V.+Vezziauthor=P.+Molinariauthor=L.+Micheliauthor=L.+D.+C.+Mannelliauthor=C.+Ghelardiniauthor=R.+Guerriniauthor=G.+Cal%C3%B2author=D.+G.+Lambert&title=Characterisation+of+the+novel+mixed+mu-NOP+peptide+ligand+dermorphin-N%2FOFQ+%28DeNo%29&doi=10.1371%2Fjournal.pone.0156897"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Characterisation of the novel mixed mu-NOP peptide ligand dermorphin-N/OFQ (DeNo)</span></div><div class="casAuthors">Bird, Mark F.; Cerlesi, Maria Camilla; Brown, Mark; Malfacini, Davide; Vezzi, Vanessa; Molinari, Paola; Micheli, Laura; Mannelli, Lorenzo Di Cesare; Ghelardini, Carla; Guerrini, Remo; Calo, Girolamo; Lambert, David G.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e0156897/1-e0156897/22</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Introduction Opioid receptors are currently classified as Mu (μ), Delta (δ), Kappa (κ) plus the opioid related nociceptin/orphanin FQ (N/OFQ) peptide receptor (NOP).  Despite compelling evidence for interactions and benefits of targeting more than one receptor type in producing analgesia, clin. ligands are Mu agonists.  In this study we have designed a Mu-NOP agonist named DeNo.  The Mu agonist component is provided by dermorphin, a peptide isolated from the skin of Phyllomedusa frogs and the NOP component by the endogenous agonist N/OFQ.  Methods We have assessed receptor binding profile of DeNo and compared with dermorphin and N/ OFQ.  In a series of functional screens we have assessed the ability to (i) increase Ca2+ in cells coexpressing recombinant receptors and a the chimeric protein Gαqi5, (ii) stimulate the binding of GTPγ[35S], (iii) inhibit cAMP formation, (iv) activate MAPKinase, (v) stimulate receptor-G protein and arrestin interaction using BRET, (vi) elec. stimulated guinea pig ileum (gpI) assay and (vii) ability to produce analgesia via the intrathecal route in rats.  Results DeNo bound to Mu (pKi; 9.55) and NOP (pKi; 10.22) and with reasonable selectivity.  This translated to increased Ca2+ in Gαqi5 expressing cells (pEC50 Mu 7.17; NOP 9.69), increased binding of GTPγ[35S] (pEC50 Mu 7.70; NOP 9.50) and receptor-G protein interaction in BRET (pEC50 Mu 8.01; NOP 9.02). cAMP formation was inhibited and arrestin was activated (pEC50 Mu 6.36; NOP 8.19).  For MAPK DeNo activated p38 and ERK1/2 at Mu but only ERK1/2 at NOP.  In the gpI DeNO inhibited elec.-evoked contractions (pEC50 8.63) that was sensitive to both Mu and NOP antagonists.  DeNo was antinociceptive in rats.  Conclusion Collectively these data validate the strategy used to create a novel bivalent Mu-NOP peptide agonist by combining dermorphin (Mu) and N/OFQ (NOP).  This mol. behaves essentially as the parent compds. in vitro.  In the antonocicoeptive assays employed in this study DeNo displays only weak antinociceptive properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGf0rqpcJ8OrVg90H21EOLACvtfcHk0lhcwsn5EDYdyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslCqu7nI&md5=5e929f3870f21dc463ccc60417dc59bd</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0156897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0156897%26sid%3Dliteratum%253Aachs%26aulast%3DBird%26aufirst%3DM.%2BF.%26aulast%3DCerlesi%26aufirst%3DM.%2BC.%26aulast%3DBrown%26aufirst%3DM.%26aulast%3DMalfacini%26aufirst%3DD.%26aulast%3DVezzi%26aufirst%3DV.%26aulast%3DMolinari%26aufirst%3DP.%26aulast%3DMicheli%26aufirst%3DL.%26aulast%3DMannelli%26aufirst%3DL.%2BD.%2BC.%26aulast%3DGhelardini%26aufirst%3DC.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DCal%25C3%25B2%26aufirst%3DG.%26aulast%3DLambert%26aufirst%3DD.%2BG.%26atitle%3DCharacterisation%2520of%2520the%2520novel%2520mixed%2520mu-NOP%2520peptide%2520ligand%2520dermorphin-N%252FOFQ%2520%2528DeNo%2529%26jtitle%3DPLoS%2520One%26date%3D2016%26volume%3D11%26doi%3D10.1371%2Fjournal.pone.0156897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lapalu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moisand, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazarguil, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cambois, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollereau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meunier, J.-C.</span></span> <span> </span><span class="NLM_article-title">Comparison of the structure-activity relationships of nociceptin and dynorphin A using chimeric peptides</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>417</i></span>,  <span class="NLM_fpage">333</span>– <span class="NLM_lpage">336</span>, <span class="refDoi"> DOI: 10.1016/s0014-5793(97)01318-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1016%2FS0014-5793%2897%2901318-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=9409745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADyaK2sXnt1ektb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=417&publication_year=1997&pages=333-336&author=S.+Lapaluauthor=C.+Moisandauthor=H.+Mazarguilauthor=G.+Camboisauthor=C.+Mollereauauthor=J.-C.+Meunier&title=Comparison+of+the+structure-activity+relationships+of+nociceptin+and+dynorphin+A+using+chimeric+peptides&doi=10.1016%2Fs0014-5793%2897%2901318-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of the structure-activity relationships of nociceptin and dynorphin A using chimeric peptides</span></div><div class="casAuthors">Lapalu, Sophie; Moisand, Christiane; Mazarguil, Honore; Cambois, Gilles; Mollereau, Catherine; Meunier, Jean-Claude</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">417</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">333-336</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The aim of the present study was to delineate the functional domains of nociceptin (noc), a neuropeptide which is structurally related to dynorphin A (dyn).  The binding and biol. potencies toward the nociceptin (ORL1) and dynorphin A (κ-opioid) receptors of twenty dyn/noc and noc/dyn hybrid peptides were compared with those of the parent heptadecapeptides.  Replacement of as many as eleven residues in the C-terminus of dynorphin by the corresponding nociceptin sequence has no significant effect on binding and biol. activity toward the κ-opioid receptor.  In marked contrast, replacement of as few as six residues (RKLANQ) in the C-terminus of nociceptin by the corresponding dynorphin sequence (LKWDNQ) dramatically impairs both affinity and activity toward the ORL1 receptor.  This clearly indicates that the two neuropeptides have different functional architectures, despite the dual structural homol. of both ligands and receptors.  Moreover, the recombinant peptide approach led us to identify hybrids whose sequences differ only at positions 5 and 6 and displaying opposite or no receptor selectivity.  One contains the dynorphin Leu5-Arg6 sequence and prefers the κ-opioid receptor, whereas the other comprises the nociceptin Thr5-Gly6 sequence and prefers the ORL1 receptor.  A third, contg. the mixed dynorphin/nociceptin Leu5-Gly6 sequence, does not discriminate between the two types of receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7aeXEaknJZrVg90H21EOLACvtfcHk0lhcwsn5EDYdyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXnt1ektb0%253D&md5=7e5ccbdfcaf3b803188e62a10c9a3a66</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2897%2901318-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252897%252901318-5%26sid%3Dliteratum%253Aachs%26aulast%3DLapalu%26aufirst%3DS.%26aulast%3DMoisand%26aufirst%3DC.%26aulast%3DMazarguil%26aufirst%3DH.%26aulast%3DCambois%26aufirst%3DG.%26aulast%3DMollereau%26aufirst%3DC.%26aulast%3DMeunier%26aufirst%3DJ.-C.%26atitle%3DComparison%2520of%2520the%2520structure-activity%2520relationships%2520of%2520nociceptin%2520and%2520dynorphin%2520A%2520using%2520chimeric%2520peptides%26jtitle%3DFEBS%2520Lett.%26date%3D1997%26volume%3D417%26spage%3D333%26epage%3D336%26doi%3D10.1016%2Fs0014-5793%2897%2901318-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzola, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapella, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pacifico, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerlesi, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malfacini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bird, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvadori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calò, G.</span></span> <span> </span><span class="NLM_article-title">Structure activity studies of nociceptin/orphanin FQ(1-13)-NH<sub>2</sub> derivatives modified in position 5</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1515</span>– <span class="NLM_lpage">1520</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.02.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1016%2Fj.bmc.2015.02.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=25716007" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisl2rtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=1515-1520&author=R.+Guerriniauthor=E.+Marzolaauthor=C.+Trapellaauthor=S.+Pacificoauthor=M.+C.+Cerlesiauthor=D.+Malfaciniauthor=F.+Ferrariauthor=M.+F.+Birdauthor=D.+G.+Lambertauthor=S.+Salvadoriauthor=G.+Cal%C3%B2&title=Structure+activity+studies+of+nociceptin%2Forphanin+FQ%281-13%29-NH2+derivatives+modified+in+position+5&doi=10.1016%2Fj.bmc.2015.02.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Structure activity studies of nociceptin/orphanin FQ(1-13)-NH2 derivatives modified in position 5</span></div><div class="casAuthors">Guerrini, Remo; Marzola, Erika; Trapella, Claudio; Pacifico, Salvatore; Cerlesi, Maria Camilla; Malfacini, Davide; Ferrari, Federica; Bird, Mark Francis; Lambert, David George; Salvadori, Severo; Calo, Girolamo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1515-1520</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Nociceptin/orphanin FQ (N/OFQ) is a heptadecapeptide acting as the endogenous ligand of the N/OFQ peptide receptor (NOP).  N/OFQ(1-13)-NH2 is the shortest N/OFQ sequence maintaining the same potency and efficacy as the natural peptide.  Thus N/OFQ(1-13)-NH2 was used as chem. template for investigating the structure activity relationship of threonine in position 5.  Twenty-eight [X5]N/OFQ(1-13)-NH2 derivs., in which Thr was substituted with natural and unnatural residues, were synthesized and characterized pharmacol. for their effects at the human NOP receptor.  Two different functional assays were used: agonist stimulated [35S]GTPγS binding in cell membranes and calcium mobilization in whole cells co-expressing chimeric G proteins.  All [X5]N/OFQ(1-13)-NH2 derivs. behaved as full NOP agonists showing large differences in their potency.  There was an excellent correlation between the results obtained in the two assays.  The results of this study suggest that: position 5 does not play a pivotal role in receptor activation; the secondary alc. function of Thr is not important for receptor binding; side chain size, lipo/hydrophilic balance as well as hydrogen bond capability are also not crucial for receptor binding; an aliph. amino function pos. charged with at least 3 carbon atom distance from the peptide backbone has a huge disrupting effect on receptor binding.  In conclusion this study demonstrates that a simple Et side chain as in compd. 23 is sufficient in N/OFQ position 5 for maintaining bioactivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBJ-IiFKEdwLVg90H21EOLACvtfcHk0lhhHYcEjuS-Qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisl2rtbc%253D&md5=edacd9f075fa7ba81bd3d8c1775c248b</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.02.008%26sid%3Dliteratum%253Aachs%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DMarzola%26aufirst%3DE.%26aulast%3DTrapella%26aufirst%3DC.%26aulast%3DPacifico%26aufirst%3DS.%26aulast%3DCerlesi%26aufirst%3DM.%2BC.%26aulast%3DMalfacini%26aufirst%3DD.%26aulast%3DFerrari%26aufirst%3DF.%26aulast%3DBird%26aufirst%3DM.%2BF.%26aulast%3DLambert%26aufirst%3DD.%2BG.%26aulast%3DSalvadori%26aufirst%3DS.%26aulast%3DCal%25C3%25B2%26aufirst%3DG.%26atitle%3DStructure%2520activity%2520studies%2520of%2520nociceptin%252Forphanin%2520FQ%25281-13%2529-NH2%2520derivatives%2520modified%2520in%2520position%25205%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D1515%26epage%3D1520%26doi%3D10.1016%2Fj.bmc.2015.02.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Varani, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calò, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigoni, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toth, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gessi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvadori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borea, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regoli, D.</span></span> <span> </span><span class="NLM_article-title">Pharmacology of [Tyr<sup>1</sup>]nociceptin analogs: receptor binding and bioassay studies</span>. <i>Naunyn-Schmiedeberg’s Arch. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>360</i></span>,  <span class="NLM_fpage">270</span>– <span class="NLM_lpage">277</span>, <span class="refDoi"> DOI: 10.1007/s002109900074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1007%2Fs002109900074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10543428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADyaK1MXnsV2ntb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=360&publication_year=1999&pages=270-277&author=K.+Varaniauthor=A.+Rizziauthor=G.+Cal%C3%B2author=R.+Bigoniauthor=G.+Tothauthor=R.+Guerriniauthor=S.+Gessiauthor=S.+Salvadoriauthor=P.+A.+Boreaauthor=D.+Regoli&title=Pharmacology+of+%5BTyr1%5Dnociceptin+analogs%3A+receptor+binding+and+bioassay+studies&doi=10.1007%2Fs002109900074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacology of [Tyr1]nociceptin analogs: receptor binding and bioassay studies</span></div><div class="casAuthors">Varani, Katia; Rizzi, Anna; Calo, Girolamo; Bigoni, Raffaella; Toth, Geza; Guerrini, Remo; Gessi, Stefania; Salvadori, Severo; Borea, Pier Andrea; Regoli, Domenico</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">360</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">270-277</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Two series of nociceptin (NC)-related peptides with or without replacement of the N-terminal Phe by Tyr have been investigated in an attempt to obtain compds. that interact with the NC receptor (ORL1) and classic opioid receptors.  When tested for their ability to displace [3H]NCNH2 ([3H]nociceptin amide; ORL1 sites) or the selective opioid receptor ligands [3H]DAMGO (μ), [3H]deltorphin II (δ) and [3H]U69593 (κ) from their resp. binding sites in guinea pig brain membranes, [Tyr1]NCNH2 and [Tyr1]NC(1-13)NH2 showed high affinities (Ki 2 nM and 5 nM, resp.) for ORL1 and approx. tenfold lower potency for μ (32 nM and 44 nM) and κ sites (42 nM and 48 nM).  They also interacted, but with low potency (Ki 410 nM and 310 nM) with δ sites.  Shorter fragments as [Tyr1]NC(1-9)NH2 and [Tyr1]NC(1-5)NH2 were found to be inactive on ORL1, δ and κ sites, and extremely weak (Ki 2224 nM and 4228 nM, resp.) on μ.  Results of bioassays performed on the guinea pig ileum (ORL1 and μ receptors), mouse vas deferens (ORL1 and δ receptors), and rabbit vas deferens (κ receptor) confirmed (at least partially) the data of the binding by showing that [Tyr1]NC analogs interact with functional ORL1 as well as with classic opioid receptors.  [Tyr1]NCNH2 and [Tyr1]NC(1-13)NH2 behaved as mixed ORL1/opioid receptor agonists showing similar affinities as the control NC sequence while [Tyr1]NC(1-9)NH2 and [Tyr1]NC(1-5)NH2 were inactive on ORL1 receptors but maintained some activities on opioid receptors: their effects were prevented by naloxone.  The results of this study indicate that the replacement of Phe1 by Tyr in NC leads to compds. which bind both the ORL1 and μ/κ receptors and may represent new promising agents for use in peripheral organs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqS2JJlWqGylbVg90H21EOLACvtfcHk0lhhHYcEjuS-Qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnsV2ntb0%253D&md5=73adde175a9251ebf2daa4fc32231165</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1007%2Fs002109900074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002109900074%26sid%3Dliteratum%253Aachs%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DCal%25C3%25B2%26aufirst%3DG.%26aulast%3DBigoni%26aufirst%3DR.%26aulast%3DToth%26aufirst%3DG.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DSalvadori%26aufirst%3DS.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26aulast%3DRegoli%26aufirst%3DD.%26atitle%3DPharmacology%2520of%2520%255BTyr1%255Dnociceptin%2520analogs%253A%2520receptor%2520binding%2520and%2520bioassay%2520studies%26jtitle%3DNaunyn-Schmiedeberg%25E2%2580%2599s%2520Arch.%2520Pharmacol.%26date%3D1999%26volume%3D360%26spage%3D270%26epage%3D277%26doi%3D10.1007%2Fs002109900074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Largent-Milnes, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, S.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamura, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanderah, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porreca, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hruby, V. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent and efficacious peptide derivative for δ/μ opioid agonist/Neurokinin 1 antagonist activity with a 2′,6′-dimethyl-l-tyrosine: In vitro, In vivo, and NMR-Based Structural Studies</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">2029</span>– <span class="NLM_lpage">2038</span>, <span class="refDoi"> DOI: 10.1021/jm101023r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101023r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC3MXislagsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2029-2038&author=T.+Yamamotoauthor=P.+Nairauthor=T.+M.+Largent-Milnesauthor=N.+E.+Jacobsenauthor=P.+Davisauthor=S.-W.+Maauthor=H.+I.+Yamamuraauthor=T.+W.+Vanderahauthor=F.+Porrecaauthor=J.+Laiauthor=V.+J.+Hruby&title=Discovery+of+a+potent+and+efficacious+peptide+derivative+for+%CE%B4%2F%CE%BC+opioid+agonist%2FNeurokinin+1+antagonist+activity+with+a+2%E2%80%B2%2C6%E2%80%B2-dimethyl-l-tyrosine%3A+In+vitro%2C+In+vivo%2C+and+NMR-Based+Structural+Studies&doi=10.1021%2Fjm101023r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent and Efficacious Peptide Derivative for δ/μ Opioid Agonist/Neurokinin 1 Antagonist Activity with a 2',6'-Dimethyl-l-Tyrosine: in Vitro, in Vivo, and NMR-Based Structural Studies</span></div><div class="casAuthors">Yamamoto, Takashi; Nair, Padma; Largent-Milnes, Tally M.; Jacobsen, Neil E.; Davis, Peg; Ma, Shou-Wu; Yamamura, Henry I.; Vanderah, Todd W.; Porreca, Frank; Lai, Josephine; Hruby, Victor J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2029-2038</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Multivalent ligands with δ/μ opioid agonist and NK1 antagonist activities have shown promising analgesic potency without detectable sign of toxicities, including motor skill impairment and opioid-induced tolerance.  To improve their biol. activities and metabolic stability, structural optimization was performed on our peptide-derived lead compds. by introducing 2',6'-dimethyl-L-tyrosine (Dmt) instead of Tyr at the first position.  The compd. 7 (Dmt-D-Ala-Gly-Phe-Met-Pro-Leu-Trp-NH-[3',5'-(CF3)2-Bzl]) showed improved multivalent bioactivities compared to those of the lead compds., had more than 6 h half-life in rat plasma, and had significant antinociceptive efficacy in vivo.  The NMR structural anal. suggested that Dmt1 incorporation in compd. 7 induces the structured conformation in the opioid pharmacophore (N-terminus) and simultaneously shifts the orientation of the NK1 pharmacophore (C-terminus), consistent with its affinities and activities at both opioid and NK1 receptors.  These results indicate that compd. 7 is a valuable research tool to seek a novel analgesic drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokq79EaGReG7Vg90H21EOLACvtfcHk0lhiVr7tgEpiTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXislagsLw%253D&md5=859f657192b27730c9f5afbbfcc1e5b8</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm101023r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101023r%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DNair%26aufirst%3DP.%26aulast%3DLargent-Milnes%26aufirst%3DT.%2BM.%26aulast%3DJacobsen%26aufirst%3DN.%2BE.%26aulast%3DDavis%26aufirst%3DP.%26aulast%3DMa%26aufirst%3DS.-W.%26aulast%3DYamamura%26aufirst%3DH.%2BI.%26aulast%3DVanderah%26aufirst%3DT.%2BW.%26aulast%3DPorreca%26aufirst%3DF.%26aulast%3DLai%26aufirst%3DJ.%26aulast%3DHruby%26aufirst%3DV.%2BJ.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520and%2520efficacious%2520peptide%2520derivative%2520for%2520%25CE%25B4%252F%25CE%25BC%2520opioid%2520agonist%252FNeurokinin%25201%2520antagonist%2520activity%2520with%2520a%25202%25E2%2580%25B2%252C6%25E2%2580%25B2-dimethyl-l-tyrosine%253A%2520In%2520vitro%252C%2520In%2520vivo%252C%2520and%2520NMR-Based%2520Structural%2520Studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2029%26epage%3D2038%26doi%3D10.1021%2Fjm101023r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giri, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Apostol, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forte, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Largent-Milnes, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rankin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molnar, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porreca, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanderah, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hruby, V. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel multifunctional ligands with μ/δ opioid agonist/Neurokinin-1 (NK1) antagonist activities for the treatment of pain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">8573</span>– <span class="NLM_lpage">8583</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01170</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01170" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1CqsbrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8573-8583&author=A.+K.+Giriauthor=C.+R.+Apostolauthor=Y.+Wangauthor=B.+L.+Forteauthor=T.+M.+Largent-Milnesauthor=P.+Davisauthor=D.+Rankinauthor=G.+Molnarauthor=K.+M.+Olsonauthor=F.+Porrecaauthor=T.+W.+Vanderahauthor=V.+J.+Hruby&title=Discovery+of+novel+multifunctional+ligands+with+%CE%BC%2F%CE%B4+opioid+agonist%2FNeurokinin-1+%28NK1%29+antagonist+activities+for+the+treatment+of+pain&doi=10.1021%2Facs.jmedchem.5b01170"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel Multifunctional Ligands with μ/δ Opioid Agonist/Neurokinin-1 (NK1) Antagonist Activities for the Treatment of Pain</span></div><div class="casAuthors">Giri, Aswini Kumar; Apostol, Christopher R.; Wang, Yue; Forte, Brittany L.; Largent-Milnes, Tally M.; Davis, Peg; Rankin, David; Molnar, Gabriella; Olson, Keith M.; Porreca, Frank; Vanderah, Todd W.; Hruby, Victor J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8573-8583</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Multifunctional ligands with agonist bioactivities at μ/δ opioid receptors (MOR/DOR) and antagonist bioactivity at the neurokinin-1 receptor (NK1R) have been designed and synthesized.  These peptide-based ligands are anticipated to produce better biol. profiles (e.g., higher analgesic effect with significantly less adverse side effects) compared to those of existing drugs and to deliver better synergistic effects than coadministration of a mixt. of multiple drugs.  A systematic structure-activity relationship (SAR) study has been conducted to find multifunctional ligands with desired activities at three receptors.  It has been found that introduction of Dmt (2,6-dimethyl-tyrosine) at the first position and NMePhe at the fourth position (ligand 3: H-Dmt-D-Ala-Gly-NMePhe-Pro-Leu-Trp-NH-Bn(3',5'-(CF3)2)) displays binding as well as functional selectivity for MOR over DOR while maintaining efficacy, potency, and antagonist activity at the NK1R.  Dmt at the first position with Phe(4-F) at the fourth position (ligand 5: H-Dmt-D-Ala-Gly-Phe(4-F)-Pro-Leu-Trp-NH-Bn(3',5'-(CF3)2)) exhibits balanced binding affinities at MOR and DOR though it has higher agonist activity at DOR over MOR.  This study has led to the discovery of several novel ligands including 3 and 5 with excellent in vitro biol. activity profiles.  Metabolic stability studies in rat plasma with ligands 3, 5, and 7 (H-Tyr-D-Ala-Gly-Phe(4-F)-Pro-Leu-Trp-NH-Bn(3',5'-(CF3)2)) showed that their stability depends on modifications at the first and fourth positions (3: T1/2 > 24 h; 5: T1/2 ≈ 6 h; 7: T1/2 > 2 h).  Preliminary in vivo studies with these two ligands have shown promising antinociceptive activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLOBSLCv97ObVg90H21EOLACvtfcHk0lhiVr7tgEpiTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1CqsbrK&md5=ab779c641a0d0d4048f064f3f74bdb57</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01170%26sid%3Dliteratum%253Aachs%26aulast%3DGiri%26aufirst%3DA.%2BK.%26aulast%3DApostol%26aufirst%3DC.%2BR.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DForte%26aufirst%3DB.%2BL.%26aulast%3DLargent-Milnes%26aufirst%3DT.%2BM.%26aulast%3DDavis%26aufirst%3DP.%26aulast%3DRankin%26aufirst%3DD.%26aulast%3DMolnar%26aufirst%3DG.%26aulast%3DOlson%26aufirst%3DK.%2BM.%26aulast%3DPorreca%26aufirst%3DF.%26aulast%3DVanderah%26aufirst%3DT.%2BW.%26aulast%3DHruby%26aufirst%3DV.%2BJ.%26atitle%3DDiscovery%2520of%2520novel%2520multifunctional%2520ligands%2520with%2520%25CE%25BC%252F%25CE%25B4%2520opioid%2520agonist%252FNeurokinin-1%2520%2528NK1%2529%2520antagonist%2520activities%2520for%2520the%2520treatment%2520of%2520pain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8573%26epage%3D8583%26doi%3D10.1021%2Facs.jmedchem.5b01170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manglik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatakrishnan, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laeremans, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feinberg, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanborn, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livingston, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorsen, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kling, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Granier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Husbands, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynor, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weis, W. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steyaert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dror, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, B. K.</span></span> <span> </span><span class="NLM_article-title">Structural insights into μ-opioid receptor activation</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>524</i></span>,  <span class="NLM_fpage">315</span>– <span class="NLM_lpage">321</span>, <span class="refDoi"> DOI: 10.1038/nature14886</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1038%2Fnature14886" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=26245379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht12jtbzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=524&publication_year=2015&pages=315-321&author=W.+Huangauthor=A.+Manglikauthor=A.+J.+Venkatakrishnanauthor=T.+Laeremansauthor=E.+N.+Feinbergauthor=A.+L.+Sanbornauthor=H.+E.+Katoauthor=K.+E.+Livingstonauthor=T.+S.+Thorsenauthor=R.+C.+Klingauthor=S.+Granierauthor=P.+Gmeinerauthor=S.+M.+Husbandsauthor=J.+R.+Traynorauthor=W.+I.+Weisauthor=J.+Steyaertauthor=R.+O.+Drorauthor=B.+K.+Kobilka&title=Structural+insights+into+%CE%BC-opioid+receptor+activation&doi=10.1038%2Fnature14886"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insights into μ-opioid receptor activation</span></div><div class="casAuthors">Huang, Weijiao; Manglik, Aashish; Venkatakrishnan, A. J.; Laeremans, Toon; Feinberg, Evan N.; Sanborn, Adrian L.; Kato, Hideaki E.; Livingston, Kathryn E.; Thorsen, Thor S.; Kling, Ralf C.; Granier, Sebastien; Gmeiner, Peter; Husbands, Stephen M.; Traynor, John R.; Weis, William I.; Steyaert, Jan; Dror, Ron O.; Kobilka, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">524</span>
        (<span class="NLM_cas:issue">7565</span>),
    <span class="NLM_cas:pages">315-321</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Activation of the μ-opioid receptor (μOR) is responsible for the efficacy of the most effective analgesics.  To shed light on the structural basis for μOR activation, here we report a 2.1 Å X-ray crystal structure of the murine μOR bound to the morphinan agonist BU72 and a G protein mimetic camelid antibody fragment Nb39 (nanobody 39).  The BU72-stabilized changes in the μOR binding pocket are subtle and differ from those obsd. for agonist-bound structures of the β2-adrenergic receptor (β2AR) and the M2 muscarinic receptor (M2R).  Comparison with active β2AR reveals a common rearrangement in the packing of three conserved amino acids in the core of the μOR, and mol. dynamics simulations illustrate how the ligand-binding pocket is conformationally linked to this conserved triad.  Addnl., an extensive polar network between the ligand-binding pocket and the cytoplasmic domains appears to play a similar role in signal propagation for all three G-protein-coupled receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkFUN1wheV07Vg90H21EOLACvtfcHk0lj4XX-2Y5_Qeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht12jtbzM&md5=b9af3e1351b04539379532c127c02651</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fnature14886&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14886%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DManglik%26aufirst%3DA.%26aulast%3DVenkatakrishnan%26aufirst%3DA.%2BJ.%26aulast%3DLaeremans%26aufirst%3DT.%26aulast%3DFeinberg%26aufirst%3DE.%2BN.%26aulast%3DSanborn%26aufirst%3DA.%2BL.%26aulast%3DKato%26aufirst%3DH.%2BE.%26aulast%3DLivingston%26aufirst%3DK.%2BE.%26aulast%3DThorsen%26aufirst%3DT.%2BS.%26aulast%3DKling%26aufirst%3DR.%2BC.%26aulast%3DGranier%26aufirst%3DS.%26aulast%3DGmeiner%26aufirst%3DP.%26aulast%3DHusbands%26aufirst%3DS.%2BM.%26aulast%3DTraynor%26aufirst%3DJ.%2BR.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26aulast%3DSteyaert%26aufirst%3DJ.%26aulast%3DDror%26aufirst%3DR.%2BO.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26atitle%3DStructural%2520insights%2520into%2520%25CE%25BC-opioid%2520receptor%2520activation%26jtitle%3DNature%26date%3D2015%26volume%3D524%26spage%3D315%26epage%3D321%26doi%3D10.1038%2Fnature14886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koehl, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paggi, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latorraca, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilger, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matile, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schertler, G. F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Granier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weis, W. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dror, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manglik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skiniotis, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, B. K.</span></span> <span> </span><span class="NLM_article-title">Structure of the μ-opioid receptor-Gi protein complex</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>558</i></span>,  <span class="NLM_fpage">547</span>– <span class="NLM_lpage">552</span>, <span class="refDoi"> DOI: 10.1038/s41586-018-0219-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1038%2Fs41586-018-0219-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=29899455" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFeqtbjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=558&publication_year=2018&pages=547-552&author=A.+Koehlauthor=H.+Huauthor=S.+Maedaauthor=Y.+Zhangauthor=Q.+Quauthor=J.+M.+Paggiauthor=N.+R.+Latorracaauthor=D.+Hilgerauthor=R.+Dawsonauthor=H.+Matileauthor=G.+F.+X.+Schertlerauthor=S.+Granierauthor=W.+I.+Weisauthor=R.+O.+Drorauthor=A.+Manglikauthor=G.+Skiniotisauthor=B.+K.+Kobilka&title=Structure+of+the+%CE%BC-opioid+receptor-Gi+protein+complex&doi=10.1038%2Fs41586-018-0219-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the μ-opioid receptor-Gi protein complex</span></div><div class="casAuthors">Koehl, Antoine; Hu, Hongli; Maeda, Shoji; Zhang, Yan; Qu, Qianhui; Paggi, Joseph M.; Latorraca, Naomi R.; Hilger, Daniel; Dawson, Roger; Matile, Hugues; Schertler, Gebhard F. X.; Granier, Sebastien; Weis, William I.; Dror, Ron O.; Manglik, Aashish; Skiniotis, Georgios; Kobilka, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">558</span>
        (<span class="NLM_cas:issue">7711</span>),
    <span class="NLM_cas:pages">547-552</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">The μ-opioid receptor (μOR) is a G-protein-coupled receptor (GPCR) and the target of most clin. and recreationally used opioids.  The induced pos. effects of analgesia and euphoria are mediated by μOR signalling through the adenylyl cyclase-inhibiting heterotrimeric G protein Gi.  Here we present the 3.5 Å resoln. cryo-electron microscopy structure of the μOR bound to the agonist peptide DAMGO and nucleotide-free Gi.  DAMGO occupies the morphinan ligand pocket, with its N terminus interacting with conserved receptor residues and its C terminus engaging regions important for opioid-ligand selectivity.  Comparison of the μOR-Gi complex to previously detd. structures of other GPCRs bound to the stimulatory G protein Gs reveals differences in the position of transmembrane receptor helix 6 and in the interactions between the G protein α-subunit and the receptor core.  Together, these results shed light on the structural features that contribute to the Gi protein-coupling specificity of the μOR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSgJZtgX6dkbVg90H21EOLACvtfcHk0lj4XX-2Y5_Qeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFeqtbjP&md5=92cddedb69cfa5f1a78cb419ef8b4ae0</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fs41586-018-0219-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-018-0219-7%26sid%3Dliteratum%253Aachs%26aulast%3DKoehl%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DMaeda%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DQu%26aufirst%3DQ.%26aulast%3DPaggi%26aufirst%3DJ.%2BM.%26aulast%3DLatorraca%26aufirst%3DN.%2BR.%26aulast%3DHilger%26aufirst%3DD.%26aulast%3DDawson%26aufirst%3DR.%26aulast%3DMatile%26aufirst%3DH.%26aulast%3DSchertler%26aufirst%3DG.%2BF.%2BX.%26aulast%3DGranier%26aufirst%3DS.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26aulast%3DDror%26aufirst%3DR.%2BO.%26aulast%3DManglik%26aufirst%3DA.%26aulast%3DSkiniotis%26aufirst%3DG.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26atitle%3DStructure%2520of%2520the%2520%25CE%25BC-opioid%2520receptor-Gi%2520protein%2520complex%26jtitle%3DNature%26date%3D2018%26volume%3D558%26spage%3D547%26epage%3D552%26doi%3D10.1038%2Fs41586-018-0219-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Della
Longa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arcovito, A.</span></span> <span> </span><span class="NLM_article-title">“In silico” study of the binding of two novel antagonists to the nociceptin receptor</span>. <i>J. Comput.-Aided Mol. Des.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">385</span>– <span class="NLM_lpage">400</span>, <span class="refDoi"> DOI: 10.1007/s10822-017-0095-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1007%2Fs10822-017-0095-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=29340866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVKrurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2018&pages=385-400&author=S.+Della%0ALongaauthor=A.+Arcovito&title=%E2%80%9CIn+silico%E2%80%9D+study+of+the+binding+of+two+novel+antagonists+to+the+nociceptin+receptor&doi=10.1007%2Fs10822-017-0095-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">'In silico' study of the binding of two novel antagonists to the nociceptin receptor</span></div><div class="casAuthors">Della Longa, Stefano; Arcovito, Alessandro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">385-400</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">In this study, a multi-flexible docking (MF-docking) procedure, i.e. docking to multiple receptor conformations extd. by preliminary mol. dynamics trajectories, together with hybrid quantum mechanics/mol. mechanics (QM/MM) simulations have been carried out to provide the binding mode of two novel NOP antagonists, one of them selective (BTRX-246040, formerly named LY-2940094) and one non selective (AT-076), i.e. able to inactivate NOP as well as the classical μ- k- and δ-opioid receptors (MOP KOP and DOP).  According to our results, the pivotal role of residue D1303,32 is analogous to that enlighten by the already known X-ray structures of opioid receptors: binding of the mols. are predicted.  The QM/MM optimization after the MF-docking procedure has provided the more likely conformations for the binding to the NOP receptor of BTRX-246040 and AT-076, based on different pharmacophores and exhibiting different selectivity profiles.  While the high selectivity for NOP of BTRX-246040 can be explained by interactions with NOP specific residues, the lack of selectivity of AT-076 could be assocd. to its ability to penetrate into the deep hydrophobic pocket of NOP, while retaining a conformation very similar to the one assumed by the antagonist JDTic into the K-opioid receptor.  The proposed binding geometries fit better the binding pocket environment providing clues for exptl. studies aimed to design selective or multifunctional opioid drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIWnXh7XbMz7Vg90H21EOLACvtfcHk0lgYhLqzoT1whQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVKrurs%253D&md5=48d116b5c4b36f5b30f584add961401e</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1007%2Fs10822-017-0095-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-017-0095-5%26sid%3Dliteratum%253Aachs%26aulast%3DDella%2BLonga%26aufirst%3DS.%26aulast%3DArcovito%26aufirst%3DA.%26atitle%3D%25E2%2580%259CIn%2520silico%25E2%2580%259D%2520study%2520of%2520the%2520binding%2520of%2520two%2520novel%2520antagonists%2520to%2520the%2520nociceptin%2520receptor%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2018%26volume%3D32%26spage%3D385%26epage%3D400%26doi%3D10.1007%2Fs10822-017-0095-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Della
Longa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arcovito, A.</span></span> <span> </span><span class="NLM_article-title">Microswitches for the activation of the nociceptin receptor induced by cebranopadol: hints from microsecond molecular dynamics</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">818</span>– <span class="NLM_lpage">831</span>, <span class="refDoi"> DOI: 10.1021/acs.jcim.8b00759</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jcim.8b00759" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC1MXovFeitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2019&pages=818-831&author=S.+Della%0ALongaauthor=A.+Arcovito&title=Microswitches+for+the+activation+of+the+nociceptin+receptor+induced+by+cebranopadol%3A+hints+from+microsecond+molecular+dynamics&doi=10.1021%2Facs.jcim.8b00759"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Microswitches for the activation of the nociceptin receptor induced by cebranopadol: hints from microsecond molecular dynamics</span></div><div class="casAuthors">Della Longa, Stefano; Arcovito, Alessandro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">818-831</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cebranopadol (CBP) is a novel analgesic acting as agonist at the nociceptin (NOP) and μ-opioid (MOP) receptors, exhibiting high potency and efficacy as an antinociceptive and antihypersensitive drug.  The binding conformation and the dynamical interactions of CBP with the NOP receptor have been investigated by mol. docking, mol. dynamics (MD) in the microsecond time scale, and hybrid quantum mechanics/mol. mechanics (QM/MM).  CBP binds to the NOP receptor as a bidentate ligand of the aspartate D1303,32 by means of both its fluoroindole and di-Me nitrogens.  Starting from the known crystal structure of the inactive state of the receptor, in complex with the antagonist compd.-24 (NOP-C24) the comparative anal. of 1 μs MD trajectories of the NOP-C24 complex itself and the NOP_free and NOP-CBP complexes provides new insights on the already known microswitches related to receptor activation, in the frame of the extended ternary complex model.  The agonist acts by destabilizing the inactive conformation of the NOP receptor, by inducing a conformational change of M1343,36, which allows W2766,48 to flip around its χ2 dihedral, going in close proximity to the receptor hydrophobic core (T1383,40, P2275,50, F2726,44), which is known to be fundamental for the activation of the opioid receptors.  A complete rational picture is also provided for the role of N1333,35 and W2766,48 undergoing crit. conformational changes related to an anticooperativity effect, i.e. the well-known role of sodium as neg. modulator of agonist binding.  Finally, the movement of residue Y3197,53 belonging to the NPxxY motif is also induced by the binding of the agonist in the inactive state, opening a gate for a water channel just as upon receptor activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1eIyuzeXtPLVg90H21EOLACvtfcHk0lgYhLqzoT1whQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXovFeitQ%253D%253D&md5=25f9fdf7ac331620084fcf75ac5393b8</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Facs.jcim.8b00759&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jcim.8b00759%26sid%3Dliteratum%253Aachs%26aulast%3DDella%2BLonga%26aufirst%3DS.%26aulast%3DArcovito%26aufirst%3DA.%26atitle%3DMicroswitches%2520for%2520the%2520activation%2520of%2520the%2520nociceptin%2520receptor%2520induced%2520by%2520cebranopadol%253A%2520hints%2520from%2520microsecond%2520molecular%2520dynamics%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2019%26volume%3D59%26spage%3D818%26epage%3D831%26doi%3D10.1021%2Facs.jcim.8b00759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McLeod, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolser, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parra, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutter, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tulshian, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hey, J. A.</span></span> <span> </span><span class="NLM_article-title">Antitussive effect of nociceptin/orphanin FQ in experimental cough models</span>. <i>Pulm. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">216</span>, <span class="refDoi"> DOI: 10.1006/pupt.2002.0357</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1006%2Fpupt.2002.0357" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=12099766" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BD38XltVKqsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2002&pages=213-216&author=R.+L.+McLeodauthor=D.+C.+Bolserauthor=Y.+Jiaauthor=L.+E.+Parraauthor=J.+C.+Mutterauthor=X.+Wangauthor=D.+B.+Tulshianauthor=R.+W.+Eganauthor=J.+A.+Hey&title=Antitussive+effect+of+nociceptin%2Forphanin+FQ+in+experimental+cough+models&doi=10.1006%2Fpupt.2002.0357"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Antitussive Effect of Nociceptin/Orphanin FQ in Experimental Cough Models</span></div><div class="casAuthors">McLeod, Robbie L.; Bolser, Donald C.; Jia, Yanlin; Parra, Leonard E.; Mutter, Jennifer C.; Wang, Xin; Tulshian, Deen B.; Egan, Robert W.; Hey, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Pulmonary Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">213-216</span>CODEN:
                <span class="NLM_cas:coden">PPTHFJ</span>;
        ISSN:<span class="NLM_cas:issn">1094-5539</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Cough is an important defensive pulmonary reflex that removes irritants, fluids or foreign materials from the airways.  However, often cough is non-productive and requires suppression.  Opioid μ receptor agonists, such as codeine are commonly used as antitussive agents and are among the most widely administered drugs in the world.  Codeine suppresses the responsiveness of one or more components of the central reflex pathway for cough and is an efficacious antitussive drug for cough due to diverse etiologies.  However, opioids produce side effects that include sedation, addiction potential and constipation.  Therefore, novel cough suppressant therapies should maintain or improve upon the antitussive efficacy profile of opioids.  Moreover, these novel therapies should have a safety profile significantly better than current antitussive therapies.  Presently, we discuss preclin. findings showing that activation of the 'opioid-like' receptor (NOP1) inhibits cough in the guinea pig and cat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK5SQIUqfLVLVg90H21EOLACvtfcHk0lgYhLqzoT1whQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltVKqsLc%253D&md5=88453aa1b1f2ed62697ffe6c96781954</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1006%2Fpupt.2002.0357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fpupt.2002.0357%26sid%3Dliteratum%253Aachs%26aulast%3DMcLeod%26aufirst%3DR.%2BL.%26aulast%3DBolser%26aufirst%3DD.%2BC.%26aulast%3DJia%26aufirst%3DY.%26aulast%3DParra%26aufirst%3DL.%2BE.%26aulast%3DMutter%26aufirst%3DJ.%2BC.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DTulshian%26aufirst%3DD.%2BB.%26aulast%3DEgan%26aufirst%3DR.%2BW.%26aulast%3DHey%26aufirst%3DJ.%2BA.%26atitle%3DAntitussive%2520effect%2520of%2520nociceptin%252Forphanin%2520FQ%2520in%2520experimental%2520cough%2520models%26jtitle%3DPulm.%2520Pharmacol.%2520Ther.%26date%3D2002%26volume%3D15%26spage%3D213%26epage%3D216%26doi%3D10.1006%2Fpupt.2002.0357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McLeod, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parra, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tulshian, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiselgof, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fawzi, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith-Torhan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hey, J. A.</span></span> <span> </span><span class="NLM_article-title">Antitussive profile of the NOP agonist Ro-64-6198 in the guinea pig</span>. <i>Pharmacology</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">143</span>– <span class="NLM_lpage">149</span>, <span class="refDoi"> DOI: 10.1159/000077448</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1159%2F000077448" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=15161996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BD2cXltFCnu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2004&pages=143-149&author=R.+L.+McLeodauthor=Y.+Jiaauthor=X.+Fernandezauthor=L.+E.+Parraauthor=X.+Wangauthor=D.+B.+Tulshianauthor=E.+J.+Kiselgofauthor=Z.+Tanauthor=A.+B.+Fawziauthor=A.+Smith-Torhanauthor=H.+Zhangauthor=J.+A.+Hey&title=Antitussive+profile+of+the+NOP+agonist+Ro-64-6198+in+the+guinea+pig&doi=10.1159%2F000077448"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Antitussive profile of the NOP agonist Ro-64-6198 in the guinea pig</span></div><div class="casAuthors">McLeod, Robbie L.; Jia, Yanlin; Fernandez, Xiomara; Parra, Leonard E.; Wang, Xin; Tulshian, Deen B.; Kiselgof, Eugenia J.; Tan, Zheng; Fawzi, Ahmad B.; Smith-Torhan, April; Zhang, Hongtao; Hey, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">143-149</span>CODEN:
                <span class="NLM_cas:coden">PHMGBN</span>;
        ISSN:<span class="NLM_cas:issn">0031-7012</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">We have previously shown that N/OFQ, the endogenous peptide ligand for the "opioid-like" NOP receptor, inhibits cough in guinea pigs and cats.  In the present study we sought to continue our characterization of the cough-suppressant effects of NOP stimulation by profiling the pulmonary and antitussive effects of a novel non-peptide NOP agonist, Ro-64-6198, in guinea pigs.  In receptor-binding assays, we confirmed that Ro-64-6198 selectively binds to NOP receptors over other opioid receptors.  The Ki values for Ro-64-6198 at NOP, MOP, KOP and DOP receptors was 0.3, 36, 214 and 3,787 nmol/l, resp.  In GTPγS-binding assays, Ro-64-6198 displayed >900-fold functional selectivity at NOP relative to MOP receptors.  We evaluated the effects of Ro-64-6198 (3 and 10 μmol/l) in isolated guinea pig nodose ganglia cells on the increases in intracellular Ca2+ concn. evoked by capsaicin stimulation (1×10-8-1×10-6 mol/l).  Similar to previously reported data with N/OFQ, Ro-64-6198 (3 and 10 μmol/l) significantly attenuated Ca2+ responses in nodose ganglia cells produced by exposure to capsaicin.  The effect of Ro-64-6198 (3 μmol/l) on capsaicin-induced intracellular Ca2+ responses was blocked by the NOP antagonist, J113397 (3 μmol/l).  In guinea pig in vivo studies, aerosolized capsaicin (10-300 μmol/l) produced a dose-dependent increase in cough no.  Ro-64-6198 given i.p. significantly inhibited cough due to capsaicin (300 μmol/l) exposure.  In a duration study we found that the max. antitussive effect (42±8% inhibition) of Ro-64-6198 (3 mg/kg) was obsd. at 1 h after i.p. administration.  Also at 1 h after administration, Ro-64-6198 (0.003-3.0 mg/kg, i.p.) produced a dose-dependent inhibition of cough.  The antitussive effect of Ro-64-6198 (3 mg/kg, i.p.) was blocked by J113397 (12 mg/kg, i.p.) but not by the classical opioid antagonist naltrexone (10 mg/kg, i.p.).  Although the antitussive action of Ro-64-6198 may be mediated by a central and/or a peripheral site of action, we hypothesize that selective oral NOP agonists that do not penetrate the blood-brain barrier may provide a novel approach for the treatment of cough.  Moreover, because these drugs do not interact at MOP receptors, they may be devoid of codeine-like side effects such as respiratory depression, sedation, constipation or proclivities for addictive liabilities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjdJxKiezFwbVg90H21EOLACvtfcHk0lj_L5mVARROFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXltFCnu74%253D&md5=303c3df4646580491f2bde89650c5bfa</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1159%2F000077448&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000077448%26sid%3Dliteratum%253Aachs%26aulast%3DMcLeod%26aufirst%3DR.%2BL.%26aulast%3DJia%26aufirst%3DY.%26aulast%3DFernandez%26aufirst%3DX.%26aulast%3DParra%26aufirst%3DL.%2BE.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DTulshian%26aufirst%3DD.%2BB.%26aulast%3DKiselgof%26aufirst%3DE.%2BJ.%26aulast%3DTan%26aufirst%3DZ.%26aulast%3DFawzi%26aufirst%3DA.%2BB.%26aulast%3DSmith-Torhan%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DHey%26aufirst%3DJ.%2BA.%26atitle%3DAntitussive%2520profile%2520of%2520the%2520NOP%2520agonist%2520Ro-64-6198%2520in%2520the%2520guinea%2520pig%26jtitle%3DPharmacology%26date%3D2004%26volume%3D71%26spage%3D143%26epage%3D149%26doi%3D10.1159%2F000077448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McLeod, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tulshian, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolser, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parra, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmer, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fawzi, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jayappa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehr, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erskine, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith-Torhan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hey, J. A.</span></span> <span> </span><span class="NLM_article-title">Effect of a novel NOP receptor agonist (SCH 225288) on guinea pig irritant-evoked, feline mechanically induced and canine infectious tracheobronchitis cough</span>. <i>Pharmacology</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">153</span>– <span class="NLM_lpage">161</span>, <span class="refDoi"> DOI: 10.1159/000235601</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1159%2F000235601" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=19696521" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFOhtrbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2009&pages=153-161&author=R.+L.+McLeodauthor=D.+B.+Tulshianauthor=G.+D.+Hoauthor=X.+Fernandezauthor=D.+C.+Bolserauthor=L.+E.+Parraauthor=J.+C.+Zimmerauthor=C.+H.+Ericksonauthor=A.+B.+Fawziauthor=H.+Jayappaauthor=C.+Lehrauthor=J.+Erskineauthor=A.+Smith-Torhanauthor=H.+Zhangauthor=J.+A.+Hey&title=Effect+of+a+novel+NOP+receptor+agonist+%28SCH+225288%29+on+guinea+pig+irritant-evoked%2C+feline+mechanically+induced+and+canine+infectious+tracheobronchitis+cough&doi=10.1159%2F000235601"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of a Novel NOP Receptor Agonist (SCH 225288) on Guinea Pig Irritant-Evoked, Feline Mechanically Induced and Canine Infectious Tracheobronchitis Cough</span></div><div class="casAuthors">McLeod, Robbie L.; Tulshian, Deen B.; Ho, Ginny D.; Fernandez, Xiomara; Bolser, Donald C.; Parra, Leonard E.; Zimmer, Jennifer C.; Erickson, Christine H.; Fawzi, Ahmad B.; Jayappa, Huchappa; Lehr, Craig; Erskine, Jason; Smith-Torhan, April; Zhang, Hongtao; Hey, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">153-161</span>CODEN:
                <span class="NLM_cas:coden">PHMGBN</span>;
        ISSN:<span class="NLM_cas:issn">0031-7012</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Background: Previous studies have demonstrated that nociceptin/orphanin FQ (N/OFQ), the endogenous peptide ligand for the G-protein-coupled NOP receptor, inhibits cough in exptl. models.  SCH 225288 is a nonpeptide, orally active NOP agonist that may provide the foundation for the development of novel treatments for cough.  Methods: First we characterized the selectivity of SCH 225288 in human receptor binding assays.  Afterwards, the antitussive activity of SCH 225288 was studied in three mechanistically distinct cough models.  Specifically, we obsd. the cough-suppressant effect of SCH 225288 in a guinea pig capsaicin irritant-evoked cough model, a feline mech. induced cough model and finally in a canine Bordetella bronchiseptica disease model.  Results: SCH 225288 selectively binds human NOP receptor (Ki = 0.38 ± 0.02 nmol/l) over classical opioid receptors (COR).  In a guinea pig capsaicin cough model, SCH 225288 (0.1-1 mg/kg) suppressed cough at 2, 4, and 6 h after oral administration.  The antitussive effect of SCH 225288 (3.0 mg/kg, p.o.) was blocked by the NOP antagonist J113397 (12 mg/kg, i.p.) but not by the classical opioid receptor (COR) antagonist, naltrexone (3.0 mg/kg, i.p.).  In the anesthetized cat, we evaluated the effects of SCH 225288 given either i.v. or via the intravertebral artery against the increases in cough no. and respiratory expiratory and inspiratory muscle (rectus abdominis and parasternal) electromyog. (EMG) activities due to perturbations of the intrathoracic trachea.  SCH 225288 (0.03-3.0 mg/kg, i.v.) inhibited both cough no. and abdominal EMG amplitudes.  Similarly, SCH 225288 (0.001-0.3 mg/kg) administered intra-arterially also diminished cough no. and abdominal EMG amplitudes.  No significant effect of the drug was noted on parasternal EMG activity.  Finally, we studied the antitussive actions of SCH 225288 (1.0 mg/kg) in a canine B. bronchiseptica disease model.  In this model, dogs were challenged intranasally with B. bronchiseptica.  Comparisons were made between a vehicle group, an SCH 225288 (1.0 mg/kg, p.o., q.d.) and a butorphanol (0.6 mg/kg, p.o., b.i.d.) group on the mean change in cough scores from baseline values and days 6-9 after B. bronchiseptica challenge.  SCH 225288 (1.0 mg/kg, p.o., q.d.) displayed a pos. antitussive tendency (p = 0.06) to inhibit B. bronchiseptica cough whereas butorphanol (0.6 mg/kg, p.o., b.i.d.) was devoid of antitussive activity.  Conclusions: Taken together, the present data show that SCH 225288 is a potent and effective antitussive agent in animal models of cough.  Furthermore, these findings indicate that NOP agonists represent a promising new therapeutic approach for the treatment of cough without the side effect liabilities assocd. with opioid antitussives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodplJfyEx3gLVg90H21EOLACvtfcHk0lj_L5mVARROFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFOhtrbE&md5=4c78dd41fcc5ff00100526d8da04d2ef</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1159%2F000235601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000235601%26sid%3Dliteratum%253Aachs%26aulast%3DMcLeod%26aufirst%3DR.%2BL.%26aulast%3DTulshian%26aufirst%3DD.%2BB.%26aulast%3DHo%26aufirst%3DG.%2BD.%26aulast%3DFernandez%26aufirst%3DX.%26aulast%3DBolser%26aufirst%3DD.%2BC.%26aulast%3DParra%26aufirst%3DL.%2BE.%26aulast%3DZimmer%26aufirst%3DJ.%2BC.%26aulast%3DErickson%26aufirst%3DC.%2BH.%26aulast%3DFawzi%26aufirst%3DA.%2BB.%26aulast%3DJayappa%26aufirst%3DH.%26aulast%3DLehr%26aufirst%3DC.%26aulast%3DErskine%26aufirst%3DJ.%26aulast%3DSmith-Torhan%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DHey%26aufirst%3DJ.%2BA.%26atitle%3DEffect%2520of%2520a%2520novel%2520NOP%2520receptor%2520agonist%2520%2528SCH%2520225288%2529%2520on%2520guinea%2520pig%2520irritant-evoked%252C%2520feline%2520mechanically%2520induced%2520and%2520canine%2520infectious%2520tracheobronchitis%2520cough%26jtitle%3DPharmacology%26date%3D2009%26volume%3D84%26spage%3D153%26epage%3D161%26doi%3D10.1159%2F000235601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McLeod, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parra, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutter, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carey, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tulshian, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fawzi, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith-Torhan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuss, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hey, J. A.</span></span> <span> </span><span class="NLM_article-title">Nociceptin inhibits cough in the guinea-pig by activation of ORL1 receptors</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">1175</span>– <span class="NLM_lpage">1178</span>, <span class="refDoi"> DOI: 10.1038/sj.bjp.0703954</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1038%2Fsj.bjp.0703954" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=11250866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BD3MXisFWitrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2001&pages=1175-1178&author=R.+L.+McLeodauthor=L.+E.+Parraauthor=J.+C.+Mutterauthor=C.+H.+Ericksonauthor=G.+J.+Careyauthor=D.+B.+Tulshianauthor=A.+B.+Fawziauthor=A.+Smith-Torhanauthor=R.+W.+Eganauthor=F.+M.+Cussauthor=J.+A.+Hey&title=Nociceptin+inhibits+cough+in+the+guinea-pig+by+activation+of+ORL1+receptors&doi=10.1038%2Fsj.bjp.0703954"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Nociceptin inhibits cough in the guinea-pig by activation of ORL1 receptors</span></div><div class="casAuthors">McLeod, Robbie L.; Parra, Leonard E.; Mutter, Jennifer C.; Erickson, Christine H.; Carey, Galen J.; Tulshian, Deen B.; Fawzi, Ahmad B.; Smith-Torhan, April; Egan, Robert W.; Cuss, Francis M.; Hey, John A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1175-1178</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We studied the central and peripheral antitussive effect of ORL1 receptor activation with nociceptin/orphanin FQ in conscious guinea pigs.  In guinea pig cough studies, nociceptin/orphanin FQ (10, 30, and 90 μg) given directly into the CNS by an intracerebroventricular (i.c.v.) route inhibited cough elicited by capsaicin exposure by approx. 23, 29 and 52%, resp.  The antitussive activity of nociceptin/orphanin FQ (90 μg, i.c.v.) was blocked by the selective ORL1 antagonist [Phe1γ(CH2-NH)Gly2]nociceptin-(1-13)-NH2 (180 μg, i.c.v.) and J 113397 (10 mg kg-1, i.p.) but not by the opioid antagonist, naltrexone (3 mg kg-1, i.p.).  Furthermore, i.v. nociceptin/orphanin FQ (1.0 and 3.0 mg kg-1) also inhibited cough approx. by 25 and 42%, resp.  These findings indicate that selective ORL1 agonists display the potential to inhibit cough by both a central and peripheral mechanism, and potentially represent a novel therapeutic approach for the treatment of cough.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH9gaplu1T_LVg90H21EOLACvtfcHk0lj98VyFmoDfCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXisFWitrs%253D&md5=48746f19039e43c21957cbaed2383962</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0703954&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0703954%26sid%3Dliteratum%253Aachs%26aulast%3DMcLeod%26aufirst%3DR.%2BL.%26aulast%3DParra%26aufirst%3DL.%2BE.%26aulast%3DMutter%26aufirst%3DJ.%2BC.%26aulast%3DErickson%26aufirst%3DC.%2BH.%26aulast%3DCarey%26aufirst%3DG.%2BJ.%26aulast%3DTulshian%26aufirst%3DD.%2BB.%26aulast%3DFawzi%26aufirst%3DA.%2BB.%26aulast%3DSmith-Torhan%26aufirst%3DA.%26aulast%3DEgan%26aufirst%3DR.%2BW.%26aulast%3DCuss%26aufirst%3DF.%2BM.%26aulast%3DHey%26aufirst%3DJ.%2BA.%26atitle%3DNociceptin%2520inhibits%2520cough%2520in%2520the%2520guinea-pig%2520by%2520activation%2520of%2520ORL1%2520receptors%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2001%26volume%3D132%26spage%3D1175%26epage%3D1178%26doi%3D10.1038%2Fsj.bjp.0703954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Undem, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, M. J.</span></span> <span> </span><span class="NLM_article-title">Effect of nociceptin in acid-evoked cough and airway sensory nerve activation in guinea pigs</span>. <i>Am. J. Respir. Crit. Care Med.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>173</i></span>,  <span class="NLM_fpage">271</span>– <span class="NLM_lpage">275</span>, <span class="refDoi"> DOI: 10.1164/rccm.200507-1043oc</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1164%2Frccm.200507-1043OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=16239621" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BD28XmslSksro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=2006&pages=271-275&author=M.-G.+Leeauthor=B.+J.+Undemauthor=C.+Brownauthor=M.+J.+Carr&title=Effect+of+nociceptin+in+acid-evoked+cough+and+airway+sensory+nerve+activation+in+guinea+pigs&doi=10.1164%2Frccm.200507-1043oc"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of nociceptin in acid-evoked cough and airway sensory nerve activation in guinea pigs</span></div><div class="casAuthors">Lee, Min-Goo; Undem, Bradley J.; Brown, Claire; Carr, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory and Critical Care Medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">173</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">271-275</span>CODEN:
                <span class="NLM_cas:coden">AJCMED</span>;
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Rationale: Nociceptin/orphanin FQ has been reported to inhibit capsaicin- and mech. provoked cough in animal models, but the mechanism of this effect has not been elucidated.  Objectives: The objectives of this study were to det. whether nociceptin inhibits acid-evoked cough in conscious animals and to evaluate the mechanism of this effect.  Methods: We tested the effect of nociceptin on acid-induced cough in conscious guinea pigs and acid-induced nerve activation in airway-specific vagal sensory neurons using calcium imaging techniques and the gramicidin-perforated patch clamp technique.  Measurements and Main Results: Nociceptin (3 mg/kg, i.p.) effectively inhibited acid-evoked cough in guinea pigs by nearly 70%.  Acid (pH 5) increased intracellular free calcium in acutely dissocd. vagal jugular ganglionic neurons.  The acid-induced increase in intracellular calcium was inhibited by a selective transient receptor potential vanilloid-1 antagonist, 5-iodo-resiniferatoxin (1 μM, ∼80% redn.).  The inhibitory effect of 5-iodo-resiniferatoxin on acid-induced increases in calcium was mimicked by nociceptin (0.1 μM).  In gramicidin-perforated patch clamp recordings on airway-specific capsaicin-sensitive jugular ganglion neurons, acid (pH 5) induced two distinct inward currents.  A transient current was evoked that was inhibited by amiloride and a sustained current was evoked that was inhibited by 5-iodo-resiniferatoxin.  Nociceptin selectively inhibited only the sustained component of acid-induced inward current.  Conclusion: These results indicate that the inhibitory effect of nociceptin on acid-induced cough may result from a direct inhibitory effect on peripheral C-fiber activity caused by the selective inhibition of acid-induced transient receptor potential vanilloid-1 activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7nu8PLku7c7Vg90H21EOLACvtfcHk0lj98VyFmoDfCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmslSksro%253D&md5=915d140a2cc8650708e1fe6291863482</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1164%2Frccm.200507-1043OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Frccm.200507-1043OC%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DM.-G.%26aulast%3DUndem%26aufirst%3DB.%2BJ.%26aulast%3DBrown%26aufirst%3DC.%26aulast%3DCarr%26aufirst%3DM.%2BJ.%26atitle%3DEffect%2520of%2520nociceptin%2520in%2520acid-evoked%2520cough%2520and%2520airway%2520sensory%2520nerve%2520activation%2520in%2520guinea%2520pigs%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2006%26volume%3D173%26spage%3D271%26epage%3D275%26doi%3D10.1164%2Frccm.200507-1043oc" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, N. M.</span></span> <span> </span><span class="NLM_article-title">Cough pharmacotherapy: current and future status</span>. <i>Expert Opin. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1745</span>– <span class="NLM_lpage">1755</span>, <span class="refDoi"> DOI: 10.1517/14656566.2011.576249</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1517%2F14656566.2011.576249" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=21524236" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC3MXos1Kqtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=1745-1755&author=P.+G.+Gibsonauthor=N.+M.+Ryan&title=Cough+pharmacotherapy%3A+current+and+future+status&doi=10.1517%2F14656566.2011.576249"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Cough pharmacotherapy: current and future status</span></div><div class="casAuthors">Gibson, Peter G.; Ryan, Nicole M.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1745-1755</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Chronic cough is responsible for a significant illness burden in the community.  Refractory cough causes substantial quality-of-life impairment in people with this problem.  Neuromodulators for sensory neuropathic cough and new compds. to block transient receptor potential (TRP) receptors hold promise for chronic cough and upper airway hypersensitivity.  Areas covered: The authors examine current evidence on the new concepts of chronic cough that relate to the study of idiopathic/refractory cough, the role of central nervous system control of cough and the role of laryngeal irritability and sensory neuropathy in cough.  Compds. in development to block TRP receptors, treatment for a neuropathic disorder with neuromodulators and cough suppression with opioids, esp. codeine and morphine, are investigated.  Relevant randomized control trials and case reports were identified through a PubMed search of English-language literature referring to these concepts.  Expert opinion: The concept that sensory neuropathic disorder may underlie some cases of chronic cough is useful in characterizing cough, understanding its mechanisms and guiding drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaoQFqlm8s5bVg90H21EOLACvtfcHk0lj98VyFmoDfCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXos1Kqtbo%253D&md5=d1bb9d5f1cd18659a2b5224f4692d8f6</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1517%2F14656566.2011.576249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656566.2011.576249%26sid%3Dliteratum%253Aachs%26aulast%3DGibson%26aufirst%3DP.%2BG.%26aulast%3DRyan%26aufirst%3DN.%2BM.%26atitle%3DCough%2520pharmacotherapy%253A%2520current%2520and%2520future%2520status%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2011%26volume%3D12%26spage%3D1745%26epage%3D1755%26doi%3D10.1517%2F14656566.2011.576249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, D.</span></span> <span> </span><span class="NLM_article-title">Pd-catalyzed dimethylation of tyrosine-derived picolinamide for synthesis of (S)-N-Boc-2,6-dimethyltyrosine and its analogues</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">246</span>– <span class="NLM_lpage">249</span>, <span class="refDoi"> DOI: 10.1021/acs.orglett.6b03548</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.orglett.6b03548" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFCgs7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2017&pages=246-249&author=X.+Wangauthor=S.+Niuauthor=L.+Xuauthor=C.+Zhangauthor=L.+Mengauthor=X.+Zhangauthor=D.+Ma&title=Pd-catalyzed+dimethylation+of+tyrosine-derived+picolinamide+for+synthesis+of+%28S%29-N-Boc-2%2C6-dimethyltyrosine+and+its+analogues&doi=10.1021%2Facs.orglett.6b03548"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Pd-catalyzed dimethylation of tyrosine-derived picolinamide for synthesis of (S)-N-Boc-2,6-dimethyltyrosine and its analogs</span></div><div class="casAuthors">Wang, Xuning; Niu, Songtao; Xu, Lanting; Zhang, Chao; Meng, Lingxing; Zhang, Xiaojing; Ma, Dawei</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">246-249</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A short and efficient synthesis of (S)-N-Boc-2,6-dimethyltyrosine (Boc = tert-butoxycarbonyl) utilizing palladium-catalyzed directed C-H functionalization is described.  This represents the first general method for the ortho-dimethylation of tyrosine derivs. and offers a practical approach for prepg. this synthetically important building block.  Notably, throughout the reaction sequence no racemization occurs at the susceptible α-chiral centers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjYiQqHYKkVLVg90H21EOLACvtfcHk0ligzQhwW4q1aQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFCgs7jK&md5=642409a9693cf6cc3e4507df60a5561d</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Facs.orglett.6b03548&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.orglett.6b03548%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DNiu%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DMeng%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DMa%26aufirst%3DD.%26atitle%3DPd-catalyzed%2520dimethylation%2520of%2520tyrosine-derived%2520picolinamide%2520for%2520synthesis%2520of%2520%2528S%2529-N-Boc-2%252C6-dimethyltyrosine%2520and%2520its%2520analogues%26jtitle%3DOrg.%2520Lett.%26date%3D2017%26volume%3D19%26spage%3D246%26epage%3D249%26doi%3D10.1021%2Facs.orglett.6b03548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bryant, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jinsmaa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvadori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okada, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazarus, L. H.</span></span> <span> </span><span class="NLM_article-title">Dmt and opioid peptides: a potent alliance</span>. <i>Biopolymers</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">86</span>– <span class="NLM_lpage">102</span>, <span class="refDoi"> DOI: 10.1002/bip.10399</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1002%2Fbip.10399" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=12767112" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BD3sXksFGnsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2003&pages=86-102&author=S.+D.+Bryantauthor=Y.+Jinsmaaauthor=S.+Salvadoriauthor=Y.+Okadaauthor=L.+H.+Lazarus&title=Dmt+and+opioid+peptides%3A+a+potent+alliance&doi=10.1002%2Fbip.10399"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Dmt and opioid peptides: A potent alliance</span></div><div class="casAuthors">Bryant, Sharon D.; Jinsmaa, Yunden; Salvadori, Severo; Okada, Yoshio; Lazarus, Lawrence H.</div><div class="citationInfo"><span class="NLM_cas:title">Biopolymers</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">86-102</span>CODEN:
                <span class="NLM_cas:coden">BIPMAA</span>;
        ISSN:<span class="NLM_cas:issn">0006-3525</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  The introduction of the Dmt (2',6'-dimethyl-L-tyrosine)-Tic pharmacophore into the design of opioid ligands produced an extraordinary family of potent δ-opioid receptor antagonists and heralded a new phase in opioid research.  First reviewed extensively in 1998, the incorporation of Dmt into a diverse group of opioid mols. stimulated the opioid field leading to the development of unique analogs with remarkable properties.  This overview will document the crucial role played by this residue in the proliferation of opioid peptides with high receptor affinity (Ki equal to or less than 1 nM) and potent bioactivity.  The discussion will include the metamorphosis between δ-opioid receptor antagonists to δ-agonists based solely on subtle structural changes at the C-terminal region of the Dmt-Tic pharmacophore as well as their behavior in vivo.  Dmt may be considered promiscuous due to the acquisition of potent μ-agonism by dermorphin and endomorphin derivs. as well as by a unique class of opioidmimetics contg. two Dmt residues sepd. by alkyl or pyrazinone linkers.  Structural studies on the Dmt-Tic compds. were enhanced tremendously by x-ray diffraction data for three potent and biol. diverse Dmt-Tic opioidmimetics that led to the development of pharmacophores for both δ-opioid receptor agonists and antagonists.  Mol. modeling studies of other unique Dmt opioid analogs illuminated structural differences between δ- and μ-receptor ligand interactions.  The future of these compds. as therapeutic applications for various medical syndromes including the control of.  Cancer-assocd. pain is only a matter of time and perseverance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiTbBjfNXJz7Vg90H21EOLACvtfcHk0ligzQhwW4q1aQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXksFGnsLg%253D&md5=3dee0fba7253ce2d0b67fdd581ee0829</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1002%2Fbip.10399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbip.10399%26sid%3Dliteratum%253Aachs%26aulast%3DBryant%26aufirst%3DS.%2BD.%26aulast%3DJinsmaa%26aufirst%3DY.%26aulast%3DSalvadori%26aufirst%3DS.%26aulast%3DOkada%26aufirst%3DY.%26aulast%3DLazarus%26aufirst%3DL.%2BH.%26atitle%3DDmt%2520and%2520opioid%2520peptides%253A%2520a%2520potent%2520alliance%26jtitle%3DBiopolymers%26date%3D2003%26volume%3D71%26spage%3D86%26epage%3D102%26doi%3D10.1002%2Fbip.10399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fenalti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giguere, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherezov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span> <span> </span><span class="NLM_article-title">Molecular control of δ-opioid receptor signalling</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>506</i></span>,  <span class="NLM_fpage">191</span>– <span class="NLM_lpage">196</span>, <span class="refDoi"> DOI: 10.1038/nature12944</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1038%2Fnature12944" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=24413399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisVaktro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=506&publication_year=2014&pages=191-196&author=G.+Fenaltiauthor=P.+M.+Giguereauthor=V.+Katritchauthor=X.-P.+Huangauthor=A.+A.+Thompsonauthor=V.+Cherezovauthor=B.+L.+Rothauthor=R.+C.+Stevens&title=Molecular+control+of+%CE%B4-opioid+receptor+signalling&doi=10.1038%2Fnature12944"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular control of δ-opioid receptor signalling</span></div><div class="casAuthors">Fenalti, Gustavo; Giguere, Patrick M.; Katritch, Vsevolod; Huang, Xi-Ping; Thompson, Aaron A.; Cherezov, Vadim; Roth, Bryan L.; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">506</span>
        (<span class="NLM_cas:issue">7487</span>),
    <span class="NLM_cas:pages">191-196</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Opioids represent widely prescribed and abused medications, although their signal transduction mechanisms are not well understood.  Here we present the 1.8 Å high-resoln. crystal structure of the human δ-opioid receptor (δ-OR), revealing the presence and fundamental role of a sodium ion in mediating allosteric control of receptor functional selectivity and constitutive activity.  The distinctive δ-OR sodium ion site architecture is centrally located in a polar interaction network in the seven-transmembrane bundle core, with the sodium ion stabilizing a reduced agonist affinity state, and thereby modulating signal transduction.  Site-directed mutagenesis and functional studies reveal that changing the allosteric sodium site residue Asn 131 to an alanine or a valine augments constitutive β-arrestin-mediated signaling.  Asp95Ala, Asn310Ala and Asn314Ala mutations transform classical δ-opioid antagonists such as naltrindole into potent β-arrestin-biased agonists.  The data establish the mol. basis for allosteric sodium ion control in opioid signaling, revealing that sodium-coordinating residues act as 'efficacy switches' at a prototypic G-protein-coupled receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUFRulZU1cfrVg90H21EOLACvtfcHk0ligzQhwW4q1aQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisVaktro%253D&md5=88159956324bb2858286a4100a9cb8bf</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fnature12944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12944%26sid%3Dliteratum%253Aachs%26aulast%3DFenalti%26aufirst%3DG.%26aulast%3DGiguere%26aufirst%3DP.%2BM.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DHuang%26aufirst%3DX.-P.%26aulast%3DThompson%26aufirst%3DA.%2BA.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DMolecular%2520control%2520of%2520%25CE%25B4-opioid%2520receptor%2520signalling%26jtitle%3DNature%26date%3D2014%26volume%3D506%26spage%3D191%26epage%3D196%26doi%3D10.1038%2Fnature12944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shimohigashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatano, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakashima, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nose, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sujaku, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saigo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinjo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagahisa, A.</span></span> <span> </span><span class="NLM_article-title">Sensitivity of opioid receptor-like receptor ORL1 for chemical modification on nociceptin, a naturally occurring nociceptive peptide</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>271</i></span>,  <span class="NLM_fpage">23642</span>– <span class="NLM_lpage">23645</span>, <span class="refDoi"> DOI: 10.1074/jbc.271.39.23642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1074%2Fjbc.271.39.23642" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=8798582" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADyaK28XlvFSltLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=23642-23645&author=Y.+Shimohigashiauthor=R.+Hatanoauthor=T.+Fujitaauthor=R.+Nakashimaauthor=T.+Noseauthor=T.+Sujakuauthor=A.+Saigoauthor=K.+Shinjoauthor=A.+Nagahisa&title=Sensitivity+of+opioid+receptor-like+receptor+ORL1+for+chemical+modification+on+nociceptin%2C+a+naturally+occurring+nociceptive+peptide&doi=10.1074%2Fjbc.271.39.23642"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Sensitivity of opioid receptor-like receptor ORL1 for chemical modification on nociceptin, a naturally occurring nociceptive peptide</span></div><div class="casAuthors">Shimohigashi, Yasuyuki; Hatano, Ryo; Fujita, Tsugumi; Nakashima, Rie; Nose, Takeru; Sujaku, Tetsujo; Saigo, Aki; Shinjo, Katsuhiro; Nagahisa, Atsushi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">271</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">23642-23645</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Nociceptin or orphanin FQ is a novel neuropeptide that activates an opioid-like G protein-coupled receptor ORL1.  This heptadecapeptide FGGFTGARKSARKLANQ resembles κ-opioid peptide dynorphin A but exhibits an opposite effect to make animals hyper-reactive to nociceptive stimulations.  In the present study, it was found that guinea pig brain contains receptors to which nociceptin binds much more strongly than to ORL1 receptors expressed in human 293 cells.  Although the Tyr1 → Phe substitution for dynorphin A eliminates almost completely an ability to bind to opioid receptors, the Phe1 → Tyr substitution in nociceptin was found to retain almost fully both receptor binding affinity and in vivo hyperalgesic activity in tail-flick assay.  Nociceptin was extremely weak to bind to opioid receptors, while Tyr1-nociceptin exhibited 10-40 times increased affinity, esp. for μ receptors, due to its N-terminal sequential identity to opioid peptides.  Shortened analogs of dynorphin A are known to retain receptor binding ability and analgesic activity, whereas the removal of C-terminal hexa- or decapeptide from nociceptin totally abolished the affinity for the ORL1 receptor.  These results indicated that the mode of interaction between nociceptin and ORL1 receptor is quite different from that between dynorphin and opioid receptor and that the C-terminal portion of nociceptin is crucial for receptor recognition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhj-YEdB1Bh7Vg90H21EOLACvtfcHk0lhqynFeQazIew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XlvFSltLw%253D&md5=cb8cca2fd4bd7a60fbc6ea8791bda51a</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1074%2Fjbc.271.39.23642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.271.39.23642%26sid%3Dliteratum%253Aachs%26aulast%3DShimohigashi%26aufirst%3DY.%26aulast%3DHatano%26aufirst%3DR.%26aulast%3DFujita%26aufirst%3DT.%26aulast%3DNakashima%26aufirst%3DR.%26aulast%3DNose%26aufirst%3DT.%26aulast%3DSujaku%26aufirst%3DT.%26aulast%3DSaigo%26aufirst%3DA.%26aulast%3DShinjo%26aufirst%3DK.%26aulast%3DNagahisa%26aufirst%3DA.%26atitle%3DSensitivity%2520of%2520opioid%2520receptor-like%2520receptor%2520ORL1%2520for%2520chemical%2520modification%2520on%2520nociceptin%252C%2520a%2520naturally%2520occurring%2520nociceptive%2520peptide%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D23642%26epage%3D23645%26doi%3D10.1074%2Fjbc.271.39.23642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morley, J. S.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships of enkephalin-like peptides</span>. <i>Annu. Rev. Pharmacol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">81</span>– <span class="NLM_lpage">110</span>, <span class="refDoi"> DOI: 10.1146/annurev.pa.20.040180.000501</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1146%2Fannurev.pa.20.040180.000501" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=6247963" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADyaL3cXktF2mtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1980&pages=81-110&author=J.+S.+Morley&title=Structure-activity+relationships+of+enkephalin-like+peptides&doi=10.1146%2Fannurev.pa.20.040180.000501"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationships of enkephalin-like peptides</span></div><div class="casAuthors">Morley, J. S.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">81-110</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    </div><div class="casAbstract">A review with 93 refs.  Met enkephalin  [58569-55-4] and leu enkephalin  [58822-25-6] analogs are considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojUGWYZiunc7Vg90H21EOLACvtfcHk0lhqynFeQazIew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXktF2mtr0%253D&md5=2ff73d3c5403aad3b494a8908da5c2b6</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pa.20.040180.000501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pa.20.040180.000501%26sid%3Dliteratum%253Aachs%26aulast%3DMorley%26aufirst%3DJ.%2BS.%26atitle%3DStructure-activity%2520relationships%2520of%2520enkephalin-like%2520peptides%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D1980%26volume%3D20%26spage%3D81%26epage%3D110%26doi%3D10.1146%2Fannurev.pa.20.040180.000501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ndong, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blais, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holleran, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proteau-Gagne, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantin-Savoie, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robert, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nadon, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beauchemin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leduc, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pineyro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gendron, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dory, Y. L.</span></span> <span> </span><span class="NLM_article-title">Exploration of the fifth position of leu-enkephalin and its role in binding and activating delta (DOP) and mu (MOP) opioid receptors</span>. <i>Pept. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>111</i></span>, <span class="NLM_elocation-id">e24070</span> <span class="refDoi"> DOI: 10.1002/pep2.24070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1002%2Fpep2.24070" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2019&author=D.+B.+Ndongauthor=V.+Blaisauthor=B.+J.+Holleranauthor=A.+Proteau-Gagneauthor=I.+Cantin-Savoieauthor=W.+Robertauthor=J.+F.+Nadonauthor=S.+Beaucheminauthor=R.+Leducauthor=G.+Pineyroauthor=B.+Guerinauthor=L.+Gendronauthor=Y.+L.+Dory&title=Exploration+of+the+fifth+position+of+leu-enkephalin+and+its+role+in+binding+and+activating+delta+%28DOP%29+and+mu+%28MOP%29+opioid+receptors&doi=10.1002%2Fpep2.24070"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1002%2Fpep2.24070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpep2.24070%26sid%3Dliteratum%253Aachs%26aulast%3DNdong%26aufirst%3DD.%2BB.%26aulast%3DBlais%26aufirst%3DV.%26aulast%3DHolleran%26aufirst%3DB.%2BJ.%26aulast%3DProteau-Gagne%26aufirst%3DA.%26aulast%3DCantin-Savoie%26aufirst%3DI.%26aulast%3DRobert%26aufirst%3DW.%26aulast%3DNadon%26aufirst%3DJ.%2BF.%26aulast%3DBeauchemin%26aufirst%3DS.%26aulast%3DLeduc%26aufirst%3DR.%26aulast%3DPineyro%26aufirst%3DG.%26aulast%3DGuerin%26aufirst%3DB.%26aulast%3DGendron%26aufirst%3DL.%26aulast%3DDory%26aufirst%3DY.%2BL.%26atitle%3DExploration%2520of%2520the%2520fifth%2520position%2520of%2520leu-enkephalin%2520and%2520its%2520role%2520in%2520binding%2520and%2520activating%2520delta%2520%2528DOP%2529%2520and%2520mu%2520%2528MOP%2529%2520opioid%2520receptors%26jtitle%3DPept.%2520Sci.%26date%3D2019%26volume%3D111%26doi%3D10.1002%2Fpep2.24070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Camarda, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calò, G.</span></span> <span> </span><span class="NLM_article-title">Chimeric G proteins in fluorimetric calcium assays: experience with opioid receptors</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>937</i></span>,  <span class="NLM_fpage">293</span>– <span class="NLM_lpage">306</span>, <span class="refDoi"> DOI: 10.1007/978-1-62703-086-1_18</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1007%2F978-1-62703-086-1_18" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=23007594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC3sXisF2gtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=937&publication_year=2013&pages=293-306&author=V.+Camardaauthor=G.+Cal%C3%B2&title=Chimeric+G+proteins+in+fluorimetric+calcium+assays%3A+experience+with+opioid+receptors&doi=10.1007%2F978-1-62703-086-1_18"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Chimeric G proteins in fluorimetric calcium assays: experience with opioid receptors</span></div><div class="casAuthors">Camarda, Valeria; Calo', Girolamo</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">937</span>
        (<span class="NLM_cas:issue">Calcium Signaling Protocols</span>),
    <span class="NLM_cas:pages">293-306</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1064-3745</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">High throughput calcium mobilization assays are extensively used for pharmacol. characterization of GPCR ligands.  These approaches, initially developed for Gq-coupled receptors, can be extended to Gi coupled GPCRs using chimeric G proteins.  Here we used the Gαqi5 protein to force the nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor, as well as the classical opioid receptors to signal through the PLC-IP3-Ca2+ pathway in CHO cells.  Calcium levels were monitored using the fluorometric imaging plate reader FlexStation II and the Ca2+ dye Fluo 4 AM.  For investigating the pharmacol. of the NOP receptor a panel of full and partial agonists and antagonists were assessed, while a small panel of agonists and antagonists was used for evaluating the pharmacol. profile of opioid receptors.  Some limitations of this assay and differences in the results obtained in comparison with those with Gi based biochem. assays are described.  Overall, the present results confirm that the chimeric G protein strategy is useful for studying the pharmacol. activity of Gi coupled receptor ligands and that the aberrant signaling does not produce any measurable change in the pharmacol. profile of the receptor under study.  Thus, this G protein strategy is extremely useful for setting up primary screening assays for NOP and classical opioid receptors and likely for other members of the GPCR family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8B1rU3SUTZLVg90H21EOLACvtfcHk0lhqynFeQazIew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXisF2gtrs%253D&md5=2aaed19c1387300bd163019b4f58bcd6</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1007%2F978-1-62703-086-1_18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-62703-086-1_18%26sid%3Dliteratum%253Aachs%26aulast%3DCamarda%26aufirst%3DV.%26aulast%3DCal%25C3%25B2%26aufirst%3DG.%26atitle%3DChimeric%2520G%2520proteins%2520in%2520fluorimetric%2520calcium%2520assays%253A%2520experience%2520with%2520opioid%2520receptors%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2013%26volume%3D937%26spage%3D293%26epage%3D306%26doi%3D10.1007%2F978-1-62703-086-1_18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Camarda, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischetti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anzellotti, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molinari, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambrosio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kostenis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regoli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapella, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Severo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calò, G.</span></span> <span> </span><span class="NLM_article-title">Pharmacological profile of NOP receptors coupled with calcium signaling via the chimeric protein Gαqi5</span>. <i>Naunyn-Schmiedeberg’s Arch. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>379</i></span>,  <span class="NLM_fpage">599</span>– <span class="NLM_lpage">607</span>, <span class="refDoi"> DOI: 10.1007/s00210-009-0396-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1007%2Fs00210-009-0396-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=19183962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVOjtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=379&publication_year=2009&pages=599-607&author=V.+Camardaauthor=C.+Fischettiauthor=N.+Anzellottiauthor=P.+Molinariauthor=C.+Ambrosioauthor=E.+Kostenisauthor=D.+Regoliauthor=C.+Trapellaauthor=R.+Guerriniauthor=S.+Severoauthor=G.+Cal%C3%B2&title=Pharmacological+profile+of+NOP+receptors+coupled+with+calcium+signaling+via+the+chimeric+protein+G%CE%B1qi5&doi=10.1007%2Fs00210-009-0396-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological profile of NOP receptors coupled with calcium signaling via the chimeric protein Gαqi5</span></div><div class="casAuthors">Camarda, Valeria; Fischetti, Carmela; Anzellotti, Nicholas; Molinari, Paola; Ambrosio, Caterina; Kostenis, Evi; Regoli, Domenico; Trapella, Claudio; Guerrini, Remo; Severo, Salvadori; Calo, Girolamo</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">379</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">599-607</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">In this study, the Gαqi5 protein was used to force the human nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor to signal through the Ca2+ pathway in CHO cells.  [Ca2+]i levels were monitored using the fluorometer FlexStation II and the Ca2+ dye Fluo 4 AM.  Concn. response curves were generated with a panel of full and partial agonists, while NOP antagonists were assessed in inhibition-response curves.  The following rank order of potency of antagonists was measured: naloxone, which is superimposable to literature findings.  The rank order of potency of full and partial agonists is also similar to that obtained in previous studies with the exception of a panel of ligands (UFP-112, Ro 64-6198, ZP120, UFP-113) whose potency was relatively low in the Gαqi5-NOP receptor calcium assay.  Interestingly, these NOP ligands are characterized by slow kinetic of interaction with the NOP receptor, as demonstrated by bioassay expts.  These results demonstrated that the FlexStation II-Gαqi5-NOP receptor calcium assay represents an adequate and useful screening for NOP receptor ligands, particularly for antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkL3dchbOaALVg90H21EOLACvtfcHk0lg5VxN1lqF9Sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVOjtL0%253D&md5=1b7c4c980137bbd062552f1fc5a84b62</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1007%2Fs00210-009-0396-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00210-009-0396-x%26sid%3Dliteratum%253Aachs%26aulast%3DCamarda%26aufirst%3DV.%26aulast%3DFischetti%26aufirst%3DC.%26aulast%3DAnzellotti%26aufirst%3DN.%26aulast%3DMolinari%26aufirst%3DP.%26aulast%3DAmbrosio%26aufirst%3DC.%26aulast%3DKostenis%26aufirst%3DE.%26aulast%3DRegoli%26aufirst%3DD.%26aulast%3DTrapella%26aufirst%3DC.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DSevero%26aufirst%3DS.%26aulast%3DCal%25C3%25B2%26aufirst%3DG.%26atitle%3DPharmacological%2520profile%2520of%2520NOP%2520receptors%2520coupled%2520with%2520calcium%2520signaling%2520via%2520the%2520chimeric%2520protein%2520G%25CE%25B1qi5%26jtitle%3DNaunyn-Schmiedeberg%25E2%2580%2599s%2520Arch.%2520Pharmacol.%26date%3D2009%26volume%3D379%26spage%3D599%26epage%3D607%26doi%3D10.1007%2Fs00210-009-0396-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerlesi, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruzza, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malfacini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianco, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapella, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calò, G.</span></span> <span> </span><span class="NLM_article-title">Pharmacological characterization of cebranopadol a novel analgesic acting as mixed nociceptin/orphanin FQ and opioid receptor agonist</span>. <i>Pharmacol. Res. Perspect.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>4</i></span>, <span class="NLM_elocation-id">e00247</span> <span class="refDoi"> DOI: 10.1002/prp2.247</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1002%2Fprp2.247" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=28116100" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2016&author=A.+Rizziauthor=M.+C.+Cerlesiauthor=C.+Ruzzaauthor=D.+Malfaciniauthor=F.+Ferrariauthor=S.+Biancoauthor=T.+Costaauthor=R.+Guerriniauthor=C.+Trapellaauthor=G.+Cal%C3%B2&title=Pharmacological+characterization+of+cebranopadol+a+novel+analgesic+acting+as+mixed+nociceptin%2Forphanin+FQ+and+opioid+receptor+agonist&doi=10.1002%2Fprp2.247"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1002%2Fprp2.247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprp2.247%26sid%3Dliteratum%253Aachs%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DCerlesi%26aufirst%3DM.%2BC.%26aulast%3DRuzza%26aufirst%3DC.%26aulast%3DMalfacini%26aufirst%3DD.%26aulast%3DFerrari%26aufirst%3DF.%26aulast%3DBianco%26aufirst%3DS.%26aulast%3DCosta%26aufirst%3DT.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DTrapella%26aufirst%3DC.%26aulast%3DCal%25C3%25B2%26aufirst%3DG.%26atitle%3DPharmacological%2520characterization%2520of%2520cebranopadol%2520a%2520novel%2520analgesic%2520acting%2520as%2520mixed%2520nociceptin%252Forphanin%2520FQ%2520and%2520opioid%2520receptor%2520agonist%26jtitle%3DPharmacol.%2520Res.%2520Perspect.%26date%3D2016%26volume%3D4%26doi%3D10.1002%2Fprp2.247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Codd, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mabus, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flores, C. M.</span></span> <span> </span><span class="NLM_article-title">Dynamic mass redistribution as a means to measure and differentiate signaling via opioid and cannabinoid receptors</span>. <i>Assay Drug Dev. Technol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">362</span>– <span class="NLM_lpage">372</span>, <span class="refDoi"> DOI: 10.1089/adt.2010.0347</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1089%2Fadt.2010.0347" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=21323580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC3MXps1Omsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2011&pages=362-372&author=E.+E.+Coddauthor=J.+R.+Mabusauthor=B.+S.+Murrayauthor=S.+P.+Zhangauthor=C.+M.+Flores&title=Dynamic+mass+redistribution+as+a+means+to+measure+and+differentiate+signaling+via+opioid+and+cannabinoid+receptors&doi=10.1089%2Fadt.2010.0347"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Dynamic Mass Redistribution as a Means to Measure and Differentiate Signaling via Opioid and Cannabinoid Receptors</span></div><div class="casAuthors">Codd, Ellen E.; Mabus, John R.; Murray, Brian S.; Zhang, Sui-Po; Flores, Christopher M.</div><div class="citationInfo"><span class="NLM_cas:title">Assay and Drug Development Technologies</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">362-372</span>CODEN:
                <span class="NLM_cas:coden">ADDTAR</span>;
        ISSN:<span class="NLM_cas:issn">1540-658X</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">Classically, G protein-coupled receptor activation by a ligand has been viewed as producing a defined response such as activation of a G protein, activation or inhibition of adenylyl cyclase, or stimulation of phospholipase C and/or alteration in calcium flux.  Newer concepts of ligand-directed signaling recognize that different ligands, ostensibly acting at the same receptors, may induce different downstream effects, complicating the selection of a screening assay.  Dynamic mass redistribution (DMR), a label-free technol. that uses light to measure ligand-induced changes in the mass of cells proximate to the biosensor, provides an integrated cellular response comprising multiple pathways and cellular events.  Using DMR, signals induced by opioid or cannabinoid agonists in cells transfected with these receptors were blocked by pharmacol. appropriate receptor antagonists as well as by pertussis toxin.  Differences among compds. in relative potencies at DMR vs. ligand-stimulated GTPγS or receptor binding endpoints, suggesting functional selectivity, were obsd.  Preliminary evidence indicates that inhibitors of intermediate steps in the cell signaling cascade, such as receptor recycling inhibitors, mitogen-activated protein kinase kinase/p38 mitogen-activated protein kinase inhibitors, or cytoskeletal disruptors, altered or attenuated the cannabinoid-induced response.  Notable is the finding that mitogen-activated protein kinase kinase 1/2 inhibitors attenuated signaling induced by the cannabinoid type 2 receptor inverse agonist AM630 but not that stimulated by the agonist CP 55,940.  Thus, DMR has the potential to not only identify ligands that activate a given G protein-coupled receptor, but also ascertain the signaling pathways engaged by a specific ligand, making DMR a useful tool in the identification of biased ligands, which may ultimately exhibit improved therapeutic profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI_9L8JxCCsbVg90H21EOLACvtfcHk0lg5VxN1lqF9Sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXps1Omsrw%253D&md5=686e2b921c4f38ad1193ad8b6b12afc1</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1089%2Fadt.2010.0347&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fadt.2010.0347%26sid%3Dliteratum%253Aachs%26aulast%3DCodd%26aufirst%3DE.%2BE.%26aulast%3DMabus%26aufirst%3DJ.%2BR.%26aulast%3DMurray%26aufirst%3DB.%2BS.%26aulast%3DZhang%26aufirst%3DS.%2BP.%26aulast%3DFlores%26aufirst%3DC.%2BM.%26atitle%3DDynamic%2520mass%2520redistribution%2520as%2520a%2520means%2520to%2520measure%2520and%2520differentiate%2520signaling%2520via%2520opioid%2520and%2520cannabinoid%2520receptors%26jtitle%3DAssay%2520Drug%2520Dev.%2520Technol.%26date%3D2011%26volume%3D9%26spage%3D362%26epage%3D372%26doi%3D10.1089%2Fadt.2010.0347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Malfacini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapella, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaveri, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kostenis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calò, G.</span></span> <span> </span><span class="NLM_article-title">NOP receptor pharmacological profile - A dynamic mass redistribution study</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>, <span class="NLM_elocation-id">e0203021</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0203021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1371%2Fjournal.pone.0203021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=30161182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1emsbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&author=D.+Malfaciniauthor=K.+Simonauthor=C.+Trapellaauthor=R.+Guerriniauthor=N.+T.+Zaveriauthor=E.+Kostenisauthor=G.+Cal%C3%B2&title=NOP+receptor+pharmacological+profile+-+A+dynamic+mass+redistribution+study&doi=10.1371%2Fjournal.pone.0203021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">NOP receptor pharmacological profile - a dynamic mass redistribution study</span></div><div class="casAuthors">Malfacini, Davide; Simon, Katharina; Trapella, Claudio; Guerrini, Remo; Zaveri, Nurulain T.; Kostenis, Evi; Calo, Girolamo</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e0203021/1-e0203021/20</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The Nociceptin/Orphanin FQ (N/OFQ) peptide NOP receptor is coupled to pertussis toxin (PTX)-sensitive G proteins (Gi/o) whose activation leads to the inhibition of both cAMP prodn. and calcium channel activity, and to the stimulation of potassium currents.  The label free dynamic mass redistribution (DMR) approach has been demonstrated useful for investigating the pharmacol. profile of G protein-coupled receptors.  Herein, we employ DMR technol. to systematically characterize the pharmacol. of a large panel of NOP receptor ligands.  These are of peptide and non-peptide nature and display varying degrees of receptor efficacy, ranging from full agonism to pure antagonism.  Using Chinese hamster ovary (CHO) cells expressing the human NOP receptor we provide rank orders of potency for full and partial agonists as well as apparent affinities for selective antagonists.  We find the pharmacol. profile of NOP receptor ligands to be similar but not identical to values reported in the literature using canonical assays for Gi/o-coupled receptors.  Our data demonstrate that holistic label-free DMR detection can be successfully used to investigate the pharmacol. of the NOP receptor and to characterize the cellular effects of novel NOP receptor ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyqLzbmCx-rbVg90H21EOLACvtfcHk0lh1DSjOWECX0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1emsbvE&md5=1ddf5dc6da796489eaefe2ffafd61d77</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0203021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0203021%26sid%3Dliteratum%253Aachs%26aulast%3DMalfacini%26aufirst%3DD.%26aulast%3DSimon%26aufirst%3DK.%26aulast%3DTrapella%26aufirst%3DC.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DZaveri%26aufirst%3DN.%2BT.%26aulast%3DKostenis%26aufirst%3DE.%26aulast%3DCal%25C3%25B2%26aufirst%3DG.%26atitle%3DNOP%2520receptor%2520pharmacological%2520profile%2520-%2520A%2520dynamic%2520mass%2520redistribution%2520study%26jtitle%3DPLoS%2520One%26date%3D2018%26volume%3D13%26doi%3D10.1371%2Fjournal.pone.0203021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schwyzer, R.</span></span> <span> </span><span class="NLM_article-title">Molecular mechanism of opioid receptor selection</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">6335</span>– <span class="NLM_lpage">6342</span>, <span class="refDoi"> DOI: 10.1021/bi00368a075</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00368a075" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADyaL2sXltV2mtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1986&pages=6335-6342&author=R.+Schwyzer&title=Molecular+mechanism+of+opioid+receptor+selection&doi=10.1021%2Fbi00368a075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanism of opioid receptor selection</span></div><div class="casAuthors">Schwyzer, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6335-42</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    </div><div class="casAbstract">Preferred conformations, orientations, and accumulations of 26 opioid peptides on lipid membranes were estd. and compared with pharmacol. and selective binding data taken from the literature.  Interaction with μ-receptors was governed by the net pos. charge effective at the message domain of the agonist peptides [z(eff)] as the Boltzmann term ez(eff) that dets. relative accumulation on anionic biol. membranes.  Selection for δ-receptors was reduced by z(eff) and correlated with e-z(eff).  Selection for κ-receptors was governed by the peptide amphiphilic moment .vector.A.  A pronounced scalar magnitude, A, and an almost perpendicular orientation of the N-terminal message domain as an α-helix were favorable for κ-site selection.  Potencies are κ-agonists and binding affinities correlated with A·ez(eff).  The classical site selectivity caused by the receptor requirements for a complementary fit of the agonist to the discriminator site is thus crucially supplemented by a selection mechanism based on peptide membrane interactions (membrane requirements).  In the model presented, the δ-site is exposed to the aq. compartment surrounding the target cell at a distance comparable to or greater than the Debye-Hueckel length and is in a cationic vicinity.  The μ-site is exposed to the anionic fixed-charge compartment of the membrane in aq. surroundings.  The κ-site is buried in a more hydrophobic membrane compartment close to the fixed-charge compartment.  The relative accumulation of the opioid message domains in these compartments is detd. by the address domains and constitutes a major part of the site selection mechanism.  The peptide .vector.A emerged as a new, important parameter for predicting site selectivity and potency and detg. peptide quant. structure-activity relationships.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpF0nG6f6M-7Vg90H21EOLACvtfcHk0lh1DSjOWECX0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXltV2mtbw%253D&md5=da128a08d2b70ccdcd82235de82a0601</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fbi00368a075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00368a075%26sid%3Dliteratum%253Aachs%26aulast%3DSchwyzer%26aufirst%3DR.%26atitle%3DMolecular%2520mechanism%2520of%2520opioid%2520receptor%2520selection%26jtitle%3DBiochemistry%26date%3D1986%26volume%3D25%26spage%3D6335%26epage%3D6342%26doi%3D10.1021%2Fbi00368a075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manglik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruse, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thian, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathiesen, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunahara, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weis, W. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Granier, S.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of the μ-opioid receptor bound to a morphinan antagonist</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>485</i></span>,  <span class="NLM_fpage">321</span>– <span class="NLM_lpage">326</span>, <span class="refDoi"> DOI: 10.1038/nature10954</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1038%2Fnature10954" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=22437502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC38XksVehs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=485&publication_year=2012&pages=321-326&author=A.+Manglikauthor=A.+C.+Kruseauthor=T.+S.+Kobilkaauthor=F.+S.+Thianauthor=J.+M.+Mathiesenauthor=R.+K.+Sunaharaauthor=L.+Pardoauthor=W.+I.+Weisauthor=B.+K.+Kobilkaauthor=S.+Granier&title=Crystal+structure+of+the+%CE%BC-opioid+receptor+bound+to+a+morphinan+antagonist&doi=10.1038%2Fnature10954"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the μ-opioid receptor bound to a morphinan antagonist</span></div><div class="casAuthors">Manglik, Aashish; Kruse, Andrew C.; Kobilka, Tong Sun; Thian, Foon Sun; Mathiesen, Jesper M.; Sunahara, Roger K.; Pardo, Leonardo; Weis, William I.; Kobilka, Brian K.; Granier, Sebastien</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">485</span>
        (<span class="NLM_cas:issue">7398</span>),
    <span class="NLM_cas:pages">321-326</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Opium is one of the world's oldest drugs, and its derivs. morphine and codeine are among the most used clin. drugs to relieve severe pain.  These prototypical opioids produce analgesia as well as many undesirable side effects (sedation, apnea and dependence) by binding to and activating the G-protein-coupled μ-opioid receptor (μ-OR) in the central nervous system.  Here the authors describe the 2.8 Å crystal structure of the mouse μ-OR in complex with an irreversible morphinan antagonist.  Compared to the buried binding pocket obsd. in most G-protein-coupled receptors published so far, the morphinan ligand binds deeply within a large solvent-exposed pocket.  Of particular interest, the μ-OR crystallizes as a two-fold sym. dimer through a four-helix bundle motif formed by transmembrane segments 5 and 6.  These high-resoln. insights into opioid receptor structure will enable the application of structure-based approaches to develop better drugs for the management of pain and addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2q4tys639jrVg90H21EOLACvtfcHk0lgmrFVvvbnYHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XksVehs7Y%253D&md5=563d5ebda53f9a408be21d60a7e5a97d</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1038%2Fnature10954&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10954%26sid%3Dliteratum%253Aachs%26aulast%3DManglik%26aufirst%3DA.%26aulast%3DKruse%26aufirst%3DA.%2BC.%26aulast%3DKobilka%26aufirst%3DT.%2BS.%26aulast%3DThian%26aufirst%3DF.%2BS.%26aulast%3DMathiesen%26aufirst%3DJ.%2BM.%26aulast%3DSunahara%26aufirst%3DR.%2BK.%26aulast%3DPardo%26aufirst%3DL.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26aulast%3DGranier%26aufirst%3DS.%26atitle%3DCrystal%2520structure%2520of%2520the%2520%25CE%25BC-opioid%2520receptor%2520bound%2520to%2520a%2520morphinan%2520antagonist%26jtitle%3DNature%26date%3D2012%26volume%3D485%26spage%3D321%26epage%3D326%26doi%3D10.1038%2Fnature10954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Granier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manglik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruse, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thian, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weis, W. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, B. K.</span></span> <span> </span><span class="NLM_article-title">Structure of the δ-opioid receptor bound to naltrindole</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>485</i></span>,  <span class="NLM_fpage">400</span>– <span class="NLM_lpage">404</span>, <span class="refDoi"> DOI: 10.1038/nature11111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1038%2Fnature11111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=22596164" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC38XntF2gtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=485&publication_year=2012&pages=400-404&author=S.+Granierauthor=A.+Manglikauthor=A.+C.+Kruseauthor=T.+S.+Kobilkaauthor=F.+S.+Thianauthor=W.+I.+Weisauthor=B.+K.+Kobilka&title=Structure+of+the+%CE%B4-opioid+receptor+bound+to+naltrindole&doi=10.1038%2Fnature11111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the δ-opioid receptor bound to naltrindole</span></div><div class="casAuthors">Granier, Sebastien; Manglik, Aashish; Kruse, Andrew C.; Kobilka, Tong Sun; Thian, Foon Sun; Weis, William I.; Kobilka, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">485</span>
        (<span class="NLM_cas:issue">7398</span>),
    <span class="NLM_cas:pages">400-404</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The opioid receptor family comprises three members, the μ-, δ- and κ-opioid receptors, which respond to classical opioid alkaloids such as morphine and heroin as well as to endogenous peptide ligands like endorphins.  They belong to the G-protein-coupled receptor (GPCR) superfamily, and are excellent therapeutic targets for pain control.  The δ-opioid receptor (δ-OR) has a role in analgesia, as well as in other neurol. functions that remain poorly understood.  The structures of the μ-OR and κ-OR have recently been solved.  Here we report the crystal structure of the mouse δ-OR, bound to the subtype-selective antagonist naltrindole.  Together with the structures of the μ-OR and κ-OR, the δ-OR structure provides insights into conserved elements of opioid ligand recognition while also revealing structural features assocd. with ligand-subtype selectivity.  The binding pocket of opioid receptors can be divided into two distinct regions.  Whereas the lower part of this pocket is highly conserved among opioid receptors, the upper part contains divergent residues that confer subtype selectivity.  This provides a structural explanation and validation for the 'message-address' model of opioid receptor pharmacol., in which distinct 'message' (efficacy) and 'address' (selectivity) determinants are contained within a single ligand.  Comparison of the address region of the δ-OR with other GPCRs reveals that this structural organization may be a more general phenomenon, extending to other GPCR families as well.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVFoJ8sg4c2LVg90H21EOLACvtfcHk0lgmrFVvvbnYHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntF2gtrc%253D&md5=892a5da1140fbfea502ee5d598455e73</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1038%2Fnature11111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11111%26sid%3Dliteratum%253Aachs%26aulast%3DGranier%26aufirst%3DS.%26aulast%3DManglik%26aufirst%3DA.%26aulast%3DKruse%26aufirst%3DA.%2BC.%26aulast%3DKobilka%26aufirst%3DT.%2BS.%26aulast%3DThian%26aufirst%3DF.%2BS.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26atitle%3DStructure%2520of%2520the%2520%25CE%25B4-opioid%2520receptor%2520bound%2520to%2520naltrindole%26jtitle%3DNature%26date%3D2012%26volume%3D485%26spage%3D400%26epage%3D404%26doi%3D10.1038%2Fnature11111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vardy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapella, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calò, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherezov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span> <span> </span><span class="NLM_article-title">Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>485</i></span>,  <span class="NLM_fpage">395</span>– <span class="NLM_lpage">399</span>, <span class="refDoi"> DOI: 10.1038/nature11085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1038%2Fnature11085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=22596163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC38XntF2jtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=485&publication_year=2012&pages=395-399&author=A.+A.+Thompsonauthor=W.+Liuauthor=E.+Chunauthor=V.+Katritchauthor=H.+Wuauthor=E.+Vardyauthor=X.-P.+Huangauthor=C.+Trapellaauthor=R.+Guerriniauthor=G.+Cal%C3%B2author=B.+L.+Rothauthor=V.+Cherezovauthor=R.+C.+Stevens&title=Structure+of+the+nociceptin%2Forphanin+FQ+receptor+in+complex+with+a+peptide+mimetic&doi=10.1038%2Fnature11085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic</span></div><div class="casAuthors">Thompson, Aaron A.; Liu, Wei; Chun, Eugene; Katritch, Vsevolod; Wu, Huixian; Vardy, Eyal; Huang, Xi-Ping; Trapella, Claudio; Guerrini, Remo; Calo, Girolamo; Roth, Bryan L.; Cherezov, Vadim; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">485</span>
        (<span class="NLM_cas:issue">7398</span>),
    <span class="NLM_cas:pages">395-399</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Members of the opioid receptor family of G-protein-coupled receptors (GPCRs) are found throughout the peripheral and central nervous system, where they have key roles in nociception and analgesia.  Unlike the classical' opioid receptors, δ, κ and μ (δ-OR, κ-OR and μ-OR), which were delineated by pharmacol. criteria in the 1970s and 1980s, the nociceptin/orphanin FQ (N/OFQ) peptide receptor (NOP, also known as ORL-1) was discovered relatively recently by mol. cloning and characterization of an orphan GPCR.  Although it shares high sequence similarity with classical opioid GPCR subtypes (∼60%), NOP has a markedly distinct pharmacol., featuring activation by the endogenous peptide N/OFQ, and unique selectivity for exogenous ligands.  Here we report the crystal structure of human NOP, solved in complex with the peptide mimetic antagonist compd.-24 (C-24), revealing at. details of ligand-receptor recognition and selectivity.  Compd.-24 mimics the first four amino-terminal residues of the NOP-selective peptide antagonist UFP-101, a close deriv. of N/OFQ, and provides important clues to the binding of these peptides.  The x-ray structure also shows substantial conformational differences in the pocket regions between NOP and the classical opioid receptors κ and μ, and these are probably due to a small no. of residues that vary between these receptors.  The NOP-compd.-24 structure explains the divergent selectivity profile of NOP and provides a new structural template for the design of NOP ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoq0_U24fZ4r7Vg90H21EOLACvtfcHk0liv5J590LRbEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntF2jtbk%253D&md5=56819d10685f8a389710e9005d595d5b</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1038%2Fnature11085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11085%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DA.%2BA.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DChun%26aufirst%3DE.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DVardy%26aufirst%3DE.%26aulast%3DHuang%26aufirst%3DX.-P.%26aulast%3DTrapella%26aufirst%3DC.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DCal%25C3%25B2%26aufirst%3DG.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DStructure%2520of%2520the%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520in%2520complex%2520with%2520a%2520peptide%2520mimetic%26jtitle%3DNature%26date%3D2012%26volume%3D485%26spage%3D395%26epage%3D399%26doi%3D10.1038%2Fnature11085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stefanucci, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimmito, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macedonio, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciarlo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pieretti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novellino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barlow, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houseknecht, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Streicher, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollica, A.</span></span> <span> </span><span class="NLM_article-title">Potent, efficacious, and stable cyclic opioid peptides with long lasting antinociceptive effect after peripheral administration</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">2673</span>– <span class="NLM_lpage">2687</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01963</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01963" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlygtbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=2673-2687&author=A.+Stefanucciauthor=M.+P.+Dimmitoauthor=G.+Macedonioauthor=L.+Ciarloauthor=S.+Pierettiauthor=E.+Novellinoauthor=W.+Leiauthor=D.+Barlowauthor=K.+L.+Houseknechtauthor=J.+M.+Streicherauthor=A.+Mollica&title=Potent%2C+efficacious%2C+and+stable+cyclic+opioid+peptides+with+long+lasting+antinociceptive+effect+after+peripheral+administration&doi=10.1021%2Facs.jmedchem.9b01963"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Potent, efficacious and stable cyclic opioid peptides with long lasting antinociceptive effect after peripheral administration</span></div><div class="casAuthors">stefanucci, azzurra; dimmito, marilisa pia; Macedonio, Giorgia; ciarlo, laura; Pieretti, Stefano; Novellino, Ettore; Lei, Wei; Barlow, Deborah; Houseknecht, Karen; Streicher, John M.; Mollica, Adriano</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2673-2687</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Four novel fluorinated cyclic analogs of biphalin with excellent to modest binding affinity for μ-, δ- and κ-receptors were synthesized.  The cyclic peptides have a combination of piperazine or hydrazine linker with or without a xylene bridge.  Among the ligands, MACE3 demonstrated a better activity than biphalin after i.v. administration, and its corresponding analog incorporating the hydrazine linker (MACE2) was able to induce longer lasting analgesia following s.c. administration.  An analog of MACE2 contg. 2,6-dimethyl-L-tyrosine (MACE4) showed the best potency and in vivo antinociceptive activity of this series.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAvej3oeuijrVg90H21EOLACvtfcHk0liv5J590LRbEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlygtbzP&md5=cdf9f02c7fab43b658bb58e959ba0013</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01963%26sid%3Dliteratum%253Aachs%26aulast%3DStefanucci%26aufirst%3DA.%26aulast%3DDimmito%26aufirst%3DM.%2BP.%26aulast%3DMacedonio%26aufirst%3DG.%26aulast%3DCiarlo%26aufirst%3DL.%26aulast%3DPieretti%26aufirst%3DS.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DLei%26aufirst%3DW.%26aulast%3DBarlow%26aufirst%3DD.%26aulast%3DHouseknecht%26aufirst%3DK.%2BL.%26aulast%3DStreicher%26aufirst%3DJ.%2BM.%26aulast%3DMollica%26aufirst%3DA.%26atitle%3DPotent%252C%2520efficacious%252C%2520and%2520stable%2520cyclic%2520opioid%2520peptides%2520with%2520long%2520lasting%2520antinociceptive%2520effect%2520after%2520peripheral%2520administration%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D2673%26epage%3D2687%26doi%3D10.1021%2Facs.jmedchem.9b01963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adcock, J. J.</span></span> <span> </span><span class="NLM_article-title">Peripheral opioid receptors and the cough reflex</span>. <i>Respir. Med.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">46</span>, <span class="refDoi"> DOI: 10.1016/s0954-6111(06)80253-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1016%2FS0954-6111%2806%2980253-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1852031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A280%3ADyaK3M3jvFymug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=1991&pages=43-46&author=J.+J.+Adcock&title=Peripheral+opioid+receptors+and+the+cough+reflex&doi=10.1016%2Fs0954-6111%2806%2980253-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Peripheral opioid receptors and the cough reflex</span></div><div class="casAuthors">Adcock J J</div><div class="citationInfo"><span class="NLM_cas:title">Respiratory medicine</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">85 Suppl A</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">43-6</span>
        ISSN:<span class="NLM_cas:issn">0954-6111</span>.
    </div><div class="casAbstract">The cough reflex originates from stimulation of sensory nerve endings located in the upper and lower respiratory tract.  Opiates are among the most potent and widely used drugs which inhibit the cough reflex, and it has been generally assumed that they act generally.  However, opioid receptors have been identified on the sensory arm of the vagus nerve.  Although the functional significance of these receptors is not clear, recent evidence suggests that their activation may be involved in the modulation of airway reflexes.  This review briefly examines the evidence to support the hypothesis that opioid receptors on vagal sensory nerves may mediate peripheral opioid-induced antitussive activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRuPQtBRpuNZDAEfvC7EH1LfW6udTcc2eZYOyZAu_Qk97ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3M3jvFymug%253D%253D&md5=7cffc0491b74c4f53fe136cd3e04adde</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2FS0954-6111%2806%2980253-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0954-6111%252806%252980253-2%26sid%3Dliteratum%253Aachs%26aulast%3DAdcock%26aufirst%3DJ.%2BJ.%26atitle%3DPeripheral%2520opioid%2520receptors%2520and%2520the%2520cough%2520reflex%26jtitle%3DRespir.%2520Med.%26date%3D1991%26volume%3D85%26spage%3D43%26epage%3D46%26doi%3D10.1016%2Fs0954-6111%2806%2980253-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tzschentke, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christoph, T.</span></span> <span> </span><span class="NLM_article-title">Cebranopadol: A novel first-in-class potent analgesic acting via NOP and opioid receptors</span>. <i>Handb. Exp. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>254</i></span>,  <span class="NLM_fpage">367</span>– <span class="NLM_lpage">398</span>, <span class="refDoi"> DOI: 10.1007/164_2019_206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1007%2F164_2019_206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=30927089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmtlGlu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=254&publication_year=2019&pages=367-398&author=T.+M.+Tzschentkeauthor=K.+Linzauthor=T.+Kochauthor=T.+Christoph&title=Cebranopadol%3A+A+novel+first-in-class+potent+analgesic+acting+via+NOP+and+opioid+receptors&doi=10.1007%2F164_2019_206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Cebranopadol: A Novel First-in-Class Potent Analgesic Acting via NOP and Opioid Receptors</span></div><div class="casAuthors">Tzschentke, Thomas M.; Linz, Klaus; Koch, Thomas; Christoph, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">254</span>
        (<span class="NLM_cas:issue">Nociceptin/Orphanin FQ Peptide Receptor</span>),
    <span class="NLM_cas:pages">367-398</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">1865-0325</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  Cebranopadol is a novel first-in-class analgesic with highly potent agonistic activity at nociceptin/orphanin FQ peptide (NOP) and opioid receptors.  It is highly potent and efficacious across a broad range of preclin. pain models.  Its side effect profile is better compared to typical opioids.  Mechanistic studies have shown that cebranopadol's activity at NOP receptors contributes to its anti-hyperalgesic effects while ameliorating some of its opioid-type side effects, including respiratory depression and abuse potential.  Phase II of clin. development has been completed, demonstrating efficacy and good tolerability in acute and chronic pain conditions.This article focusses on reviewing data on the preclin. in vitro and in vivo pharmacol., safety, and tolerability, as well as clin. trials with cebranopadol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHzG6iKGqiQrVg90H21EOLACvtfcHk0lhjXNWNGqcb2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmtlGlu74%253D&md5=d2a3e8bdec9bf9516ab3d17f333b7ef2</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1007%2F164_2019_206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F164_2019_206%26sid%3Dliteratum%253Aachs%26aulast%3DTzschentke%26aufirst%3DT.%2BM.%26aulast%3DLinz%26aufirst%3DK.%26aulast%3DKoch%26aufirst%3DT.%26aulast%3DChristoph%26aufirst%3DT.%26atitle%3DCebranopadol%253A%2520A%2520novel%2520first-in-class%2520potent%2520analgesic%2520acting%2520via%2520NOP%2520and%2520opioid%2520receptors%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2019%26volume%3D254%26spage%3D367%26epage%3D398%26doi%3D10.1007%2F164_2019_206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Volkow, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanco, C.</span></span> <span> </span><span class="NLM_article-title">The changing opioid crisis: development, challenges and opportunities</span>. <i>Mol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">218</span>– <span class="NLM_lpage">233</span>, <span class="refDoi"> DOI: 10.1038/s41380-020-0661-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1038%2Fs41380-020-0661-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=32020048" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A280%3ADC%252BB38%252FotlWmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2021&pages=218-233&author=N.+D.+Volkowauthor=C.+Blanco&title=The+changing+opioid+crisis%3A+development%2C+challenges+and+opportunities&doi=10.1038%2Fs41380-020-0661-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">The changing opioid crisis: development, challenges and opportunities</span></div><div class="casAuthors">Volkow Nora D; Blanco Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Molecular psychiatry</span>
        (<span class="NLM_cas:date">2021</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">218-233</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The current opioid epidemic is one of the most severe public health crisis in US history.  Responding to it has been difficult due to its rapidly changing nature and the severity of its associated outcomes.  This review examines the origin and evolution of the crisis, the pharmacological properties of opioids, the neurobiology of opioid use and opioid use disorder (OUD), medications for opioid use disorder (MOUD), and existing and promising approaches to prevention.  The results of the review indicate that the opioid epidemic is a complex, evolving phenomenon that involves neurobiological vulnerabilities and social determinants of health.  Successfully addressing the epidemic will require advances in basic science, development of more acceptable and effective treatments, and implementation of public health approaches, including prevention.  The advances achieved in addressing the current crisis should also serve to advance the science and treatment of other substance use disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRpwlk7oh-UxTDnmmyUf5qOfW6udTcc2eZYOyZAu_Qk97ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB38%252FotlWmtw%253D%253D&md5=94c6994b58aac47bf364be91aa59f3f1</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1038%2Fs41380-020-0661-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41380-020-0661-4%26sid%3Dliteratum%253Aachs%26aulast%3DVolkow%26aufirst%3DN.%2BD.%26aulast%3DBlanco%26aufirst%3DC.%26atitle%3DThe%2520changing%2520opioid%2520crisis%253A%2520development%252C%2520challenges%2520and%2520opportunities%26jtitle%3DMol.%2520Psychiatry%26date%3D2021%26volume%3D26%26spage%3D218%26epage%3D233%26doi%3D10.1038%2Fs41380-020-0661-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benoiton, N. L.</span></span> <i>Chemistry of Peptide Synthesis</i>; <span class="NLM_publisher-name">Taylor & Francis</span>: <span class="NLM_publisher-loc">London</span>, <span class="NLM_year">2006</span>; pp  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">155</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=125-155&author=N.+L.+Benoiton&title=Chemistry+of+Peptide+Synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBenoiton%26aufirst%3DN.%2BL.%26btitle%3DChemistry%2520of%2520Peptide%2520Synthesis%26pub%3DTaylor%2520%2526%2520Francis%26date%3D2006%26spage%3D125%26epage%3D155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neubig, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spedding, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenakin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span> <span> </span><span class="NLM_article-title">International union of pharmacology committee on receptor nomenclature and drug classification. XXXVIII. Update on terms and symbols in quantitative pharmacology</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">597</span>– <span class="NLM_lpage">606</span>, <span class="refDoi"> DOI: 10.1124/pr.55.4.4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1124%2Fpr.55.4.4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=14657418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtlWkuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2003&pages=597-606&author=R.+R.+Neubigauthor=M.+Speddingauthor=T.+Kenakinauthor=A.+Christopoulos&title=International+union+of+pharmacology+committee+on+receptor+nomenclature+and+drug+classification.+XXXVIII.+Update+on+terms+and+symbols+in+quantitative+pharmacology&doi=10.1124%2Fpr.55.4.4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on terms and symbols in quantitative pharmacology</span></div><div class="casAuthors">Neubig, Richard R.; Spedding, Michael; Kenakin, Terry; Christopoulos, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">597-606</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  The recommendations that follow have been updated from the proposals of a Tech. Subcommittee set up by the International Union of Pharmacol. Committee on Receptor Nomenclature and Drug Classification.  International Union of Pharmacol. Committee on Receptor Nomenclature and Drug Classification. IX.  Recommendations on terms and symbols in quant. pharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobvkWoNCTvu7Vg90H21EOLACvtfcHk0ljO4IbRuQE_gA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtlWkuw%253D%253D&md5=8a467ff5e3812d34d42179491555793d</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1124%2Fpr.55.4.4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.55.4.4%26sid%3Dliteratum%253Aachs%26aulast%3DNeubig%26aufirst%3DR.%2BR.%26aulast%3DSpedding%26aufirst%3DM.%26aulast%3DKenakin%26aufirst%3DT.%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DInternational%2520union%2520of%2520pharmacology%2520committee%2520on%2520receptor%2520nomenclature%2520and%2520drug%2520classification.%2520XXXVIII.%2520Update%2520on%2520terms%2520and%2520symbols%2520in%2520quantitative%2520pharmacology%26jtitle%3DPharmacol.%2520Rev.%26date%3D2003%26volume%3D55%26spage%3D597%26epage%3D606%26doi%3D10.1124%2Fpr.55.4.4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murtola, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Páll, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hess, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindahl, E.</span></span> <span> </span><span class="NLM_article-title">GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers</span>. <i>SoftwareX</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>1–2</i></span>,  <span class="NLM_fpage">19</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1016/j.softx.2015.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1016%2Fj.softx.2015.06.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1%E2%80%932&publication_year=2015&pages=19-25&author=M.+J.+Abrahamauthor=T.+Murtolaauthor=R.+Schulzauthor=S.+P%C3%A1llauthor=J.+C.+Smithauthor=B.+Hessauthor=E.+Lindahl&title=GROMACS%3A+High+performance+molecular+simulations+through+multi-level+parallelism+from+laptops+to+supercomputers&doi=10.1016%2Fj.softx.2015.06.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.softx.2015.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.softx.2015.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DAbraham%26aufirst%3DM.%2BJ.%26aulast%3DMurtola%26aufirst%3DT.%26aulast%3DSchulz%26aufirst%3DR.%26aulast%3DP%25C3%25A1ll%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DJ.%2BC.%26aulast%3DHess%26aufirst%3DB.%26aulast%3DLindahl%26aufirst%3DE.%26atitle%3DGROMACS%253A%2520High%2520performance%2520molecular%2520simulations%2520through%2520multi-level%2520parallelism%2520from%2520laptops%2520to%2520supercomputers%26jtitle%3DSoftwareX%26date%3D2015%26volume%3D1%25E2%2580%25932%26spage%3D19%26epage%3D25%26doi%3D10.1016%2Fj.softx.2015.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hornak, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okur, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strockbine, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roitberg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmerling, C.</span></span> <span> </span><span class="NLM_article-title">Comparison of multiple Amber force fields and development of improved protein backbone parameters</span>. <i>Proteins</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">712</span>– <span class="NLM_lpage">725</span>, <span class="refDoi"> DOI: 10.1002/prot.21123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1002%2Fprot.21123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=16981200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFWqt7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2006&pages=712-725&author=V.+Hornakauthor=R.+Abelauthor=A.+Okurauthor=B.+Strockbineauthor=A.+Roitbergauthor=C.+Simmerling&title=Comparison+of+multiple+Amber+force+fields+and+development+of+improved+protein+backbone+parameters&doi=10.1002%2Fprot.21123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of multiple Amber force fields and development of improved protein backbone parameters</span></div><div class="casAuthors">Hornak, Viktor; Abel, Robert; Okur, Asim; Strockbine, Bentley; Roitberg, Adrian; Simmerling, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Proteins: Structure, Function, and Bioinformatics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">712-725</span>CODEN:
                <span class="NLM_cas:coden">PSFBAF</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The ff94 force field that is commonly assocd. with the Amber simulation package is one of the most widely used parameter sets for biomol. simulation.  After a decade of extensive use and testing, limitations in this force field, such as over-stabilization of α-helixes, were reported by the authors and other researchers.  This led to a no. of attempts to improve these parameters, resulting in a variety of "Amber" force fields and significant difficulty in detg. which should be used for a particular application.  The authors show that several of these continue to suffer from inadequate balance between different secondary structure elements.  In addn., the approach used in most of these studies neglected to account for the existence in Amber of two sets of backbone .vphi./ψ dihedral terms.  This led to parameter sets that provide unreasonable conformational preferences for glycine.  The authors report here an effort to improve the .vphi./ψ dihedral terms in the ff99 energy function.  Dihedral term parameters are based on fitting the energies of multiple conformations of glycine and alanine tetrapeptides from high level ab initio quantum mech. calcns.  The new parameters for backbone dihedrals replace those in the existing ff99 force field.  This parameter set, which the authors denote ff99SB, achieves a better balance of secondary structure elements as judged by improved distribution of backbone dihedrals for glycine and alanine with respect to PDB survey data.  It also accomplishes improved agreement with published exptl. data for conformational preferences of short alanine peptides and better accord with exptl. NMR relaxation data of test protein systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmoASzza-Gd7Vg90H21EOLACvtfcHk0ljO4IbRuQE_gA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFWqt7fM&md5=de683a26eca9e83ae524726e97ac22fa</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1002%2Fprot.21123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.21123%26sid%3Dliteratum%253Aachs%26aulast%3DHornak%26aufirst%3DV.%26aulast%3DAbel%26aufirst%3DR.%26aulast%3DOkur%26aufirst%3DA.%26aulast%3DStrockbine%26aufirst%3DB.%26aulast%3DRoitberg%26aufirst%3DA.%26aulast%3DSimmerling%26aufirst%3DC.%26atitle%3DComparison%2520of%2520multiple%2520Amber%2520force%2520fields%2520and%2520development%2520of%2520improved%2520protein%2520backbone%2520parameters%26jtitle%3DProteins%26date%3D2006%26volume%3D65%26spage%3D712%26epage%3D725%26doi%3D10.1002%2Fprot.21123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pettersen, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goddard, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Couch, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenblatt, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrin, T. E.</span></span> <span> </span><span class="NLM_article-title">UCSF Chimera? A visualization system for exploratory research and analysis</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1605</span>– <span class="NLM_lpage">1612</span>, <span class="refDoi"> DOI: 10.1002/jcc.20084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1002%2Fjcc.20084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=15264254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvVOhsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=1605-1612&author=E.+F.+Pettersenauthor=T.+D.+Goddardauthor=C.+C.+Huangauthor=G.+S.+Couchauthor=D.+M.+Greenblattauthor=E.+C.+Mengauthor=T.+E.+Ferrin&title=UCSF+Chimera%3F+A+visualization+system+for+exploratory+research+and+analysis&doi=10.1002%2Fjcc.20084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">UCSF Chimera-A visualization system for exploratory research and analysis</span></div><div class="casAuthors">Pettersen, Eric F.; Goddard, Thomas D.; Huang, Conrad C.; Couch, Gregory S.; Greenblatt, Daniel M.; Meng, Elaine C.; Ferrin, Thomas E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1605-1612</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The design, implementation, and capabilities of an extensible visualization system, UCSF Chimera, are discussed.  Chimera is segmented into a core that provides basic services and visualization, and extensions that provide most higher level functionality.  This architecture ensures that the extension mechanism satisfies the demands of outside developers who wish to incorporate new features.  Two unusual extensions are presented: Multiscale, which adds the ability to visualize large-scale mol. assemblies such as viral coats, and Collab., which allows researchers to share a Chimera session interactively despite being at sep. locales.  Other extensions include Multalign Viewer, for showing multiple sequence alignments and assocd. structures; ViewDock, for screening docked ligand orientations; Movie, for replaying mol. dynamics trajectories; and Vol. Viewer, for display and anal. of volumetric data.  A discussion of the usage of Chimera in real-world situations is given, along with anticipated future directions.  Chimera includes full user documentation, is free to academic and nonprofit users, and is available for Microsoft Windows, Linux, Apple Mac OS X, SGI IRIX, and HP Tru64 Unix from http://www.cgl.ucsf.edu/chimera/.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFmD4M5S0cPbVg90H21EOLACvtfcHk0ljO4IbRuQE_gA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvVOhsbs%253D&md5=944b175f440c1ff323705987cf937ee7</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1002%2Fjcc.20084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.20084%26sid%3Dliteratum%253Aachs%26aulast%3DPettersen%26aufirst%3DE.%2BF.%26aulast%3DGoddard%26aufirst%3DT.%2BD.%26aulast%3DHuang%26aufirst%3DC.%2BC.%26aulast%3DCouch%26aufirst%3DG.%2BS.%26aulast%3DGreenblatt%26aufirst%3DD.%2BM.%26aulast%3DMeng%26aufirst%3DE.%2BC.%26aulast%3DFerrin%26aufirst%3DT.%2BE.%26atitle%3DUCSF%2520Chimera%253F%2520A%2520visualization%2520system%2520for%2520exploratory%2520research%2520and%2520analysis%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2004%26volume%3D25%26spage%3D1605%26epage%3D1612%26doi%3D10.1002%2Fjcc.20084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Faul, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erdfelder, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, A.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchner, A.</span></span> <span> </span><span class="NLM_article-title">G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences</span>. <i>Behav. Res. Methods</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">175</span>– <span class="NLM_lpage">191</span>, <span class="refDoi"> DOI: 10.3758/bf03193146</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.3758%2FBF03193146" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=17695343" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A280%3ADC%252BD2svns12rsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2007&pages=175-191&author=F.+Faulauthor=E.+Erdfelderauthor=A.-G.+Langauthor=A.+Buchner&title=G*Power+3%3A+a+flexible+statistical+power+analysis+program+for+the+social%2C+behavioral%2C+and+biomedical+sciences&doi=10.3758%2Fbf03193146"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences</span></div><div class="casAuthors">Faul Franz; Erdfelder Edgar; Lang Albert-Georg; Buchner Axel</div><div class="citationInfo"><span class="NLM_cas:title">Behavior research methods</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">175-91</span>
        ISSN:<span class="NLM_cas:issn">1554-351X</span>.
    </div><div class="casAbstract">G*Power (Erdfelder, Faul, & Buchner, 1996) was designed as a general stand-alone power analysis program for statistical tests commonly used in social and behavioral research.  G*Power 3 is a major extension of, and improvement over, the previous versions.  It runs on widely used computer platforms (i.e., Windows XP, Windows Vista, and Mac OS X 10.4) and covers many different statistical tests of the t, F, and chi2 test families.  In addition, it includes power analyses for z tests and some exact tests.  G*Power 3 provides improved effect size calculators and graphic options, supports both distribution-based and design-based input modes, and offers all types of power analyses in which users might be interested.  Like its predecessors, G*Power 3 is free.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSSIxwUvmTx9Re4jJGKT5N0fW6udTcc2eakWFF-YOgnBLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svns12rsQ%253D%253D&md5=53033ebef486a78a60dc63473beaf603</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.3758%2FBF03193146&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3758%252FBF03193146%26sid%3Dliteratum%253Aachs%26aulast%3DFaul%26aufirst%3DF.%26aulast%3DErdfelder%26aufirst%3DE.%26aulast%3DLang%26aufirst%3DA.-G.%26aulast%3DBuchner%26aufirst%3DA.%26atitle%3DG%252APower%25203%253A%2520a%2520flexible%2520statistical%2520power%2520analysis%2520program%2520for%2520the%2520social%252C%2520behavioral%252C%2520and%2520biomedical%2520sciences%26jtitle%3DBehav.%2520Res.%2520Methods%26date%3D2007%26volume%3D39%26spage%3D175%26epage%3D191%26doi%3D10.3758%2Fbf03193146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Belvisi, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freund-Michel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hele, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crispino, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birrell, M. A.</span></span> <span> </span><span class="NLM_article-title">Inhibitory activity of the novel CB2 receptor agonist, GW833972A, on guinea-pig and human sensory nerve function in the airways</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>155</i></span>,  <span class="NLM_fpage">547</span>– <span class="NLM_lpage">557</span>, <span class="refDoi"> DOI: 10.1038/bjp.2008.298</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1038%2Fbjp.2008.298" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=18695648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1emurrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=2008&pages=547-557&author=M.+G.+Belvisiauthor=H.+J.+Patelauthor=V.+Freund-Michelauthor=D.+J.+Heleauthor=N.+Crispinoauthor=M.+A.+Birrell&title=Inhibitory+activity+of+the+novel+CB2+receptor+agonist%2C+GW833972A%2C+on+guinea-pig+and+human+sensory+nerve+function+in+the+airways&doi=10.1038%2Fbjp.2008.298"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitory activity of the novel CB2 receptor agonist, GW833972A, on guinea-pig and human sensory nerve function in the airways</span></div><div class="casAuthors">Belvisi, M. G.; Patel, H. J.; Freund-Michel, V.; Hele, D. J.; Crispino, N.; Birrell, M. A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">155</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">547-557</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Sensory nerves regulate central and local reflexes such as airway plasma protein leakage, bronchoconstriction and cough.  Sensory nerve activity may be enhanced during inflammation such that these protective effects become exacerbated and deleterious.  Cannabinoids are known to inhibit airway sensory nerve function.  However, there is still controversy surrounding which receptor is involved in eliciting these effects.  We have adopted a pharmacol. approach, including using a novel, more selective CB2 receptor agonist, GW 833972A (1000-fold selective CB2/CB1), and receptor selective antagonists to investigate the inhibitory activity of cannabinoids on sensory nerve activity in vitro and in vivo in guinea-pig models of cough and plasma extravasation.  GW 833972A inhibited capsaicin-induced depolarization of the human and guinea-pig and prostaglandin E2 (PGE2) and hypertonic saline-induced depolarization of the guinea-pig isolated vagus nerve in vitro.  GW 833972A also inhibited citric acid-induced cough but not plasma extravasation in the guinea-pig and this effect was blocked by a CB2 receptor antagonist.  This confirms and extends previous studies highlighting the role of CB2 receptors in the modulation of sensory nerve activity elicited both by the exogenous ligands capsaicin and hypertonic saline but also by endogenous modulators such as PGE2 and low pH stimuli.  These data establish the CB2 receptor as an interesting target for the treatment of chronic cough.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB4UzjWZMStbVg90H21EOLACvtfcHk0lgHlXCOKsgg2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1emurrO&md5=2d1c30445c13581c2053902d64c39955</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1038%2Fbjp.2008.298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjp.2008.298%26sid%3Dliteratum%253Aachs%26aulast%3DBelvisi%26aufirst%3DM.%2BG.%26aulast%3DPatel%26aufirst%3DH.%2BJ.%26aulast%3DFreund-Michel%26aufirst%3DV.%26aulast%3DHele%26aufirst%3DD.%2BJ.%26aulast%3DCrispino%26aufirst%3DN.%26aulast%3DBirrell%26aufirst%3DM.%2BA.%26atitle%3DInhibitory%2520activity%2520of%2520the%2520novel%2520CB2%2520receptor%2520agonist%252C%2520GW833972A%252C%2520on%2520guinea-pig%2520and%2520human%2520sensory%2520nerve%2520function%2520in%2520the%2520airways%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D155%26spage%3D547%26epage%3D557%26doi%3D10.1038%2Fbjp.2008.298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article has not yet been cited by other publications.</p></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c02062/20210520/images/medium/jm0c02062_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c02062/20210520/images/large/jm0c02062_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02062&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c02062/20210520/images/medium/jm0c02062_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c02062/20210520/images/large/jm0c02062_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. SAR investigation leading to a series of [Tyr/Dmt<sup>1</sup>,Xaa<sup>5</sup>]N/OFQ(1-13)-NH<sub>2</sub> peptide derivatives as possible mixed NOP/opioid receptor ligands.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c02062/20210520/images/large/jm0c02062_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02062&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c02062/20210520/images/medium/jm0c02062_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c02062/20210520/images/large/jm0c02062_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Effects of [Dmt<sup>1,5</sup>]N/OFQ(1-13)-NH<sub>2</sub> at NOP and classical opioid receptors in calcium mobilization studies.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c02062/20210520/images/large/jm0c02062_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02062&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c02062/20210520/images/medium/jm0c02062_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c02062/20210520/images/large/jm0c02062_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Orthosteric site of [Dmt<sup>1,5</sup>]N/OFQ(1-9)-NH<sub>2</sub> (colored purple) in the active mu receptor, according to “<i>in silico</i>” docking and MD (starting receptor structure from PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DDF">6DDF</a>). Only the first five residues are shown. The reported DAMGO conformation (the same PDB code) is superimposed (yellow). (B) Hydrophobic contacts between Dmt<sup>1</sup>, Phe<sup>4</sup>, and Dmt<sup>5</sup> with their neighboring residues. (C–E) Interaction histograms of residues Dmt<sup>1</sup>, Phe<sup>4</sup>, and Dmt<sup>5</sup>, respectively, including hydrophobic, polar, H-bonds, water bridges of first and second order, salt bridges, and π–cation and π–π stacking as derived from long-lasting MD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c02062/20210520/images/large/jm0c02062_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02062&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c02062/20210520/images/medium/jm0c02062_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c02062/20210520/images/large/jm0c02062_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Maps of hydrophobic (A), polar (B), H-bond (C), π–π stacking (D), and π–cation (E) interactions between the mu receptor and the studied ligands along MD trajectories. Only residues 1–5 are considered for [Dmt<sup>1,5</sup>]N/OFQ(1-9)-NH<sub>2</sub> and N/OFQ(1-9)-NH<sub>2</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c02062/20210520/images/large/jm0c02062_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02062&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c02062/20210520/images/medium/jm0c02062_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c02062/20210520/images/large/jm0c02062_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of [Dmt<sup>1,5</sup>]N/OFQ(1-13)-NH<sub>2</sub> on citric acid-induced cough in conscious guinea pigs. Schematic representation of the experimental procedure for the cough measurement in conscious guinea pigs and pooled data of cough number after [Dmt<sup>1,5</sup>]N/OFQ(1-13)-NH<sub>2</sub> (1 mM) or vehicle (0.9% NaCl) nebulization, 30 min before the nebulization of the tussive agent, citric acid (0.4 M). Values are the mean ± SEM of the numbers of coughs/15 min, with data points overlaid (<i>n</i> = 6 guinea pigs for each condition). *<i>p</i> < 0.05 vs vehicle, Student’s <i>t</i>-test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c02062/20210520/images/large/jm0c02062_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02062&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i30">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77072" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77072" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 64 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meunier, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollereau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toll, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suaudeau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moisand, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvinerie, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butour, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guillemot, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrara, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monsarrat, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazarguil, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vassart, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmentier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costentin, J.</span></span> <span> </span><span class="NLM_article-title">Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>377</i></span>,  <span class="NLM_fpage">532</span>– <span class="NLM_lpage">535</span>, <span class="refDoi"> DOI: 10.1038/377532a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1038%2F377532a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=7566152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADyaK2MXoslWltr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=377&publication_year=1995&pages=532-535&author=J.-C.+Meunierauthor=C.+Mollereauauthor=L.+Tollauthor=C.+Suaudeauauthor=C.+Moisandauthor=P.+Alvinerieauthor=J.+L.+Butourauthor=J.+C.+Guillemotauthor=P.+Ferraraauthor=B.+Monsarratauthor=H.+Mazarguilauthor=G.+Vassartauthor=M.+Parmentierauthor=J.+Costentin&title=Isolation+and+structure+of+the+endogenous+agonist+of+opioid+receptor-like+ORL1+receptor&doi=10.1038%2F377532a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor</span></div><div class="casAuthors">Meunier, Jean-Claude; Mollereau, Catherine; Toll, Lawrence; Suaudeau, Charles; Moisand, Christiane; Alvinerie, Paul; Butour, Jean-Luc; Guillemot, Jean-Claude; Ferrara, Pascual; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">377</span>
        (<span class="NLM_cas:issue">6549</span>),
    <span class="NLM_cas:pages">532-5</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">The ORL1 receptor, an orphan receptor whose human and murine complementary DNAs have recently been characterized, structurally resembles opioid receptors and is neg. coupled with adenylate cyclase.  ORL1 transcripts are particularly abundant in the central nervous system.  Here the authors report the isolation, on the basis of its ability to inhibit the cyclase in a stable recombinant CHO(ORL1+) cell line, of a neuropeptide that resembles dynorphin A and whose amino acid sequences is Phe-Gly-Gly-Phe-Thr-Gly-Ala-Arg-Lys-Ser-Ala-Arg-Lys-Leu-Ala-Asn-Gln.  A rat-brain cDNA encodes the peptide flanked by Lys-Arg proteolytic cleavage motifs.  The synthetic heptadecapeptide potently inhibits adenylate cyclase in CHO(ORL1+) cells in culture and induces hyperalgesia when administered intracerebroventricularly to mice.  Taken together, these data indicate that the newly discovered heptadecapeptide is an endogenous agonist of the ORL1 receptor and that it may be endowed with pro-nociceptive properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-Ma-3fqZODbVg90H21EOLACvtfcHk0lhB5u9go_WejQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXoslWltr4%253D&md5=664f5b56671b66e3c7caee4d2acc4a5b</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2F377532a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F377532a0%26sid%3Dliteratum%253Aachs%26aulast%3DMeunier%26aufirst%3DJ.-C.%26aulast%3DMollereau%26aufirst%3DC.%26aulast%3DToll%26aufirst%3DL.%26aulast%3DSuaudeau%26aufirst%3DC.%26aulast%3DMoisand%26aufirst%3DC.%26aulast%3DAlvinerie%26aufirst%3DP.%26aulast%3DButour%26aufirst%3DJ.%2BL.%26aulast%3DGuillemot%26aufirst%3DJ.%2BC.%26aulast%3DFerrara%26aufirst%3DP.%26aulast%3DMonsarrat%26aufirst%3DB.%26aulast%3DMazarguil%26aufirst%3DH.%26aulast%3DVassart%26aufirst%3DG.%26aulast%3DParmentier%26aufirst%3DM.%26aulast%3DCostentin%26aufirst%3DJ.%26atitle%3DIsolation%2520and%2520structure%2520of%2520the%2520endogenous%2520agonist%2520of%2520opioid%2520receptor-like%2520ORL1%2520receptor%26jtitle%3DNature%26date%3D1995%26volume%3D377%26spage%3D532%26epage%3D535%26doi%3D10.1038%2F377532a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reinscheid, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nothacker, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ardati, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henningsen, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunzow, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grandy, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monsma, F. J.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Civelli, O.</span></span> <span> </span><span class="NLM_article-title">Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>270</i></span>,  <span class="NLM_fpage">792</span>– <span class="NLM_lpage">794</span>, <span class="refDoi"> DOI: 10.1126/science.270.5237.792</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1126%2Fscience.270.5237.792" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=7481766" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADyaK2MXptV2isr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1995&pages=792-794&author=R.+K.+Reinscheidauthor=H.+P.+Nothackerauthor=A.+Boursonauthor=A.+Ardatiauthor=R.+A.+Henningsenauthor=J.+R.+Bunzowauthor=D.+K.+Grandyauthor=H.+Langenauthor=F.+J.+Monsmaauthor=O.+Civelli&title=Orphanin+FQ%3A+a+neuropeptide+that+activates+an+opioidlike+G+protein-coupled+receptor&doi=10.1126%2Fscience.270.5237.792"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor</span></div><div class="casAuthors">Reinscheid, Rainer K.; Nothacker, Hans-Peter; Bourson, Anne; Ardati, Ali; Henningsen, Robert A.; Bunzow, James R.; Grady, David K.; Langen, Hanno; Monsma, Frederick J., Jr.; Civelli, Olivier</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">270</span>
        (<span class="NLM_cas:issue">5237</span>),
    <span class="NLM_cas:pages">792-4</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A heptadecapeptide was identified and purified from porcine brain tissue as a ligand for an orphan heterotrimeric GTP-binding protein (G protein)- coupled receptor (LC132) that is similar in sequence to opioid receptors.  This peptide, orphanin FQ, has a primary structure reminiscent of that of opioid peptides.  Nanomolar concns. of orphanin FQ inhibited forskolin-stimulated adenylyl cyclase activity in cells transfected with LC132.  This inhibitory activity was not affected by the addn. of opioid ligands, nor did the peptide activate opioid receptors.  Orphanin FQ bound to its receptor in a saturable manner and with high affinity.  When injected intracerebroventricularly into mice, orphanin FQ caused a decrease in locomotor activity but did not induce analgesia in the hot-plate test.  However, the peptide produced hyperalgesia in the tail-flick assay.  Thus, orphanin FQ may act as a transmitter in the brain by modulating nociceptive and locomotor behavior.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpERb2sP0w_6bVg90H21EOLACvtfcHk0ljnol6s9Uds-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXptV2isr4%253D&md5=64b046d1497af57d0841c0de710dcad5</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1126%2Fscience.270.5237.792&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.270.5237.792%26sid%3Dliteratum%253Aachs%26aulast%3DReinscheid%26aufirst%3DR.%2BK.%26aulast%3DNothacker%26aufirst%3DH.%2BP.%26aulast%3DBourson%26aufirst%3DA.%26aulast%3DArdati%26aufirst%3DA.%26aulast%3DHenningsen%26aufirst%3DR.%2BA.%26aulast%3DBunzow%26aufirst%3DJ.%2BR.%26aulast%3DGrandy%26aufirst%3DD.%2BK.%26aulast%3DLangen%26aufirst%3DH.%26aulast%3DMonsma%26aufirst%3DF.%2BJ.%26aulast%3DCivelli%26aufirst%3DO.%26atitle%3DOrphanin%2520FQ%253A%2520a%2520neuropeptide%2520that%2520activates%2520an%2520opioidlike%2520G%2520protein-coupled%2520receptor%26jtitle%3DScience%26date%3D1995%26volume%3D270%26spage%3D792%26epage%3D794%26doi%3D10.1126%2Fscience.270.5237.792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Toll, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruchas, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calò, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaveri, N. T.</span></span> <span> </span><span class="NLM_article-title">Nociceptin/Orphanin FQ receptor structure, signaling, ligands, functions, and interactions with opioid systems</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">419</span>– <span class="NLM_lpage">457</span>, <span class="refDoi"> DOI: 10.1124/pr.114.009209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1124%2Fpr.114.009209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=26956246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A280%3ADC%252BC28josFaltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2016&pages=419-457&author=L.+Tollauthor=M.+R.+Bruchasauthor=G.+Cal%C3%B2author=B.+M.+Coxauthor=N.+T.+Zaveri&title=Nociceptin%2FOrphanin+FQ+receptor+structure%2C+signaling%2C+ligands%2C+functions%2C+and+interactions+with+opioid+systems&doi=10.1124%2Fpr.114.009209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems</span></div><div class="casAuthors">Toll Lawrence; Bruchas Michael R; Calo' Girolamo; Cox Brian M; Zaveri Nurulain T</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">419-57</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The NOP receptor (nociceptin/orphanin FQ opioid peptide receptor) is the most recently discovered member of the opioid receptor family and, together with its endogenous ligand, N/OFQ, make up the fourth members of the opioid receptor and opioid peptide family.  Because of its more recent discovery, an understanding of the cellular and behavioral actions induced by NOP receptor activation are less well developed than for the other members of the opioid receptor family.  All of these factors are important because NOP receptor activation has a clear modulatory role on mu opioid receptor-mediated actions and thereby affects opioid analgesia, tolerance development, and reward.  In addition to opioid modulatory actions, NOP receptor activation has important effects on motor function and other physiologic processes.  This review discusses how NOP pharmacology intersects, contrasts, and interacts with the mu opioid receptor in terms of tertiary structure and mechanism of receptor activation; location of receptors in the central nervous system; mechanisms of desensitization and downregulation; cellular actions; intracellular signal transduction pathways; and behavioral actions with respect to analgesia, tolerance, dependence, and reward.  This is followed by a discussion of the agonists and antagonists that have most contributed to our current knowledge.  Because NOP receptors are highly expressed in brain and spinal cord and NOP receptor activation sometimes synergizes with mu receptor-mediated actions and sometimes opposes them, an understanding of NOP receptor pharmacology in the context of these interactions with the opioid receptors will be crucial to the development of novel therapeutics that engage the NOP receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT4KujB2a63gCEJCPKhJPuqfW6udTcc2eaeMinq8uU3grntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28josFaltw%253D%253D&md5=2a2c601fcd493fa3f67b0adee9259e02</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1124%2Fpr.114.009209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.114.009209%26sid%3Dliteratum%253Aachs%26aulast%3DToll%26aufirst%3DL.%26aulast%3DBruchas%26aufirst%3DM.%2BR.%26aulast%3DCal%25C3%25B2%26aufirst%3DG.%26aulast%3DCox%26aufirst%3DB.%2BM.%26aulast%3DZaveri%26aufirst%3DN.%2BT.%26atitle%3DNociceptin%252FOrphanin%2520FQ%2520receptor%2520structure%252C%2520signaling%252C%2520ligands%252C%2520functions%252C%2520and%2520interactions%2520with%2520opioid%2520systems%26jtitle%3DPharmacol.%2520Rev.%26date%3D2016%26volume%3D68%26spage%3D419%26epage%3D457%26doi%3D10.1124%2Fpr.114.009209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, D. G.</span></span> <span> </span><span class="NLM_article-title">The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">694</span>– <span class="NLM_lpage">710</span>, <span class="refDoi"> DOI: 10.1038/nrd2572</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1038%2Fnrd2572" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=18670432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptFOqsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=694-710&author=D.+G.+Lambert&title=The+nociceptin%2Forphanin+FQ+receptor%3A+a+target+with+broad+therapeutic+potential&doi=10.1038%2Fnrd2572"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential</span></div><div class="casAuthors">Lambert, David G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">694-710</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  In this Review, Lambert describes the physiol. and potential clin. applications of nociceptin/orphanin FQ and its receptor.  This peptide-receptor system has been implicated in a wide range of biol. functions such as pain, drug abuse, cardiovascular control and immunity.  Identification of the enigmatic nociceptin/orphanin FQ peptide (N/OFQ) in 1995 represented the first successful use of reverse pharmacol. and led to deorphanization of the N/OFQ receptor (NOP).  Subsequently, the N/OFQ-NOP system has been implicated in a wide range of biol. functions, including pain, drug abuse, cardiovascular control and immunity.  Although this could be considered a hurdle for the development of pharmaceuticals selective for a specific disease indication, NOP represents a viable drug target.  This article describes potential clin. indications and highlights the current status of the very limited no. of clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuID92HZwUB7Vg90H21EOLACvtfcHk0ljnol6s9Uds-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptFOqsL0%253D&md5=46c1952ed4a0ac1aa7779276bda5bba6</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrd2572&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2572%26sid%3Dliteratum%253Aachs%26aulast%3DLambert%26aufirst%3DD.%2BG.%26atitle%3DThe%2520nociceptin%252Forphanin%2520FQ%2520receptor%253A%2520a%2520target%2520with%2520broad%2520therapeutic%2520potential%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2008%26volume%3D7%26spage%3D694%26epage%3D710%26doi%3D10.1038%2Fnrd2572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schröder, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, T.</span></span> <span> </span><span class="NLM_article-title">Functional plasticity of the N/OFQ-NOP receptor system determines analgesic properties of NOP receptor agonists</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>171</i></span>,  <span class="NLM_fpage">3777</span>– <span class="NLM_lpage">3800</span>, <span class="refDoi"> DOI: 10.1111/bph.12744</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1111%2Fbph.12744" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=24762001" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A280%3ADC%252BC2cnmsVensg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2014&pages=3777-3800&author=W.+Schr%C3%B6derauthor=D.+G.+Lambertauthor=M.+C.+Koauthor=T.+Koch&title=Functional+plasticity+of+the+N%2FOFQ-NOP+receptor+system+determines+analgesic+properties+of+NOP+receptor+agonists&doi=10.1111%2Fbph.12744"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Functional plasticity of the N/OFQ-NOP receptor system determines analgesic properties of NOP receptor agonists</span></div><div class="casAuthors">Schroder W; Lambert D G; Ko M C; Koch T</div><div class="citationInfo"><span class="NLM_cas:title">British journal of pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3777-800</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Despite high sequence similarity between NOP (nociceptin/orphanin FQ opioid peptide) and opioid receptors, marked differences in endogenous ligand selectivity, signal transduction, phosphorylation, desensitization, internalization and trafficking have been identified; underscoring the evolutionary difference between NOP and opioid receptors.  Activation of NOP receptors affects nociceptive transmission in a site-specific manner, with antinociceptive effects prevailing after peripheral and spinal activation, and pronociceptive effects after supraspinal activation in rodents.  The net effect of systemically administered NOP receptor agonists on nociception is proposed to depend on the relative contribution of peripheral, spinal and supraspinal activation, and this may depend on experimental conditions.  Functional expression and regulation of NOP receptors at peripheral and central sites of the nociceptive pathway exhibits a high degree of plasticity under conditions of neuropathic and inflammatory pain.  In rodents, systemically administered NOP receptor agonists exerted antihypersensitive effects in models of neuropathic and inflammatory pain.  However, they were largely ineffective in acute pain while concomitantly evoking severe motor side effects.  In contrast, systemic administration of NOP receptor agonists to non-human primates (NHPs) exerted potent and efficacious antinociception in the absence of motor and sedative side effects.  The reason for this species difference with respect to antinociceptive efficacy and tolerability is not clear.  Moreover, co-activation of NOP and μ-opioid peptide (MOP) receptors synergistically produced antinociception in NHPs.  Hence, both selective NOP receptor as well as NOP/MOP receptor agonists may hold potential for clinical use as analgesics effective in conditions of acute and chronic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRKk8UmQyPtHQ8IxFYvehhofW6udTcc2ebwzR4bz5q43rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cnmsVensg%253D%253D&md5=04241ff79c2ff0853c7a4513961d0648</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1111%2Fbph.12744&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12744%26sid%3Dliteratum%253Aachs%26aulast%3DSchr%25C3%25B6der%26aufirst%3DW.%26aulast%3DLambert%26aufirst%3DD.%2BG.%26aulast%3DKo%26aufirst%3DM.%2BC.%26aulast%3DKoch%26aufirst%3DT.%26atitle%3DFunctional%2520plasticity%2520of%2520the%2520N%252FOFQ-NOP%2520receptor%2520system%2520determines%2520analgesic%2520properties%2520of%2520NOP%2520receptor%2520agonists%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2014%26volume%3D171%26spage%3D3777%26epage%3D3800%26doi%3D10.1111%2Fbph.12744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Toll, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozawa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cippitelli, A.</span></span> <span> </span><span class="NLM_article-title">NOP-related mechanisms in pain and analgesia</span>. <i>Handb. Exp. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>254</i></span>,  <span class="NLM_fpage">165</span>– <span class="NLM_lpage">186</span>, <span class="refDoi"> DOI: 10.1007/164_2019_214</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1007%2F164_2019_214" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=31119465" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmtlGlurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=254&publication_year=2019&pages=165-186&author=L.+Tollauthor=A.+Ozawaauthor=A.+Cippitelli&title=NOP-related+mechanisms+in+pain+and+analgesia&doi=10.1007%2F164_2019_214"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">NOP-Related Mechanisms in Pain and Analgesia</span></div><div class="casAuthors">Toll, Lawrence; Ozawa, Akihiko; Cippitelli, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">254</span>
        (<span class="NLM_cas:issue">Nociceptin/Orphanin FQ Peptide Receptor</span>),
    <span class="NLM_cas:pages">165-186</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">1865-0325</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  Since the discovery of the NOP receptor and N/OFQ as the endogenous ligand, evidence has appeared demonstrating the involvement of this receptor system in pain.  However, as data accumulated, it became clear that not only the potency but the activity per se was different when N/OFQ or small mol. NOP agonists were administered in the brain vs. the spinal cord and it also depended upon the pain assay used.  When administered systemically, NOP receptor agonists are generally ineffective in attenuating heat pain but are antinociceptive in an acute inflammatory pain model.  Most antagonists administered systemically have no antinociceptive activity of their own, even though selective peptide NOP antagonists have potent antinociceptive activity when administered i.c.v.  Chronic pain models provide different results as well, as small mol. NOP receptor agonists have potent anti-allodynic and anti-hyperalgesic activity after systemic administration.  A considerable no. of electrophysiol. and anatomical expts., in particular with NOP-eGFP mice, have been conducted in an attempt to explain the complicated profile resulting from NOP receptor modulation, to examine receptor plasticity, and to elucidate mechanisms by which selective NOP agonists, bifunctional NOP/mu agonists, or NOP receptor antagonists modulate acute and chronic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgJGQSmP8Q77Vg90H21EOLACvtfcHk0ljtr-QHiY-F5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmtlGlurk%253D&md5=c018e446413a389756f637094ab3f086</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1007%2F164_2019_214&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F164_2019_214%26sid%3Dliteratum%253Aachs%26aulast%3DToll%26aufirst%3DL.%26aulast%3DOzawa%26aufirst%3DA.%26aulast%3DCippitelli%26aufirst%3DA.%26atitle%3DNOP-related%2520mechanisms%2520in%2520pain%2520and%2520analgesia%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2019%26volume%3D254%26spage%3D165%26epage%3D186%26doi%3D10.1007%2F164_2019_214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kiguchi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, M. C.</span></span> <span> </span><span class="NLM_article-title">Effects of NOP-related ligands in nonhuman primates</span>. <i>Handb. Exp. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>254</i></span>,  <span class="NLM_fpage">323</span>– <span class="NLM_lpage">343</span>, <span class="refDoi"> DOI: 10.1007/164_2019_211</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1007%2F164_2019_211" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=30879202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmtlGlurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=254&publication_year=2019&pages=323-343&author=N.+Kiguchiauthor=M.+C.+Ko&title=Effects+of+NOP-related+ligands+in+nonhuman+primates&doi=10.1007%2F164_2019_211"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of NOP-Related Ligands in Nonhuman Primates</span></div><div class="casAuthors">Kiguchi, Norikazu; Ko, Mei-Chuan</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">254</span>
        (<span class="NLM_cas:issue">Nociceptin/Orphanin FQ Peptide Receptor</span>),
    <span class="NLM_cas:pages">323-343</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">1865-0325</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">The nociceptin/orphanin FQ peptide (NOP) receptor-related ligands have been demonstrated in preclin. studies for several therapeutic applications.  This article highlights (1) how nonhuman primates (NHP) were used to facilitate the development and application of positron emission tomog. tracers in humans; (2) effects of an endogenous NOP ligand, nociceptin/orphanin FQ, and its interaction with mu opioid peptide (MOP) receptor agonists; and (3) promising functional profiles of NOP-related agonists in NHP as analgesics and treatment for substance use disorders.  NHP models offer the most phylogenetically appropriate evaluation of opioid and non-opioid receptor functions and drug effects.  Based on preclin. and clin. data of ligands with mixed NOP/MOP receptor agonist activity, several factors including their intrinsic efficacies for activating NOP vs. MOP receptors and different study endpoints in NHP could contribute to different pharmacol. profiles.  Ample evidence from NHP studies indicates that bifunctional NOP/MOP receptor agonists have opened an exciting avenue for developing safe, effective medications with fewer side effects for treating pain and drug addiction.  In particular, bifunctional NOP/MOP partial agonists hold a great potential as (1) effective spinal analgesics without itch side effects; (2) safe, nonaddictive analgesics without opioid side effects such as respiratory depression; and (3) effective medications for substance use disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxfWAnvaq1t7Vg90H21EOLACvtfcHk0lj3cOjTnBckpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmtlGlurg%253D&md5=5e66fee75b464850aec7f44f4abae0ca</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1007%2F164_2019_211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F164_2019_211%26sid%3Dliteratum%253Aachs%26aulast%3DKiguchi%26aufirst%3DN.%26aulast%3DKo%26aufirst%3DM.%2BC.%26atitle%3DEffects%2520of%2520NOP-related%2520ligands%2520in%2520nonhuman%2520primates%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2019%26volume%3D254%26spage%3D323%26epage%3D343%26doi%3D10.1007%2F164_2019_211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Linz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christoph, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tzschentke, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiene, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gautrois, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schröder, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kögel, B. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beier, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Englberger, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schunk, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Vry, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahnel, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frosch, S.</span></span> <span> </span><span class="NLM_article-title">Cebranopadol: a novel potent analgesic nociceptin/orphanin FQ peptide and opioid receptor agonist</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>349</i></span>,  <span class="NLM_fpage">535</span>– <span class="NLM_lpage">548</span>, <span class="refDoi"> DOI: 10.1124/jpet.114.213694</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1124%2Fjpet.114.213694" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=24713140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVGltbrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=349&publication_year=2014&pages=535-548&author=K.+Linzauthor=T.+Christophauthor=T.+M.+Tzschentkeauthor=T.+Kochauthor=K.+Schieneauthor=M.+Gautroisauthor=W.+Schr%C3%B6derauthor=B.+Y.+K%C3%B6gelauthor=H.+Beierauthor=W.+Englbergerauthor=S.+Schunkauthor=J.+De+Vryauthor=U.+Jahnelauthor=S.+Frosch&title=Cebranopadol%3A+a+novel+potent+analgesic+nociceptin%2Forphanin+FQ+peptide+and+opioid+receptor+agonist&doi=10.1124%2Fjpet.114.213694"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Cebranopadol: a novel potent analgesic nociceptin/orphanin FQ peptide and opioid receptor agonist</span></div><div class="casAuthors">Linz, Klaus; Christoph, Thomas; Tzschentke, Thomas M.; Koch, Thomas; Schiene, Klaus; Gautrois, Michael; Schroeder, Wolfgang; Koegel, Babette Y.; Beier, Horst; Englberger, Werner; Schunk, Stefan; De Vry, Jean; Jahnel, Ulrich; Frosch, Stefanie</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">349</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">535-548, 14 pp.</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Cebranopadol (trans-6'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro[cyclohexane-1,1'(3'H)-pyrano[3,4-b]indol]-4-amine) is a novel analgesic nociceptin/orphanin FQ peptide (NOP) and opioid receptor agonist [Ki (nM)/EC50 (nM)/relative efficacy (%): human NOP receptor 0.9/13.0/89; human mu-opioid peptide (MOP) receptor 0.7/1.2/104; human kappa-opioid peptide receptor 2.6/17/67; human delta-opioid peptide receptor 18/110/105].  Cebranopadol exhibits highly potent and efficacious antinociceptive and antihypersensitive effects in several rat models of acute and chronic pain (tail-flick, rheumatoid arthritis, bone cancer, spinal nerve ligation, diabetic neuropathy) with ED50 values of 0.5-5.6 μg/kg after i.v. and 25.1 μg/kg after oral administration.  In comparison with selective MOP receptor agonists, cebranopadol was more potent in models of chronic neuropathic than acute nociceptive pain.  Cebranopadol's duration of action is long (up to 7 h after i.v. 12 μg/kg; >9 h after oral 55 μg/kg in the rat tail-flick test).  The antihypersensitive activity of cebranopadol in the spinal nerve ligation model was partially reversed by pretreatment with the selective NOP receptor antagonist J-1133'7[1-[(3R,4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one] or the opioid receptor antagonist naloxone, indicating that both NOP and opioid receptor agonism are involved in this activity.  Development of analgesic tolerance in the chronic constriction injury model was clearly delayed compared with that from an equianalgesic dose of morphine (complete tolerance on day 26 vs. day 11, resp.).  Unlike morphine, cebranopadol did not disrupt motor coordination and respiration at doses within and exceeding the analgesic dose range.  Cebranopadol, by its combination of agonism at NOP and opioid receptors, affords highly potent and efficacious analgesia in various pain models with a favorable side effect profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvDj3QJY4fYrVg90H21EOLACvtfcHk0lj3cOjTnBckpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVGltbrE&md5=c3fcc301bf4dde5706565d9187578df4</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1124%2Fjpet.114.213694&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.114.213694%26sid%3Dliteratum%253Aachs%26aulast%3DLinz%26aufirst%3DK.%26aulast%3DChristoph%26aufirst%3DT.%26aulast%3DTzschentke%26aufirst%3DT.%2BM.%26aulast%3DKoch%26aufirst%3DT.%26aulast%3DSchiene%26aufirst%3DK.%26aulast%3DGautrois%26aufirst%3DM.%26aulast%3DSchr%25C3%25B6der%26aufirst%3DW.%26aulast%3DK%25C3%25B6gel%26aufirst%3DB.%2BY.%26aulast%3DBeier%26aufirst%3DH.%26aulast%3DEnglberger%26aufirst%3DW.%26aulast%3DSchunk%26aufirst%3DS.%26aulast%3DDe%2BVry%26aufirst%3DJ.%26aulast%3DJahnel%26aufirst%3DU.%26aulast%3DFrosch%26aufirst%3DS.%26atitle%3DCebranopadol%253A%2520a%2520novel%2520potent%2520analgesic%2520nociceptin%252Forphanin%2520FQ%2520peptide%2520and%2520opioid%2520receptor%2520agonist%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2014%26volume%3D349%26spage%3D535%26epage%3D548%26doi%3D10.1124%2Fjpet.114.213694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Calò, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, D. G.</span></span> <span> </span><span class="NLM_article-title">Nociceptin/orphanin FQ receptor ligands and translational challenges: focus on cebranopadol as an innovative analgesic</span>. <i>Br. J. Anaesth.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>121</i></span>,  <span class="NLM_fpage">1105</span>– <span class="NLM_lpage">1114</span>, <span class="refDoi"> DOI: 10.1016/j.bja.2018.06.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1016%2Fj.bja.2018.06.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=30336855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC1MXkvVGjtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2018&pages=1105-1114&author=G.+Cal%C3%B2author=D.+G.+Lambert&title=Nociceptin%2Forphanin+FQ+receptor+ligands+and+translational+challenges%3A+focus+on+cebranopadol+as+an+innovative+analgesic&doi=10.1016%2Fj.bja.2018.06.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Nociceptin/orphanin FQ receptor ligands and translational challenges: focus on cebranopadol as an innovative analgesic</span></div><div class="casAuthors">Calo, G.; Lambert, D. G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Anaesthesia</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1105-1114</span>CODEN:
                <span class="NLM_cas:coden">BJANAD</span>;
        ISSN:<span class="NLM_cas:issn">1471-6771</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Opioids are characterised as classical (mu, delta, and kappa) along with the non-classical nociceptin/orphanin FQ (N/OFQ) receptor or NOP.  Targeting NOP has therapeutic indications in control of the cardiovascular and respiratory systems and micturition, and a profile as an antidepressant.  For all of these indications, there are translational human data.  Opioids such as morphine and fentanyl (activating the mu receptor) are the mainstay of pain treatment in the perioperative period, despite a challenging side-effect profile.  Opioids in general have poor efficacy in neuropathic pain.  Moreover, longer term use is assocd. with tolerance.  There is good evidence interactions between opioid receptors, and receptor co-activation can reduce side-effects without compromising analgesia; this is particularly true for mu and NOP co-activation.  Recent pharmaceutical development has produced a mixed opioid/NOP agonist, cebranopadol.  This new chem. entity is effective in animal models of nociceptive and neuropathic pain with greater efficacy in the latter.  In animal models, there is little evidence for respiratory depression, and tolerance (compared with morphine) only develops after long treatment periods.  There is now early phase clin. development in diabetic neuropathy, cancer pain, and low back pain where cebranopadol displays significant efficacy.  In 1996, N/OFQ was formally identified with an innovative analgesic profile.  Approx. 20 yr later, cebranopadol as a clin. ligand is advancing through the human trials process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYrn8LanDB8bVg90H21EOLACvtfcHk0lj3cOjTnBckpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXkvVGjtg%253D%253D&md5=bcc4df676d94a0250830edd3ea13c74e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.bja.2018.06.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bja.2018.06.024%26sid%3Dliteratum%253Aachs%26aulast%3DCal%25C3%25B2%26aufirst%3DG.%26aulast%3DLambert%26aufirst%3DD.%2BG.%26atitle%3DNociceptin%252Forphanin%2520FQ%2520receptor%2520ligands%2520and%2520translational%2520challenges%253A%2520focus%2520on%2520cebranopadol%2520as%2520an%2520innovative%2520analgesic%26jtitle%3DBr.%2520J.%2520Anaesth.%26date%3D2018%26volume%3D121%26spage%3D1105%26epage%3D1114%26doi%3D10.1016%2Fj.bja.2018.06.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ding, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiguchi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasuda, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daga, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polgar, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czoty, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kishioka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaveri, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, M.-C.</span></span> <span> </span><span class="NLM_article-title">A bifunctional nociceptin and mu opioid receptor agonist is analgesic without opioid side effects in nonhuman primates</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>, <span class="NLM_elocation-id">eaar3483</span> <span class="refDoi"> DOI: 10.1126/scitranslmed.aar3483</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1126%2Fscitranslmed.aar3483" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=30158150" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&author=H.+Dingauthor=N.+Kiguchiauthor=D.+Yasudaauthor=P.+R.+Dagaauthor=W.+E.+Polgarauthor=J.+J.+Luauthor=P.+W.+Czotyauthor=S.+Kishiokaauthor=N.+T.+Zaveriauthor=M.-C.+Ko&title=A+bifunctional+nociceptin+and+mu+opioid+receptor+agonist+is+analgesic+without+opioid+side+effects+in+nonhuman+primates&doi=10.1126%2Fscitranslmed.aar3483"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aar3483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aar3483%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DH.%26aulast%3DKiguchi%26aufirst%3DN.%26aulast%3DYasuda%26aufirst%3DD.%26aulast%3DDaga%26aufirst%3DP.%2BR.%26aulast%3DPolgar%26aufirst%3DW.%2BE.%26aulast%3DLu%26aufirst%3DJ.%2BJ.%26aulast%3DCzoty%26aufirst%3DP.%2BW.%26aulast%3DKishioka%26aufirst%3DS.%26aulast%3DZaveri%26aufirst%3DN.%2BT.%26aulast%3DKo%26aufirst%3DM.-C.%26atitle%3DA%2520bifunctional%2520nociceptin%2520and%2520mu%2520opioid%2520receptor%2520agonist%2520is%2520analgesic%2520without%2520opioid%2520side%2520effects%2520in%2520nonhuman%2520primates%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2018%26volume%3D10%26doi%3D10.1126%2Fscitranslmed.aar3483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kiguchi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cami-Kobeci, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sukhtankar, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czoty, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeLoid, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, F.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toll, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Husbands, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, M.-C.</span></span> <span> </span><span class="NLM_article-title">BU10038 as a safe opioid analgesic with fewer side-effects after systemic and intrathecal administration in primates</span>. <i>Br. J. Anaesth.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">e146</span>– <span class="NLM_lpage">e156</span>, <span class="refDoi"> DOI: 10.1016/j.bja.2018.10.065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1016%2Fj.bja.2018.10.065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=30916003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC1MXktFOrtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2019&pages=e146-e156&author=N.+Kiguchiauthor=H.+Dingauthor=G.+Cami-Kobeciauthor=D.+D.+Sukhtankarauthor=P.+W.+Czotyauthor=H.+B.+DeLoidauthor=F.-C.+Hsuauthor=L.+Tollauthor=S.+M.+Husbandsauthor=M.-C.+Ko&title=BU10038+as+a+safe+opioid+analgesic+with+fewer+side-effects+after+systemic+and+intrathecal+administration+in+primates&doi=10.1016%2Fj.bja.2018.10.065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">BU10038 as a safe opioid analgesic with fewer side-effects after systemic and intrathecal administration in primates</span></div><div class="casAuthors">Kiguchi, Norikazu; Ding, Huiping; Cami-Kobeci, Gerta; Sukhtankar, Devki D.; Czoty, Paul W.; DeLoid, Heather B.; Hsu, Fang-Chi; Toll, Lawrence; Husbands, Stephen M.; Ko, Mei-Chuan</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Anaesthesia</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e146-e156</span>CODEN:
                <span class="NLM_cas:coden">BJANAD</span>;
        ISSN:<span class="NLM_cas:issn">1471-6771</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The marked increase in mis-use of prescription opioids has greatly affected our society.  One potential soln. is to develop improved analgesics which have agonist action at both mu opioid peptide (MOP) and nociceptin/orphanin FQ peptide (NOP) receptors.  BU10038 is a recently identified bifunctional MOP/NOP partial agonist.  The aim of this study was to det. the functional profile of systemic or spinal delivery of BU10038 in primates after acute and chronic administration.  A series of behavioral and physiol. assays have been established specifically to reflect the therapeutic (analgesia) and side-effects (abuse potential, respiratory depression, itch, phys. dependence, and tolerance) of opioid analgesics in rhesus monkeys.  After systemic administration, BU10038 (0.001-0.01 mg kg-1) dose-dependently produced long-lasting antinociceptive and antihypersensitive effects.  Unlike the MOP agonist oxycodone, BU10038 lacked reinforcing effects (i.e. little or no abuse liability), and BU10038 did not compromise the physiol. functions of primates including respiration, cardiovascular activities, and body temp. at antinociceptive doses and a 10-30-fold higher dose (0.01-0.1 mg kg-1).  After intrathecal administration, BU10038 (3 μg) exerted morphine-comparable antinociception and antihypersensitivity without itch scratching responses.  Unlike morphine, BU10038 did not cause the development of phys. dependence and tolerance after repeated and chronic administration.  These in vivo findings demonstrate the translational potential of bifunctional MOP/NOP receptor agonists such as BU10038 as a safe, non-addictive analgesic with fewer side-effects in primates.  This study strongly supports that bifunctional MOP/NOP agonists may provide improved analgesics and an alternative soln. for the ongoing prescription opioid crisis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlVLOISUSOFbVg90H21EOLACvtfcHk0ljxHV7M1CIVnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXktFOrtr8%253D&md5=77bae3bd7f251e8a5db31de871acca02</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.bja.2018.10.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bja.2018.10.065%26sid%3Dliteratum%253Aachs%26aulast%3DKiguchi%26aufirst%3DN.%26aulast%3DDing%26aufirst%3DH.%26aulast%3DCami-Kobeci%26aufirst%3DG.%26aulast%3DSukhtankar%26aufirst%3DD.%2BD.%26aulast%3DCzoty%26aufirst%3DP.%2BW.%26aulast%3DDeLoid%26aufirst%3DH.%2BB.%26aulast%3DHsu%26aufirst%3DF.-C.%26aulast%3DToll%26aufirst%3DL.%26aulast%3DHusbands%26aufirst%3DS.%2BM.%26aulast%3DKo%26aufirst%3DM.-C.%26atitle%3DBU10038%2520as%2520a%2520safe%2520opioid%2520analgesic%2520with%2520fewer%2520side-effects%2520after%2520systemic%2520and%2520intrathecal%2520administration%2520in%2520primates%26jtitle%3DBr.%2520J.%2520Anaesth.%26date%3D2019%26volume%3D122%26spage%3De146%26epage%3De156%26doi%3D10.1016%2Fj.bja.2018.10.065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chao, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ou, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuang, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsu-An Hsu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loh, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shih, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueng, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, S. H.</span></span> <span> </span><span class="NLM_article-title">BPR1M97, a dual mu opioid receptor/nociceptin-orphanin FQ peptide receptor agonist, produces potent antinociceptive effects with safer properties than morphine</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>166</i></span>,  <span class="NLM_fpage">107678</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2019.107678</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1016%2Fj.neuropharm.2019.107678" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=31278929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtl2gtrfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2020&pages=107678&author=P.+K.+Chaoauthor=H.+F.+Changauthor=W.+T.+Changauthor=T.+K.+Yehauthor=L.+C.+Ouauthor=J.+Y.+Chuangauthor=J.+Tsu-An+Hsuauthor=P.+L.+Taoauthor=H.+H.+Lohauthor=C.+Shihauthor=S.+H.+Uengauthor=S.+H.+Yeh&title=BPR1M97%2C+a+dual+mu+opioid+receptor%2Fnociceptin-orphanin+FQ+peptide+receptor+agonist%2C+produces+potent+antinociceptive+effects+with+safer+properties+than+morphine&doi=10.1016%2Fj.neuropharm.2019.107678"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">BPR1M97, a dual mu opioid receptor/nociceptin-orphanin FQ peptide receptor agonist, produces potent antinociceptive effects with safer properties than morphine</span></div><div class="casAuthors">Chao, Po-Kuan; Chang, Hsiao-Fu; Chang, Wan-Ting; Yeh, Teng-Kuang; Ou, Li-Chin; Chuang, Jian-Ying; Tsu-An Hsu, John; Tao, Pao-Luh; Loh, Horace H.; Shih, Chuan; Ueng, Shau-Hua; Yeh, Shiu-Hwa</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">107678</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">There is unmet need to design an analgesic with fewer side effects for severe pain management.  Although traditional opioids are the most effective painkillers, they are accompanied by severe adverse responses, such as respiratory depression, constipation symptoms, tolerance, withdrawal, and addiction.  We indicated BPR1M97 as a dual mu opioid receptor (MOP)/nociceptin-orphanin FQ peptide (NOP) receptor full agonist and investigated the pharmacol. of BPR1M97 in multiple animal models.  In vitro studies on BPR1M97 were assessed using cyclic-adenosine monophosphate prodn., β-arrestin, internalization, and membrane potential assays.  In vivo studies were characterized using the tail-flick, tail-clip, lung functional, heart functional, acetone drop, von Frey hair, charcoal meal, glass bead, locomotor activity, conditioned place preference (CPP) and naloxone pptn. tests.  BPR1M97 elicited full agonist properties for all cell-based assays tested in MOP-expressing cells.  However, it acted as a G protein-biased agonist for NOP.  BPR1M97 initiated faster antinociceptive effects at 10 min after s.c. injection and elicited better analgesia in cancer-induced pain than morphine.  Unlike morphine, BPR1M97 caused less respiratory, cardiovascular, and gastrointestinal dysfunction.  In addn., BPR1M97 decreased global activity and induced less withdrawal jumping pptd. by naloxone.  Thus, BPR1M97 could serve as a novel small mol. dual receptor agonist for antinociception with fewer side effects than morphine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcOK2jCjR8ubVg90H21EOLACvtfcHk0ljxHV7M1CIVnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtl2gtrfN&md5=a2d5202400186003f9c81f4e4f22303b</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2019.107678&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2019.107678%26sid%3Dliteratum%253Aachs%26aulast%3DChao%26aufirst%3DP.%2BK.%26aulast%3DChang%26aufirst%3DH.%2BF.%26aulast%3DChang%26aufirst%3DW.%2BT.%26aulast%3DYeh%26aufirst%3DT.%2BK.%26aulast%3DOu%26aufirst%3DL.%2BC.%26aulast%3DChuang%26aufirst%3DJ.%2BY.%26aulast%3DTsu-An%2BHsu%26aufirst%3DJ.%26aulast%3DTao%26aufirst%3DP.%2BL.%26aulast%3DLoh%26aufirst%3DH.%2BH.%26aulast%3DShih%26aufirst%3DC.%26aulast%3DUeng%26aufirst%3DS.%2BH.%26aulast%3DYeh%26aufirst%3DS.%2BH.%26atitle%3DBPR1M97%252C%2520a%2520dual%2520mu%2520opioid%2520receptor%252Fnociceptin-orphanin%2520FQ%2520peptide%2520receptor%2520agonist%252C%2520produces%2520potent%2520antinociceptive%2520effects%2520with%2520safer%2520properties%2520than%2520morphine%26jtitle%3DNeuropharmacology%26date%3D2020%26volume%3D166%26spage%3D107678%26doi%3D10.1016%2Fj.neuropharm.2019.107678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kiguchi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, M.-C.</span></span> <span> </span><span class="NLM_article-title">Therapeutic potentials of NOP and MOP receptor coactivation for the treatment of pain and opioid abuse</span>. <i>J. Neurosci. Res.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="refDoi"> DOI: 10.1002/jnr.24624</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1002%2Fjnr.24624" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=32255240" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=N.+Kiguchiauthor=H.+Dingauthor=M.-C.+Ko&title=Therapeutic+potentials+of+NOP+and+MOP+receptor+coactivation+for+the+treatment+of+pain+and+opioid+abuse&doi=10.1002%2Fjnr.24624"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1002%2Fjnr.24624&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjnr.24624%26sid%3Dliteratum%253Aachs%26aulast%3DKiguchi%26aufirst%3DN.%26aulast%3DDing%26aufirst%3DH.%26aulast%3DKo%26aufirst%3DM.-C.%26atitle%3DTherapeutic%2520potentials%2520of%2520NOP%2520and%2520MOP%2520receptor%2520coactivation%2520for%2520the%2520treatment%2520of%2520pain%2520and%2520opioid%2520abuse%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2020%26doi%3D10.1002%2Fjnr.24624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Azzam, A. A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, D. G.</span></span> <span> </span><span class="NLM_article-title">Hot topics in opioid pharmacology: mixed and biased opioids</span>. <i>Br. J. Anaesth.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">e136</span>– <span class="NLM_lpage">e145</span>, <span class="refDoi"> DOI: 10.1016/j.bja.2019.03.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1016%2Fj.bja.2019.03.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=31010646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnvV2mtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2019&pages=e136-e145&author=A.+A.+H.+Azzamauthor=J.+McDonaldauthor=D.+G.+Lambert&title=Hot+topics+in+opioid+pharmacology%3A+mixed+and+biased+opioids&doi=10.1016%2Fj.bja.2019.03.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Hot topics in opioid pharmacology: mixed and biased opioids</span></div><div class="casAuthors">Azzam, Ammar A. H.; McDonald, John; Lambert, David G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Anaesthesia</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e136-e145</span>CODEN:
                <span class="NLM_cas:coden">BJANAD</span>;
        ISSN:<span class="NLM_cas:issn">1471-6771</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Analgesic design and evaluation have been driven by the desire to create high-affinity high-selectivity mu (μ)-opioid peptide (MOP) receptor agonists.  Such ligands are the mainstay of current clin. practice, and include morphine and fentanyl.  Advances in this sphere have come from designing pharmacokinetic advantage, as in rapid metab. for remifentanil.  These produce analgesia, but also the adverse-effect profile that currently defines this drug class: ventilatory depression, tolerance, and abuse liability.  The MOP receptor is part of a family, and there are significant functional interactions between other members of the family (delta [δ]-opioid peptide [DOP], kappa [κ]-opioid peptide [KOP], and nociceptin/orphanin FQ receptor [NOP]).  Exptl., MOP agonism and DOP antagonism produce anti-nociception (animals) with no tolerance, and low doses of MOP and NOP ligands synergise to antinociceptive advantage.  In this latter context, the lack of effect of NOP agonists on ventilation is an addnl. advantage.  Recent development has been to move towards low-selectivity multifunctional 'mixed ligands', such as cebranopadol, or ligand mixts., such as Targinact.  Moreover, the observation that β-arrestin coupling underlies the side-effect profile for MOP ligands (from knockout animal studies) led to the discovery of biased (to G-protein and away from β-arrestin intracellular signalling) MOP ligands, such as oliceridine.  There is sufficient excitement in the opioid field to suggest that opioid analgesics without significant side-effects may be on the horizon, and the 'opioid Holy Grail' might be in reach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_ORCa8YK6UbVg90H21EOLACvtfcHk0ljxHV7M1CIVnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnvV2mtbs%253D&md5=915276eb393731de0a519ee5fcab14e6</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.bja.2019.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bja.2019.03.006%26sid%3Dliteratum%253Aachs%26aulast%3DAzzam%26aufirst%3DA.%2BA.%2BH.%26aulast%3DMcDonald%26aufirst%3DJ.%26aulast%3DLambert%26aufirst%3DD.%2BG.%26atitle%3DHot%2520topics%2520in%2520opioid%2520pharmacology%253A%2520mixed%2520and%2520biased%2520opioids%26jtitle%3DBr.%2520J.%2520Anaesth.%26date%3D2019%26volume%3D122%26spage%3De136%26epage%3De145%26doi%3D10.1016%2Fj.bja.2019.03.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anand, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kochan, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nastase, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montgomery, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griggs, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynor, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosberg, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jutkiewicz, E. M.</span></span> <span> </span><span class="NLM_article-title">In vivo effects of μ-opioid receptor agonist/δ-opioid receptor antagonist peptidomimetics following acute and repeated administration</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>175</i></span>,  <span class="NLM_fpage">2013</span>– <span class="NLM_lpage">2027</span>, <span class="refDoi"> DOI: 10.1111/bph.14148</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1111%2Fbph.14148" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=29352503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC1cXot1Cru70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=2018&pages=2013-2027&author=J.+P.+Anandauthor=K.+E.+Kochanauthor=A.+F.+Nastaseauthor=D.+Montgomeryauthor=N.+W.+Griggsauthor=J.+R.+Traynorauthor=H.+I.+Mosbergauthor=E.+M.+Jutkiewicz&title=In+vivo+effects+of+%CE%BC-opioid+receptor+agonist%2F%CE%B4-opioid+receptor+antagonist+peptidomimetics+following+acute+and+repeated+administration&doi=10.1111%2Fbph.14148"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo effects of μ-opioid receptor agonist/δ-opioid receptor antagonist peptidomimetics following acute and repeated administration</span></div><div class="casAuthors">Anand, Jessica P.; Kochan, Kelsey E.; Nastase, Anthony F.; Montgomery, Deanna; Griggs, Nicholas W.; Traynor, John R.; Mosberg, Henry I.; Jutkiewicz, Emily M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">175</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2013-2027</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Agonists at μ-opioid receptors (μ-receptors) are used for pain management but produce adverse effects including tolerance, dependence and euphoria.  The co-administration of a μ-receptor agonist with a δ-opioid receptor (δ-receptor) antagonist has been shown to produce antinociception with reduced development of some side effects.  We characterized the effects of three μ-receptor agonist/δ-receptor antagonist peptidomimetics in vivo after acute and repeated administration to det. if this profile provides a viable alternative to traditional opioid analgesics.  Three μ-receptor agonist / δ-receptor antagonist peptidomimetics, AAH8, AMB46 and AMB47, and morphine were evaluated for the development of tolerance and dependence after 5 days of twice daily treatment with escalating doses of drug (10-50 mg·kg-1).  Antinociceptive effects were measured in the warm water tail withdrawal assay before and after repeated drug treatment.  Phys. dependence was evaluated by naltrexone-pptd. withdrawal jumping.  The rewarding effects of AAH8 were evaluated using a conditioned place preference (CPP) assay with twice daily conditioning sessions performed for 5 days.  Morphine, AAH8, AMB47 and AMB46 all demonstrated acute antinociceptive effects, but repeated administration only produced tolerance in animals treated with morphine and AMB46.  Injection of naltrexone pptd. fewer jumps in mice treated repeatedly with AAH8 as compared with morphine, AMB47 or AMB46.  Conditioning with morphine, but not AAH8, produced significant CPP.  AAH8 may be a better alternative than traditional opioid analgesics, producing antinociception with less development of tolerance and dependence and may be less rewarding than morphine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruammciHxwYLVg90H21EOLACvtfcHk0lh5OPw3xxMoOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXot1Cru70%253D&md5=6ad59ce996adbd8e4e76019e851e1ce5</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1111%2Fbph.14148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.14148%26sid%3Dliteratum%253Aachs%26aulast%3DAnand%26aufirst%3DJ.%2BP.%26aulast%3DKochan%26aufirst%3DK.%2BE.%26aulast%3DNastase%26aufirst%3DA.%2BF.%26aulast%3DMontgomery%26aufirst%3DD.%26aulast%3DGriggs%26aufirst%3DN.%2BW.%26aulast%3DTraynor%26aufirst%3DJ.%2BR.%26aulast%3DMosberg%26aufirst%3DH.%2BI.%26aulast%3DJutkiewicz%26aufirst%3DE.%2BM.%26atitle%3DIn%2520vivo%2520effects%2520of%2520%25CE%25BC-opioid%2520receptor%2520agonist%252F%25CE%25B4-opioid%2520receptor%2520antagonist%2520peptidomimetics%2520following%2520acute%2520and%2520repeated%2520administration%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2018%26volume%3D175%26spage%3D2013%26epage%3D2027%26doi%3D10.1111%2Fbph.14148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aceto, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Negus, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banks, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akgun, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Portoghese, P. S.</span></span> <span> </span><span class="NLM_article-title">MDAN-21: a bivalent opioid ligand containing mu-agonist and delta-antagonist pharmacophores and its effects in rhesus monkeys</span>. <i>Int. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>2012</i></span>,  <span class="NLM_fpage">327257</span>, <span class="refDoi"> DOI: 10.1155/2012/327257</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1155%2F2012%2F327257" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=25954526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A280%3ADC%252BC2MfitV2jtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2012&publication_year=2012&pages=327257&author=M.+D.+Acetoauthor=L.+S.+Harrisauthor=S.+S.+Negusauthor=M.+L.+Banksauthor=L.+D.+Hughesauthor=E.+Akgunauthor=P.+S.+Portoghese&title=MDAN-21%3A+a+bivalent+opioid+ligand+containing+mu-agonist+and+delta-antagonist+pharmacophores+and+its+effects+in+rhesus+monkeys&doi=10.1155%2F2012%2F327257"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">MDAN-21: A Bivalent Opioid Ligand Containing mu-Agonist and Delta-Antagonist Pharmacophores and Its Effects in Rhesus Monkeys</span></div><div class="casAuthors">Aceto Mario D; Harris Louis S; Negus S Stevens; Banks Matthew L; Hughes Larry D; Akgun Eyup; Portoghese Philip S</div><div class="citationInfo"><span class="NLM_cas:title">International journal of medicinal chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2012</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">327257</span>
        ISSN:<span class="NLM_cas:issn">2090-2069</span>.
    </div><div class="casAbstract">MDAN-21, 7'-{2-[(7-{2-[({(5α, 6α)-4,5-Epoxy-3,14-dihydroxy-17-methylmorphin-6-yl}-aminocarbonyl)metoxy]-acetylamino}-heptylaminocarbonyl)-methoxy]-acetylamino}-naltrindole, a bivalent opioid ligand containing a mu-opioid receptor agonist (derived from oxymorphone) linked to the delta-opioid receptor antagonist (related to naltrindole) by a spacer of 21 atoms, was reported to have potent analgesic properties in mice.  Tolerance, physical dependence, and conditioned place preference were not evident in that species.  The finding that bivalent ligands in this series, with spacers 19 atoms or greater, were devoid of tolerance and dependence led to the proposal that MDAN-21 targets heteromeric mu-delta-opioid receptors.  The present study focused on its effects in nonhuman primates (Macaca mulatta), a species with a physiology and behavioral repertoire not unlike humans.  With regard to opioids, this species usually better predicts clinical outcomes.  MDAN-21 substituted for morphine in morphine-dependent monkeys in the remarkably low dose range 0.006-0.032 mg/kg, subcutaneously.  Although MDAN-21 failed to produce reliable thermal analgesia in the dose range 0.0032-0.032 mg/kg, intramuscularly, it was active in the same dose range and by the same route of administration, in the capsaicin-induced thermal allodynia assay.  The results suggest that MDAN-21 may be useful in the treatment of opioid dependence and allodynia.  The data provide additional evidence that opioid withdrawal is associated with sensitized pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTOLp2jGEspD8K3uFsUIZtkfW6udTcc2eY_nMaqf1eTx7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MfitV2jtQ%253D%253D&md5=4ef855db6741aff9565944d70738e520</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1155%2F2012%2F327257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2012%252F327257%26sid%3Dliteratum%253Aachs%26aulast%3DAceto%26aufirst%3DM.%2BD.%26aulast%3DHarris%26aufirst%3DL.%2BS.%26aulast%3DNegus%26aufirst%3DS.%2BS.%26aulast%3DBanks%26aufirst%3DM.%2BL.%26aulast%3DHughes%26aufirst%3DL.%2BD.%26aulast%3DAkgun%26aufirst%3DE.%26aulast%3DPortoghese%26aufirst%3DP.%2BS.%26atitle%3DMDAN-21%253A%2520a%2520bivalent%2520opioid%2520ligand%2520containing%2520mu-agonist%2520and%2520delta-antagonist%2520pharmacophores%2520and%2520its%2520effects%2520in%2520rhesus%2520monkeys%26jtitle%3DInt.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D2012%26spage%3D327257%26doi%3D10.1155%2F2012%2F327257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Greedy, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradbury, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grivas, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cami-Kobeci, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Archambeau, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosse, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aceto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynor, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Husbands, S. M.</span></span> <span> </span><span class="NLM_article-title">Orvinols with mixed kappa/mu opioid receptor agonist activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3207</span>– <span class="NLM_lpage">3216</span>, <span class="refDoi"> DOI: 10.1021/jm301543e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301543e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtVWrtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3207-3216&author=B.+M.+Greedyauthor=F.+Bradburyauthor=M.+P.+Thomasauthor=K.+Grivasauthor=G.+Cami-Kobeciauthor=A.+Archambeauauthor=K.+Bosseauthor=M.+J.+Clarkauthor=M.+Acetoauthor=J.+W.+Lewisauthor=J.+R.+Traynorauthor=S.+M.+Husbands&title=Orvinols+with+mixed+kappa%2Fmu+opioid+receptor+agonist+activity&doi=10.1021%2Fjm301543e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Orvinols with Mixed Kappa/Mu Opioid Receptor Agonist Activity</span></div><div class="casAuthors">Greedy, Benjamin M.; Bradbury, Faye; Thomas, Mark P.; Grivas, Konstantinos; Cami-Kobeci, Gerta; Archambeau, Ashley; Bosse, Kelly; Clark, Mary J.; Aceto, Mario; Lewis, John W.; Traynor, John R.; Husbands, Stephen M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3207-3216</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Dual-acting kappa opioid receptor (KOR) agonist and mu opioid receptor (MOR) partial agonist ligands have been put forward as potential treatment agents for cocaine and other psychostimulant abuse.  Members of the orvinol series of ligands are known for their high binding affinity to both KOR and MOR, but efficacy at the individual receptors has not been thoroughly evaluated.  In this study, it is shown that a predictive model for efficacy at KOR can be derived, with efficacy being controlled by the length of the group attached to C20 and by the introduction of branching into the side chain.  In vivo evaluation of two ligands with the desired in vitro profile confirms both display KOR, and to a lesser extent MOR, activity in an analgesic assay suggesting that, in this series, in vitro measures of efficacy using the [35S]GTPγS assay are predictive of the in vivo profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJpdjCZTQt5bVg90H21EOLACvtfcHk0lh5OPw3xxMoOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtVWrtbo%253D&md5=d692909a8c772cfa79f3c9697a9c64d1</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm301543e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301543e%26sid%3Dliteratum%253Aachs%26aulast%3DGreedy%26aufirst%3DB.%2BM.%26aulast%3DBradbury%26aufirst%3DF.%26aulast%3DThomas%26aufirst%3DM.%2BP.%26aulast%3DGrivas%26aufirst%3DK.%26aulast%3DCami-Kobeci%26aufirst%3DG.%26aulast%3DArchambeau%26aufirst%3DA.%26aulast%3DBosse%26aufirst%3DK.%26aulast%3DClark%26aufirst%3DM.%2BJ.%26aulast%3DAceto%26aufirst%3DM.%26aulast%3DLewis%26aufirst%3DJ.%2BW.%26aulast%3DTraynor%26aufirst%3DJ.%2BR.%26aulast%3DHusbands%26aufirst%3DS.%2BM.%26atitle%3DOrvinols%2520with%2520mixed%2520kappa%252Fmu%2520opioid%2520receptor%2520agonist%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3207%26epage%3D3216%26doi%3D10.1021%2Fjm301543e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulkarni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhushan, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Portoghese, P. S.</span></span> <span> </span><span class="NLM_article-title">A bivalent ligand (KDAN-18) containing δ-antagonist and κ-agonist pharmacophores bridges δ2 and κ1 opioid receptor phenotypes†</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">1713</span>– <span class="NLM_lpage">1716</span>, <span class="refDoi"> DOI: 10.1021/jm034234f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm034234f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnsleis7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1713-1716&author=D.+J.+Danielsauthor=A.+Kulkarniauthor=Z.+Xieauthor=R.+G.+Bhushanauthor=P.+S.+Portoghese&title=A+bivalent+ligand+%28KDAN-18%29+containing+%CE%B4-antagonist+and+%CE%BA-agonist+pharmacophores+bridges+%CE%B42+and+%CE%BA1+opioid+receptor+phenotypes%E2%80%A0&doi=10.1021%2Fjm034234f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">A Bivalent Ligand (KDAN-18) Containing δ-Antagonist and κ-Agonist Pharmacophores Bridges δ2 and κ1 Opioid Receptor Phenotypes</span></div><div class="casAuthors">Daniels, David J.; Kulkarni, Amol; Xie, Zhihua; Bhushan, Rashmi G.; Portoghese, Philip S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1713-1716</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To characterize δ- and κ-opioid receptor phenotypes, bivalent ligands (KDAN series) contg. δ-antagonist (naltrindole) and κ1-agonist (ICI-199,441) pharmacophores were synthesized and evaluated by the intrathecal route using the mouse tail-flick assay and binding studies.  The data have suggested that KDAN-18 (2) bridges phenotypic δ2- and κ1-receptors.  A conceptual model is presented to explain the organizational differences between the opioid receptors that give rise to the phenotypes (δ1, δ2, κ1, κ2).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJUuIBhG8Hu7Vg90H21EOLACvtfcHk0lgSz4r9_fUqnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnsleis7c%253D&md5=c183f9b2bd1d7a13161d2e3b5b236611</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm034234f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm034234f%26sid%3Dliteratum%253Aachs%26aulast%3DDaniels%26aufirst%3DD.%2BJ.%26aulast%3DKulkarni%26aufirst%3DA.%26aulast%3DXie%26aufirst%3DZ.%26aulast%3DBhushan%26aufirst%3DR.%2BG.%26aulast%3DPortoghese%26aufirst%3DP.%2BS.%26atitle%3DA%2520bivalent%2520ligand%2520%2528KDAN-18%2529%2520containing%2520%25CE%25B4-antagonist%2520and%2520%25CE%25BA-agonist%2520pharmacophores%2520bridges%2520%25CE%25B42%2520and%2520%25CE%25BA1%2520opioid%2520receptor%2520phenotypes%25E2%2580%25A0%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1713%26epage%3D1716%26doi%3D10.1021%2Fjm034234f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Molinari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camarda, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzola, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvadori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzola, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molinari, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calò, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span> <span> </span><span class="NLM_article-title">[Dmt<sup>1</sup>]N/OFQ(1-13)-NH<sub>2</sub>: a potent nociceptin/orphanin FQ and opioid receptor universal agonist</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>168</i></span>,  <span class="NLM_fpage">151</span>– <span class="NLM_lpage">162</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.2012.02115.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1111%2Fj.1476-5381.2012.02115.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=22827708" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC3sXitFOktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2013&pages=151-162&author=S.+Molinariauthor=V.+Camardaauthor=A.+Rizziauthor=G.+Marzolaauthor=S.+Salvadoriauthor=E.+Marzolaauthor=P.+Molinariauthor=J.+McDonaldauthor=M.+Koauthor=D.+Lambertauthor=G.+Cal%C3%B2author=R.+Guerrini&title=%5BDmt1%5DN%2FOFQ%281-13%29-NH2%3A+a+potent+nociceptin%2Forphanin+FQ+and+opioid+receptor+universal+agonist&doi=10.1111%2Fj.1476-5381.2012.02115.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">[Dmt1]N/OFQ(1-13)-NH2: a potent nociceptin/orphanin FQ and opioid receptor universal agonist</span></div><div class="casAuthors">Molinari, S.; Camarda, V.; Rizzi, A.; Marzola, G.; Salvadori, S.; Marzola, E.; Molinari, P.; McDonald, J.; Ko, M. C.; Lambert, D. G.; Calo, G.; Guerrini, R.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">168</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">151-162</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose Intrathecally (i.t.) administered nociceptin/orphanin FQ (N/OFQ) evokes antinociceptive effects in rodents.  Recent studies in monkeys demonstrated that i.t. co-application of N/OFQ and morphine elicits synergistic antinociceptive actions suggesting mixed N/OFQ peptide (NOP) and μ opioid receptor agonists as innovative spinal analgesics.  Thus, novel N/OFQ related peptides were synthesized in order to identify and pharmacol. characterize a mixed NOP/ μ opioid receptor agonist.  Exptl. Approach The following in vitro assays were used: calcium mobilization in cells expressing the human NOP or classical opioid receptors and chimeric G proteins, receptor and [35S]-GTPγS binding, [35S]-GTPγS binding in rat spinal cord membranes, guinea pig ileum bioassay.  In vivo expts. were performed in monkeys using the tail withdrawal assay.  Key Results From calcium mobilization studies [Dmt1]N/OFQ(1-13)-NH2 was selected as the most potent and least selective compd.  The mixed NOP/opioid full agonist activity and high affinity of [Dmt1]N/OFQ(1-13)-NH2 was confirmed at human recombinant receptors in receptor binding, calcium mobilization and/or [35S]-GTPγS binding studies, at rat spinal cord receptors in [35S]-GTPγS binding expts., and at guinea pig receptors inhibiting neurogenic contractions in the ileum.  In vivo in the tail withdrawal assay in monkeys i.t. [Dmt1]N/OFQ(1-13)-NH2 was able to elicit robust and long-lasting antinociceptive effects.  Conclusions and Implications Collectively, these results demonstrate that [Dmt1]N/OFQ(1-13)-NH2 behaves as NOP/opioid receptor universal agonist and substantiate the suggestion that such mixed ligands are worthy of development as innovative spinal analgesics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqe2WHGVR0p2rVg90H21EOLACvtfcHk0lgSz4r9_fUqnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXitFOktg%253D%253D&md5=aa3e4fc89f2daf2c8a12a5bc95289118</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2012.02115.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2012.02115.x%26sid%3Dliteratum%253Aachs%26aulast%3DMolinari%26aufirst%3DS.%26aulast%3DCamarda%26aufirst%3DV.%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DMarzola%26aufirst%3DG.%26aulast%3DSalvadori%26aufirst%3DS.%26aulast%3DMarzola%26aufirst%3DE.%26aulast%3DMolinari%26aufirst%3DP.%26aulast%3DMcDonald%26aufirst%3DJ.%26aulast%3DKo%26aufirst%3DM.%26aulast%3DLambert%26aufirst%3DD.%26aulast%3DCal%25C3%25B2%26aufirst%3DG.%26aulast%3DGuerrini%26aufirst%3DR.%26atitle%3D%255BDmt1%255DN%252FOFQ%25281-13%2529-NH2%253A%2520a%2520potent%2520nociceptin%252Forphanin%2520FQ%2520and%2520opioid%2520receptor%2520universal%2520agonist%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D168%26spage%3D151%26epage%3D162%26doi%3D10.1111%2Fj.1476-5381.2012.02115.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzola, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapella, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelà, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molinari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerlesi, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malfacini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvadori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calò, G.</span></span> <span> </span><span class="NLM_article-title">A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">3703</span>– <span class="NLM_lpage">3712</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2014.05.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1016%2Fj.bmc.2014.05.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=24878361" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC2cXosl2isr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=3703-3712&author=R.+Guerriniauthor=E.+Marzolaauthor=C.+Trapellaauthor=M.+Pel%C3%A0author=S.+Molinariauthor=M.+C.+Cerlesiauthor=D.+Malfaciniauthor=A.+Rizziauthor=S.+Salvadoriauthor=G.+Cal%C3%B2&title=A+novel+and+facile+synthesis+of+tetra+branched+derivatives+of+nociceptin%2Forphanin+FQ&doi=10.1016%2Fj.bmc.2014.05.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ</span></div><div class="casAuthors">Guerrini, Remo; Marzola, Erika; Trapella, Claudio; Pela', Michela; Molinari, Stefano; Cerlesi, Maria Camilla; Malfacini, Davide; Rizzi, Anna; Salvadori, Severo; Calo', Girolamo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3703-3712</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Branched peptides have been found to be useful in several research fields however their synthesis and purifn. is complicated.  Here we present a novel and facile synthesis of tetra branched derivs. of nociceptin/orphanin FQ (N/OFQ).  Three N/OFQ tetra branched derivs. were prepd. using novel cores (PWT1, PWT2 and PWT3) contg. a maleimido moiety. [Cys18]N/OFQ-NH2 was linked to the cores via thiol-Michael reaction characterized by high yield and purity of the desired final product.  In the elec. stimulated mouse Vas deferens PWT-N/OFQ derivs. mimicked the inhibitory action of the natural sequence showing similar maximal effects and 3 fold higher potencies.  The NOP selective antagonist SB-612111 antagonized the effects of N/OFQ and PWT derivs. with similar pKB values (8.02-8.48).  In vivo after supraspinal administration PWT2-N/OFQ stimulated food intake in mice mimicking the action of N/OFQ.  Compared to the natural peptide PWT2-N/OFQ was 40 fold more potent and elicited larger effects.  These findings suggest that the PWT chem. strategy can be successfully applied to biol. active peptides to generate, with unprecedented high purity and yield, tetra branched derivs. displaying an in vitro pharmacol. profile similar to that of the natural sequence assocd., in vivo, to increased potency and effectiveness.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9fI1tT-vvlrVg90H21EOLACvtfcHk0lgSz4r9_fUqnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXosl2isr4%253D&md5=8c08302a2080aaa8754cf5bda60e7d4c</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.05.005%26sid%3Dliteratum%253Aachs%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DMarzola%26aufirst%3DE.%26aulast%3DTrapella%26aufirst%3DC.%26aulast%3DPel%25C3%25A0%26aufirst%3DM.%26aulast%3DMolinari%26aufirst%3DS.%26aulast%3DCerlesi%26aufirst%3DM.%2BC.%26aulast%3DMalfacini%26aufirst%3DD.%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DSalvadori%26aufirst%3DS.%26aulast%3DCal%25C3%25B2%26aufirst%3DG.%26atitle%3DA%2520novel%2520and%2520facile%2520synthesis%2520of%2520tetra%2520branched%2520derivatives%2520of%2520nociceptin%252Forphanin%2520FQ%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D3703%26epage%3D3712%26doi%3D10.1016%2Fj.bmc.2014.05.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cerlesi, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bird, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiguchi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malfacini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruzza, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calò, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span> <span> </span><span class="NLM_article-title">Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt<sup>1</sup>]N/OFQ(1-13)</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>794</i></span>,  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">126</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2016.11.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1016%2Fj.ejphar.2016.11.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=27871910" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFGgtLfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=794&publication_year=2017&pages=115-126&author=M.+C.+Cerlesiauthor=H.+Dingauthor=M.+F.+Birdauthor=N.+Kiguchiauthor=F.+Ferrariauthor=D.+Malfaciniauthor=A.+Rizziauthor=C.+Ruzzaauthor=D.+G.+Lambertauthor=M.+C.+Koauthor=G.+Cal%C3%B2author=R.+Guerrini&title=Pharmacological+studies+on+the+NOP+and+opioid+receptor+agonist+PWT2-%5BDmt1%5DN%2FOFQ%281-13%29&doi=10.1016%2Fj.ejphar.2016.11.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt1]N/OFQ(1-13)</span></div><div class="casAuthors">Cerlesi, Maria Camilla; Ding, Huiping; Bird, Mark F.; Kiguchi, Norikazu; Ferrari, Federica; Malfacini, Davide; Rizzi, Anna; Ruzza, Chiara; Lambert, David G.; Ko, Mei-Chuan; Calo, Girolamo; Guerrini, Remo</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">794</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">115-126</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">An innovative chem. strategy named peptide welding technol. (PWT) has been developed for the facile synthesis of tetrabranched peptides. [Dmt1]N/OFQ(1-13)-NH2 acts as a universal agonist for nociceptin/orphanin FQ (N/OFQ) and classical opioid receptors.  The present study investigated the pharmacol. profile of the PWT deriv. of [Dmt1]N/OFQ(1-13)NH2 (PWT2-[Dmt1]) in several assays in vitro and in vivo after spinal administration in monkeys subjected to the tail withdrawal assay.  PWT2-[Dmt1] mimicked the effects of [Dmt1]N/OFQ(1-13)-NH2 displaying full agonist activity, similar affinity/potency and selectivity at human recombinant N/OFQ (NOP) and opioid receptors in receptor binding, stimulation of [35S]GTPγS binding, calcium mobilization in cells expressing chimeric G proteins, and BRET studies for measuring receptor/G-protein and receptor/β-arrestin 2 interaction.  In vivo in monkeys PWT2-[Dmt1] elicited dose-dependent and robust antinociceptive effects being more potent and longer lasting than [Dmt1]N/OFQ(1-13)-NH2.  The analgesic action of PWT2-[Dmt1] was sensitive to the NOP receptor antagonist J-113397, but not naltrexone.  Thus, the present study demonstrated that the tetrabranched deriv. of [Dmt1]N/OFQ(1-13)-NH2 obtained with the PWT technol. maintains the in vitro pharmacol. profile of the parent peptide but displays higher potency and longer lasting action in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaU2tLfW3W0LVg90H21EOLACvtfcHk0lgFlPDOo39JrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFGgtLfI&md5=972be07440d904aa7463e15506271d23</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2016.11.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2016.11.026%26sid%3Dliteratum%253Aachs%26aulast%3DCerlesi%26aufirst%3DM.%2BC.%26aulast%3DDing%26aufirst%3DH.%26aulast%3DBird%26aufirst%3DM.%2BF.%26aulast%3DKiguchi%26aufirst%3DN.%26aulast%3DFerrari%26aufirst%3DF.%26aulast%3DMalfacini%26aufirst%3DD.%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DRuzza%26aufirst%3DC.%26aulast%3DLambert%26aufirst%3DD.%2BG.%26aulast%3DKo%26aufirst%3DM.%2BC.%26aulast%3DCal%25C3%25B2%26aufirst%3DG.%26aulast%3DGuerrini%26aufirst%3DR.%26atitle%3DPharmacological%2520studies%2520on%2520the%2520NOP%2520and%2520opioid%2520receptor%2520agonist%2520PWT2-%255BDmt1%255DN%252FOFQ%25281-13%2529%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2017%26volume%3D794%26spage%3D115%26epage%3D126%26doi%3D10.1016%2Fj.ejphar.2016.11.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pacifico, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albanese, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Illuminati, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fantinati, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzola, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neto, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturaro, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruzza, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calò̀, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span> <span> </span><span class="NLM_article-title">Tetrabranched hetero-conjugated peptides as bifunctional agonists of the NOP and mu opioid receptors</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">2444</span>– <span class="NLM_lpage">2451</span>, <span class="refDoi"> DOI: 10.1021/acs.bioconjchem.9b00519</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.bioconjchem.9b00519" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhs1KksL3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2019&pages=2444-2451&author=S.+Pacificoauthor=V.+Albaneseauthor=D.+Illuminatiauthor=A.+Fantinatiauthor=E.+Marzolaauthor=F.+Ferrariauthor=J.+A.+Netoauthor=C.+Sturaroauthor=C.+Ruzzaauthor=G.+Cal%C3%B2%CC%80author=D.+Pretiauthor=R.+Guerrini&title=Tetrabranched+hetero-conjugated+peptides+as+bifunctional+agonists+of+the+NOP+and+mu+opioid+receptors&doi=10.1021%2Facs.bioconjchem.9b00519"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Tetrabranched Hetero-Conjugated Peptides as Bifunctional Agonists of the NOP and Mu Opioid Receptors</span></div><div class="casAuthors">Pacifico, Salvatore; Albanese, Valentina; Illuminati, Davide; Fantinati, Anna; Marzola, Erika; Ferrari, Federica; Neto, Joaquim Azevedo; Sturaro, Chiara; Ruzza, Chiara; Calo, Girolamo; Preti, Delia; Guerrini, Remo</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2444-2451</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The general aim of the work was the validation of a new synthetic methodol. designed for obtaining bifunctional heterotetrabranched peptide ligands.  Applying an easily accessible synthetic route, we provided a small series of heteromultimeric peptide conjugates targeting the nociceptin/orphanin FQ (N/OFQ) peptide receptors (NOP) and mu opioid receptors.  Among these, H-PWT1-N/OFQ-[Dmt1]dermorphin demonstrated a similar and high agonist potency at the NOP and mu receptors.  The achieved results confirmed the robustness of the approach that is extremely versatile and virtually applicable to different peptide sequences whose pharmacol. activity can be combined for generating dual acting multimeric compds.  These innovative pharmacol. tools will be extremely helpful for investigating the consequences of the simultaneous activation and/or blockage of different peptidergic receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom00_e11aupbVg90H21EOLACvtfcHk0lgFlPDOo39JrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhs1KksL3K&md5=643c7bb57212e5eed8193d852eb444fd</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Facs.bioconjchem.9b00519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.bioconjchem.9b00519%26sid%3Dliteratum%253Aachs%26aulast%3DPacifico%26aufirst%3DS.%26aulast%3DAlbanese%26aufirst%3DV.%26aulast%3DIlluminati%26aufirst%3DD.%26aulast%3DFantinati%26aufirst%3DA.%26aulast%3DMarzola%26aufirst%3DE.%26aulast%3DFerrari%26aufirst%3DF.%26aulast%3DNeto%26aufirst%3DJ.%2BA.%26aulast%3DSturaro%26aufirst%3DC.%26aulast%3DRuzza%26aufirst%3DC.%26aulast%3DCal%25C3%25B2%25CC%2580%26aufirst%3DG.%26aulast%3DPreti%26aufirst%3DD.%26aulast%3DGuerrini%26aufirst%3DR.%26atitle%3DTetrabranched%2520hetero-conjugated%2520peptides%2520as%2520bifunctional%2520agonists%2520of%2520the%2520NOP%2520and%2520mu%2520opioid%2520receptors%26jtitle%3DBioconjugate%2520Chem.%26date%3D2019%26volume%3D30%26spage%3D2444%26epage%3D2451%26doi%3D10.1021%2Facs.bioconjchem.9b00519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bird, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerlesi, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malfacini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vezzi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molinari, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Micheli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mannelli, L. D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghelardini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calò, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, D. G.</span></span> <span> </span><span class="NLM_article-title">Characterisation of the novel mixed mu-NOP peptide ligand dermorphin-N/OFQ (DeNo)</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>, <span class="NLM_elocation-id">e0156897</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0156897</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1371%2Fjournal.pone.0156897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=27272042" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslCqu7nI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&author=M.+F.+Birdauthor=M.+C.+Cerlesiauthor=M.+Brownauthor=D.+Malfaciniauthor=V.+Vezziauthor=P.+Molinariauthor=L.+Micheliauthor=L.+D.+C.+Mannelliauthor=C.+Ghelardiniauthor=R.+Guerriniauthor=G.+Cal%C3%B2author=D.+G.+Lambert&title=Characterisation+of+the+novel+mixed+mu-NOP+peptide+ligand+dermorphin-N%2FOFQ+%28DeNo%29&doi=10.1371%2Fjournal.pone.0156897"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Characterisation of the novel mixed mu-NOP peptide ligand dermorphin-N/OFQ (DeNo)</span></div><div class="casAuthors">Bird, Mark F.; Cerlesi, Maria Camilla; Brown, Mark; Malfacini, Davide; Vezzi, Vanessa; Molinari, Paola; Micheli, Laura; Mannelli, Lorenzo Di Cesare; Ghelardini, Carla; Guerrini, Remo; Calo, Girolamo; Lambert, David G.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e0156897/1-e0156897/22</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Introduction Opioid receptors are currently classified as Mu (μ), Delta (δ), Kappa (κ) plus the opioid related nociceptin/orphanin FQ (N/OFQ) peptide receptor (NOP).  Despite compelling evidence for interactions and benefits of targeting more than one receptor type in producing analgesia, clin. ligands are Mu agonists.  In this study we have designed a Mu-NOP agonist named DeNo.  The Mu agonist component is provided by dermorphin, a peptide isolated from the skin of Phyllomedusa frogs and the NOP component by the endogenous agonist N/OFQ.  Methods We have assessed receptor binding profile of DeNo and compared with dermorphin and N/ OFQ.  In a series of functional screens we have assessed the ability to (i) increase Ca2+ in cells coexpressing recombinant receptors and a the chimeric protein Gαqi5, (ii) stimulate the binding of GTPγ[35S], (iii) inhibit cAMP formation, (iv) activate MAPKinase, (v) stimulate receptor-G protein and arrestin interaction using BRET, (vi) elec. stimulated guinea pig ileum (gpI) assay and (vii) ability to produce analgesia via the intrathecal route in rats.  Results DeNo bound to Mu (pKi; 9.55) and NOP (pKi; 10.22) and with reasonable selectivity.  This translated to increased Ca2+ in Gαqi5 expressing cells (pEC50 Mu 7.17; NOP 9.69), increased binding of GTPγ[35S] (pEC50 Mu 7.70; NOP 9.50) and receptor-G protein interaction in BRET (pEC50 Mu 8.01; NOP 9.02). cAMP formation was inhibited and arrestin was activated (pEC50 Mu 6.36; NOP 8.19).  For MAPK DeNo activated p38 and ERK1/2 at Mu but only ERK1/2 at NOP.  In the gpI DeNO inhibited elec.-evoked contractions (pEC50 8.63) that was sensitive to both Mu and NOP antagonists.  DeNo was antinociceptive in rats.  Conclusion Collectively these data validate the strategy used to create a novel bivalent Mu-NOP peptide agonist by combining dermorphin (Mu) and N/OFQ (NOP).  This mol. behaves essentially as the parent compds. in vitro.  In the antonocicoeptive assays employed in this study DeNo displays only weak antinociceptive properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGf0rqpcJ8OrVg90H21EOLACvtfcHk0lgFlPDOo39JrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslCqu7nI&md5=5e929f3870f21dc463ccc60417dc59bd</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0156897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0156897%26sid%3Dliteratum%253Aachs%26aulast%3DBird%26aufirst%3DM.%2BF.%26aulast%3DCerlesi%26aufirst%3DM.%2BC.%26aulast%3DBrown%26aufirst%3DM.%26aulast%3DMalfacini%26aufirst%3DD.%26aulast%3DVezzi%26aufirst%3DV.%26aulast%3DMolinari%26aufirst%3DP.%26aulast%3DMicheli%26aufirst%3DL.%26aulast%3DMannelli%26aufirst%3DL.%2BD.%2BC.%26aulast%3DGhelardini%26aufirst%3DC.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DCal%25C3%25B2%26aufirst%3DG.%26aulast%3DLambert%26aufirst%3DD.%2BG.%26atitle%3DCharacterisation%2520of%2520the%2520novel%2520mixed%2520mu-NOP%2520peptide%2520ligand%2520dermorphin-N%252FOFQ%2520%2528DeNo%2529%26jtitle%3DPLoS%2520One%26date%3D2016%26volume%3D11%26doi%3D10.1371%2Fjournal.pone.0156897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lapalu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moisand, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazarguil, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cambois, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollereau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meunier, J.-C.</span></span> <span> </span><span class="NLM_article-title">Comparison of the structure-activity relationships of nociceptin and dynorphin A using chimeric peptides</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>417</i></span>,  <span class="NLM_fpage">333</span>– <span class="NLM_lpage">336</span>, <span class="refDoi"> DOI: 10.1016/s0014-5793(97)01318-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1016%2FS0014-5793%2897%2901318-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=9409745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADyaK2sXnt1ektb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=417&publication_year=1997&pages=333-336&author=S.+Lapaluauthor=C.+Moisandauthor=H.+Mazarguilauthor=G.+Camboisauthor=C.+Mollereauauthor=J.-C.+Meunier&title=Comparison+of+the+structure-activity+relationships+of+nociceptin+and+dynorphin+A+using+chimeric+peptides&doi=10.1016%2Fs0014-5793%2897%2901318-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of the structure-activity relationships of nociceptin and dynorphin A using chimeric peptides</span></div><div class="casAuthors">Lapalu, Sophie; Moisand, Christiane; Mazarguil, Honore; Cambois, Gilles; Mollereau, Catherine; Meunier, Jean-Claude</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">417</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">333-336</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The aim of the present study was to delineate the functional domains of nociceptin (noc), a neuropeptide which is structurally related to dynorphin A (dyn).  The binding and biol. potencies toward the nociceptin (ORL1) and dynorphin A (κ-opioid) receptors of twenty dyn/noc and noc/dyn hybrid peptides were compared with those of the parent heptadecapeptides.  Replacement of as many as eleven residues in the C-terminus of dynorphin by the corresponding nociceptin sequence has no significant effect on binding and biol. activity toward the κ-opioid receptor.  In marked contrast, replacement of as few as six residues (RKLANQ) in the C-terminus of nociceptin by the corresponding dynorphin sequence (LKWDNQ) dramatically impairs both affinity and activity toward the ORL1 receptor.  This clearly indicates that the two neuropeptides have different functional architectures, despite the dual structural homol. of both ligands and receptors.  Moreover, the recombinant peptide approach led us to identify hybrids whose sequences differ only at positions 5 and 6 and displaying opposite or no receptor selectivity.  One contains the dynorphin Leu5-Arg6 sequence and prefers the κ-opioid receptor, whereas the other comprises the nociceptin Thr5-Gly6 sequence and prefers the ORL1 receptor.  A third, contg. the mixed dynorphin/nociceptin Leu5-Gly6 sequence, does not discriminate between the two types of receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7aeXEaknJZrVg90H21EOLACvtfcHk0ljwk1j8T3cbbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXnt1ektb0%253D&md5=7e5ccbdfcaf3b803188e62a10c9a3a66</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2897%2901318-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252897%252901318-5%26sid%3Dliteratum%253Aachs%26aulast%3DLapalu%26aufirst%3DS.%26aulast%3DMoisand%26aufirst%3DC.%26aulast%3DMazarguil%26aufirst%3DH.%26aulast%3DCambois%26aufirst%3DG.%26aulast%3DMollereau%26aufirst%3DC.%26aulast%3DMeunier%26aufirst%3DJ.-C.%26atitle%3DComparison%2520of%2520the%2520structure-activity%2520relationships%2520of%2520nociceptin%2520and%2520dynorphin%2520A%2520using%2520chimeric%2520peptides%26jtitle%3DFEBS%2520Lett.%26date%3D1997%26volume%3D417%26spage%3D333%26epage%3D336%26doi%3D10.1016%2Fs0014-5793%2897%2901318-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzola, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapella, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pacifico, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerlesi, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malfacini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bird, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvadori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calò, G.</span></span> <span> </span><span class="NLM_article-title">Structure activity studies of nociceptin/orphanin FQ(1-13)-NH<sub>2</sub> derivatives modified in position 5</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1515</span>– <span class="NLM_lpage">1520</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.02.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1016%2Fj.bmc.2015.02.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=25716007" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisl2rtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=1515-1520&author=R.+Guerriniauthor=E.+Marzolaauthor=C.+Trapellaauthor=S.+Pacificoauthor=M.+C.+Cerlesiauthor=D.+Malfaciniauthor=F.+Ferrariauthor=M.+F.+Birdauthor=D.+G.+Lambertauthor=S.+Salvadoriauthor=G.+Cal%C3%B2&title=Structure+activity+studies+of+nociceptin%2Forphanin+FQ%281-13%29-NH2+derivatives+modified+in+position+5&doi=10.1016%2Fj.bmc.2015.02.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Structure activity studies of nociceptin/orphanin FQ(1-13)-NH2 derivatives modified in position 5</span></div><div class="casAuthors">Guerrini, Remo; Marzola, Erika; Trapella, Claudio; Pacifico, Salvatore; Cerlesi, Maria Camilla; Malfacini, Davide; Ferrari, Federica; Bird, Mark Francis; Lambert, David George; Salvadori, Severo; Calo, Girolamo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1515-1520</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Nociceptin/orphanin FQ (N/OFQ) is a heptadecapeptide acting as the endogenous ligand of the N/OFQ peptide receptor (NOP).  N/OFQ(1-13)-NH2 is the shortest N/OFQ sequence maintaining the same potency and efficacy as the natural peptide.  Thus N/OFQ(1-13)-NH2 was used as chem. template for investigating the structure activity relationship of threonine in position 5.  Twenty-eight [X5]N/OFQ(1-13)-NH2 derivs., in which Thr was substituted with natural and unnatural residues, were synthesized and characterized pharmacol. for their effects at the human NOP receptor.  Two different functional assays were used: agonist stimulated [35S]GTPγS binding in cell membranes and calcium mobilization in whole cells co-expressing chimeric G proteins.  All [X5]N/OFQ(1-13)-NH2 derivs. behaved as full NOP agonists showing large differences in their potency.  There was an excellent correlation between the results obtained in the two assays.  The results of this study suggest that: position 5 does not play a pivotal role in receptor activation; the secondary alc. function of Thr is not important for receptor binding; side chain size, lipo/hydrophilic balance as well as hydrogen bond capability are also not crucial for receptor binding; an aliph. amino function pos. charged with at least 3 carbon atom distance from the peptide backbone has a huge disrupting effect on receptor binding.  In conclusion this study demonstrates that a simple Et side chain as in compd. 23 is sufficient in N/OFQ position 5 for maintaining bioactivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBJ-IiFKEdwLVg90H21EOLACvtfcHk0ljwk1j8T3cbbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisl2rtbc%253D&md5=edacd9f075fa7ba81bd3d8c1775c248b</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.02.008%26sid%3Dliteratum%253Aachs%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DMarzola%26aufirst%3DE.%26aulast%3DTrapella%26aufirst%3DC.%26aulast%3DPacifico%26aufirst%3DS.%26aulast%3DCerlesi%26aufirst%3DM.%2BC.%26aulast%3DMalfacini%26aufirst%3DD.%26aulast%3DFerrari%26aufirst%3DF.%26aulast%3DBird%26aufirst%3DM.%2BF.%26aulast%3DLambert%26aufirst%3DD.%2BG.%26aulast%3DSalvadori%26aufirst%3DS.%26aulast%3DCal%25C3%25B2%26aufirst%3DG.%26atitle%3DStructure%2520activity%2520studies%2520of%2520nociceptin%252Forphanin%2520FQ%25281-13%2529-NH2%2520derivatives%2520modified%2520in%2520position%25205%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D1515%26epage%3D1520%26doi%3D10.1016%2Fj.bmc.2015.02.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Varani, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calò, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigoni, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toth, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gessi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvadori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borea, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regoli, D.</span></span> <span> </span><span class="NLM_article-title">Pharmacology of [Tyr<sup>1</sup>]nociceptin analogs: receptor binding and bioassay studies</span>. <i>Naunyn-Schmiedeberg’s Arch. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>360</i></span>,  <span class="NLM_fpage">270</span>– <span class="NLM_lpage">277</span>, <span class="refDoi"> DOI: 10.1007/s002109900074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1007%2Fs002109900074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10543428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADyaK1MXnsV2ntb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=360&publication_year=1999&pages=270-277&author=K.+Varaniauthor=A.+Rizziauthor=G.+Cal%C3%B2author=R.+Bigoniauthor=G.+Tothauthor=R.+Guerriniauthor=S.+Gessiauthor=S.+Salvadoriauthor=P.+A.+Boreaauthor=D.+Regoli&title=Pharmacology+of+%5BTyr1%5Dnociceptin+analogs%3A+receptor+binding+and+bioassay+studies&doi=10.1007%2Fs002109900074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacology of [Tyr1]nociceptin analogs: receptor binding and bioassay studies</span></div><div class="casAuthors">Varani, Katia; Rizzi, Anna; Calo, Girolamo; Bigoni, Raffaella; Toth, Geza; Guerrini, Remo; Gessi, Stefania; Salvadori, Severo; Borea, Pier Andrea; Regoli, Domenico</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">360</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">270-277</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Two series of nociceptin (NC)-related peptides with or without replacement of the N-terminal Phe by Tyr have been investigated in an attempt to obtain compds. that interact with the NC receptor (ORL1) and classic opioid receptors.  When tested for their ability to displace [3H]NCNH2 ([3H]nociceptin amide; ORL1 sites) or the selective opioid receptor ligands [3H]DAMGO (μ), [3H]deltorphin II (δ) and [3H]U69593 (κ) from their resp. binding sites in guinea pig brain membranes, [Tyr1]NCNH2 and [Tyr1]NC(1-13)NH2 showed high affinities (Ki 2 nM and 5 nM, resp.) for ORL1 and approx. tenfold lower potency for μ (32 nM and 44 nM) and κ sites (42 nM and 48 nM).  They also interacted, but with low potency (Ki 410 nM and 310 nM) with δ sites.  Shorter fragments as [Tyr1]NC(1-9)NH2 and [Tyr1]NC(1-5)NH2 were found to be inactive on ORL1, δ and κ sites, and extremely weak (Ki 2224 nM and 4228 nM, resp.) on μ.  Results of bioassays performed on the guinea pig ileum (ORL1 and μ receptors), mouse vas deferens (ORL1 and δ receptors), and rabbit vas deferens (κ receptor) confirmed (at least partially) the data of the binding by showing that [Tyr1]NC analogs interact with functional ORL1 as well as with classic opioid receptors.  [Tyr1]NCNH2 and [Tyr1]NC(1-13)NH2 behaved as mixed ORL1/opioid receptor agonists showing similar affinities as the control NC sequence while [Tyr1]NC(1-9)NH2 and [Tyr1]NC(1-5)NH2 were inactive on ORL1 receptors but maintained some activities on opioid receptors: their effects were prevented by naloxone.  The results of this study indicate that the replacement of Phe1 by Tyr in NC leads to compds. which bind both the ORL1 and μ/κ receptors and may represent new promising agents for use in peripheral organs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqS2JJlWqGylbVg90H21EOLACvtfcHk0ljwk1j8T3cbbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnsV2ntb0%253D&md5=73adde175a9251ebf2daa4fc32231165</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1007%2Fs002109900074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002109900074%26sid%3Dliteratum%253Aachs%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DCal%25C3%25B2%26aufirst%3DG.%26aulast%3DBigoni%26aufirst%3DR.%26aulast%3DToth%26aufirst%3DG.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DSalvadori%26aufirst%3DS.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26aulast%3DRegoli%26aufirst%3DD.%26atitle%3DPharmacology%2520of%2520%255BTyr1%255Dnociceptin%2520analogs%253A%2520receptor%2520binding%2520and%2520bioassay%2520studies%26jtitle%3DNaunyn-Schmiedeberg%25E2%2580%2599s%2520Arch.%2520Pharmacol.%26date%3D1999%26volume%3D360%26spage%3D270%26epage%3D277%26doi%3D10.1007%2Fs002109900074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Largent-Milnes, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, S.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamura, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanderah, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porreca, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hruby, V. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent and efficacious peptide derivative for δ/μ opioid agonist/Neurokinin 1 antagonist activity with a 2′,6′-dimethyl-l-tyrosine: In vitro, In vivo, and NMR-Based Structural Studies</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">2029</span>– <span class="NLM_lpage">2038</span>, <span class="refDoi"> DOI: 10.1021/jm101023r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101023r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC3MXislagsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2029-2038&author=T.+Yamamotoauthor=P.+Nairauthor=T.+M.+Largent-Milnesauthor=N.+E.+Jacobsenauthor=P.+Davisauthor=S.-W.+Maauthor=H.+I.+Yamamuraauthor=T.+W.+Vanderahauthor=F.+Porrecaauthor=J.+Laiauthor=V.+J.+Hruby&title=Discovery+of+a+potent+and+efficacious+peptide+derivative+for+%CE%B4%2F%CE%BC+opioid+agonist%2FNeurokinin+1+antagonist+activity+with+a+2%E2%80%B2%2C6%E2%80%B2-dimethyl-l-tyrosine%3A+In+vitro%2C+In+vivo%2C+and+NMR-Based+Structural+Studies&doi=10.1021%2Fjm101023r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent and Efficacious Peptide Derivative for δ/μ Opioid Agonist/Neurokinin 1 Antagonist Activity with a 2',6'-Dimethyl-l-Tyrosine: in Vitro, in Vivo, and NMR-Based Structural Studies</span></div><div class="casAuthors">Yamamoto, Takashi; Nair, Padma; Largent-Milnes, Tally M.; Jacobsen, Neil E.; Davis, Peg; Ma, Shou-Wu; Yamamura, Henry I.; Vanderah, Todd W.; Porreca, Frank; Lai, Josephine; Hruby, Victor J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2029-2038</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Multivalent ligands with δ/μ opioid agonist and NK1 antagonist activities have shown promising analgesic potency without detectable sign of toxicities, including motor skill impairment and opioid-induced tolerance.  To improve their biol. activities and metabolic stability, structural optimization was performed on our peptide-derived lead compds. by introducing 2',6'-dimethyl-L-tyrosine (Dmt) instead of Tyr at the first position.  The compd. 7 (Dmt-D-Ala-Gly-Phe-Met-Pro-Leu-Trp-NH-[3',5'-(CF3)2-Bzl]) showed improved multivalent bioactivities compared to those of the lead compds., had more than 6 h half-life in rat plasma, and had significant antinociceptive efficacy in vivo.  The NMR structural anal. suggested that Dmt1 incorporation in compd. 7 induces the structured conformation in the opioid pharmacophore (N-terminus) and simultaneously shifts the orientation of the NK1 pharmacophore (C-terminus), consistent with its affinities and activities at both opioid and NK1 receptors.  These results indicate that compd. 7 is a valuable research tool to seek a novel analgesic drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokq79EaGReG7Vg90H21EOLACvtfcHk0lhE-ClZlR7-fQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXislagsLw%253D&md5=859f657192b27730c9f5afbbfcc1e5b8</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm101023r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101023r%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DNair%26aufirst%3DP.%26aulast%3DLargent-Milnes%26aufirst%3DT.%2BM.%26aulast%3DJacobsen%26aufirst%3DN.%2BE.%26aulast%3DDavis%26aufirst%3DP.%26aulast%3DMa%26aufirst%3DS.-W.%26aulast%3DYamamura%26aufirst%3DH.%2BI.%26aulast%3DVanderah%26aufirst%3DT.%2BW.%26aulast%3DPorreca%26aufirst%3DF.%26aulast%3DLai%26aufirst%3DJ.%26aulast%3DHruby%26aufirst%3DV.%2BJ.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520and%2520efficacious%2520peptide%2520derivative%2520for%2520%25CE%25B4%252F%25CE%25BC%2520opioid%2520agonist%252FNeurokinin%25201%2520antagonist%2520activity%2520with%2520a%25202%25E2%2580%25B2%252C6%25E2%2580%25B2-dimethyl-l-tyrosine%253A%2520In%2520vitro%252C%2520In%2520vivo%252C%2520and%2520NMR-Based%2520Structural%2520Studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2029%26epage%3D2038%26doi%3D10.1021%2Fjm101023r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giri, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Apostol, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forte, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Largent-Milnes, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rankin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molnar, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porreca, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanderah, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hruby, V. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel multifunctional ligands with μ/δ opioid agonist/Neurokinin-1 (NK1) antagonist activities for the treatment of pain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">8573</span>– <span class="NLM_lpage">8583</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01170</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01170" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1CqsbrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8573-8583&author=A.+K.+Giriauthor=C.+R.+Apostolauthor=Y.+Wangauthor=B.+L.+Forteauthor=T.+M.+Largent-Milnesauthor=P.+Davisauthor=D.+Rankinauthor=G.+Molnarauthor=K.+M.+Olsonauthor=F.+Porrecaauthor=T.+W.+Vanderahauthor=V.+J.+Hruby&title=Discovery+of+novel+multifunctional+ligands+with+%CE%BC%2F%CE%B4+opioid+agonist%2FNeurokinin-1+%28NK1%29+antagonist+activities+for+the+treatment+of+pain&doi=10.1021%2Facs.jmedchem.5b01170"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel Multifunctional Ligands with μ/δ Opioid Agonist/Neurokinin-1 (NK1) Antagonist Activities for the Treatment of Pain</span></div><div class="casAuthors">Giri, Aswini Kumar; Apostol, Christopher R.; Wang, Yue; Forte, Brittany L.; Largent-Milnes, Tally M.; Davis, Peg; Rankin, David; Molnar, Gabriella; Olson, Keith M.; Porreca, Frank; Vanderah, Todd W.; Hruby, Victor J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8573-8583</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Multifunctional ligands with agonist bioactivities at μ/δ opioid receptors (MOR/DOR) and antagonist bioactivity at the neurokinin-1 receptor (NK1R) have been designed and synthesized.  These peptide-based ligands are anticipated to produce better biol. profiles (e.g., higher analgesic effect with significantly less adverse side effects) compared to those of existing drugs and to deliver better synergistic effects than coadministration of a mixt. of multiple drugs.  A systematic structure-activity relationship (SAR) study has been conducted to find multifunctional ligands with desired activities at three receptors.  It has been found that introduction of Dmt (2,6-dimethyl-tyrosine) at the first position and NMePhe at the fourth position (ligand 3: H-Dmt-D-Ala-Gly-NMePhe-Pro-Leu-Trp-NH-Bn(3',5'-(CF3)2)) displays binding as well as functional selectivity for MOR over DOR while maintaining efficacy, potency, and antagonist activity at the NK1R.  Dmt at the first position with Phe(4-F) at the fourth position (ligand 5: H-Dmt-D-Ala-Gly-Phe(4-F)-Pro-Leu-Trp-NH-Bn(3',5'-(CF3)2)) exhibits balanced binding affinities at MOR and DOR though it has higher agonist activity at DOR over MOR.  This study has led to the discovery of several novel ligands including 3 and 5 with excellent in vitro biol. activity profiles.  Metabolic stability studies in rat plasma with ligands 3, 5, and 7 (H-Tyr-D-Ala-Gly-Phe(4-F)-Pro-Leu-Trp-NH-Bn(3',5'-(CF3)2)) showed that their stability depends on modifications at the first and fourth positions (3: T1/2 > 24 h; 5: T1/2 ≈ 6 h; 7: T1/2 > 2 h).  Preliminary in vivo studies with these two ligands have shown promising antinociceptive activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLOBSLCv97ObVg90H21EOLACvtfcHk0lhE-ClZlR7-fQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1CqsbrK&md5=ab779c641a0d0d4048f064f3f74bdb57</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01170%26sid%3Dliteratum%253Aachs%26aulast%3DGiri%26aufirst%3DA.%2BK.%26aulast%3DApostol%26aufirst%3DC.%2BR.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DForte%26aufirst%3DB.%2BL.%26aulast%3DLargent-Milnes%26aufirst%3DT.%2BM.%26aulast%3DDavis%26aufirst%3DP.%26aulast%3DRankin%26aufirst%3DD.%26aulast%3DMolnar%26aufirst%3DG.%26aulast%3DOlson%26aufirst%3DK.%2BM.%26aulast%3DPorreca%26aufirst%3DF.%26aulast%3DVanderah%26aufirst%3DT.%2BW.%26aulast%3DHruby%26aufirst%3DV.%2BJ.%26atitle%3DDiscovery%2520of%2520novel%2520multifunctional%2520ligands%2520with%2520%25CE%25BC%252F%25CE%25B4%2520opioid%2520agonist%252FNeurokinin-1%2520%2528NK1%2529%2520antagonist%2520activities%2520for%2520the%2520treatment%2520of%2520pain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8573%26epage%3D8583%26doi%3D10.1021%2Facs.jmedchem.5b01170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manglik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatakrishnan, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laeremans, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feinberg, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanborn, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livingston, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorsen, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kling, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Granier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Husbands, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynor, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weis, W. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steyaert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dror, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, B. K.</span></span> <span> </span><span class="NLM_article-title">Structural insights into μ-opioid receptor activation</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>524</i></span>,  <span class="NLM_fpage">315</span>– <span class="NLM_lpage">321</span>, <span class="refDoi"> DOI: 10.1038/nature14886</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1038%2Fnature14886" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=26245379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht12jtbzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=524&publication_year=2015&pages=315-321&author=W.+Huangauthor=A.+Manglikauthor=A.+J.+Venkatakrishnanauthor=T.+Laeremansauthor=E.+N.+Feinbergauthor=A.+L.+Sanbornauthor=H.+E.+Katoauthor=K.+E.+Livingstonauthor=T.+S.+Thorsenauthor=R.+C.+Klingauthor=S.+Granierauthor=P.+Gmeinerauthor=S.+M.+Husbandsauthor=J.+R.+Traynorauthor=W.+I.+Weisauthor=J.+Steyaertauthor=R.+O.+Drorauthor=B.+K.+Kobilka&title=Structural+insights+into+%CE%BC-opioid+receptor+activation&doi=10.1038%2Fnature14886"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insights into μ-opioid receptor activation</span></div><div class="casAuthors">Huang, Weijiao; Manglik, Aashish; Venkatakrishnan, A. J.; Laeremans, Toon; Feinberg, Evan N.; Sanborn, Adrian L.; Kato, Hideaki E.; Livingston, Kathryn E.; Thorsen, Thor S.; Kling, Ralf C.; Granier, Sebastien; Gmeiner, Peter; Husbands, Stephen M.; Traynor, John R.; Weis, William I.; Steyaert, Jan; Dror, Ron O.; Kobilka, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">524</span>
        (<span class="NLM_cas:issue">7565</span>),
    <span class="NLM_cas:pages">315-321</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Activation of the μ-opioid receptor (μOR) is responsible for the efficacy of the most effective analgesics.  To shed light on the structural basis for μOR activation, here we report a 2.1 Å X-ray crystal structure of the murine μOR bound to the morphinan agonist BU72 and a G protein mimetic camelid antibody fragment Nb39 (nanobody 39).  The BU72-stabilized changes in the μOR binding pocket are subtle and differ from those obsd. for agonist-bound structures of the β2-adrenergic receptor (β2AR) and the M2 muscarinic receptor (M2R).  Comparison with active β2AR reveals a common rearrangement in the packing of three conserved amino acids in the core of the μOR, and mol. dynamics simulations illustrate how the ligand-binding pocket is conformationally linked to this conserved triad.  Addnl., an extensive polar network between the ligand-binding pocket and the cytoplasmic domains appears to play a similar role in signal propagation for all three G-protein-coupled receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkFUN1wheV07Vg90H21EOLACvtfcHk0lhE-ClZlR7-fQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht12jtbzM&md5=b9af3e1351b04539379532c127c02651</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fnature14886&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14886%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DManglik%26aufirst%3DA.%26aulast%3DVenkatakrishnan%26aufirst%3DA.%2BJ.%26aulast%3DLaeremans%26aufirst%3DT.%26aulast%3DFeinberg%26aufirst%3DE.%2BN.%26aulast%3DSanborn%26aufirst%3DA.%2BL.%26aulast%3DKato%26aufirst%3DH.%2BE.%26aulast%3DLivingston%26aufirst%3DK.%2BE.%26aulast%3DThorsen%26aufirst%3DT.%2BS.%26aulast%3DKling%26aufirst%3DR.%2BC.%26aulast%3DGranier%26aufirst%3DS.%26aulast%3DGmeiner%26aufirst%3DP.%26aulast%3DHusbands%26aufirst%3DS.%2BM.%26aulast%3DTraynor%26aufirst%3DJ.%2BR.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26aulast%3DSteyaert%26aufirst%3DJ.%26aulast%3DDror%26aufirst%3DR.%2BO.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26atitle%3DStructural%2520insights%2520into%2520%25CE%25BC-opioid%2520receptor%2520activation%26jtitle%3DNature%26date%3D2015%26volume%3D524%26spage%3D315%26epage%3D321%26doi%3D10.1038%2Fnature14886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koehl, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paggi, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latorraca, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilger, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matile, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schertler, G. F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Granier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weis, W. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dror, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manglik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skiniotis, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, B. K.</span></span> <span> </span><span class="NLM_article-title">Structure of the μ-opioid receptor-Gi protein complex</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>558</i></span>,  <span class="NLM_fpage">547</span>– <span class="NLM_lpage">552</span>, <span class="refDoi"> DOI: 10.1038/s41586-018-0219-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1038%2Fs41586-018-0219-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=29899455" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFeqtbjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=558&publication_year=2018&pages=547-552&author=A.+Koehlauthor=H.+Huauthor=S.+Maedaauthor=Y.+Zhangauthor=Q.+Quauthor=J.+M.+Paggiauthor=N.+R.+Latorracaauthor=D.+Hilgerauthor=R.+Dawsonauthor=H.+Matileauthor=G.+F.+X.+Schertlerauthor=S.+Granierauthor=W.+I.+Weisauthor=R.+O.+Drorauthor=A.+Manglikauthor=G.+Skiniotisauthor=B.+K.+Kobilka&title=Structure+of+the+%CE%BC-opioid+receptor-Gi+protein+complex&doi=10.1038%2Fs41586-018-0219-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the μ-opioid receptor-Gi protein complex</span></div><div class="casAuthors">Koehl, Antoine; Hu, Hongli; Maeda, Shoji; Zhang, Yan; Qu, Qianhui; Paggi, Joseph M.; Latorraca, Naomi R.; Hilger, Daniel; Dawson, Roger; Matile, Hugues; Schertler, Gebhard F. X.; Granier, Sebastien; Weis, William I.; Dror, Ron O.; Manglik, Aashish; Skiniotis, Georgios; Kobilka, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">558</span>
        (<span class="NLM_cas:issue">7711</span>),
    <span class="NLM_cas:pages">547-552</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">The μ-opioid receptor (μOR) is a G-protein-coupled receptor (GPCR) and the target of most clin. and recreationally used opioids.  The induced pos. effects of analgesia and euphoria are mediated by μOR signalling through the adenylyl cyclase-inhibiting heterotrimeric G protein Gi.  Here we present the 3.5 Å resoln. cryo-electron microscopy structure of the μOR bound to the agonist peptide DAMGO and nucleotide-free Gi.  DAMGO occupies the morphinan ligand pocket, with its N terminus interacting with conserved receptor residues and its C terminus engaging regions important for opioid-ligand selectivity.  Comparison of the μOR-Gi complex to previously detd. structures of other GPCRs bound to the stimulatory G protein Gs reveals differences in the position of transmembrane receptor helix 6 and in the interactions between the G protein α-subunit and the receptor core.  Together, these results shed light on the structural features that contribute to the Gi protein-coupling specificity of the μOR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSgJZtgX6dkbVg90H21EOLACvtfcHk0lgGfpXDVy6EeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFeqtbjP&md5=92cddedb69cfa5f1a78cb419ef8b4ae0</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fs41586-018-0219-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-018-0219-7%26sid%3Dliteratum%253Aachs%26aulast%3DKoehl%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DMaeda%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DQu%26aufirst%3DQ.%26aulast%3DPaggi%26aufirst%3DJ.%2BM.%26aulast%3DLatorraca%26aufirst%3DN.%2BR.%26aulast%3DHilger%26aufirst%3DD.%26aulast%3DDawson%26aufirst%3DR.%26aulast%3DMatile%26aufirst%3DH.%26aulast%3DSchertler%26aufirst%3DG.%2BF.%2BX.%26aulast%3DGranier%26aufirst%3DS.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26aulast%3DDror%26aufirst%3DR.%2BO.%26aulast%3DManglik%26aufirst%3DA.%26aulast%3DSkiniotis%26aufirst%3DG.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26atitle%3DStructure%2520of%2520the%2520%25CE%25BC-opioid%2520receptor-Gi%2520protein%2520complex%26jtitle%3DNature%26date%3D2018%26volume%3D558%26spage%3D547%26epage%3D552%26doi%3D10.1038%2Fs41586-018-0219-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Della
Longa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arcovito, A.</span></span> <span> </span><span class="NLM_article-title">“In silico” study of the binding of two novel antagonists to the nociceptin receptor</span>. <i>J. Comput.-Aided Mol. Des.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">385</span>– <span class="NLM_lpage">400</span>, <span class="refDoi"> DOI: 10.1007/s10822-017-0095-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1007%2Fs10822-017-0095-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=29340866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVKrurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2018&pages=385-400&author=S.+Della%0ALongaauthor=A.+Arcovito&title=%E2%80%9CIn+silico%E2%80%9D+study+of+the+binding+of+two+novel+antagonists+to+the+nociceptin+receptor&doi=10.1007%2Fs10822-017-0095-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">'In silico' study of the binding of two novel antagonists to the nociceptin receptor</span></div><div class="casAuthors">Della Longa, Stefano; Arcovito, Alessandro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">385-400</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">In this study, a multi-flexible docking (MF-docking) procedure, i.e. docking to multiple receptor conformations extd. by preliminary mol. dynamics trajectories, together with hybrid quantum mechanics/mol. mechanics (QM/MM) simulations have been carried out to provide the binding mode of two novel NOP antagonists, one of them selective (BTRX-246040, formerly named LY-2940094) and one non selective (AT-076), i.e. able to inactivate NOP as well as the classical μ- k- and δ-opioid receptors (MOP KOP and DOP).  According to our results, the pivotal role of residue D1303,32 is analogous to that enlighten by the already known X-ray structures of opioid receptors: binding of the mols. are predicted.  The QM/MM optimization after the MF-docking procedure has provided the more likely conformations for the binding to the NOP receptor of BTRX-246040 and AT-076, based on different pharmacophores and exhibiting different selectivity profiles.  While the high selectivity for NOP of BTRX-246040 can be explained by interactions with NOP specific residues, the lack of selectivity of AT-076 could be assocd. to its ability to penetrate into the deep hydrophobic pocket of NOP, while retaining a conformation very similar to the one assumed by the antagonist JDTic into the K-opioid receptor.  The proposed binding geometries fit better the binding pocket environment providing clues for exptl. studies aimed to design selective or multifunctional opioid drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIWnXh7XbMz7Vg90H21EOLACvtfcHk0lgGfpXDVy6EeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVKrurs%253D&md5=48d116b5c4b36f5b30f584add961401e</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1007%2Fs10822-017-0095-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-017-0095-5%26sid%3Dliteratum%253Aachs%26aulast%3DDella%2BLonga%26aufirst%3DS.%26aulast%3DArcovito%26aufirst%3DA.%26atitle%3D%25E2%2580%259CIn%2520silico%25E2%2580%259D%2520study%2520of%2520the%2520binding%2520of%2520two%2520novel%2520antagonists%2520to%2520the%2520nociceptin%2520receptor%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2018%26volume%3D32%26spage%3D385%26epage%3D400%26doi%3D10.1007%2Fs10822-017-0095-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Della
Longa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arcovito, A.</span></span> <span> </span><span class="NLM_article-title">Microswitches for the activation of the nociceptin receptor induced by cebranopadol: hints from microsecond molecular dynamics</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">818</span>– <span class="NLM_lpage">831</span>, <span class="refDoi"> DOI: 10.1021/acs.jcim.8b00759</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jcim.8b00759" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC1MXovFeitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2019&pages=818-831&author=S.+Della%0ALongaauthor=A.+Arcovito&title=Microswitches+for+the+activation+of+the+nociceptin+receptor+induced+by+cebranopadol%3A+hints+from+microsecond+molecular+dynamics&doi=10.1021%2Facs.jcim.8b00759"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Microswitches for the activation of the nociceptin receptor induced by cebranopadol: hints from microsecond molecular dynamics</span></div><div class="casAuthors">Della Longa, Stefano; Arcovito, Alessandro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">818-831</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cebranopadol (CBP) is a novel analgesic acting as agonist at the nociceptin (NOP) and μ-opioid (MOP) receptors, exhibiting high potency and efficacy as an antinociceptive and antihypersensitive drug.  The binding conformation and the dynamical interactions of CBP with the NOP receptor have been investigated by mol. docking, mol. dynamics (MD) in the microsecond time scale, and hybrid quantum mechanics/mol. mechanics (QM/MM).  CBP binds to the NOP receptor as a bidentate ligand of the aspartate D1303,32 by means of both its fluoroindole and di-Me nitrogens.  Starting from the known crystal structure of the inactive state of the receptor, in complex with the antagonist compd.-24 (NOP-C24) the comparative anal. of 1 μs MD trajectories of the NOP-C24 complex itself and the NOP_free and NOP-CBP complexes provides new insights on the already known microswitches related to receptor activation, in the frame of the extended ternary complex model.  The agonist acts by destabilizing the inactive conformation of the NOP receptor, by inducing a conformational change of M1343,36, which allows W2766,48 to flip around its χ2 dihedral, going in close proximity to the receptor hydrophobic core (T1383,40, P2275,50, F2726,44), which is known to be fundamental for the activation of the opioid receptors.  A complete rational picture is also provided for the role of N1333,35 and W2766,48 undergoing crit. conformational changes related to an anticooperativity effect, i.e. the well-known role of sodium as neg. modulator of agonist binding.  Finally, the movement of residue Y3197,53 belonging to the NPxxY motif is also induced by the binding of the agonist in the inactive state, opening a gate for a water channel just as upon receptor activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1eIyuzeXtPLVg90H21EOLACvtfcHk0lgGfpXDVy6EeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXovFeitQ%253D%253D&md5=25f9fdf7ac331620084fcf75ac5393b8</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Facs.jcim.8b00759&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jcim.8b00759%26sid%3Dliteratum%253Aachs%26aulast%3DDella%2BLonga%26aufirst%3DS.%26aulast%3DArcovito%26aufirst%3DA.%26atitle%3DMicroswitches%2520for%2520the%2520activation%2520of%2520the%2520nociceptin%2520receptor%2520induced%2520by%2520cebranopadol%253A%2520hints%2520from%2520microsecond%2520molecular%2520dynamics%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2019%26volume%3D59%26spage%3D818%26epage%3D831%26doi%3D10.1021%2Facs.jcim.8b00759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McLeod, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolser, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parra, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutter, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tulshian, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hey, J. A.</span></span> <span> </span><span class="NLM_article-title">Antitussive effect of nociceptin/orphanin FQ in experimental cough models</span>. <i>Pulm. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">216</span>, <span class="refDoi"> DOI: 10.1006/pupt.2002.0357</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1006%2Fpupt.2002.0357" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=12099766" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BD38XltVKqsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2002&pages=213-216&author=R.+L.+McLeodauthor=D.+C.+Bolserauthor=Y.+Jiaauthor=L.+E.+Parraauthor=J.+C.+Mutterauthor=X.+Wangauthor=D.+B.+Tulshianauthor=R.+W.+Eganauthor=J.+A.+Hey&title=Antitussive+effect+of+nociceptin%2Forphanin+FQ+in+experimental+cough+models&doi=10.1006%2Fpupt.2002.0357"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Antitussive Effect of Nociceptin/Orphanin FQ in Experimental Cough Models</span></div><div class="casAuthors">McLeod, Robbie L.; Bolser, Donald C.; Jia, Yanlin; Parra, Leonard E.; Mutter, Jennifer C.; Wang, Xin; Tulshian, Deen B.; Egan, Robert W.; Hey, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Pulmonary Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">213-216</span>CODEN:
                <span class="NLM_cas:coden">PPTHFJ</span>;
        ISSN:<span class="NLM_cas:issn">1094-5539</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Cough is an important defensive pulmonary reflex that removes irritants, fluids or foreign materials from the airways.  However, often cough is non-productive and requires suppression.  Opioid μ receptor agonists, such as codeine are commonly used as antitussive agents and are among the most widely administered drugs in the world.  Codeine suppresses the responsiveness of one or more components of the central reflex pathway for cough and is an efficacious antitussive drug for cough due to diverse etiologies.  However, opioids produce side effects that include sedation, addiction potential and constipation.  Therefore, novel cough suppressant therapies should maintain or improve upon the antitussive efficacy profile of opioids.  Moreover, these novel therapies should have a safety profile significantly better than current antitussive therapies.  Presently, we discuss preclin. findings showing that activation of the 'opioid-like' receptor (NOP1) inhibits cough in the guinea pig and cat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK5SQIUqfLVLVg90H21EOLACvtfcHk0lg0axuvOnvITQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltVKqsLc%253D&md5=88453aa1b1f2ed62697ffe6c96781954</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1006%2Fpupt.2002.0357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fpupt.2002.0357%26sid%3Dliteratum%253Aachs%26aulast%3DMcLeod%26aufirst%3DR.%2BL.%26aulast%3DBolser%26aufirst%3DD.%2BC.%26aulast%3DJia%26aufirst%3DY.%26aulast%3DParra%26aufirst%3DL.%2BE.%26aulast%3DMutter%26aufirst%3DJ.%2BC.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DTulshian%26aufirst%3DD.%2BB.%26aulast%3DEgan%26aufirst%3DR.%2BW.%26aulast%3DHey%26aufirst%3DJ.%2BA.%26atitle%3DAntitussive%2520effect%2520of%2520nociceptin%252Forphanin%2520FQ%2520in%2520experimental%2520cough%2520models%26jtitle%3DPulm.%2520Pharmacol.%2520Ther.%26date%3D2002%26volume%3D15%26spage%3D213%26epage%3D216%26doi%3D10.1006%2Fpupt.2002.0357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McLeod, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parra, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tulshian, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiselgof, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fawzi, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith-Torhan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hey, J. A.</span></span> <span> </span><span class="NLM_article-title">Antitussive profile of the NOP agonist Ro-64-6198 in the guinea pig</span>. <i>Pharmacology</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">143</span>– <span class="NLM_lpage">149</span>, <span class="refDoi"> DOI: 10.1159/000077448</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1159%2F000077448" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=15161996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BD2cXltFCnu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2004&pages=143-149&author=R.+L.+McLeodauthor=Y.+Jiaauthor=X.+Fernandezauthor=L.+E.+Parraauthor=X.+Wangauthor=D.+B.+Tulshianauthor=E.+J.+Kiselgofauthor=Z.+Tanauthor=A.+B.+Fawziauthor=A.+Smith-Torhanauthor=H.+Zhangauthor=J.+A.+Hey&title=Antitussive+profile+of+the+NOP+agonist+Ro-64-6198+in+the+guinea+pig&doi=10.1159%2F000077448"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Antitussive profile of the NOP agonist Ro-64-6198 in the guinea pig</span></div><div class="casAuthors">McLeod, Robbie L.; Jia, Yanlin; Fernandez, Xiomara; Parra, Leonard E.; Wang, Xin; Tulshian, Deen B.; Kiselgof, Eugenia J.; Tan, Zheng; Fawzi, Ahmad B.; Smith-Torhan, April; Zhang, Hongtao; Hey, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">143-149</span>CODEN:
                <span class="NLM_cas:coden">PHMGBN</span>;
        ISSN:<span class="NLM_cas:issn">0031-7012</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">We have previously shown that N/OFQ, the endogenous peptide ligand for the "opioid-like" NOP receptor, inhibits cough in guinea pigs and cats.  In the present study we sought to continue our characterization of the cough-suppressant effects of NOP stimulation by profiling the pulmonary and antitussive effects of a novel non-peptide NOP agonist, Ro-64-6198, in guinea pigs.  In receptor-binding assays, we confirmed that Ro-64-6198 selectively binds to NOP receptors over other opioid receptors.  The Ki values for Ro-64-6198 at NOP, MOP, KOP and DOP receptors was 0.3, 36, 214 and 3,787 nmol/l, resp.  In GTPγS-binding assays, Ro-64-6198 displayed >900-fold functional selectivity at NOP relative to MOP receptors.  We evaluated the effects of Ro-64-6198 (3 and 10 μmol/l) in isolated guinea pig nodose ganglia cells on the increases in intracellular Ca2+ concn. evoked by capsaicin stimulation (1×10-8-1×10-6 mol/l).  Similar to previously reported data with N/OFQ, Ro-64-6198 (3 and 10 μmol/l) significantly attenuated Ca2+ responses in nodose ganglia cells produced by exposure to capsaicin.  The effect of Ro-64-6198 (3 μmol/l) on capsaicin-induced intracellular Ca2+ responses was blocked by the NOP antagonist, J113397 (3 μmol/l).  In guinea pig in vivo studies, aerosolized capsaicin (10-300 μmol/l) produced a dose-dependent increase in cough no.  Ro-64-6198 given i.p. significantly inhibited cough due to capsaicin (300 μmol/l) exposure.  In a duration study we found that the max. antitussive effect (42±8% inhibition) of Ro-64-6198 (3 mg/kg) was obsd. at 1 h after i.p. administration.  Also at 1 h after administration, Ro-64-6198 (0.003-3.0 mg/kg, i.p.) produced a dose-dependent inhibition of cough.  The antitussive effect of Ro-64-6198 (3 mg/kg, i.p.) was blocked by J113397 (12 mg/kg, i.p.) but not by the classical opioid antagonist naltrexone (10 mg/kg, i.p.).  Although the antitussive action of Ro-64-6198 may be mediated by a central and/or a peripheral site of action, we hypothesize that selective oral NOP agonists that do not penetrate the blood-brain barrier may provide a novel approach for the treatment of cough.  Moreover, because these drugs do not interact at MOP receptors, they may be devoid of codeine-like side effects such as respiratory depression, sedation, constipation or proclivities for addictive liabilities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjdJxKiezFwbVg90H21EOLACvtfcHk0lg0axuvOnvITQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXltFCnu74%253D&md5=303c3df4646580491f2bde89650c5bfa</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1159%2F000077448&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000077448%26sid%3Dliteratum%253Aachs%26aulast%3DMcLeod%26aufirst%3DR.%2BL.%26aulast%3DJia%26aufirst%3DY.%26aulast%3DFernandez%26aufirst%3DX.%26aulast%3DParra%26aufirst%3DL.%2BE.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DTulshian%26aufirst%3DD.%2BB.%26aulast%3DKiselgof%26aufirst%3DE.%2BJ.%26aulast%3DTan%26aufirst%3DZ.%26aulast%3DFawzi%26aufirst%3DA.%2BB.%26aulast%3DSmith-Torhan%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DHey%26aufirst%3DJ.%2BA.%26atitle%3DAntitussive%2520profile%2520of%2520the%2520NOP%2520agonist%2520Ro-64-6198%2520in%2520the%2520guinea%2520pig%26jtitle%3DPharmacology%26date%3D2004%26volume%3D71%26spage%3D143%26epage%3D149%26doi%3D10.1159%2F000077448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McLeod, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tulshian, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolser, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parra, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmer, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fawzi, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jayappa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehr, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erskine, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith-Torhan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hey, J. A.</span></span> <span> </span><span class="NLM_article-title">Effect of a novel NOP receptor agonist (SCH 225288) on guinea pig irritant-evoked, feline mechanically induced and canine infectious tracheobronchitis cough</span>. <i>Pharmacology</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">153</span>– <span class="NLM_lpage">161</span>, <span class="refDoi"> DOI: 10.1159/000235601</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1159%2F000235601" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=19696521" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFOhtrbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2009&pages=153-161&author=R.+L.+McLeodauthor=D.+B.+Tulshianauthor=G.+D.+Hoauthor=X.+Fernandezauthor=D.+C.+Bolserauthor=L.+E.+Parraauthor=J.+C.+Zimmerauthor=C.+H.+Ericksonauthor=A.+B.+Fawziauthor=H.+Jayappaauthor=C.+Lehrauthor=J.+Erskineauthor=A.+Smith-Torhanauthor=H.+Zhangauthor=J.+A.+Hey&title=Effect+of+a+novel+NOP+receptor+agonist+%28SCH+225288%29+on+guinea+pig+irritant-evoked%2C+feline+mechanically+induced+and+canine+infectious+tracheobronchitis+cough&doi=10.1159%2F000235601"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of a Novel NOP Receptor Agonist (SCH 225288) on Guinea Pig Irritant-Evoked, Feline Mechanically Induced and Canine Infectious Tracheobronchitis Cough</span></div><div class="casAuthors">McLeod, Robbie L.; Tulshian, Deen B.; Ho, Ginny D.; Fernandez, Xiomara; Bolser, Donald C.; Parra, Leonard E.; Zimmer, Jennifer C.; Erickson, Christine H.; Fawzi, Ahmad B.; Jayappa, Huchappa; Lehr, Craig; Erskine, Jason; Smith-Torhan, April; Zhang, Hongtao; Hey, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">153-161</span>CODEN:
                <span class="NLM_cas:coden">PHMGBN</span>;
        ISSN:<span class="NLM_cas:issn">0031-7012</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Background: Previous studies have demonstrated that nociceptin/orphanin FQ (N/OFQ), the endogenous peptide ligand for the G-protein-coupled NOP receptor, inhibits cough in exptl. models.  SCH 225288 is a nonpeptide, orally active NOP agonist that may provide the foundation for the development of novel treatments for cough.  Methods: First we characterized the selectivity of SCH 225288 in human receptor binding assays.  Afterwards, the antitussive activity of SCH 225288 was studied in three mechanistically distinct cough models.  Specifically, we obsd. the cough-suppressant effect of SCH 225288 in a guinea pig capsaicin irritant-evoked cough model, a feline mech. induced cough model and finally in a canine Bordetella bronchiseptica disease model.  Results: SCH 225288 selectively binds human NOP receptor (Ki = 0.38 ± 0.02 nmol/l) over classical opioid receptors (COR).  In a guinea pig capsaicin cough model, SCH 225288 (0.1-1 mg/kg) suppressed cough at 2, 4, and 6 h after oral administration.  The antitussive effect of SCH 225288 (3.0 mg/kg, p.o.) was blocked by the NOP antagonist J113397 (12 mg/kg, i.p.) but not by the classical opioid receptor (COR) antagonist, naltrexone (3.0 mg/kg, i.p.).  In the anesthetized cat, we evaluated the effects of SCH 225288 given either i.v. or via the intravertebral artery against the increases in cough no. and respiratory expiratory and inspiratory muscle (rectus abdominis and parasternal) electromyog. (EMG) activities due to perturbations of the intrathoracic trachea.  SCH 225288 (0.03-3.0 mg/kg, i.v.) inhibited both cough no. and abdominal EMG amplitudes.  Similarly, SCH 225288 (0.001-0.3 mg/kg) administered intra-arterially also diminished cough no. and abdominal EMG amplitudes.  No significant effect of the drug was noted on parasternal EMG activity.  Finally, we studied the antitussive actions of SCH 225288 (1.0 mg/kg) in a canine B. bronchiseptica disease model.  In this model, dogs were challenged intranasally with B. bronchiseptica.  Comparisons were made between a vehicle group, an SCH 225288 (1.0 mg/kg, p.o., q.d.) and a butorphanol (0.6 mg/kg, p.o., b.i.d.) group on the mean change in cough scores from baseline values and days 6-9 after B. bronchiseptica challenge.  SCH 225288 (1.0 mg/kg, p.o., q.d.) displayed a pos. antitussive tendency (p = 0.06) to inhibit B. bronchiseptica cough whereas butorphanol (0.6 mg/kg, p.o., b.i.d.) was devoid of antitussive activity.  Conclusions: Taken together, the present data show that SCH 225288 is a potent and effective antitussive agent in animal models of cough.  Furthermore, these findings indicate that NOP agonists represent a promising new therapeutic approach for the treatment of cough without the side effect liabilities assocd. with opioid antitussives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodplJfyEx3gLVg90H21EOLACvtfcHk0lg0axuvOnvITQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFOhtrbE&md5=4c78dd41fcc5ff00100526d8da04d2ef</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1159%2F000235601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000235601%26sid%3Dliteratum%253Aachs%26aulast%3DMcLeod%26aufirst%3DR.%2BL.%26aulast%3DTulshian%26aufirst%3DD.%2BB.%26aulast%3DHo%26aufirst%3DG.%2BD.%26aulast%3DFernandez%26aufirst%3DX.%26aulast%3DBolser%26aufirst%3DD.%2BC.%26aulast%3DParra%26aufirst%3DL.%2BE.%26aulast%3DZimmer%26aufirst%3DJ.%2BC.%26aulast%3DErickson%26aufirst%3DC.%2BH.%26aulast%3DFawzi%26aufirst%3DA.%2BB.%26aulast%3DJayappa%26aufirst%3DH.%26aulast%3DLehr%26aufirst%3DC.%26aulast%3DErskine%26aufirst%3DJ.%26aulast%3DSmith-Torhan%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DHey%26aufirst%3DJ.%2BA.%26atitle%3DEffect%2520of%2520a%2520novel%2520NOP%2520receptor%2520agonist%2520%2528SCH%2520225288%2529%2520on%2520guinea%2520pig%2520irritant-evoked%252C%2520feline%2520mechanically%2520induced%2520and%2520canine%2520infectious%2520tracheobronchitis%2520cough%26jtitle%3DPharmacology%26date%3D2009%26volume%3D84%26spage%3D153%26epage%3D161%26doi%3D10.1159%2F000235601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McLeod, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parra, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutter, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carey, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tulshian, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fawzi, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith-Torhan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuss, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hey, J. A.</span></span> <span> </span><span class="NLM_article-title">Nociceptin inhibits cough in the guinea-pig by activation of ORL1 receptors</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">1175</span>– <span class="NLM_lpage">1178</span>, <span class="refDoi"> DOI: 10.1038/sj.bjp.0703954</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1038%2Fsj.bjp.0703954" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=11250866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BD3MXisFWitrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2001&pages=1175-1178&author=R.+L.+McLeodauthor=L.+E.+Parraauthor=J.+C.+Mutterauthor=C.+H.+Ericksonauthor=G.+J.+Careyauthor=D.+B.+Tulshianauthor=A.+B.+Fawziauthor=A.+Smith-Torhanauthor=R.+W.+Eganauthor=F.+M.+Cussauthor=J.+A.+Hey&title=Nociceptin+inhibits+cough+in+the+guinea-pig+by+activation+of+ORL1+receptors&doi=10.1038%2Fsj.bjp.0703954"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Nociceptin inhibits cough in the guinea-pig by activation of ORL1 receptors</span></div><div class="casAuthors">McLeod, Robbie L.; Parra, Leonard E.; Mutter, Jennifer C.; Erickson, Christine H.; Carey, Galen J.; Tulshian, Deen B.; Fawzi, Ahmad B.; Smith-Torhan, April; Egan, Robert W.; Cuss, Francis M.; Hey, John A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1175-1178</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We studied the central and peripheral antitussive effect of ORL1 receptor activation with nociceptin/orphanin FQ in conscious guinea pigs.  In guinea pig cough studies, nociceptin/orphanin FQ (10, 30, and 90 μg) given directly into the CNS by an intracerebroventricular (i.c.v.) route inhibited cough elicited by capsaicin exposure by approx. 23, 29 and 52%, resp.  The antitussive activity of nociceptin/orphanin FQ (90 μg, i.c.v.) was blocked by the selective ORL1 antagonist [Phe1γ(CH2-NH)Gly2]nociceptin-(1-13)-NH2 (180 μg, i.c.v.) and J 113397 (10 mg kg-1, i.p.) but not by the opioid antagonist, naltrexone (3 mg kg-1, i.p.).  Furthermore, i.v. nociceptin/orphanin FQ (1.0 and 3.0 mg kg-1) also inhibited cough approx. by 25 and 42%, resp.  These findings indicate that selective ORL1 agonists display the potential to inhibit cough by both a central and peripheral mechanism, and potentially represent a novel therapeutic approach for the treatment of cough.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH9gaplu1T_LVg90H21EOLACvtfcHk0limNAE7Ukfalw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXisFWitrs%253D&md5=48746f19039e43c21957cbaed2383962</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0703954&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0703954%26sid%3Dliteratum%253Aachs%26aulast%3DMcLeod%26aufirst%3DR.%2BL.%26aulast%3DParra%26aufirst%3DL.%2BE.%26aulast%3DMutter%26aufirst%3DJ.%2BC.%26aulast%3DErickson%26aufirst%3DC.%2BH.%26aulast%3DCarey%26aufirst%3DG.%2BJ.%26aulast%3DTulshian%26aufirst%3DD.%2BB.%26aulast%3DFawzi%26aufirst%3DA.%2BB.%26aulast%3DSmith-Torhan%26aufirst%3DA.%26aulast%3DEgan%26aufirst%3DR.%2BW.%26aulast%3DCuss%26aufirst%3DF.%2BM.%26aulast%3DHey%26aufirst%3DJ.%2BA.%26atitle%3DNociceptin%2520inhibits%2520cough%2520in%2520the%2520guinea-pig%2520by%2520activation%2520of%2520ORL1%2520receptors%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2001%26volume%3D132%26spage%3D1175%26epage%3D1178%26doi%3D10.1038%2Fsj.bjp.0703954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Undem, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, M. J.</span></span> <span> </span><span class="NLM_article-title">Effect of nociceptin in acid-evoked cough and airway sensory nerve activation in guinea pigs</span>. <i>Am. J. Respir. Crit. Care Med.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>173</i></span>,  <span class="NLM_fpage">271</span>– <span class="NLM_lpage">275</span>, <span class="refDoi"> DOI: 10.1164/rccm.200507-1043oc</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1164%2Frccm.200507-1043OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=16239621" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BD28XmslSksro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=2006&pages=271-275&author=M.-G.+Leeauthor=B.+J.+Undemauthor=C.+Brownauthor=M.+J.+Carr&title=Effect+of+nociceptin+in+acid-evoked+cough+and+airway+sensory+nerve+activation+in+guinea+pigs&doi=10.1164%2Frccm.200507-1043oc"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of nociceptin in acid-evoked cough and airway sensory nerve activation in guinea pigs</span></div><div class="casAuthors">Lee, Min-Goo; Undem, Bradley J.; Brown, Claire; Carr, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory and Critical Care Medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">173</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">271-275</span>CODEN:
                <span class="NLM_cas:coden">AJCMED</span>;
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Rationale: Nociceptin/orphanin FQ has been reported to inhibit capsaicin- and mech. provoked cough in animal models, but the mechanism of this effect has not been elucidated.  Objectives: The objectives of this study were to det. whether nociceptin inhibits acid-evoked cough in conscious animals and to evaluate the mechanism of this effect.  Methods: We tested the effect of nociceptin on acid-induced cough in conscious guinea pigs and acid-induced nerve activation in airway-specific vagal sensory neurons using calcium imaging techniques and the gramicidin-perforated patch clamp technique.  Measurements and Main Results: Nociceptin (3 mg/kg, i.p.) effectively inhibited acid-evoked cough in guinea pigs by nearly 70%.  Acid (pH 5) increased intracellular free calcium in acutely dissocd. vagal jugular ganglionic neurons.  The acid-induced increase in intracellular calcium was inhibited by a selective transient receptor potential vanilloid-1 antagonist, 5-iodo-resiniferatoxin (1 μM, ∼80% redn.).  The inhibitory effect of 5-iodo-resiniferatoxin on acid-induced increases in calcium was mimicked by nociceptin (0.1 μM).  In gramicidin-perforated patch clamp recordings on airway-specific capsaicin-sensitive jugular ganglion neurons, acid (pH 5) induced two distinct inward currents.  A transient current was evoked that was inhibited by amiloride and a sustained current was evoked that was inhibited by 5-iodo-resiniferatoxin.  Nociceptin selectively inhibited only the sustained component of acid-induced inward current.  Conclusion: These results indicate that the inhibitory effect of nociceptin on acid-induced cough may result from a direct inhibitory effect on peripheral C-fiber activity caused by the selective inhibition of acid-induced transient receptor potential vanilloid-1 activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7nu8PLku7c7Vg90H21EOLACvtfcHk0limNAE7Ukfalw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmslSksro%253D&md5=915d140a2cc8650708e1fe6291863482</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1164%2Frccm.200507-1043OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Frccm.200507-1043OC%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DM.-G.%26aulast%3DUndem%26aufirst%3DB.%2BJ.%26aulast%3DBrown%26aufirst%3DC.%26aulast%3DCarr%26aufirst%3DM.%2BJ.%26atitle%3DEffect%2520of%2520nociceptin%2520in%2520acid-evoked%2520cough%2520and%2520airway%2520sensory%2520nerve%2520activation%2520in%2520guinea%2520pigs%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2006%26volume%3D173%26spage%3D271%26epage%3D275%26doi%3D10.1164%2Frccm.200507-1043oc" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, N. M.</span></span> <span> </span><span class="NLM_article-title">Cough pharmacotherapy: current and future status</span>. <i>Expert Opin. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1745</span>– <span class="NLM_lpage">1755</span>, <span class="refDoi"> DOI: 10.1517/14656566.2011.576249</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1517%2F14656566.2011.576249" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=21524236" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC3MXos1Kqtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=1745-1755&author=P.+G.+Gibsonauthor=N.+M.+Ryan&title=Cough+pharmacotherapy%3A+current+and+future+status&doi=10.1517%2F14656566.2011.576249"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Cough pharmacotherapy: current and future status</span></div><div class="casAuthors">Gibson, Peter G.; Ryan, Nicole M.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1745-1755</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Chronic cough is responsible for a significant illness burden in the community.  Refractory cough causes substantial quality-of-life impairment in people with this problem.  Neuromodulators for sensory neuropathic cough and new compds. to block transient receptor potential (TRP) receptors hold promise for chronic cough and upper airway hypersensitivity.  Areas covered: The authors examine current evidence on the new concepts of chronic cough that relate to the study of idiopathic/refractory cough, the role of central nervous system control of cough and the role of laryngeal irritability and sensory neuropathy in cough.  Compds. in development to block TRP receptors, treatment for a neuropathic disorder with neuromodulators and cough suppression with opioids, esp. codeine and morphine, are investigated.  Relevant randomized control trials and case reports were identified through a PubMed search of English-language literature referring to these concepts.  Expert opinion: The concept that sensory neuropathic disorder may underlie some cases of chronic cough is useful in characterizing cough, understanding its mechanisms and guiding drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaoQFqlm8s5bVg90H21EOLACvtfcHk0limNAE7Ukfalw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXos1Kqtbo%253D&md5=d1bb9d5f1cd18659a2b5224f4692d8f6</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1517%2F14656566.2011.576249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656566.2011.576249%26sid%3Dliteratum%253Aachs%26aulast%3DGibson%26aufirst%3DP.%2BG.%26aulast%3DRyan%26aufirst%3DN.%2BM.%26atitle%3DCough%2520pharmacotherapy%253A%2520current%2520and%2520future%2520status%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2011%26volume%3D12%26spage%3D1745%26epage%3D1755%26doi%3D10.1517%2F14656566.2011.576249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, D.</span></span> <span> </span><span class="NLM_article-title">Pd-catalyzed dimethylation of tyrosine-derived picolinamide for synthesis of (S)-N-Boc-2,6-dimethyltyrosine and its analogues</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">246</span>– <span class="NLM_lpage">249</span>, <span class="refDoi"> DOI: 10.1021/acs.orglett.6b03548</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.orglett.6b03548" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFCgs7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2017&pages=246-249&author=X.+Wangauthor=S.+Niuauthor=L.+Xuauthor=C.+Zhangauthor=L.+Mengauthor=X.+Zhangauthor=D.+Ma&title=Pd-catalyzed+dimethylation+of+tyrosine-derived+picolinamide+for+synthesis+of+%28S%29-N-Boc-2%2C6-dimethyltyrosine+and+its+analogues&doi=10.1021%2Facs.orglett.6b03548"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Pd-catalyzed dimethylation of tyrosine-derived picolinamide for synthesis of (S)-N-Boc-2,6-dimethyltyrosine and its analogs</span></div><div class="casAuthors">Wang, Xuning; Niu, Songtao; Xu, Lanting; Zhang, Chao; Meng, Lingxing; Zhang, Xiaojing; Ma, Dawei</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">246-249</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A short and efficient synthesis of (S)-N-Boc-2,6-dimethyltyrosine (Boc = tert-butoxycarbonyl) utilizing palladium-catalyzed directed C-H functionalization is described.  This represents the first general method for the ortho-dimethylation of tyrosine derivs. and offers a practical approach for prepg. this synthetically important building block.  Notably, throughout the reaction sequence no racemization occurs at the susceptible α-chiral centers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjYiQqHYKkVLVg90H21EOLACvtfcHk0lhM509yzFc4kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFCgs7jK&md5=642409a9693cf6cc3e4507df60a5561d</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Facs.orglett.6b03548&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.orglett.6b03548%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DNiu%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DMeng%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DMa%26aufirst%3DD.%26atitle%3DPd-catalyzed%2520dimethylation%2520of%2520tyrosine-derived%2520picolinamide%2520for%2520synthesis%2520of%2520%2528S%2529-N-Boc-2%252C6-dimethyltyrosine%2520and%2520its%2520analogues%26jtitle%3DOrg.%2520Lett.%26date%3D2017%26volume%3D19%26spage%3D246%26epage%3D249%26doi%3D10.1021%2Facs.orglett.6b03548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bryant, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jinsmaa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvadori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okada, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazarus, L. H.</span></span> <span> </span><span class="NLM_article-title">Dmt and opioid peptides: a potent alliance</span>. <i>Biopolymers</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">86</span>– <span class="NLM_lpage">102</span>, <span class="refDoi"> DOI: 10.1002/bip.10399</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1002%2Fbip.10399" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=12767112" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BD3sXksFGnsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2003&pages=86-102&author=S.+D.+Bryantauthor=Y.+Jinsmaaauthor=S.+Salvadoriauthor=Y.+Okadaauthor=L.+H.+Lazarus&title=Dmt+and+opioid+peptides%3A+a+potent+alliance&doi=10.1002%2Fbip.10399"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Dmt and opioid peptides: A potent alliance</span></div><div class="casAuthors">Bryant, Sharon D.; Jinsmaa, Yunden; Salvadori, Severo; Okada, Yoshio; Lazarus, Lawrence H.</div><div class="citationInfo"><span class="NLM_cas:title">Biopolymers</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">86-102</span>CODEN:
                <span class="NLM_cas:coden">BIPMAA</span>;
        ISSN:<span class="NLM_cas:issn">0006-3525</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  The introduction of the Dmt (2',6'-dimethyl-L-tyrosine)-Tic pharmacophore into the design of opioid ligands produced an extraordinary family of potent δ-opioid receptor antagonists and heralded a new phase in opioid research.  First reviewed extensively in 1998, the incorporation of Dmt into a diverse group of opioid mols. stimulated the opioid field leading to the development of unique analogs with remarkable properties.  This overview will document the crucial role played by this residue in the proliferation of opioid peptides with high receptor affinity (Ki equal to or less than 1 nM) and potent bioactivity.  The discussion will include the metamorphosis between δ-opioid receptor antagonists to δ-agonists based solely on subtle structural changes at the C-terminal region of the Dmt-Tic pharmacophore as well as their behavior in vivo.  Dmt may be considered promiscuous due to the acquisition of potent μ-agonism by dermorphin and endomorphin derivs. as well as by a unique class of opioidmimetics contg. two Dmt residues sepd. by alkyl or pyrazinone linkers.  Structural studies on the Dmt-Tic compds. were enhanced tremendously by x-ray diffraction data for three potent and biol. diverse Dmt-Tic opioidmimetics that led to the development of pharmacophores for both δ-opioid receptor agonists and antagonists.  Mol. modeling studies of other unique Dmt opioid analogs illuminated structural differences between δ- and μ-receptor ligand interactions.  The future of these compds. as therapeutic applications for various medical syndromes including the control of.  Cancer-assocd. pain is only a matter of time and perseverance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiTbBjfNXJz7Vg90H21EOLACvtfcHk0lhM509yzFc4kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXksFGnsLg%253D&md5=3dee0fba7253ce2d0b67fdd581ee0829</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1002%2Fbip.10399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbip.10399%26sid%3Dliteratum%253Aachs%26aulast%3DBryant%26aufirst%3DS.%2BD.%26aulast%3DJinsmaa%26aufirst%3DY.%26aulast%3DSalvadori%26aufirst%3DS.%26aulast%3DOkada%26aufirst%3DY.%26aulast%3DLazarus%26aufirst%3DL.%2BH.%26atitle%3DDmt%2520and%2520opioid%2520peptides%253A%2520a%2520potent%2520alliance%26jtitle%3DBiopolymers%26date%3D2003%26volume%3D71%26spage%3D86%26epage%3D102%26doi%3D10.1002%2Fbip.10399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fenalti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giguere, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherezov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span> <span> </span><span class="NLM_article-title">Molecular control of δ-opioid receptor signalling</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>506</i></span>,  <span class="NLM_fpage">191</span>– <span class="NLM_lpage">196</span>, <span class="refDoi"> DOI: 10.1038/nature12944</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1038%2Fnature12944" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=24413399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisVaktro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=506&publication_year=2014&pages=191-196&author=G.+Fenaltiauthor=P.+M.+Giguereauthor=V.+Katritchauthor=X.-P.+Huangauthor=A.+A.+Thompsonauthor=V.+Cherezovauthor=B.+L.+Rothauthor=R.+C.+Stevens&title=Molecular+control+of+%CE%B4-opioid+receptor+signalling&doi=10.1038%2Fnature12944"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular control of δ-opioid receptor signalling</span></div><div class="casAuthors">Fenalti, Gustavo; Giguere, Patrick M.; Katritch, Vsevolod; Huang, Xi-Ping; Thompson, Aaron A.; Cherezov, Vadim; Roth, Bryan L.; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">506</span>
        (<span class="NLM_cas:issue">7487</span>),
    <span class="NLM_cas:pages">191-196</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Opioids represent widely prescribed and abused medications, although their signal transduction mechanisms are not well understood.  Here we present the 1.8 Å high-resoln. crystal structure of the human δ-opioid receptor (δ-OR), revealing the presence and fundamental role of a sodium ion in mediating allosteric control of receptor functional selectivity and constitutive activity.  The distinctive δ-OR sodium ion site architecture is centrally located in a polar interaction network in the seven-transmembrane bundle core, with the sodium ion stabilizing a reduced agonist affinity state, and thereby modulating signal transduction.  Site-directed mutagenesis and functional studies reveal that changing the allosteric sodium site residue Asn 131 to an alanine or a valine augments constitutive β-arrestin-mediated signaling.  Asp95Ala, Asn310Ala and Asn314Ala mutations transform classical δ-opioid antagonists such as naltrindole into potent β-arrestin-biased agonists.  The data establish the mol. basis for allosteric sodium ion control in opioid signaling, revealing that sodium-coordinating residues act as 'efficacy switches' at a prototypic G-protein-coupled receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUFRulZU1cfrVg90H21EOLACvtfcHk0lhM509yzFc4kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisVaktro%253D&md5=88159956324bb2858286a4100a9cb8bf</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fnature12944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12944%26sid%3Dliteratum%253Aachs%26aulast%3DFenalti%26aufirst%3DG.%26aulast%3DGiguere%26aufirst%3DP.%2BM.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DHuang%26aufirst%3DX.-P.%26aulast%3DThompson%26aufirst%3DA.%2BA.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DMolecular%2520control%2520of%2520%25CE%25B4-opioid%2520receptor%2520signalling%26jtitle%3DNature%26date%3D2014%26volume%3D506%26spage%3D191%26epage%3D196%26doi%3D10.1038%2Fnature12944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shimohigashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatano, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakashima, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nose, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sujaku, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saigo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinjo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagahisa, A.</span></span> <span> </span><span class="NLM_article-title">Sensitivity of opioid receptor-like receptor ORL1 for chemical modification on nociceptin, a naturally occurring nociceptive peptide</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>271</i></span>,  <span class="NLM_fpage">23642</span>– <span class="NLM_lpage">23645</span>, <span class="refDoi"> DOI: 10.1074/jbc.271.39.23642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1074%2Fjbc.271.39.23642" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=8798582" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADyaK28XlvFSltLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=23642-23645&author=Y.+Shimohigashiauthor=R.+Hatanoauthor=T.+Fujitaauthor=R.+Nakashimaauthor=T.+Noseauthor=T.+Sujakuauthor=A.+Saigoauthor=K.+Shinjoauthor=A.+Nagahisa&title=Sensitivity+of+opioid+receptor-like+receptor+ORL1+for+chemical+modification+on+nociceptin%2C+a+naturally+occurring+nociceptive+peptide&doi=10.1074%2Fjbc.271.39.23642"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Sensitivity of opioid receptor-like receptor ORL1 for chemical modification on nociceptin, a naturally occurring nociceptive peptide</span></div><div class="casAuthors">Shimohigashi, Yasuyuki; Hatano, Ryo; Fujita, Tsugumi; Nakashima, Rie; Nose, Takeru; Sujaku, Tetsujo; Saigo, Aki; Shinjo, Katsuhiro; Nagahisa, Atsushi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">271</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">23642-23645</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Nociceptin or orphanin FQ is a novel neuropeptide that activates an opioid-like G protein-coupled receptor ORL1.  This heptadecapeptide FGGFTGARKSARKLANQ resembles κ-opioid peptide dynorphin A but exhibits an opposite effect to make animals hyper-reactive to nociceptive stimulations.  In the present study, it was found that guinea pig brain contains receptors to which nociceptin binds much more strongly than to ORL1 receptors expressed in human 293 cells.  Although the Tyr1 → Phe substitution for dynorphin A eliminates almost completely an ability to bind to opioid receptors, the Phe1 → Tyr substitution in nociceptin was found to retain almost fully both receptor binding affinity and in vivo hyperalgesic activity in tail-flick assay.  Nociceptin was extremely weak to bind to opioid receptors, while Tyr1-nociceptin exhibited 10-40 times increased affinity, esp. for μ receptors, due to its N-terminal sequential identity to opioid peptides.  Shortened analogs of dynorphin A are known to retain receptor binding ability and analgesic activity, whereas the removal of C-terminal hexa- or decapeptide from nociceptin totally abolished the affinity for the ORL1 receptor.  These results indicated that the mode of interaction between nociceptin and ORL1 receptor is quite different from that between dynorphin and opioid receptor and that the C-terminal portion of nociceptin is crucial for receptor recognition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhj-YEdB1Bh7Vg90H21EOLACvtfcHk0lhM509yzFc4kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XlvFSltLw%253D&md5=cb8cca2fd4bd7a60fbc6ea8791bda51a</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1074%2Fjbc.271.39.23642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.271.39.23642%26sid%3Dliteratum%253Aachs%26aulast%3DShimohigashi%26aufirst%3DY.%26aulast%3DHatano%26aufirst%3DR.%26aulast%3DFujita%26aufirst%3DT.%26aulast%3DNakashima%26aufirst%3DR.%26aulast%3DNose%26aufirst%3DT.%26aulast%3DSujaku%26aufirst%3DT.%26aulast%3DSaigo%26aufirst%3DA.%26aulast%3DShinjo%26aufirst%3DK.%26aulast%3DNagahisa%26aufirst%3DA.%26atitle%3DSensitivity%2520of%2520opioid%2520receptor-like%2520receptor%2520ORL1%2520for%2520chemical%2520modification%2520on%2520nociceptin%252C%2520a%2520naturally%2520occurring%2520nociceptive%2520peptide%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D23642%26epage%3D23645%26doi%3D10.1074%2Fjbc.271.39.23642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morley, J. S.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships of enkephalin-like peptides</span>. <i>Annu. Rev. Pharmacol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">81</span>– <span class="NLM_lpage">110</span>, <span class="refDoi"> DOI: 10.1146/annurev.pa.20.040180.000501</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1146%2Fannurev.pa.20.040180.000501" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=6247963" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADyaL3cXktF2mtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1980&pages=81-110&author=J.+S.+Morley&title=Structure-activity+relationships+of+enkephalin-like+peptides&doi=10.1146%2Fannurev.pa.20.040180.000501"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationships of enkephalin-like peptides</span></div><div class="casAuthors">Morley, J. S.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">81-110</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    </div><div class="casAbstract">A review with 93 refs.  Met enkephalin  [58569-55-4] and leu enkephalin  [58822-25-6] analogs are considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojUGWYZiunc7Vg90H21EOLACvtfcHk0lhkr8tbUo1PfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXktF2mtr0%253D&md5=2ff73d3c5403aad3b494a8908da5c2b6</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pa.20.040180.000501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pa.20.040180.000501%26sid%3Dliteratum%253Aachs%26aulast%3DMorley%26aufirst%3DJ.%2BS.%26atitle%3DStructure-activity%2520relationships%2520of%2520enkephalin-like%2520peptides%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D1980%26volume%3D20%26spage%3D81%26epage%3D110%26doi%3D10.1146%2Fannurev.pa.20.040180.000501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ndong, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blais, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holleran, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proteau-Gagne, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantin-Savoie, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robert, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nadon, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beauchemin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leduc, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pineyro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gendron, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dory, Y. L.</span></span> <span> </span><span class="NLM_article-title">Exploration of the fifth position of leu-enkephalin and its role in binding and activating delta (DOP) and mu (MOP) opioid receptors</span>. <i>Pept. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>111</i></span>, <span class="NLM_elocation-id">e24070</span> <span class="refDoi"> DOI: 10.1002/pep2.24070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1002%2Fpep2.24070" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2019&author=D.+B.+Ndongauthor=V.+Blaisauthor=B.+J.+Holleranauthor=A.+Proteau-Gagneauthor=I.+Cantin-Savoieauthor=W.+Robertauthor=J.+F.+Nadonauthor=S.+Beaucheminauthor=R.+Leducauthor=G.+Pineyroauthor=B.+Guerinauthor=L.+Gendronauthor=Y.+L.+Dory&title=Exploration+of+the+fifth+position+of+leu-enkephalin+and+its+role+in+binding+and+activating+delta+%28DOP%29+and+mu+%28MOP%29+opioid+receptors&doi=10.1002%2Fpep2.24070"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1002%2Fpep2.24070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpep2.24070%26sid%3Dliteratum%253Aachs%26aulast%3DNdong%26aufirst%3DD.%2BB.%26aulast%3DBlais%26aufirst%3DV.%26aulast%3DHolleran%26aufirst%3DB.%2BJ.%26aulast%3DProteau-Gagne%26aufirst%3DA.%26aulast%3DCantin-Savoie%26aufirst%3DI.%26aulast%3DRobert%26aufirst%3DW.%26aulast%3DNadon%26aufirst%3DJ.%2BF.%26aulast%3DBeauchemin%26aufirst%3DS.%26aulast%3DLeduc%26aufirst%3DR.%26aulast%3DPineyro%26aufirst%3DG.%26aulast%3DGuerin%26aufirst%3DB.%26aulast%3DGendron%26aufirst%3DL.%26aulast%3DDory%26aufirst%3DY.%2BL.%26atitle%3DExploration%2520of%2520the%2520fifth%2520position%2520of%2520leu-enkephalin%2520and%2520its%2520role%2520in%2520binding%2520and%2520activating%2520delta%2520%2528DOP%2529%2520and%2520mu%2520%2528MOP%2529%2520opioid%2520receptors%26jtitle%3DPept.%2520Sci.%26date%3D2019%26volume%3D111%26doi%3D10.1002%2Fpep2.24070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Camarda, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calò, G.</span></span> <span> </span><span class="NLM_article-title">Chimeric G proteins in fluorimetric calcium assays: experience with opioid receptors</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>937</i></span>,  <span class="NLM_fpage">293</span>– <span class="NLM_lpage">306</span>, <span class="refDoi"> DOI: 10.1007/978-1-62703-086-1_18</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1007%2F978-1-62703-086-1_18" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=23007594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC3sXisF2gtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=937&publication_year=2013&pages=293-306&author=V.+Camardaauthor=G.+Cal%C3%B2&title=Chimeric+G+proteins+in+fluorimetric+calcium+assays%3A+experience+with+opioid+receptors&doi=10.1007%2F978-1-62703-086-1_18"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Chimeric G proteins in fluorimetric calcium assays: experience with opioid receptors</span></div><div class="casAuthors">Camarda, Valeria; Calo', Girolamo</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">937</span>
        (<span class="NLM_cas:issue">Calcium Signaling Protocols</span>),
    <span class="NLM_cas:pages">293-306</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1064-3745</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">High throughput calcium mobilization assays are extensively used for pharmacol. characterization of GPCR ligands.  These approaches, initially developed for Gq-coupled receptors, can be extended to Gi coupled GPCRs using chimeric G proteins.  Here we used the Gαqi5 protein to force the nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor, as well as the classical opioid receptors to signal through the PLC-IP3-Ca2+ pathway in CHO cells.  Calcium levels were monitored using the fluorometric imaging plate reader FlexStation II and the Ca2+ dye Fluo 4 AM.  For investigating the pharmacol. of the NOP receptor a panel of full and partial agonists and antagonists were assessed, while a small panel of agonists and antagonists was used for evaluating the pharmacol. profile of opioid receptors.  Some limitations of this assay and differences in the results obtained in comparison with those with Gi based biochem. assays are described.  Overall, the present results confirm that the chimeric G protein strategy is useful for studying the pharmacol. activity of Gi coupled receptor ligands and that the aberrant signaling does not produce any measurable change in the pharmacol. profile of the receptor under study.  Thus, this G protein strategy is extremely useful for setting up primary screening assays for NOP and classical opioid receptors and likely for other members of the GPCR family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8B1rU3SUTZLVg90H21EOLACvtfcHk0lhkr8tbUo1PfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXisF2gtrs%253D&md5=2aaed19c1387300bd163019b4f58bcd6</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1007%2F978-1-62703-086-1_18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-62703-086-1_18%26sid%3Dliteratum%253Aachs%26aulast%3DCamarda%26aufirst%3DV.%26aulast%3DCal%25C3%25B2%26aufirst%3DG.%26atitle%3DChimeric%2520G%2520proteins%2520in%2520fluorimetric%2520calcium%2520assays%253A%2520experience%2520with%2520opioid%2520receptors%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2013%26volume%3D937%26spage%3D293%26epage%3D306%26doi%3D10.1007%2F978-1-62703-086-1_18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Camarda, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischetti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anzellotti, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molinari, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambrosio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kostenis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regoli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapella, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Severo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calò, G.</span></span> <span> </span><span class="NLM_article-title">Pharmacological profile of NOP receptors coupled with calcium signaling via the chimeric protein Gαqi5</span>. <i>Naunyn-Schmiedeberg’s Arch. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>379</i></span>,  <span class="NLM_fpage">599</span>– <span class="NLM_lpage">607</span>, <span class="refDoi"> DOI: 10.1007/s00210-009-0396-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1007%2Fs00210-009-0396-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=19183962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVOjtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=379&publication_year=2009&pages=599-607&author=V.+Camardaauthor=C.+Fischettiauthor=N.+Anzellottiauthor=P.+Molinariauthor=C.+Ambrosioauthor=E.+Kostenisauthor=D.+Regoliauthor=C.+Trapellaauthor=R.+Guerriniauthor=S.+Severoauthor=G.+Cal%C3%B2&title=Pharmacological+profile+of+NOP+receptors+coupled+with+calcium+signaling+via+the+chimeric+protein+G%CE%B1qi5&doi=10.1007%2Fs00210-009-0396-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological profile of NOP receptors coupled with calcium signaling via the chimeric protein Gαqi5</span></div><div class="casAuthors">Camarda, Valeria; Fischetti, Carmela; Anzellotti, Nicholas; Molinari, Paola; Ambrosio, Caterina; Kostenis, Evi; Regoli, Domenico; Trapella, Claudio; Guerrini, Remo; Severo, Salvadori; Calo, Girolamo</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">379</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">599-607</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">In this study, the Gαqi5 protein was used to force the human nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor to signal through the Ca2+ pathway in CHO cells.  [Ca2+]i levels were monitored using the fluorometer FlexStation II and the Ca2+ dye Fluo 4 AM.  Concn. response curves were generated with a panel of full and partial agonists, while NOP antagonists were assessed in inhibition-response curves.  The following rank order of potency of antagonists was measured: naloxone, which is superimposable to literature findings.  The rank order of potency of full and partial agonists is also similar to that obtained in previous studies with the exception of a panel of ligands (UFP-112, Ro 64-6198, ZP120, UFP-113) whose potency was relatively low in the Gαqi5-NOP receptor calcium assay.  Interestingly, these NOP ligands are characterized by slow kinetic of interaction with the NOP receptor, as demonstrated by bioassay expts.  These results demonstrated that the FlexStation II-Gαqi5-NOP receptor calcium assay represents an adequate and useful screening for NOP receptor ligands, particularly for antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkL3dchbOaALVg90H21EOLACvtfcHk0lhkr8tbUo1PfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVOjtL0%253D&md5=1b7c4c980137bbd062552f1fc5a84b62</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1007%2Fs00210-009-0396-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00210-009-0396-x%26sid%3Dliteratum%253Aachs%26aulast%3DCamarda%26aufirst%3DV.%26aulast%3DFischetti%26aufirst%3DC.%26aulast%3DAnzellotti%26aufirst%3DN.%26aulast%3DMolinari%26aufirst%3DP.%26aulast%3DAmbrosio%26aufirst%3DC.%26aulast%3DKostenis%26aufirst%3DE.%26aulast%3DRegoli%26aufirst%3DD.%26aulast%3DTrapella%26aufirst%3DC.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DSevero%26aufirst%3DS.%26aulast%3DCal%25C3%25B2%26aufirst%3DG.%26atitle%3DPharmacological%2520profile%2520of%2520NOP%2520receptors%2520coupled%2520with%2520calcium%2520signaling%2520via%2520the%2520chimeric%2520protein%2520G%25CE%25B1qi5%26jtitle%3DNaunyn-Schmiedeberg%25E2%2580%2599s%2520Arch.%2520Pharmacol.%26date%3D2009%26volume%3D379%26spage%3D599%26epage%3D607%26doi%3D10.1007%2Fs00210-009-0396-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerlesi, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruzza, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malfacini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianco, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapella, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calò, G.</span></span> <span> </span><span class="NLM_article-title">Pharmacological characterization of cebranopadol a novel analgesic acting as mixed nociceptin/orphanin FQ and opioid receptor agonist</span>. <i>Pharmacol. Res. Perspect.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>4</i></span>, <span class="NLM_elocation-id">e00247</span> <span class="refDoi"> DOI: 10.1002/prp2.247</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1002%2Fprp2.247" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=28116100" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2016&author=A.+Rizziauthor=M.+C.+Cerlesiauthor=C.+Ruzzaauthor=D.+Malfaciniauthor=F.+Ferrariauthor=S.+Biancoauthor=T.+Costaauthor=R.+Guerriniauthor=C.+Trapellaauthor=G.+Cal%C3%B2&title=Pharmacological+characterization+of+cebranopadol+a+novel+analgesic+acting+as+mixed+nociceptin%2Forphanin+FQ+and+opioid+receptor+agonist&doi=10.1002%2Fprp2.247"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1002%2Fprp2.247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprp2.247%26sid%3Dliteratum%253Aachs%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DCerlesi%26aufirst%3DM.%2BC.%26aulast%3DRuzza%26aufirst%3DC.%26aulast%3DMalfacini%26aufirst%3DD.%26aulast%3DFerrari%26aufirst%3DF.%26aulast%3DBianco%26aufirst%3DS.%26aulast%3DCosta%26aufirst%3DT.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DTrapella%26aufirst%3DC.%26aulast%3DCal%25C3%25B2%26aufirst%3DG.%26atitle%3DPharmacological%2520characterization%2520of%2520cebranopadol%2520a%2520novel%2520analgesic%2520acting%2520as%2520mixed%2520nociceptin%252Forphanin%2520FQ%2520and%2520opioid%2520receptor%2520agonist%26jtitle%3DPharmacol.%2520Res.%2520Perspect.%26date%3D2016%26volume%3D4%26doi%3D10.1002%2Fprp2.247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Codd, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mabus, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flores, C. M.</span></span> <span> </span><span class="NLM_article-title">Dynamic mass redistribution as a means to measure and differentiate signaling via opioid and cannabinoid receptors</span>. <i>Assay Drug Dev. Technol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">362</span>– <span class="NLM_lpage">372</span>, <span class="refDoi"> DOI: 10.1089/adt.2010.0347</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1089%2Fadt.2010.0347" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=21323580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC3MXps1Omsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2011&pages=362-372&author=E.+E.+Coddauthor=J.+R.+Mabusauthor=B.+S.+Murrayauthor=S.+P.+Zhangauthor=C.+M.+Flores&title=Dynamic+mass+redistribution+as+a+means+to+measure+and+differentiate+signaling+via+opioid+and+cannabinoid+receptors&doi=10.1089%2Fadt.2010.0347"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Dynamic Mass Redistribution as a Means to Measure and Differentiate Signaling via Opioid and Cannabinoid Receptors</span></div><div class="casAuthors">Codd, Ellen E.; Mabus, John R.; Murray, Brian S.; Zhang, Sui-Po; Flores, Christopher M.</div><div class="citationInfo"><span class="NLM_cas:title">Assay and Drug Development Technologies</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">362-372</span>CODEN:
                <span class="NLM_cas:coden">ADDTAR</span>;
        ISSN:<span class="NLM_cas:issn">1540-658X</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">Classically, G protein-coupled receptor activation by a ligand has been viewed as producing a defined response such as activation of a G protein, activation or inhibition of adenylyl cyclase, or stimulation of phospholipase C and/or alteration in calcium flux.  Newer concepts of ligand-directed signaling recognize that different ligands, ostensibly acting at the same receptors, may induce different downstream effects, complicating the selection of a screening assay.  Dynamic mass redistribution (DMR), a label-free technol. that uses light to measure ligand-induced changes in the mass of cells proximate to the biosensor, provides an integrated cellular response comprising multiple pathways and cellular events.  Using DMR, signals induced by opioid or cannabinoid agonists in cells transfected with these receptors were blocked by pharmacol. appropriate receptor antagonists as well as by pertussis toxin.  Differences among compds. in relative potencies at DMR vs. ligand-stimulated GTPγS or receptor binding endpoints, suggesting functional selectivity, were obsd.  Preliminary evidence indicates that inhibitors of intermediate steps in the cell signaling cascade, such as receptor recycling inhibitors, mitogen-activated protein kinase kinase/p38 mitogen-activated protein kinase inhibitors, or cytoskeletal disruptors, altered or attenuated the cannabinoid-induced response.  Notable is the finding that mitogen-activated protein kinase kinase 1/2 inhibitors attenuated signaling induced by the cannabinoid type 2 receptor inverse agonist AM630 but not that stimulated by the agonist CP 55,940.  Thus, DMR has the potential to not only identify ligands that activate a given G protein-coupled receptor, but also ascertain the signaling pathways engaged by a specific ligand, making DMR a useful tool in the identification of biased ligands, which may ultimately exhibit improved therapeutic profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI_9L8JxCCsbVg90H21EOLACvtfcHk0lj8_XU5SVBTPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXps1Omsrw%253D&md5=686e2b921c4f38ad1193ad8b6b12afc1</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1089%2Fadt.2010.0347&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fadt.2010.0347%26sid%3Dliteratum%253Aachs%26aulast%3DCodd%26aufirst%3DE.%2BE.%26aulast%3DMabus%26aufirst%3DJ.%2BR.%26aulast%3DMurray%26aufirst%3DB.%2BS.%26aulast%3DZhang%26aufirst%3DS.%2BP.%26aulast%3DFlores%26aufirst%3DC.%2BM.%26atitle%3DDynamic%2520mass%2520redistribution%2520as%2520a%2520means%2520to%2520measure%2520and%2520differentiate%2520signaling%2520via%2520opioid%2520and%2520cannabinoid%2520receptors%26jtitle%3DAssay%2520Drug%2520Dev.%2520Technol.%26date%3D2011%26volume%3D9%26spage%3D362%26epage%3D372%26doi%3D10.1089%2Fadt.2010.0347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Malfacini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapella, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaveri, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kostenis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calò, G.</span></span> <span> </span><span class="NLM_article-title">NOP receptor pharmacological profile - A dynamic mass redistribution study</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>, <span class="NLM_elocation-id">e0203021</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0203021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1371%2Fjournal.pone.0203021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=30161182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1emsbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&author=D.+Malfaciniauthor=K.+Simonauthor=C.+Trapellaauthor=R.+Guerriniauthor=N.+T.+Zaveriauthor=E.+Kostenisauthor=G.+Cal%C3%B2&title=NOP+receptor+pharmacological+profile+-+A+dynamic+mass+redistribution+study&doi=10.1371%2Fjournal.pone.0203021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">NOP receptor pharmacological profile - a dynamic mass redistribution study</span></div><div class="casAuthors">Malfacini, Davide; Simon, Katharina; Trapella, Claudio; Guerrini, Remo; Zaveri, Nurulain T.; Kostenis, Evi; Calo, Girolamo</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e0203021/1-e0203021/20</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The Nociceptin/Orphanin FQ (N/OFQ) peptide NOP receptor is coupled to pertussis toxin (PTX)-sensitive G proteins (Gi/o) whose activation leads to the inhibition of both cAMP prodn. and calcium channel activity, and to the stimulation of potassium currents.  The label free dynamic mass redistribution (DMR) approach has been demonstrated useful for investigating the pharmacol. profile of G protein-coupled receptors.  Herein, we employ DMR technol. to systematically characterize the pharmacol. of a large panel of NOP receptor ligands.  These are of peptide and non-peptide nature and display varying degrees of receptor efficacy, ranging from full agonism to pure antagonism.  Using Chinese hamster ovary (CHO) cells expressing the human NOP receptor we provide rank orders of potency for full and partial agonists as well as apparent affinities for selective antagonists.  We find the pharmacol. profile of NOP receptor ligands to be similar but not identical to values reported in the literature using canonical assays for Gi/o-coupled receptors.  Our data demonstrate that holistic label-free DMR detection can be successfully used to investigate the pharmacol. of the NOP receptor and to characterize the cellular effects of novel NOP receptor ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyqLzbmCx-rbVg90H21EOLACvtfcHk0lj8_XU5SVBTPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1emsbvE&md5=1ddf5dc6da796489eaefe2ffafd61d77</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0203021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0203021%26sid%3Dliteratum%253Aachs%26aulast%3DMalfacini%26aufirst%3DD.%26aulast%3DSimon%26aufirst%3DK.%26aulast%3DTrapella%26aufirst%3DC.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DZaveri%26aufirst%3DN.%2BT.%26aulast%3DKostenis%26aufirst%3DE.%26aulast%3DCal%25C3%25B2%26aufirst%3DG.%26atitle%3DNOP%2520receptor%2520pharmacological%2520profile%2520-%2520A%2520dynamic%2520mass%2520redistribution%2520study%26jtitle%3DPLoS%2520One%26date%3D2018%26volume%3D13%26doi%3D10.1371%2Fjournal.pone.0203021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schwyzer, R.</span></span> <span> </span><span class="NLM_article-title">Molecular mechanism of opioid receptor selection</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">6335</span>– <span class="NLM_lpage">6342</span>, <span class="refDoi"> DOI: 10.1021/bi00368a075</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00368a075" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADyaL2sXltV2mtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1986&pages=6335-6342&author=R.+Schwyzer&title=Molecular+mechanism+of+opioid+receptor+selection&doi=10.1021%2Fbi00368a075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanism of opioid receptor selection</span></div><div class="casAuthors">Schwyzer, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6335-42</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    </div><div class="casAbstract">Preferred conformations, orientations, and accumulations of 26 opioid peptides on lipid membranes were estd. and compared with pharmacol. and selective binding data taken from the literature.  Interaction with μ-receptors was governed by the net pos. charge effective at the message domain of the agonist peptides [z(eff)] as the Boltzmann term ez(eff) that dets. relative accumulation on anionic biol. membranes.  Selection for δ-receptors was reduced by z(eff) and correlated with e-z(eff).  Selection for κ-receptors was governed by the peptide amphiphilic moment .vector.A.  A pronounced scalar magnitude, A, and an almost perpendicular orientation of the N-terminal message domain as an α-helix were favorable for κ-site selection.  Potencies are κ-agonists and binding affinities correlated with A·ez(eff).  The classical site selectivity caused by the receptor requirements for a complementary fit of the agonist to the discriminator site is thus crucially supplemented by a selection mechanism based on peptide membrane interactions (membrane requirements).  In the model presented, the δ-site is exposed to the aq. compartment surrounding the target cell at a distance comparable to or greater than the Debye-Hueckel length and is in a cationic vicinity.  The μ-site is exposed to the anionic fixed-charge compartment of the membrane in aq. surroundings.  The κ-site is buried in a more hydrophobic membrane compartment close to the fixed-charge compartment.  The relative accumulation of the opioid message domains in these compartments is detd. by the address domains and constitutes a major part of the site selection mechanism.  The peptide .vector.A emerged as a new, important parameter for predicting site selectivity and potency and detg. peptide quant. structure-activity relationships.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpF0nG6f6M-7Vg90H21EOLACvtfcHk0lj8_XU5SVBTPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXltV2mtbw%253D&md5=da128a08d2b70ccdcd82235de82a0601</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fbi00368a075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00368a075%26sid%3Dliteratum%253Aachs%26aulast%3DSchwyzer%26aufirst%3DR.%26atitle%3DMolecular%2520mechanism%2520of%2520opioid%2520receptor%2520selection%26jtitle%3DBiochemistry%26date%3D1986%26volume%3D25%26spage%3D6335%26epage%3D6342%26doi%3D10.1021%2Fbi00368a075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manglik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruse, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thian, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathiesen, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunahara, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weis, W. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Granier, S.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of the μ-opioid receptor bound to a morphinan antagonist</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>485</i></span>,  <span class="NLM_fpage">321</span>– <span class="NLM_lpage">326</span>, <span class="refDoi"> DOI: 10.1038/nature10954</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1038%2Fnature10954" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=22437502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC38XksVehs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=485&publication_year=2012&pages=321-326&author=A.+Manglikauthor=A.+C.+Kruseauthor=T.+S.+Kobilkaauthor=F.+S.+Thianauthor=J.+M.+Mathiesenauthor=R.+K.+Sunaharaauthor=L.+Pardoauthor=W.+I.+Weisauthor=B.+K.+Kobilkaauthor=S.+Granier&title=Crystal+structure+of+the+%CE%BC-opioid+receptor+bound+to+a+morphinan+antagonist&doi=10.1038%2Fnature10954"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the μ-opioid receptor bound to a morphinan antagonist</span></div><div class="casAuthors">Manglik, Aashish; Kruse, Andrew C.; Kobilka, Tong Sun; Thian, Foon Sun; Mathiesen, Jesper M.; Sunahara, Roger K.; Pardo, Leonardo; Weis, William I.; Kobilka, Brian K.; Granier, Sebastien</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">485</span>
        (<span class="NLM_cas:issue">7398</span>),
    <span class="NLM_cas:pages">321-326</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Opium is one of the world's oldest drugs, and its derivs. morphine and codeine are among the most used clin. drugs to relieve severe pain.  These prototypical opioids produce analgesia as well as many undesirable side effects (sedation, apnea and dependence) by binding to and activating the G-protein-coupled μ-opioid receptor (μ-OR) in the central nervous system.  Here the authors describe the 2.8 Å crystal structure of the mouse μ-OR in complex with an irreversible morphinan antagonist.  Compared to the buried binding pocket obsd. in most G-protein-coupled receptors published so far, the morphinan ligand binds deeply within a large solvent-exposed pocket.  Of particular interest, the μ-OR crystallizes as a two-fold sym. dimer through a four-helix bundle motif formed by transmembrane segments 5 and 6.  These high-resoln. insights into opioid receptor structure will enable the application of structure-based approaches to develop better drugs for the management of pain and addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2q4tys639jrVg90H21EOLACvtfcHk0lhhmLaGT7xJVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XksVehs7Y%253D&md5=563d5ebda53f9a408be21d60a7e5a97d</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1038%2Fnature10954&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10954%26sid%3Dliteratum%253Aachs%26aulast%3DManglik%26aufirst%3DA.%26aulast%3DKruse%26aufirst%3DA.%2BC.%26aulast%3DKobilka%26aufirst%3DT.%2BS.%26aulast%3DThian%26aufirst%3DF.%2BS.%26aulast%3DMathiesen%26aufirst%3DJ.%2BM.%26aulast%3DSunahara%26aufirst%3DR.%2BK.%26aulast%3DPardo%26aufirst%3DL.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26aulast%3DGranier%26aufirst%3DS.%26atitle%3DCrystal%2520structure%2520of%2520the%2520%25CE%25BC-opioid%2520receptor%2520bound%2520to%2520a%2520morphinan%2520antagonist%26jtitle%3DNature%26date%3D2012%26volume%3D485%26spage%3D321%26epage%3D326%26doi%3D10.1038%2Fnature10954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Granier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manglik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruse, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thian, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weis, W. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, B. K.</span></span> <span> </span><span class="NLM_article-title">Structure of the δ-opioid receptor bound to naltrindole</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>485</i></span>,  <span class="NLM_fpage">400</span>– <span class="NLM_lpage">404</span>, <span class="refDoi"> DOI: 10.1038/nature11111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1038%2Fnature11111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=22596164" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC38XntF2gtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=485&publication_year=2012&pages=400-404&author=S.+Granierauthor=A.+Manglikauthor=A.+C.+Kruseauthor=T.+S.+Kobilkaauthor=F.+S.+Thianauthor=W.+I.+Weisauthor=B.+K.+Kobilka&title=Structure+of+the+%CE%B4-opioid+receptor+bound+to+naltrindole&doi=10.1038%2Fnature11111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the δ-opioid receptor bound to naltrindole</span></div><div class="casAuthors">Granier, Sebastien; Manglik, Aashish; Kruse, Andrew C.; Kobilka, Tong Sun; Thian, Foon Sun; Weis, William I.; Kobilka, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">485</span>
        (<span class="NLM_cas:issue">7398</span>),
    <span class="NLM_cas:pages">400-404</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The opioid receptor family comprises three members, the μ-, δ- and κ-opioid receptors, which respond to classical opioid alkaloids such as morphine and heroin as well as to endogenous peptide ligands like endorphins.  They belong to the G-protein-coupled receptor (GPCR) superfamily, and are excellent therapeutic targets for pain control.  The δ-opioid receptor (δ-OR) has a role in analgesia, as well as in other neurol. functions that remain poorly understood.  The structures of the μ-OR and κ-OR have recently been solved.  Here we report the crystal structure of the mouse δ-OR, bound to the subtype-selective antagonist naltrindole.  Together with the structures of the μ-OR and κ-OR, the δ-OR structure provides insights into conserved elements of opioid ligand recognition while also revealing structural features assocd. with ligand-subtype selectivity.  The binding pocket of opioid receptors can be divided into two distinct regions.  Whereas the lower part of this pocket is highly conserved among opioid receptors, the upper part contains divergent residues that confer subtype selectivity.  This provides a structural explanation and validation for the 'message-address' model of opioid receptor pharmacol., in which distinct 'message' (efficacy) and 'address' (selectivity) determinants are contained within a single ligand.  Comparison of the address region of the δ-OR with other GPCRs reveals that this structural organization may be a more general phenomenon, extending to other GPCR families as well.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVFoJ8sg4c2LVg90H21EOLACvtfcHk0lhhmLaGT7xJVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntF2gtrc%253D&md5=892a5da1140fbfea502ee5d598455e73</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1038%2Fnature11111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11111%26sid%3Dliteratum%253Aachs%26aulast%3DGranier%26aufirst%3DS.%26aulast%3DManglik%26aufirst%3DA.%26aulast%3DKruse%26aufirst%3DA.%2BC.%26aulast%3DKobilka%26aufirst%3DT.%2BS.%26aulast%3DThian%26aufirst%3DF.%2BS.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26atitle%3DStructure%2520of%2520the%2520%25CE%25B4-opioid%2520receptor%2520bound%2520to%2520naltrindole%26jtitle%3DNature%26date%3D2012%26volume%3D485%26spage%3D400%26epage%3D404%26doi%3D10.1038%2Fnature11111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vardy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapella, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calò, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherezov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span> <span> </span><span class="NLM_article-title">Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>485</i></span>,  <span class="NLM_fpage">395</span>– <span class="NLM_lpage">399</span>, <span class="refDoi"> DOI: 10.1038/nature11085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1038%2Fnature11085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=22596163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC38XntF2jtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=485&publication_year=2012&pages=395-399&author=A.+A.+Thompsonauthor=W.+Liuauthor=E.+Chunauthor=V.+Katritchauthor=H.+Wuauthor=E.+Vardyauthor=X.-P.+Huangauthor=C.+Trapellaauthor=R.+Guerriniauthor=G.+Cal%C3%B2author=B.+L.+Rothauthor=V.+Cherezovauthor=R.+C.+Stevens&title=Structure+of+the+nociceptin%2Forphanin+FQ+receptor+in+complex+with+a+peptide+mimetic&doi=10.1038%2Fnature11085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic</span></div><div class="casAuthors">Thompson, Aaron A.; Liu, Wei; Chun, Eugene; Katritch, Vsevolod; Wu, Huixian; Vardy, Eyal; Huang, Xi-Ping; Trapella, Claudio; Guerrini, Remo; Calo, Girolamo; Roth, Bryan L.; Cherezov, Vadim; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">485</span>
        (<span class="NLM_cas:issue">7398</span>),
    <span class="NLM_cas:pages">395-399</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Members of the opioid receptor family of G-protein-coupled receptors (GPCRs) are found throughout the peripheral and central nervous system, where they have key roles in nociception and analgesia.  Unlike the classical' opioid receptors, δ, κ and μ (δ-OR, κ-OR and μ-OR), which were delineated by pharmacol. criteria in the 1970s and 1980s, the nociceptin/orphanin FQ (N/OFQ) peptide receptor (NOP, also known as ORL-1) was discovered relatively recently by mol. cloning and characterization of an orphan GPCR.  Although it shares high sequence similarity with classical opioid GPCR subtypes (∼60%), NOP has a markedly distinct pharmacol., featuring activation by the endogenous peptide N/OFQ, and unique selectivity for exogenous ligands.  Here we report the crystal structure of human NOP, solved in complex with the peptide mimetic antagonist compd.-24 (C-24), revealing at. details of ligand-receptor recognition and selectivity.  Compd.-24 mimics the first four amino-terminal residues of the NOP-selective peptide antagonist UFP-101, a close deriv. of N/OFQ, and provides important clues to the binding of these peptides.  The x-ray structure also shows substantial conformational differences in the pocket regions between NOP and the classical opioid receptors κ and μ, and these are probably due to a small no. of residues that vary between these receptors.  The NOP-compd.-24 structure explains the divergent selectivity profile of NOP and provides a new structural template for the design of NOP ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoq0_U24fZ4r7Vg90H21EOLACvtfcHk0lhhmLaGT7xJVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntF2jtbk%253D&md5=56819d10685f8a389710e9005d595d5b</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1038%2Fnature11085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11085%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DA.%2BA.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DChun%26aufirst%3DE.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DVardy%26aufirst%3DE.%26aulast%3DHuang%26aufirst%3DX.-P.%26aulast%3DTrapella%26aufirst%3DC.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DCal%25C3%25B2%26aufirst%3DG.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DStructure%2520of%2520the%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520in%2520complex%2520with%2520a%2520peptide%2520mimetic%26jtitle%3DNature%26date%3D2012%26volume%3D485%26spage%3D395%26epage%3D399%26doi%3D10.1038%2Fnature11085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stefanucci, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimmito, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macedonio, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciarlo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pieretti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novellino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barlow, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houseknecht, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Streicher, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollica, A.</span></span> <span> </span><span class="NLM_article-title">Potent, efficacious, and stable cyclic opioid peptides with long lasting antinociceptive effect after peripheral administration</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">2673</span>– <span class="NLM_lpage">2687</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01963</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01963" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlygtbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=2673-2687&author=A.+Stefanucciauthor=M.+P.+Dimmitoauthor=G.+Macedonioauthor=L.+Ciarloauthor=S.+Pierettiauthor=E.+Novellinoauthor=W.+Leiauthor=D.+Barlowauthor=K.+L.+Houseknechtauthor=J.+M.+Streicherauthor=A.+Mollica&title=Potent%2C+efficacious%2C+and+stable+cyclic+opioid+peptides+with+long+lasting+antinociceptive+effect+after+peripheral+administration&doi=10.1021%2Facs.jmedchem.9b01963"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Potent, efficacious and stable cyclic opioid peptides with long lasting antinociceptive effect after peripheral administration</span></div><div class="casAuthors">stefanucci, azzurra; dimmito, marilisa pia; Macedonio, Giorgia; ciarlo, laura; Pieretti, Stefano; Novellino, Ettore; Lei, Wei; Barlow, Deborah; Houseknecht, Karen; Streicher, John M.; Mollica, Adriano</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2673-2687</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Four novel fluorinated cyclic analogs of biphalin with excellent to modest binding affinity for μ-, δ- and κ-receptors were synthesized.  The cyclic peptides have a combination of piperazine or hydrazine linker with or without a xylene bridge.  Among the ligands, MACE3 demonstrated a better activity than biphalin after i.v. administration, and its corresponding analog incorporating the hydrazine linker (MACE2) was able to induce longer lasting analgesia following s.c. administration.  An analog of MACE2 contg. 2,6-dimethyl-L-tyrosine (MACE4) showed the best potency and in vivo antinociceptive activity of this series.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAvej3oeuijrVg90H21EOLACvtfcHk0lizn1Tnxh4ZcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlygtbzP&md5=cdf9f02c7fab43b658bb58e959ba0013</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01963&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01963%26sid%3Dliteratum%253Aachs%26aulast%3DStefanucci%26aufirst%3DA.%26aulast%3DDimmito%26aufirst%3DM.%2BP.%26aulast%3DMacedonio%26aufirst%3DG.%26aulast%3DCiarlo%26aufirst%3DL.%26aulast%3DPieretti%26aufirst%3DS.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DLei%26aufirst%3DW.%26aulast%3DBarlow%26aufirst%3DD.%26aulast%3DHouseknecht%26aufirst%3DK.%2BL.%26aulast%3DStreicher%26aufirst%3DJ.%2BM.%26aulast%3DMollica%26aufirst%3DA.%26atitle%3DPotent%252C%2520efficacious%252C%2520and%2520stable%2520cyclic%2520opioid%2520peptides%2520with%2520long%2520lasting%2520antinociceptive%2520effect%2520after%2520peripheral%2520administration%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D2673%26epage%3D2687%26doi%3D10.1021%2Facs.jmedchem.9b01963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adcock, J. J.</span></span> <span> </span><span class="NLM_article-title">Peripheral opioid receptors and the cough reflex</span>. <i>Respir. Med.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">46</span>, <span class="refDoi"> DOI: 10.1016/s0954-6111(06)80253-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1016%2FS0954-6111%2806%2980253-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1852031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A280%3ADyaK3M3jvFymug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=1991&pages=43-46&author=J.+J.+Adcock&title=Peripheral+opioid+receptors+and+the+cough+reflex&doi=10.1016%2Fs0954-6111%2806%2980253-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Peripheral opioid receptors and the cough reflex</span></div><div class="casAuthors">Adcock J J</div><div class="citationInfo"><span class="NLM_cas:title">Respiratory medicine</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">85 Suppl A</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">43-6</span>
        ISSN:<span class="NLM_cas:issn">0954-6111</span>.
    </div><div class="casAbstract">The cough reflex originates from stimulation of sensory nerve endings located in the upper and lower respiratory tract.  Opiates are among the most potent and widely used drugs which inhibit the cough reflex, and it has been generally assumed that they act generally.  However, opioid receptors have been identified on the sensory arm of the vagus nerve.  Although the functional significance of these receptors is not clear, recent evidence suggests that their activation may be involved in the modulation of airway reflexes.  This review briefly examines the evidence to support the hypothesis that opioid receptors on vagal sensory nerves may mediate peripheral opioid-induced antitussive activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRuPQtBRpuNZDAEfvC7EH1LfW6udTcc2eZxlCxHvNXnB7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3M3jvFymug%253D%253D&md5=7cffc0491b74c4f53fe136cd3e04adde</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2FS0954-6111%2806%2980253-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0954-6111%252806%252980253-2%26sid%3Dliteratum%253Aachs%26aulast%3DAdcock%26aufirst%3DJ.%2BJ.%26atitle%3DPeripheral%2520opioid%2520receptors%2520and%2520the%2520cough%2520reflex%26jtitle%3DRespir.%2520Med.%26date%3D1991%26volume%3D85%26spage%3D43%26epage%3D46%26doi%3D10.1016%2Fs0954-6111%2806%2980253-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tzschentke, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christoph, T.</span></span> <span> </span><span class="NLM_article-title">Cebranopadol: A novel first-in-class potent analgesic acting via NOP and opioid receptors</span>. <i>Handb. Exp. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>254</i></span>,  <span class="NLM_fpage">367</span>– <span class="NLM_lpage">398</span>, <span class="refDoi"> DOI: 10.1007/164_2019_206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1007%2F164_2019_206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=30927089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmtlGlu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=254&publication_year=2019&pages=367-398&author=T.+M.+Tzschentkeauthor=K.+Linzauthor=T.+Kochauthor=T.+Christoph&title=Cebranopadol%3A+A+novel+first-in-class+potent+analgesic+acting+via+NOP+and+opioid+receptors&doi=10.1007%2F164_2019_206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Cebranopadol: A Novel First-in-Class Potent Analgesic Acting via NOP and Opioid Receptors</span></div><div class="casAuthors">Tzschentke, Thomas M.; Linz, Klaus; Koch, Thomas; Christoph, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">254</span>
        (<span class="NLM_cas:issue">Nociceptin/Orphanin FQ Peptide Receptor</span>),
    <span class="NLM_cas:pages">367-398</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">1865-0325</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  Cebranopadol is a novel first-in-class analgesic with highly potent agonistic activity at nociceptin/orphanin FQ peptide (NOP) and opioid receptors.  It is highly potent and efficacious across a broad range of preclin. pain models.  Its side effect profile is better compared to typical opioids.  Mechanistic studies have shown that cebranopadol's activity at NOP receptors contributes to its anti-hyperalgesic effects while ameliorating some of its opioid-type side effects, including respiratory depression and abuse potential.  Phase II of clin. development has been completed, demonstrating efficacy and good tolerability in acute and chronic pain conditions.This article focusses on reviewing data on the preclin. in vitro and in vivo pharmacol., safety, and tolerability, as well as clin. trials with cebranopadol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHzG6iKGqiQrVg90H21EOLACvtfcHk0lizn1Tnxh4ZcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmtlGlu74%253D&md5=d2a3e8bdec9bf9516ab3d17f333b7ef2</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1007%2F164_2019_206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F164_2019_206%26sid%3Dliteratum%253Aachs%26aulast%3DTzschentke%26aufirst%3DT.%2BM.%26aulast%3DLinz%26aufirst%3DK.%26aulast%3DKoch%26aufirst%3DT.%26aulast%3DChristoph%26aufirst%3DT.%26atitle%3DCebranopadol%253A%2520A%2520novel%2520first-in-class%2520potent%2520analgesic%2520acting%2520via%2520NOP%2520and%2520opioid%2520receptors%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2019%26volume%3D254%26spage%3D367%26epage%3D398%26doi%3D10.1007%2F164_2019_206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Volkow, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanco, C.</span></span> <span> </span><span class="NLM_article-title">The changing opioid crisis: development, challenges and opportunities</span>. <i>Mol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">218</span>– <span class="NLM_lpage">233</span>, <span class="refDoi"> DOI: 10.1038/s41380-020-0661-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1038%2Fs41380-020-0661-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=32020048" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A280%3ADC%252BB38%252FotlWmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2021&pages=218-233&author=N.+D.+Volkowauthor=C.+Blanco&title=The+changing+opioid+crisis%3A+development%2C+challenges+and+opportunities&doi=10.1038%2Fs41380-020-0661-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">The changing opioid crisis: development, challenges and opportunities</span></div><div class="casAuthors">Volkow Nora D; Blanco Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Molecular psychiatry</span>
        (<span class="NLM_cas:date">2021</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">218-233</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The current opioid epidemic is one of the most severe public health crisis in US history.  Responding to it has been difficult due to its rapidly changing nature and the severity of its associated outcomes.  This review examines the origin and evolution of the crisis, the pharmacological properties of opioids, the neurobiology of opioid use and opioid use disorder (OUD), medications for opioid use disorder (MOUD), and existing and promising approaches to prevention.  The results of the review indicate that the opioid epidemic is a complex, evolving phenomenon that involves neurobiological vulnerabilities and social determinants of health.  Successfully addressing the epidemic will require advances in basic science, development of more acceptable and effective treatments, and implementation of public health approaches, including prevention.  The advances achieved in addressing the current crisis should also serve to advance the science and treatment of other substance use disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRpwlk7oh-UxTDnmmyUf5qOfW6udTcc2ebI1GMKkYeBjLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB38%252FotlWmtw%253D%253D&md5=94c6994b58aac47bf364be91aa59f3f1</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1038%2Fs41380-020-0661-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41380-020-0661-4%26sid%3Dliteratum%253Aachs%26aulast%3DVolkow%26aufirst%3DN.%2BD.%26aulast%3DBlanco%26aufirst%3DC.%26atitle%3DThe%2520changing%2520opioid%2520crisis%253A%2520development%252C%2520challenges%2520and%2520opportunities%26jtitle%3DMol.%2520Psychiatry%26date%3D2021%26volume%3D26%26spage%3D218%26epage%3D233%26doi%3D10.1038%2Fs41380-020-0661-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benoiton, N. L.</span></span> <i>Chemistry of Peptide Synthesis</i>; <span class="NLM_publisher-name">Taylor & Francis</span>: <span class="NLM_publisher-loc">London</span>, <span class="NLM_year">2006</span>; pp  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">155</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=125-155&author=N.+L.+Benoiton&title=Chemistry+of+Peptide+Synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBenoiton%26aufirst%3DN.%2BL.%26btitle%3DChemistry%2520of%2520Peptide%2520Synthesis%26pub%3DTaylor%2520%2526%2520Francis%26date%3D2006%26spage%3D125%26epage%3D155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neubig, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spedding, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenakin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span> <span> </span><span class="NLM_article-title">International union of pharmacology committee on receptor nomenclature and drug classification. XXXVIII. Update on terms and symbols in quantitative pharmacology</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">597</span>– <span class="NLM_lpage">606</span>, <span class="refDoi"> DOI: 10.1124/pr.55.4.4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1124%2Fpr.55.4.4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=14657418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtlWkuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2003&pages=597-606&author=R.+R.+Neubigauthor=M.+Speddingauthor=T.+Kenakinauthor=A.+Christopoulos&title=International+union+of+pharmacology+committee+on+receptor+nomenclature+and+drug+classification.+XXXVIII.+Update+on+terms+and+symbols+in+quantitative+pharmacology&doi=10.1124%2Fpr.55.4.4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on terms and symbols in quantitative pharmacology</span></div><div class="casAuthors">Neubig, Richard R.; Spedding, Michael; Kenakin, Terry; Christopoulos, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">597-606</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  The recommendations that follow have been updated from the proposals of a Tech. Subcommittee set up by the International Union of Pharmacol. Committee on Receptor Nomenclature and Drug Classification.  International Union of Pharmacol. Committee on Receptor Nomenclature and Drug Classification. IX.  Recommendations on terms and symbols in quant. pharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobvkWoNCTvu7Vg90H21EOLACvtfcHk0lh3R2iP8oHx_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtlWkuw%253D%253D&md5=8a467ff5e3812d34d42179491555793d</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1124%2Fpr.55.4.4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.55.4.4%26sid%3Dliteratum%253Aachs%26aulast%3DNeubig%26aufirst%3DR.%2BR.%26aulast%3DSpedding%26aufirst%3DM.%26aulast%3DKenakin%26aufirst%3DT.%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DInternational%2520union%2520of%2520pharmacology%2520committee%2520on%2520receptor%2520nomenclature%2520and%2520drug%2520classification.%2520XXXVIII.%2520Update%2520on%2520terms%2520and%2520symbols%2520in%2520quantitative%2520pharmacology%26jtitle%3DPharmacol.%2520Rev.%26date%3D2003%26volume%3D55%26spage%3D597%26epage%3D606%26doi%3D10.1124%2Fpr.55.4.4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murtola, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Páll, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hess, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindahl, E.</span></span> <span> </span><span class="NLM_article-title">GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers</span>. <i>SoftwareX</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>1–2</i></span>,  <span class="NLM_fpage">19</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1016/j.softx.2015.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1016%2Fj.softx.2015.06.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1%E2%80%932&publication_year=2015&pages=19-25&author=M.+J.+Abrahamauthor=T.+Murtolaauthor=R.+Schulzauthor=S.+P%C3%A1llauthor=J.+C.+Smithauthor=B.+Hessauthor=E.+Lindahl&title=GROMACS%3A+High+performance+molecular+simulations+through+multi-level+parallelism+from+laptops+to+supercomputers&doi=10.1016%2Fj.softx.2015.06.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.softx.2015.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.softx.2015.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DAbraham%26aufirst%3DM.%2BJ.%26aulast%3DMurtola%26aufirst%3DT.%26aulast%3DSchulz%26aufirst%3DR.%26aulast%3DP%25C3%25A1ll%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DJ.%2BC.%26aulast%3DHess%26aufirst%3DB.%26aulast%3DLindahl%26aufirst%3DE.%26atitle%3DGROMACS%253A%2520High%2520performance%2520molecular%2520simulations%2520through%2520multi-level%2520parallelism%2520from%2520laptops%2520to%2520supercomputers%26jtitle%3DSoftwareX%26date%3D2015%26volume%3D1%25E2%2580%25932%26spage%3D19%26epage%3D25%26doi%3D10.1016%2Fj.softx.2015.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hornak, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okur, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strockbine, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roitberg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmerling, C.</span></span> <span> </span><span class="NLM_article-title">Comparison of multiple Amber force fields and development of improved protein backbone parameters</span>. <i>Proteins</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">712</span>– <span class="NLM_lpage">725</span>, <span class="refDoi"> DOI: 10.1002/prot.21123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1002%2Fprot.21123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=16981200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFWqt7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2006&pages=712-725&author=V.+Hornakauthor=R.+Abelauthor=A.+Okurauthor=B.+Strockbineauthor=A.+Roitbergauthor=C.+Simmerling&title=Comparison+of+multiple+Amber+force+fields+and+development+of+improved+protein+backbone+parameters&doi=10.1002%2Fprot.21123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of multiple Amber force fields and development of improved protein backbone parameters</span></div><div class="casAuthors">Hornak, Viktor; Abel, Robert; Okur, Asim; Strockbine, Bentley; Roitberg, Adrian; Simmerling, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Proteins: Structure, Function, and Bioinformatics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">712-725</span>CODEN:
                <span class="NLM_cas:coden">PSFBAF</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The ff94 force field that is commonly assocd. with the Amber simulation package is one of the most widely used parameter sets for biomol. simulation.  After a decade of extensive use and testing, limitations in this force field, such as over-stabilization of α-helixes, were reported by the authors and other researchers.  This led to a no. of attempts to improve these parameters, resulting in a variety of "Amber" force fields and significant difficulty in detg. which should be used for a particular application.  The authors show that several of these continue to suffer from inadequate balance between different secondary structure elements.  In addn., the approach used in most of these studies neglected to account for the existence in Amber of two sets of backbone .vphi./ψ dihedral terms.  This led to parameter sets that provide unreasonable conformational preferences for glycine.  The authors report here an effort to improve the .vphi./ψ dihedral terms in the ff99 energy function.  Dihedral term parameters are based on fitting the energies of multiple conformations of glycine and alanine tetrapeptides from high level ab initio quantum mech. calcns.  The new parameters for backbone dihedrals replace those in the existing ff99 force field.  This parameter set, which the authors denote ff99SB, achieves a better balance of secondary structure elements as judged by improved distribution of backbone dihedrals for glycine and alanine with respect to PDB survey data.  It also accomplishes improved agreement with published exptl. data for conformational preferences of short alanine peptides and better accord with exptl. NMR relaxation data of test protein systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmoASzza-Gd7Vg90H21EOLACvtfcHk0lh3R2iP8oHx_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFWqt7fM&md5=de683a26eca9e83ae524726e97ac22fa</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1002%2Fprot.21123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.21123%26sid%3Dliteratum%253Aachs%26aulast%3DHornak%26aufirst%3DV.%26aulast%3DAbel%26aufirst%3DR.%26aulast%3DOkur%26aufirst%3DA.%26aulast%3DStrockbine%26aufirst%3DB.%26aulast%3DRoitberg%26aufirst%3DA.%26aulast%3DSimmerling%26aufirst%3DC.%26atitle%3DComparison%2520of%2520multiple%2520Amber%2520force%2520fields%2520and%2520development%2520of%2520improved%2520protein%2520backbone%2520parameters%26jtitle%3DProteins%26date%3D2006%26volume%3D65%26spage%3D712%26epage%3D725%26doi%3D10.1002%2Fprot.21123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pettersen, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goddard, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Couch, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenblatt, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrin, T. E.</span></span> <span> </span><span class="NLM_article-title">UCSF Chimera? A visualization system for exploratory research and analysis</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1605</span>– <span class="NLM_lpage">1612</span>, <span class="refDoi"> DOI: 10.1002/jcc.20084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1002%2Fjcc.20084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=15264254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvVOhsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=1605-1612&author=E.+F.+Pettersenauthor=T.+D.+Goddardauthor=C.+C.+Huangauthor=G.+S.+Couchauthor=D.+M.+Greenblattauthor=E.+C.+Mengauthor=T.+E.+Ferrin&title=UCSF+Chimera%3F+A+visualization+system+for+exploratory+research+and+analysis&doi=10.1002%2Fjcc.20084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">UCSF Chimera-A visualization system for exploratory research and analysis</span></div><div class="casAuthors">Pettersen, Eric F.; Goddard, Thomas D.; Huang, Conrad C.; Couch, Gregory S.; Greenblatt, Daniel M.; Meng, Elaine C.; Ferrin, Thomas E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1605-1612</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The design, implementation, and capabilities of an extensible visualization system, UCSF Chimera, are discussed.  Chimera is segmented into a core that provides basic services and visualization, and extensions that provide most higher level functionality.  This architecture ensures that the extension mechanism satisfies the demands of outside developers who wish to incorporate new features.  Two unusual extensions are presented: Multiscale, which adds the ability to visualize large-scale mol. assemblies such as viral coats, and Collab., which allows researchers to share a Chimera session interactively despite being at sep. locales.  Other extensions include Multalign Viewer, for showing multiple sequence alignments and assocd. structures; ViewDock, for screening docked ligand orientations; Movie, for replaying mol. dynamics trajectories; and Vol. Viewer, for display and anal. of volumetric data.  A discussion of the usage of Chimera in real-world situations is given, along with anticipated future directions.  Chimera includes full user documentation, is free to academic and nonprofit users, and is available for Microsoft Windows, Linux, Apple Mac OS X, SGI IRIX, and HP Tru64 Unix from http://www.cgl.ucsf.edu/chimera/.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFmD4M5S0cPbVg90H21EOLACvtfcHk0lhWGfEDGTAayw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvVOhsbs%253D&md5=944b175f440c1ff323705987cf937ee7</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1002%2Fjcc.20084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.20084%26sid%3Dliteratum%253Aachs%26aulast%3DPettersen%26aufirst%3DE.%2BF.%26aulast%3DGoddard%26aufirst%3DT.%2BD.%26aulast%3DHuang%26aufirst%3DC.%2BC.%26aulast%3DCouch%26aufirst%3DG.%2BS.%26aulast%3DGreenblatt%26aufirst%3DD.%2BM.%26aulast%3DMeng%26aufirst%3DE.%2BC.%26aulast%3DFerrin%26aufirst%3DT.%2BE.%26atitle%3DUCSF%2520Chimera%253F%2520A%2520visualization%2520system%2520for%2520exploratory%2520research%2520and%2520analysis%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2004%26volume%3D25%26spage%3D1605%26epage%3D1612%26doi%3D10.1002%2Fjcc.20084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Faul, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erdfelder, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, A.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchner, A.</span></span> <span> </span><span class="NLM_article-title">G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences</span>. <i>Behav. Res. Methods</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">175</span>– <span class="NLM_lpage">191</span>, <span class="refDoi"> DOI: 10.3758/bf03193146</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.3758%2FBF03193146" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=17695343" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A280%3ADC%252BD2svns12rsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2007&pages=175-191&author=F.+Faulauthor=E.+Erdfelderauthor=A.-G.+Langauthor=A.+Buchner&title=G*Power+3%3A+a+flexible+statistical+power+analysis+program+for+the+social%2C+behavioral%2C+and+biomedical+sciences&doi=10.3758%2Fbf03193146"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences</span></div><div class="casAuthors">Faul Franz; Erdfelder Edgar; Lang Albert-Georg; Buchner Axel</div><div class="citationInfo"><span class="NLM_cas:title">Behavior research methods</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">175-91</span>
        ISSN:<span class="NLM_cas:issn">1554-351X</span>.
    </div><div class="casAbstract">G*Power (Erdfelder, Faul, & Buchner, 1996) was designed as a general stand-alone power analysis program for statistical tests commonly used in social and behavioral research.  G*Power 3 is a major extension of, and improvement over, the previous versions.  It runs on widely used computer platforms (i.e., Windows XP, Windows Vista, and Mac OS X 10.4) and covers many different statistical tests of the t, F, and chi2 test families.  In addition, it includes power analyses for z tests and some exact tests.  G*Power 3 provides improved effect size calculators and graphic options, supports both distribution-based and design-based input modes, and offers all types of power analyses in which users might be interested.  Like its predecessors, G*Power 3 is free.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSSIxwUvmTx9Re4jJGKT5N0fW6udTcc2eZK6aGMKYs1ELntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svns12rsQ%253D%253D&md5=53033ebef486a78a60dc63473beaf603</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.3758%2FBF03193146&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3758%252FBF03193146%26sid%3Dliteratum%253Aachs%26aulast%3DFaul%26aufirst%3DF.%26aulast%3DErdfelder%26aufirst%3DE.%26aulast%3DLang%26aufirst%3DA.-G.%26aulast%3DBuchner%26aufirst%3DA.%26atitle%3DG%252APower%25203%253A%2520a%2520flexible%2520statistical%2520power%2520analysis%2520program%2520for%2520the%2520social%252C%2520behavioral%252C%2520and%2520biomedical%2520sciences%26jtitle%3DBehav.%2520Res.%2520Methods%26date%3D2007%26volume%3D39%26spage%3D175%26epage%3D191%26doi%3D10.3758%2Fbf03193146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Belvisi, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freund-Michel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hele, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crispino, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birrell, M. A.</span></span> <span> </span><span class="NLM_article-title">Inhibitory activity of the novel CB2 receptor agonist, GW833972A, on guinea-pig and human sensory nerve function in the airways</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>155</i></span>,  <span class="NLM_fpage">547</span>– <span class="NLM_lpage">557</span>, <span class="refDoi"> DOI: 10.1038/bjp.2008.298</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=10.1038%2Fbjp.2008.298" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=18695648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1emurrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=2008&pages=547-557&author=M.+G.+Belvisiauthor=H.+J.+Patelauthor=V.+Freund-Michelauthor=D.+J.+Heleauthor=N.+Crispinoauthor=M.+A.+Birrell&title=Inhibitory+activity+of+the+novel+CB2+receptor+agonist%2C+GW833972A%2C+on+guinea-pig+and+human+sensory+nerve+function+in+the+airways&doi=10.1038%2Fbjp.2008.298"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitory activity of the novel CB2 receptor agonist, GW833972A, on guinea-pig and human sensory nerve function in the airways</span></div><div class="casAuthors">Belvisi, M. G.; Patel, H. J.; Freund-Michel, V.; Hele, D. J.; Crispino, N.; Birrell, M. A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">155</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">547-557</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Sensory nerves regulate central and local reflexes such as airway plasma protein leakage, bronchoconstriction and cough.  Sensory nerve activity may be enhanced during inflammation such that these protective effects become exacerbated and deleterious.  Cannabinoids are known to inhibit airway sensory nerve function.  However, there is still controversy surrounding which receptor is involved in eliciting these effects.  We have adopted a pharmacol. approach, including using a novel, more selective CB2 receptor agonist, GW 833972A (1000-fold selective CB2/CB1), and receptor selective antagonists to investigate the inhibitory activity of cannabinoids on sensory nerve activity in vitro and in vivo in guinea-pig models of cough and plasma extravasation.  GW 833972A inhibited capsaicin-induced depolarization of the human and guinea-pig and prostaglandin E2 (PGE2) and hypertonic saline-induced depolarization of the guinea-pig isolated vagus nerve in vitro.  GW 833972A also inhibited citric acid-induced cough but not plasma extravasation in the guinea-pig and this effect was blocked by a CB2 receptor antagonist.  This confirms and extends previous studies highlighting the role of CB2 receptors in the modulation of sensory nerve activity elicited both by the exogenous ligands capsaicin and hypertonic saline but also by endogenous modulators such as PGE2 and low pH stimuli.  These data establish the CB2 receptor as an interesting target for the treatment of chronic cough.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB4UzjWZMStbVg90H21EOLACvtfcHk0lhWGfEDGTAayw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1emurrO&md5=2d1c30445c13581c2053902d64c39955</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1038%2Fbjp.2008.298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjp.2008.298%26sid%3Dliteratum%253Aachs%26aulast%3DBelvisi%26aufirst%3DM.%2BG.%26aulast%3DPatel%26aufirst%3DH.%2BJ.%26aulast%3DFreund-Michel%26aufirst%3DV.%26aulast%3DHele%26aufirst%3DD.%2BJ.%26aulast%3DCrispino%26aufirst%3DN.%26aulast%3DBirrell%26aufirst%3DM.%2BA.%26atitle%3DInhibitory%2520activity%2520of%2520the%2520novel%2520CB2%2520receptor%2520agonist%252C%2520GW833972A%252C%2520on%2520guinea-pig%2520and%2520human%2520sensory%2520nerve%2520function%2520in%2520the%2520airways%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D155%26spage%3D547%26epage%3D557%26doi%3D10.1038%2Fbjp.2008.298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DDF" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6DDF','PDB','6DDF'); return false;">PDB: 6DDF</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5C1M" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5C1M','PDB','5C1M'); return false;">PDB: 5C1M</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i27"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c02062">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_62028"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c02062?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c02062</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Synthesis of Fmoc-2′,6′-dimethyltyrosine; synthetic procedures for the preparation of Fmoc-2′,6′-dimethyltyrosine; structures of nonproteinogenic amino acids; HPLC chromatograms and ESI mass spectra of the final peptide derivatives; model setup of non-natural peptides for MD; model setup of the mu receptor; model setup of the peptide-mu receptor complexes; and analysis of MD trajectories (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c02062/suppl_file/jm0c02062_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c02062/suppl_file/jm0c02062_si_002.csv">CSV</a>)</p></li><li><p class="inline">Model coordinates: representative structure of the [Dmt<sup>1,5</sup>]N/OFQ(1-9)-NH<sub>2</sub>-mu receptor complex (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c02062/suppl_file/jm0c02062_si_003.pdb">PDB</a>)</p></li><li><p class="inline">Model coordinates: representative structure of the N/OFQ(1-9)NH<sub>2</sub>-mu receptor complex (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c02062/suppl_file/jm0c02062_si_004.pdb">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c02062/suppl_file/jm0c02062_si_001.pdf">jm0c02062_si_001.pdf (3.63 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c02062/suppl_file/jm0c02062_si_002.csv">jm0c02062_si_002.csv (10.33 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c02062/suppl_file/jm0c02062_si_003.pdb">jm0c02062_si_003.pdb (187.16 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c02062/suppl_file/jm0c02062_si_004.pdb">jm0c02062_si_004.pdb (201.74 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c02062&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-10%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c02062%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c02062" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679982fe7be23dd7","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
